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Background: Guidelines recommend walking to increase moderate to vigorous physical activity (MVPA)
for health benefits.
Objectives: To assess the effectiveness, cost-effectiveness and acceptability of a pedometer-based walking
intervention in inactive adults, delivered postally or through dedicated practice nurse physical activity
(PA) consultations.
Design: Parallel three-arm trial, cluster randomised by household.
Setting: Seven London-based general practices.
Participants: A total of 11,015 people without PA contraindications, aged 45–75 years, randomly selected
from practices, were invited. A total of 6399 people were non-responders, and 548 people self-reporting
achieving PA guidelines were excluded. A total of 1023 people from 922 households were randomised to
usual care (n = 338), postal intervention (n = 339) or nurse support (n = 346). The recruitment rate was
10% (1023/10,467). A total of 956 participants (93%) provided outcome data.
Interventions: Intervention groups received pedometers, 12-week walking programmes advising
participants to gradually add ‘3000 steps in 30 minutes’ most days weekly and PA diaries. The nurse group
was offered three dedicated PA consultations.
Main outcome measures: The primary and main secondary outcomes were changes from baseline to
12 months in average daily step counts and time in MVPA (in ≥ 10-minute bouts), respectively, from 7-day
accelerometry. Individual resource-use data informed the within-trial economic evaluation and the Markov
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model for simulating long-term cost-effectiveness. Qualitative evaluations assessed nurse and participant
views. A 3-year follow-up was conducted.
Results: Baseline average daily step count was 7479 [standard deviation (SD) 2671], average minutes per
week in MVPA bouts was 94 minutes (SD 102 minutes) for those randomised. PA increased significantly
at 12 months in both intervention groups compared with the control group, with no difference between
interventions; additional steps per day were 642 steps [95% confidence interval (CI) 329 to 955 steps] for
the postal group and 677 steps (95% CI 365 to 989 steps) for nurse support, and additional MVPA in
bouts (minutes per week) was 33 minutes per week (95% CI 17 to 49 minutes per week) for the postal
group and 35 minutes per week (95% CI 19 to 51 minutes per week) for nurse support. Intervention
groups showed no increase in adverse events. Incremental cost per step was 19p and £3.61 per minute
in a ≥ 10-minute MVPA bout for nurse support, whereas the postal group took more steps and cost less
than the control group. The postal group had a 50% chance of being cost-effective at a £20,000 per
quality-adjusted life-year (QALY) threshold within 1 year and had both lower costs [–£11M (95% CI
–£12M to –£10M) per 100,000 population] and more QALYs [759 QALYs gained (95% CI 400 to 1247
QALYs)] than the nurse support and control groups in the long term. Participants and nurses found the
interventions acceptable and enjoyable. Three-year follow-up data showed persistent intervention effects
(nurse support plus postal vs. control) on steps per day [648 steps (95% CI 272 to 1024 steps)] and MVPA
bouts [26 minutes per week (95% CI 8 to 44 minutes per week)].
Limitations: The 10% recruitment level, with lower levels in Asian and socioeconomically deprived
participants, limits the generalisability of the findings. Assessors were unmasked to the group.
Conclusions: A primary care pedometer-based walking intervention in 45- to 75-year-olds increased
12-month step counts by around one-tenth, and time in MVPA bouts by around one-third, with similar
effects for the nurse support and postal groups, and persistent 3-year effects. The postal intervention
provides cost-effective, long-term quality-of-life benefits. A primary care pedometer intervention delivered
by post could help address the public health physical inactivity challenge.
Future work: Exploring different recruitment strategies to increase uptake. Integrating the Pedometer And
Consultation Evaluation-UP (PACE-UP) trial with evolving PA monitoring technologies.
Trial registration: Current Controlled Trials ISRCTN98538934.
Funding: This project was funded by the National Institute for Health Research (NIHR) Health Technology
Assessment programme and will be published in full in Health Technology Assessment; Vol. 22, No. 37.
See the NIHR Journals Library website for further project information.
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Plain English summary
Physical inactivity is common and causes ill health. Walking briskly enough to make you warm andincrease breathing and heart rate, but allow conversation, is moderate-intensity physical activity. Brisk
walking for 30 minutes most days is a good way to improve health. Pedometers measure step counts and
can increase physical activity levels, but few studies involving pedometers have objectively measured
participants’ physical activity or included long-term follow-up.
The Pedometer And Consultation Evaluation-UP (PACE-UP) trial recruited 1023 inactive 45- to 75-year-olds
from seven South London practices, and randomised them to a usual physical activity (control) group or to
one of two intervention groups. The postal group participants were sent a pedometer, diary and 12-week
pedometer-based walking programme, advising them to gradually add in 3000 steps or a 30-minute
walk on 5 or more days weekly. The nurse-support group received the same materials through practice
nurse physical activity consultations. Physical activity and participant-reported 12-month outcomes were
compared with the beginning of the trial, along with the costs of each trial group. A further 3-year
follow-up was conducted and long-term value for money was estimated.
Both intervention groups significantly increased their walking (step counts and time in moderate-intensity
physical activity) compared with controls, with no difference between nurse and postal groups. Interventions
were safe and acceptable to participants and nurses. There was no effect on body size, pain or depression,
but the nurse-support group participants increased their confidence in their ability to exercise. The 3-year
follow-up found persistent positive effects of both interventions on physical activity levels. The postal
intervention provided more value for money than the nurse-support group or the control group in the short
and long term.
A primary care pedometer intervention, delivered by post or with nurse support, could provide an effective
way to increase physical activity levels in adults and older adults, with the postal route offering the most
value for money.
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Scientific summary
Background
Physical activity (PA) helps adults and older adults to remain healthy, and improves physical function and
emotional well-being. Inactivity is an important risk factor for mortality and leads to high health service
costs. One way to achieve current national and international PA guidelines for health is by doing at least
30 minutes of moderate to vigorous physical activity (MVPA) in at least 10-minute bouts on ≥ 5 days
weekly. However, a graded dose–response relationship exists for PA and health; therefore, for inactive
people, any PA increase is valuable, as is decreasing sedentary time. Walking is the most common adult
PA, and moderate-intensity walking approximates 100 steps per minute, so using a pedometer to add
‘3000 steps in 30 minutes’ onto habitual activity helps to achieve PA guidelines. Systematic reviews of
pedometer-based walking interventions show significant step count increases. However, studies were
mainly small, recruited volunteers and had short-term follow-up. In addition, previous pedometer studies
have not rigorously evaluated their effectiveness with or without face-to-face support, and have used step
counts, not MVPA, as the outcome. Programmes using personalised PA goals and behavioural strategies
can achieve PA increases. Cochrane reviews have called for PA interventions to include objective PA
measurement, adverse events reporting, comparisons of face-to-face interventions with remote
interventions, longer follow-up and cost-effectiveness evaluations. Primary care provides an ideal context
for PA interventions, allowing population-based sampling, practice nurse involvement and continuity of
care. Brief PA advice in primary care is advocated; however, more primary care PA trials are required.
Objectives
The research questions were:
1. Does a 3-month postal pedometer-based walking intervention increase PA (step count and time in
MVPA in bouts) in inactive 45- to 75-year old primary care patients at 12-month follow-up?
2. Do dedicated practice nurse PA consultations provide additional benefit?
We also present cost-effectiveness analyses and effects on patient-reported outcomes, anthropometric
measures and adverse events. A qualitative evaluation explored participant and practice nurse views.
Longer-term follow-up was conducted at 3 years.
Methods
Design
A three-arm parallel-group, cluster randomised trial, comparing a 3-month pedometer-based walking
intervention, by post or with nurse-support, with usual care. Randomisation was by household, allowing
individuals and couples to participate, in a 1 : 1 : 1 ratio.
Participants and setting
Recruitment was from seven ethnically and socially diverse, south London-based general practice populations,
between September 2012 and October 2013. The 12-month follow-up was completed in October 2014.
Eligible patients were aged 45–75 years, without contraindications to increasing MVPA. Exclusions included
care home residents and those with unsuitable medical conditions. Random samples of 400 eligible
households per practice were selected; this process was repeated until enough individuals were recruited.
Individual invitations were posted. Those participants who reported achieving ≥ 150 minutes of MVPA
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weekly on a validated self-report PA questionnaire were excluded. Anonymised demographic data were
available through general practice records for all those invited, enabling investigation of trial recruitment
inequalities. Non-participants were invited to complete a questionnaire.
Procedures and intervention
Individual informed consent was obtained and baseline assessment undertaken prior to randomisation.
Identical outcome assessments were conducted for all three groups. An accelerometer (GT3X+; ActiGraph
LLC, Pensacola, FL, USA) was used for baseline, and 3- and 12-month masked PA assessment of step
counts and time in different PA intensities. The interventions incorporated behaviour change techniques
(BCTs) and included individualised step count and PA goals and the ‘3000 in 30’ PA intensity message.
The key intervention components were pedometers (SW-200 Yamax Digi-Walker; Yamasa Tokei Keiki Co.
Ltd, Tokyo, Japan) to record individual step counts, a patient handbook, a PA diary (including an individual
12-week walking plan) and three individually tailored practice nurse PA (10- to 20-minute) consultations
(nurse-support group only). The patient handbook and diary explained that adding 3000 steps per day
(or a 30-minute walk) on ≥ 5 days weekly to their baseline, progressing over 12 weeks, would help to
achieve PA guidelines. BCTs, including goals and planning, self-monitoring, feedback and encouraging
social support, were included in the handbook, diary and nurse consultations. Control group participants
were offered a pedometer, a handbook and a diary after the 12-month follow-up.
Outcomes
All primary and secondary PA outcomes were assessed by 7-day accelerometry measurements. The primary
outcome was change in average daily step count between baseline and 12 months. The secondary PA
outcomes were changes in step counts between baseline and 3 months; changes in time spent weekly in
MVPA in ≥ 10-minute bouts; and time spent being sedentary between baseline and 3 and 12 months. The
other secondary outcome was cost-effectiveness.
Ancillary outcomes were:
l changes in anthropometry (body mass index, waist circumference, body fat) at 12 months
l changes in patient-reported outcomes – exercise self-efficacy, anxiety, depression [as measured via the
Hospital Anxiety and Depression Scale (HADS)], health-related quality of life [as measured via the
EuroQol-5 Dimensions, five-level version (EQ-5D-5L)], pain and self-reported PA variables [as measured
via the International Physical Activity Questionnaire (IPAQ), short form and the General Practice Physical
Activity Questionnaire (GPPAQ)] at 3 and 12 months
l adverse outcomes – falls, injuries, fractures, cardiovascular events and deaths – assessed from trial
monitoring procedures, 3- and 12-month questionnaires and primary care records.
Sample size
A sample of 993 (331 per group) was needed to detect the 1000 steps per day difference at 12 months,
comparing any two groups, with 90% power, at a p-value of 0.01, allowing for household clustering and
15% attrition.
Statistical analyses
Accelerometry regression analyses were in two stages. Stage 1 estimated the average daily step count at
12 months and at baseline, derived by using the same two-level model (level 1, day within individual; level 2,
individual) in which daily step counts were regressed on day order of wearing the accelerometer (from day 1
to day 7) and day of week, as fixed effects. At stage 2, the estimated 12-month average daily step count
was regressed on the estimated baseline average daily step count, month of baseline accelerometry, age,
sex, general practice and treatment group, effectively measuring the change in step count over 12 months.
In this analysis, level 1 was individual and level 2 was household. MVPA in ≥ 10-minute bouts, sedentary
time, wear time and 3-month outcomes were analysed using identical approaches. The change in
anthropometric and patient-reported outcomes was estimated using stage 2 models.
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Economic evaluation
Cost-effectiveness was estimated, from the NHS viewpoint, to generate the incremental cost per change in
step count, minutes of MVPA in ≥ 10-minute bouts and quality-adjusted life-years (QALYs). The probability
of the interventions being cost-effective given different willingness-to-pay values for QALYs and incremental
net benefit (difference between monetised benefit and costs of the intervention vs. the comparator) was
calculated. A Markov model used the results to simulate lifetime cost-effectiveness. Deterministic and
probabilistic sensitivity analyses were undertaken for short- and long-term analyses.
Process evaluation
Data were collected contemporaneously with trial data collection, and associations between process
measures and trial outcome measures were sought.
Qualitative evaluation
Telephone interviews were conducted with nurse and postal participants, targeting some participants who
had increased their PA and some who had not, to investigate their views of the intervention and the
barriers to, and facilitators of, increasing PA levels. A practice nurse focus group session was conducted to
understand practice nurses’ experience of delivering the intervention.
Three-year follow-up
Participant follow-up was conducted 3 years from baseline, including postal 7-day accelerometry,
questionnaire and qualitative telephone interviews. The latter were carried out with randomly selected
nurse and postal participants, to examine the factors affecting PA levels and maintenance of any increase
in PA; and with control participants, to see the effect of the 12-month minimal intervention on PA levels.
Results
Of the 11,015 people invited, 6399 did not respond, 548 self-reported PA guideline achievements and were
excluded and 10% (1023/10,467) were randomised. Participation rates were lower in men, younger subjects,
those living in deprived postcode areas and Asian patients. Black people were equally likely to participate
as white people. Baseline findings for all those randomised were as follows: average steps per day, 7479
steps [standard deviation (SD) 2671 steps]; and average minutes per week in MVPA of ≥ 10-minute bouts,
94 minutes (SD 102 minutes). Overall, 21% of participants (218/1023) achieved the PA guidelines of
≥ 150 minutes of MVPA in bouts. A total of 93% of participants (956/1023) were included in the 12-month
primary analyses.
At the interim 3-month outcome, both intervention groups had increased their steps per day from baseline
compared with the control group. Additional steps per day were 692 steps [95% confidence interval (CI)
363 to 1020 steps; p < 0.001] for the postal group, and 1172 steps (95% CI 844 to 1501 steps; p < 0.001)
for the nurse-support group. The difference between intervention groups was statistically significant: 481
steps (95% CI 153 to 809 steps; p = 0.004). MVPA findings showed a similar pattern: additional MVPA in
bouts (minutes per week) was 43 minutes (95% CI 26 to 60 minutes; p < 0.001) for the postal group, and
61 minutes (95% CI 44 to 78 minutes; p < 0.001) for the nurse-support group; the difference between
intervention groups was 18 minutes (95% CI 1 to 35 minutes; p = 0.04). Sedentary time and accelerometer
wear time were similar between groups.
For the primary outcome, both intervention groups increased their step counts from baseline to 12 months
compared with control participants; additional steps per day were 642 steps (95% CI 329 to 955 steps;
p < 0.001) for the postal group, and 677 steps (95% CI 365 to 989 steps; p < 0.001) for the nurse-support
group, with no statistically significant difference between intervention groups (36 steps, 95% CI –277 to
349 steps). Time spent in MVPA in bouts showed a similar pattern: both intervention groups increased
at 12 months compared with control participants. Additional MVPA in bouts (minutes per week) was
33 minutes (95% CI 17 to 49 minutes; p < 0.001,) for the postal group, and 35 minutes (95% CI 19 to
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51 minutes; p < 0.001) for the nurse-support group, with no statistically significant difference between
intervention groups (2 minutes, 95% CI –14 to 17 minutes). Sedentary time and accelerometer wear time
were similar between groups.
The interventions had no significant effects on anthropometric measures, anxiety, depression, health-related
quality of life or pain scores. The 12-month exercise self-efficacy score was significantly higher in the
nurse-support group compared with control participants. None of the following acted as an effect modifier
for the intervention effect: age, sex, taking part as a couple, body mass index, disability, pain, socioeconomic
group and exercise self-efficacy. Total adverse events (self-reported or from primary care records) and serious
adverse events (from trial safety monitoring) were similar between groups.
Economic evaluation
The incremental cost per step was £0.19 and £3.61 per minute in a ≥ 10-minute MVPA bout for the
nurse-support group, whereas the postal group took more steps and cost less than control participants.
The postal group had a 50% chance of being cost-effective at a £20,000 per QALY threshold within
1 year, and had both lower costs (–£11M, 95% CI –£12 to –£10) and higher QALYs (759 QALYs gained,
95% CI 400 to 1247 QALYs) than the nurse-support and control groups in the long term, with an
incremental net benefit of £26M per 100,000 population. Sensitivity analyses largely supported findings,
except in the trial analysis, in which four alternative assumptions were made: (1) extending the perspective
to participants, (2) excluding health service use, (3) using self-reported adverse events and (4) using
3-month outcome data, when control dominated postal. Long-term cost-effectiveness results were
very robust.
Process evaluation
A total of 256 out of 346 participants (74%) in the nurse-support group attended all three sessions, and
268 out of 339 participants (79%) in the postal group and 281 out of 346 participants (81%) in the
nurse-support group returned completed step count diaries. Positive associations were seen between
increases in step count and time in MVPA in bouts and between both the number of nurse sessions
attended and completed step count diary return.
Qualitative evaluation
Forty-three trial participants were interviewed. The intervention was acceptable and primary care was an
appropriate setting. Almost all participants felt that they had benefited, irrespective of their step count
change. Important facilitators included a desire for a healthy lifestyle, improved physical health, enjoying
walking, having a flexible routine, appropriate external monitoring and self-monitoring and social support.
Important barriers included health problems, an inflexible routine, the weather, work and other commitments.
Although the postal group participants were mainly confident to increase their PA without individually tailored
nurse support, two important caveats were health problems and overcoming barriers. Practice nurses enjoyed
delivering the Pedometer And Consultation Evaluation-UP (PACE-UP) intervention, and believed that taking
part, especially in the BCT training, enhanced the quality and delivery of support provided within routine
consultations.
Three-year follow-up
Of the 1023 trial participants, 681 (67%) provided adequate accelerometry outcome data. The nurse-support
and postal intervention groups both showed persistent effects on the 3-year follow-up PA measures, with
no difference between them; for the nurse-support group and the postal group versus the control group,
additional steps per day were 648 steps (95% CI 272 to 1024 steps), and additional MVPA in ≥ 10-minute
bouts (minutes per week) were 26 minutes (95% CI 8 to 44 minutes). Qualitative interview findings at
3 years on factors affecting PA maintenance with intervention group participants complemented earlier
qualitative findings. The pedometer was reported as ‘kick-starting’ regular activity and helping to maintain
activity. Factors that facilitated PA level maintenance were striving to maintain good health, self-motivation,
social support and good weather. Lack of time was the most frequently cited barrier; other barriers were
often the reverse of facilitators, such as poor health or bad weather. Findings from the control group
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participants, who were sent the pedometer and materials at 12 months, suggested that many had not used
them. The persistent 3-year intervention effects, despite control participants receiving intervention materials
at 12 months, suggest that other postal group factors were important (e.g. telephone contact after sending
out materials and returning completed PA diaries). The postal group seemed to require this additional
minimal support (not provided face to face, or by a health professional) in order to be effective.
Conclusions
The PACE-UP pedometer-based walking intervention increased step counts by about one-tenth, and time
in MVPA in bouts by about one-third, at 1 year, in predominantly inactive 45- to 75-year-old primary care
patients. Nurse and postal delivery had similar effects on 12-month PA outcomes. The intervention was
safe and acceptable to patients and nurses. The postal group had a 50% chance of being cost-effective
at a £20,000 per QALY threshold within 1 year, and was significantly more cost-effective than nurse
support and the control group in the long term, thus providing a cost-effective way of delivering long-term
quality-of-life benefits. Both intervention groups had persistent positive effects on objective PA levels at
3 years, suggesting long-term benefit.
Implications for health care
l A primary care pedometer-based walking intervention, delivered by post with minimal support, could
provide an effective and cost-effective approach to addressing the public health physical inactivity challenge.
l The 3000 steps in 30 minutes neatly captures intensity and could become a useful new public health
goal, particularly as many people can measure steps easily with their mobile phones.
l The PACE-UP 12-week pedometer-based walking intervention could be considered for inclusion into
the NHS Health Check programme, aimed at a similar age group (of 40- to 74-year-olds) and/or the
NHS Diabetes Prevention Programme.
Recommendations for research
l The PACE-UP trial generalisability is limited by the 10% overall recruitment rate and lower recruitment
in Asian and socioeconomically deprived patients. Further research into different recruitment methods
is needed, as is research assessing the recruitment achievable if this programme were to be offered
outside a trial setting over a more prolonged time period.
l Although overall postal outcomes were as effective as, and more cost-effective than, nurse outcomes,
further research is required to understand who would benefit most from the individual tailoring offered
by a nurse-supported intervention.
l There has been a recent dramatic increase in the use of wearables to monitor personal PA levels,
including smartphones, wrist-worn devices, online monitoring and mobile apps. Further research into
how the PACE-UP 12-week PA programme could be integrated into the use of these devices (with or
without a pedometer) is needed.
Trial registration
This trial is registered as ISRCTN98538934.
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Chapter 1 Introduction: why this study was needed
Benefits and risks of physical activity and current physical activity
guidelines
What are the benefits of physical activity for adults and older adults?
Physical activity (PA) leads to reduced mortality, a reduced risk of > 20 diseases and conditions, and
improved function, quality of life and emotional well-being.1 Physical inactivity is the fourth leading risk
factor for global mortality;2 in 2008, it was estimated to have caused 9% of premature mortality and
5.3 million deaths worldwide.3 Physical inactivity is also a major cost burden on health services.1,4,5
What are the current physical activity guidelines and who is achieving them?
Adults and older adults are advised to be active daily and, for health benefits, should achieve at least
150 minutes (2.5 hours) weekly of at least moderate-intensity activity [moderate to vigorous PA (MVPA)] or
75 minutes of vigorous-intensity PA, or an equivalent combination, achieved in bouts of at least 10 minutes’
duration.1,2 Muscle-strengthening activities are also recommended on at least 2 days weekly,1,2 but are not
part of our intervention, which is focused on increasing walking. One effective way to achieve the aerobic
PA recommendations is by undertaking 30 minutes of moderate-intensity PA on at least 5 days weekly.1,6,7
Regular walking is the most common PA of adults and older adults, and walking at a moderate pace (3 miles
or 5 km per hour) qualifies as moderate-intensity PA.8 Time spent being sedentary for extended periods
should also be minimised, as this is an independent disease risk factor,1 which increases steeply with age from
45 years.9 There is an increasing awareness that as a dose–response relationship exists for PA and health
benefits, getting inactive people to do a little more PA is also important, rather than just relying on trying to
achieve PA recommendations.10,11 Emphasising that the 30 minutes can be built up from 10-minute bouts is
an important message for older adults and those with disabilities, enabling them to increase their MVPA
gradually. Among adults in England aged ≥ 19 years, 66% of men and 56% of women self-reported meeting
the recommended PA levels, whereas only 58% of men and 52% of women aged 60–74 years did so.12
Lower socioeconomic groups9 and Indian, Pakistani, Bangladeshi and Chinese ethnic groups are significantly
less likely to report meeting the recommended PA levels, whereas the activity levels of other ethnic groups
(black Caribbean, black African and Irish) are similar to that of the general population.13 Over one-third of
adults worldwide are insufficiently active, but there is large geographical variation.10,14 However, PA, including
walking, is very unreliably recalled, so surveys overestimate PA levels.15 Objective accelerometry found that
only 5% of men and 4% of women aged 35–64 years and 5% of men and 0% of women aged ≥ 65 years
achieved the recommended PA levels, which is a fraction of those who self-report achieving them.9
What are the risks from increasing physical activity?
The risks from a sedentary lifestyle far exceed the risks from regular PA.6,16,17 Moderate-intensity PA carries
a low injury risk,18 mainly musculoskeletal injury or falls.19 Walking is very low risk, ‘a near perfect exercise’.8
Screening participants for contraindications before participating in light- to moderate-intensity PA programmes
is no longer advocated.6,20 An important safety feature of our study is that individualised goals can be set
from the participant’s own baseline, in line with the advice that older adults in particular should start with
low-intensity PA and increase the intensity gradually: the ‘start low and go slow’ approach.16,17 This worked
well with our previous PA trial in older adults, which employed a similar approach and showed no increase in
adverse events (AEs).21
DOI: 10.3310/hta22370 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 37
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Harris et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
1
Strategies for increasing physical activity
How can adults and older adults increase their physical activity levels?
A systematic review of PA interventions reported moderately positive short-term effects, but the findings
were limited by mainly unreliable self-report measures in motivated volunteers.22 This review has recently
been updated by three complementary Cochrane reviews assessing (1) face-to-face PA interventions,23
(2) remote (including postal and telephone) and web 2.0 interventions24 and (3) a direct comparison of
these two approaches.23 Evidence supports the effectiveness of both face-to-face interventions and remote
or web 2.0 interventions for promoting PA. However, the reviewers called for future studies to provide
greater detail of the components of face-to-face interventions and to assess the impact on quality of life,
AEs and economic data,23 and to include participants from varying socioeconomic and ethnic groups.24
Only one study25 met the review criteria to compare face-to-face interventions with remote or web 2.0
interventions (many trials were excluded as a result of having less than 1 year’s follow-up data or an
inadequate control group); this study showed no effect on cardiorespiratory fitness25 and there were no
reported data for PA, quality of life or cost-effectiveness.23 The review concluded that there was insufficient
evidence to assess whether face-to-face interventions or remote and web 2.0 approaches are more
effective at promoting PA, and called for more high-quality comparative studies.23 None of the studies
included in the reviews provided objective PA measurement.23,24 Other studies have concluded that exercise
programmes in diverse populations can promote short- to medium-term increases in PA when
interventions are based on health behaviour theoretical constructs, individually tailored with personalised
activity goals and using behavioural strategies.26,27 A critical review and a best-practice statement on older
people’s PA interventions advised home-based rather than gym-based programmes, and behavioural
strategies (e.g. goal-setting, self-monitoring, self-efficacy, support, relapse prevention training), rather than
health education alone.17,27 National Institute for Health and Care Excellence (NICE)’s guidance concluded
that no particular behaviour change model was superior and that training should focus on generic
competencies and skills, rather than on specific models.28 More recent complementary NICE guidance
specifically recommended that goals, planning, feedback and monitoring techniques should be included in
behaviour change interventions.29 Starting low, but gradually increasing to moderate intensity is promoted
as best practice, with advice to incorporate interventions into the daily routine (e.g. walking).17 A recent
systematic review of walking interventions concluded that interventions tailored to people’s needs,
targeted at the most sedentary people and delivered at the level of the individual or household, can be
effective, although evidence directly comparing interventions targeted at individuals, couples or households
was lacking.30
Are pedometers helpful?
Pedometers are small, cheap devices, worn at the hip, providing direct step count feedback. A systematic
review (of 26 studies) found that pedometers increased steps per day by 2491 steps [95% confidence
interval (CI) 1098 to 3885 steps] and PA levels by 27%, with significant reductions in body mass index (BMI)
and blood pressure.31 A second review (of 32 studies) found an average increase of 2000 steps per day.32
Step count goals and diaries were key factors.31,32 Several limitations were recognised: study sizes were small
and long-term effects were undetermined; many studies included several components (e.g. pedometer and
support), so independent effects were difficult to establish; and the inclusion of older people and men was
limited.31,32 Recent studies have addressed some of these limitations. A pedometer plus behaviour change
intervention increased PA at 3 months, but not at 6 months, in 210 older women, with pedometers
providing no additional benefit.33 Two trials in high-risk groups showed sustained step count increases at
12 months.34,35 A recent study of 298 older adults found a significant increase in both step counts and time
in MVPA at 3 months and 12 months from a practice nurse-delivered pedometer-based walking intervention,
but did not separate out pedometer- and nurse support-related effects.21 NICE recently updated its advice
from advising the use of pedometers only as part of research36 to advising their use as part of packages,
including support to set realistic goals, monitoring and feedback.37
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How do step count goals relate to physical activity recommendations?
Step count goals lead to more effective interventions, but no specific approach to goal-setting is favoured.28
Goals are based on a fixed target (e.g. 10,000 steps per day)38,39 or on advising incremental increases from
the baseline as a percentage (5% per week,40 10% biweekly41 or 20% monthly33) or on a fixed number of
extra steps. Those advocating a fixed number of extra daily steps have developed step-based guidelines to
fit with existing evidence-based guidelines with an emphasis on 30 minutes of MVPA on ≥ 5 days weekly.42
Despite individual variation, moderate-intensity walking appears to be approximately equal to at least
100 steps per minute.42,43 Multiplied by 30 minutes, this produces a minimum of 3000 steps per day, to be
done over and above habitual activity, which is the ‘3000 in 30’ message.43 Several studies have advocated
adding in 3000 steps per day on most days weekly, either from the beginning34 or by increasing incrementally
(initially an extra 1500 steps per day and increasing),44,45 or by increasing by 500 steps per day biweekly.35
Studies that advised adding 3000 steps per day from the baseline produced significant improvements in
step counts at 3 months and two measured outcomes at 12 months, and showed sustained improvements
in step counts,34,35 waist circumference34 and fasting glucose levels,35 but no sustained improvements to date
in MVPA levels. Although there is no evidence at present to inform a moderate-intensity cadence (steps per
minute) in older adults, Tudor-Locke et al.46 advocate using the adult cadence of 100 steps per minute in
older adults (while recognising that this may be unobtainable for some individuals) and advising that the
30 minutes can be broken down into bouts of at least 10 minutes. This model was used in a primary care
walking intervention in 41 older people, which found significant step count increases from baseline to
week 12, which were maintained at week 24.47,48
Could accelerometers be useful in a pedometer-based walking intervention?
Accelerometers are small activity monitors worn like pedometers, but are more expensive; however, they
are able to provide a time-stamped record of PA frequency (step counts) and intensity (activity counts).
They require computer analysis, function as blinded pedometers in objectively measuring baseline and
outcome data, and provide objective data on time spent in different PA intensities, including time spent in
MVPA and time spent being sedentary, two important public health outcomes. Pedometer studies without
accelerometers have relied on self-reported measures of these outcomes. Accelerometers are valid and
acceptable to adults9,49 and older adults.9,21,50–53 Although both instruments measure step count and are
highly correlated,50 pedometers usually record lower step counts, and accelerometers cannot reliably be
substituted for pedometers at an individual level.54 Thus, although we used the accelerometer to measure
outcomes, including step count, MVPA and sedentary time, we used the blinded pedometer, worn
simultaneously at baseline, to set individual step count targets.
Are pedometers cost-effective?
There is limited knowledge on the cost-effectiveness of pedometer-based interventions in the UK. Recent
systematic reviews that considered the economic outcomes of pedometer-based interventions found no
evidence,55,56 partly because of an insufficient number of data.57 However, a recent study assessed the
cost-effectiveness of giving an individualised walking programme and pedometer with or without a PA
consultation alongside a community-based trial of 79 people.58 The incremental cost-effectiveness ratios
(ICERs) per persons achieving an additional 15,000 steps per week were £591 and £92 with and without
the consultation, respectively. However, even with this highly selected sample, no data on quality of life
were collected, and the impacts on long-term outcomes were not estimated.
What is the role of primary care in promoting physical activity?
Primary care centres (general practices) in the UK provide health care and health promotion, free at the
point of access, to a registered list of local patients (for many of whom PA will be of benefit), using disease
registers to provide annual or more frequent chronic disease reviews via a multidisciplinary health-care
team providing continuity of care. NICE guidance found that brief interventions in primary care are
cost-effective, and it therefore recommends that all primary care practitioners should take the opportunity
to identify inactive adults and provide advice on increasing PA levels.36 New 5-yearly NHS health checks
include adults aged 40–74 years and incorporate advice on increasing PA, often from primary care nurses.59
Primary care nurses are effective at increasing PA, particularly walking, in this age group.60 Not only can PA
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advice through consultation with health professionals be individually tailored61 and have more impact than
other PA advice,62 but this is particularly the case for older adults,63 especially given the uncertainty about
the effectiveness of exercise referral schemes from primary care.64 Exercise-prescribing guidance in primary
care reinforces the importance of follow-up to chart progress, set goals, solve problems, and identify and
use social support;65 this will be an important feature of the nurse PA consultations in this trial. Evaluation of
the UK Step-O-Metre programme, delivering pedometers through primary care, showed self-reported PA
increases, but advised investigation with a randomised controlled trial (RCT) design.44 Two trials, both in older
primary care patients, have assessed the effectiveness of pedometers plus primary care PA consultations;
one small trial (n = 41) showed a significant effect on step counts at 3 months, which was maintained at
6 months,47,48 and the other was our recent Pedometer Accelerometer Evaluation-LIFT (PACE-LIFT) trial21
(n = 298), which showed differences in both step counts and time in MVPA in bouts of at least 10 minutes,
at 3 and 12 months for the nurse intervention compared with the control group. Neither trial separated out
pedometer effects from the support provided.21,47,48
Theoretical base, piloting and preparatory work to develop the intervention
The pedometer-based intervention is based on work cited above,31,32 showing that pedometers can
increase step counts and PA intensity.31,32 It extends current understanding by also including older adults
and men, having a 12-month follow-up and ensuring that the pedometer and support components could
be evaluated separately. The patient handbook, diary (both available on the journals library website:
www.journalslibrary.nihr.ac.uk/programmes/hta/103202/#/) and practice nurse PA consultations use behaviour
change techniques (BCTs; e.g. goal-setting, self-monitoring, feedback, boosting motivation, encouraging
social support, addressing barriers or relapse anticipation). These techniques have been successfully used
by non-specialists in primary care after brief training,66 and are emphasised in the Improving Health:
Changing Behaviour: NHS Health Trainer Handbook,67 based on evidence from a range of psychological
methods and intended for NHS behaviour change programmes, with local adaptation.67 They also include
techniques specifically recommended to be included in more recent NICE guidance (goals, planning,
feedback and monitoring).29 We adapted the Improving Health: Changing Behaviour: NHS Health Trainer
Handbook67 for use in this trial into Pedometer And Consultation Evaluation-UP (PACE-UP) nurse and
patient handbooks, to focus specifically on PA using pedometers. The BCTs were classified in accordance
with the refined taxonomy of BCTs for PA interventions by Michie et al.68 Diary recording of pedometer
step counts provides clear material for PA goal-setting, self-monitoring and feedback, and should fit well
with this approach. We have adopted the approach used by others44,45 of advocating adding in 3000 steps
per day to an individual’s baseline on most days weekly in an incremental manner, and of advising on
gradually increasing PA intensity to achieve more time in MVPA, with the message that 3000 steps in
30 minutes will help people to achieve PA guidelines.43 Relevant pilot and preparatory work includes
observational work using pedometers and accelerometers in primary care53 and a successful trial with older
primary care patients developing the PA consultations and pedometer-based walking intervention (the
PACE-LIFT trial; ISRCTN4212256121,69). The PACE-LIFT trial demonstrated that tailored support from practice
nurse PA consultations combined with a pedometer-based walking programme (plus accelerometer feedback
on PA intensity) led to an increase in both step counts and time in MVPA compared with the control group
at both 3 and 12 months in 60- to 75-year-old primary care patients. The trial was limited in terms of both
ethnic and socioeconomic diversity, has not yet published on sedentary time or cost-effectiveness and, as
mentioned, was unable to separate out the effects of the pedometer (and accelerometer feedback) from the
effects of nurse support.21
Rationale for research
The PACE-UP trial aimed to fill the gaps in the current evidence base by evaluating the effect of a
pedometer-based walking intervention, with and without additional nurse PA consultations in a
population-based, primary care sample of inactive adults and older adults. The initial trial included follow-up
to 1 year and aimed to ensure that adequate numbers of men, older adults and individuals from diverse
socioeconomic and ethnic backgrounds were included. It also enabled the effectiveness of taking part as an
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individual or as a couple to be estimated. The intervention used step goals and diaries, and the PA
consultations and patient handbook were based on BCTs, such as those used in the Improving Health:
Changing Behaviour: NHS Health Trainer Handbook.67 To objectively test the effectiveness of the
intervention on important public health outcomes, such as time spent in MVPA and time spent being
sedentary, PA outcomes were assessed by accelerometry. Anonymised practice demographic data were
available for all those invited to participate, enabling the investigation of inequalities in trial participation.
Qualitative evaluations were also needed to explore the reasons for trial non-participation, the acceptability
of the intervention to both participants and practice nurses and the barriers to, and facilitators of, the
intervention. An economic evaluation was performed alongside the trial and was also used to inform
long-term cost-effectiveness.
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Chapter 2 Methods
This chapter is a summary of the full study protocol for the trial as originally funded, except for theparagraph which describes changes to the published protocol. Some of the material, including the
tables, has already appeared in publication,70 and is reproduced here under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution and reproduction in any medium, provided the original work is properly cited. The Creative
Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to
the data made available in this article,70 unless otherwise stated. Further funding was later awarded by the
National Institute for Health Research (NIHR) Health Technology Assessment programme for a 3-year
follow-up of the trial cohort, the methods and results of which are described in Chapter 8.
Study design
The PACE-UP walking intervention trial was a pragmatic, three-arm parallel-cluster trial (randomised
by household to allow individuals and couples to participate). It was based in primary care with 45- to
75-year-old inactive adults, with a 12-month follow-up period, and compared the following three groups:
control (usual PA); pedometer and written instructions by post (pedometer by post); and pedometer,
written instructions and practice nurse individually tailored PA consultations (pedometer plus
nurse support).
Study aims and objectives
Study aims
The main hypotheses to be addressed were as follows:
1. Does a 3-month postal pedometer-based walking intervention increase PA in inactive 45- to 75-year-olds
at the 12-month follow-up point?
2. Does providing practice nurse support through dedicated PA consultations provide additional benefit?
The study also aimed to assess the cost-effectiveness of both interventions, whether or not any factors
modified the intervention effects and the effect of the interventions on patient-reported outcomes,
anthropometric measures and primary care-recorded AEs.
Primary objectives (relating to the primary outcome of step counts)
In inactive adults aged 45–75 years, the primary objectives were to:
l confirm that tailored support from practice nurse PA consultations combined with a pedometer-based
walking programme can promote an increase in step counts compared with the control group at
12 months (pedometer plus nurse support vs. control)
l determine whether or not the simple provision by post of pedometers plus written instructions for a
pedometer-based walking programme can promote an increase in step counts compared with the
control group at 12 months (pedometer by post vs. control)
l estimate the effect of tailored support from practice nurse PA consultations combined with a
pedometer-based walking programme compared with the postal pedometer-based walking
programme, on step counts at 12 months (pedometer plus nurse support vs. pedometer by post).
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Secondary objectives (relating to secondary outcomes of time in moderate to vigorous
physical activity in bouts, sedentary time and cost-effectiveness)
In inactive adults aged 45–75 years, the secondary objectives were to:
l confirm that tailored support from practice nurse PA consultations combined with a pedometer-based
walking programme can promote an increase in steps counts at 3 months and time spent in MVPA in
≥ 10-minute bouts at 3 and 12 months, and a decrease in sedentary time at 3 and 12 months
compared with control (pedometer plus nurse support vs. control)
l determine whether or not the simple provision by post of pedometers plus written instructions for
a pedometer-based walking programme can promote an increase in step counts at 3 months, an
increase in time spent in MVPA in ≥ 10-minute bouts at 3 and 12 months and a decrease in sedentary
time at 3 and 12 months compared with the control group (pedometer by post vs. control)
l estimate the effect of tailored support from practice nurse PA consultations in addition to the
pedometer-based walking programme alone on step counts at 3 months, and time spent in MVPA
in ≥ 10-minute bouts and sedentary time at 3 and 12 months (pedometer plus nurse support vs.
pedometer by post)
l determine the cost-effectiveness of these alternative approaches to increasing PA levels at both 12 months
and from a lifetime perspective from the viewpoint of the NHS and participants (see Chapter 4).
Other objectives
l To determine the effect of the interventions on anthropometric measures (BMI, waist circumference
and body fat) at 12 months.
l To determine the effect of the interventions on patient-reported outcomes (self-reported PA levels,
anxiety and depression score, exercise self-efficacy, quality of life, pain, AEs) and on primary
care-recorded AEs at 3 months and 12 months.
l To determine whether or not age groups (< 60 years vs. ≥ 60 years), sex, taking part as a couple,
socioeconomic group, disability, pain, BMI and exercise self-efficacy modify the effect of the intervention
on increasing step count at 3 months and 12 months (ethnic group was originally intended to be
included as an effect modifier, but there was inadequate power for this analysis because of the low
number of non-white participants; see Changes from the published protocol).
l To compare the age, sex, socioeconomic group and ethnicity of those taking part in the trial with those
invited but not participating, and to explore the reasons for not participating (see Chapter 5).
l To assess the fidelity and quality of the intervention implementation over time, by the evaluation of
patient diary step count goals and recorded step counts for both intervention groups at the 3-month
assessment, and the number and timing of recorded practice nurse contacts for the nurse support
group (see Chapter 6).
l To explore the intervention’s acceptability to practice nurses and inactive adults, the reasons for
dropout and the durability of effects, by qualitative interviews with participants after the 12-month
follow-up, and a focus group with the nurses on study completion (see Chapter 7).
Practice and participant inclusion/exclusion criteria
Practice inclusion criteria
General practices were recruited through the Primary Care Research Network – Greater London. Practices
were required to be in the south-west London cluster, have a practice list size of > 9000, give a commitment
to participate over the duration of the study, have a practice nurse interested and with time to carry out the
PA interventions and trial procedures, and have the availability of a room for the research assistant to recruit
participants and carry out baseline and follow-up assessments.
METHODS
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Participant inclusion criteria
Participants were patients aged 45–75 years, who were registered with one of the recruited south-west
London general practices, were able to walk outside the home and had no contraindications to increasing
their MVPA levels.
Participant exclusion criteria
l Physical activity based (by screening question on invitation letter). In order to maximise the benefits of the
intervention to individuals and the NHS, the trial focused on less-active adults, using a single-item validated
questionnaire measure of self-reported PA as a screening question to identify them.60 Those who reported
achieving a minimum of 150 minutes of MVPA weekly1 on their response letter were excluded (participants
who, on subsequent baseline accelerometer assessment, were found to be above this PA level were not
excluded, as they would be included if this intervention were to be rolled out in primary care).
l Health based [either by the Read code from primary care records or by general practitioner (GP)/practice
nurse opinion, or from the telephone or face-to-face baseline assessment with the research assistant] for
the following reasons:
¢ housebound or living in a residential or nursing home
¢ three or more falls in the previous year, or one or more falls in the previous year requiring
medical attention
¢ terminal illness
¢ dementia or significant cognitive impairment
¢ registered blind
¢ new-onset chest pain, myocardial infarction, a coronary artery bypass graft or an angioplasty within
the last 3 months
¢ a medical or psychiatric condition that the GP (or practice nurse) considered to exclude the patient
(e.g. acute systemic illness such as pneumonia, acute rheumatoid arthritis, unstable/acute heart
failure, significant neurological disease/impairment, unable to move about independently,
psychotic illness)
¢ pregnancy.
Recruitment of practices and participants: informed consent
Practice recruitment
The Primary Care Research Network – Greater London identified practices that fitted the above practice
inclusion criteria. Practice recruitment was challenging for a number of reasons, including difficulties in
finding practices with sufficient space to accommodate a research assistant on a regular basis, finding
practices with nurses willing and with sufficient time to be engaged in delivering the intervention and
finding practices that were prepared to provide administrative support. The Primary Care Research
Network – Greater London provided us with strong support to recruit practices. Initially, six practices were
recruited, with an additional practice added half-way through to boost recruitment. This was necessary,
as recruitment at that point was running at just below 10% and we were concerned that we would not
achieve the target recruitment from the original six practices within 12 months. The practices were
selected to include a range of sociodemographic factors and geographical circumstances based on the
practice postcode Index of Multiple Deprivation71 (IMD) scores (at least one practice from each quintile).
Participant recruitment
Practice staff identified patients aged 45–74 years on their primary care electronic patient record system,
and, using Read codes and local care home knowledge, excluded ineligible patients (patients were aged
45–74 years when selected, but some were aged 75 years by the time of recruitment or randomisation).
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A list of potentially eligible patients was produced and ordered by household, with a unique household
identifier number. An anonymised list was then used by the research team to create at least four random
samples of 400 individuals at each practice. A maximum of two people per household were selected (we
were aiming to select couples). If a household had two individuals, one was selected at random, and if the
second individual had an age difference of ≤ 15 years, they were also selected; if they fell outside this age
range, they were not included. If a household had more than two individuals, one was selected at random,
and if there was a second individual aged within ≤ 15 years they were also selected; if there was not a
second individual aged within ≤ 15 years, this became an individual household. Each sample list was
examined by practice nurses or GPs to ensure trial suitability prior to invitation (see Participant exclusion
criteria). Participants were recruited between September 2012 and October 2013, and follow-up was
completed by October 2014.
Non-responders and non-participants
See Chapter 5 for more details.
Informed consent
Patients were sent an invitation letter from their own practice, along with a participant information sheet
and a screening question on self-reported PA. A reminder invitation was sent if no reply was received after
6 weeks. A log was kept of the response rates from each practice. The decision regarding participation
in the study was entirely voluntary. Those interested in participating returned the reply slip, including a
response to a single screening question about their usual PA levels. If the participant self-reported as not
achieving the PA guidelines,1 the research assistant arranged a baseline appointment for them and ran
through the participant information sheet, and handled any questions or concerns that they had. If they
were happy to proceed, they signed the study consent form; this form included consent to be contacted for
qualitative interviews and consent for their general practice records for the year of the trial to be downloaded
after trial follow-up was completed. Participants who had difficulty understanding, speaking or reading
English were accompanied by a family member or friend during the research assistant appointment.
Participants within a couple could attend together or separately.
Changes from the published protocol
We planned to recruit from six general practices, but to enable target recruitment, a seventh practice
was added in December 2012. Changes from protocol-planned analyses70 were approved by the Trial
Steering Committee (TSC), prior to analysis. We report MVPA in ≥ 10-minute bouts, as this relates more
closely to PA guidelines.1,2 Only 20% of participants were non-white; ethnic group was therefore excluded
from the subgroup analyses, as a result of low power.
Interventions
Table 1 shows the components of the intervention provided to the postal and nurse groups. Table 2
shows the content of the patient handbook and the patient diary and the BCTs that were included in each
of them, rated according to Michie et al.’s CALO-RE taxonomy.68 Table 3 shows the timing and session
content for the three dedicated nurse PA consultations and the BCTs intended to be covered in each
session. Figure 1 provides a summary of the 12-week walking programme in terms of steps per day or
time spent walking, to be added to each individual’s baseline average daily steps. The training received by
the practice nurses in order to deliver the interventions is described in Chapter 6. A figure summarising
the trial procedures and complex intervention components is shown in Appendix 1, Figure 17.
METHODS
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Procedure for the postal intervention group
The participants received (by post) a pedometer (Yamax Digi-Walker, SW-200 model; Yamasa Tokei Keiki
Co., Ltd, Tokyo, Japan), instructions and a 12-week step count diary for the 12-week walking intervention
(see Figure 1). The research assistant contacted the participant to check that the pedometer had been
received and to resolve any difficulties with the equipment. At the end of the 12-month follow-up period,
the postal group were offered a single practice nurse PA appointment, if they wanted it.
Procedure for the nurse intervention group
Three dedicated PA consultations (week 1, week 5 and week 9) were arranged with the practice nurse,
to individually tailor and support the 12-week pedometer-based walking programme (see Figure 1). At
their first appointment, participants were given the same pedometer, diary and handbook that the postal
group received. Participants were asked to wear a pedometer and keep a diary record of daily steps for
4 weeks between appointments, in order to review targets and goals at their next appointment. Participants
were seen individually or as a couple.
TABLE 1 Components of the complex intervention for the PACE-UP trial
Component What was provided Trial arm receiving
Additional details on
components
Pedometer Yamax Digi-Walker (Yamasa
Tokei Keiki Co., Ltd, Tokyo,
Japan), SW-200 model
l Postal group –
pedometer posted
with instructions
l Nurse-support group –
pedometer given with
instructions by
the nurse
Provided direct step count to
participants. Required daily
manual recording and resetting
PACE-UP handbook,
12-week walking plan
and step count diarya
Handbook to support
the 12-week walking
programme. Individualised
walking plan (see Figure 1).
Diary to record weekly
step count and walks for
12 weeks
l Postal group – posted
l Nurse-support group –
given by nurse
Baseline average daily step counts
(from the blinded pedometer
assessment) were used to create
individual targets. The 12-week
walking programme gradually
increased targets to achieve an
additional 3000 steps per day
(approximately 30 minutes of
brisk walking) on ≥ 5 days weekly.
Daily step counts and target
achievement were recorded in the
diary. Table 2 lists BCTs in the
PACE-UP handbook and diary
Practice nurse-
dedicated PA
consultations
Three individually tailored
consultations. Participants
could be seen individually
or as a couple
Nurse-support group only Session timings, content and
planned BCTs are shown in
Table 3. Sessions reinforced the
intervention defined in the diary
and the handbook. The nurse
consultation allowed some
additional BCTs to be used and
provided an opportunity to
individually tailor the intervention
to participants’ needs
a The handbook, 12-week walking plan and step count diary are available on the NIHR Journals Library website
(www.journalslibrary.nihr.ac.uk/programmes/hta/103202/#/).
This table has been adapted from Harris et al.70 This article is published under license to BioMed Central Ltd. This is an Open
Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies
to the data made available in this article, unless otherwise stated.
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Procedure for the control group
The participants were advised to continue their usual activity levels and were not offered the 12-week
walking intervention, but were free to participate in any other PA, just as they would if they were not
enrolled in the trial. At the end of the 12-month follow-up period, the control group was offered to
receive a pedometer and the PACE-UP 12-week walking programme handbook and diary, either by post
or as part of a single PA practice nurse appointment, as preferred.
TABLE 2 The PACE-UP patient handbook, and diary and BCTs included
Component Guide to content aBCTs68
Patient handbook l Health benefits of increasing walking
l PA guidelines
l Moderate-intensity PA and relating it to number of steps
l PACE-UP walking programme and step count targets
l Review participant baseline step count
l How to increase PA safely
l Useful websites
l How to keep going when the PACE-UP programme finishes
1 and 2
4
7, 9 and 16
19
21
4
16, 1, 2, 26, 29 and 35
Patient diary l How to use the pedometer and record steps in diary
l Frequently asked questions on the PACE-UP trial
l Weekly recording of step count and walking in diary (weeks 1–12)
l Achievement of targets (weeks 1–12)
l Planning when to walk, where to walk, who to walk with
l Week 2, tips and motivators: make walking part of your
daily routine
l Week 3, tips and motivators: remember personal benefits, what to
do if you are falling behind your targets
l Week 4, keep it up: praise and reward yourself, encouraging
social support
l Week 5, keep motivated: write down step counts, ask for support
l Week 6, now we are moving: obstacles and solutions
l Week 7, how to make these changes permanent – ideas for new
walks, making time for walking, what gains have been made so far?
l Week 8, maintain the gain: pacing, tips for safe exercising
l Week 9, be busy being active: keep monitoring with the pedometer,
places, people and thoughts that motivate you
l Week 10, change does not happen in a straight line! Preparing
for setbacks
l Week 11, make it a healthy habit: building regular exercise habits,
creating if-then plans
l Week 12, I’ve changed: how to keep up your walking programme
l Congratulations, you have completed the programme
l How to keep going when the PACE-UP programme finishes
16 and 21
7, 9, 19 and 26
10, 12 and 13
20 and 29
20
2, 20 and 35
12, 13 and 29
12, 16 and 29
8
38, 17 and 11
9, 21 and 35
16, 29 and 36
8 and 35
1, 2, 7 and 23
16, 20 and 29
11, 16 and 17
1, 16 and 29
a 1 provide general information on behaviour–health link; 2 provide information on consequences to the individual;
4 provide normative information about others’ behaviour; 7 action-planning; 8 barrier identification; 9 set graded tasks;
10 prompt review of behavioural goals; 11 prompt review of outcome goals; 12 prompt rewards contingent on effort;
13 prompt rewards contingent on successful behaviour; 16 prompt self-monitoring of behaviour; 17 prompting
self-monitoring of behavioural outcome; 19 provide feedback on performance; 20 provide information on when and
where to perform the behaviour; 21 provide instructions on how to perform the behaviour; 23 teach to use prompts/cues;
26 prompt practice; 29 plan social support/social change; 35 relapse prevention/coping planning; 36 stress management/
emotional control training; and 38 time management.
This table has been adapted from Harris et al.70 This article is published under license to BioMed Central Ltd. This is an Open
Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to
the data made available in this article, unless otherwise stated.
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Outcome measures
Primary and secondary outcome measures
These were selected to reflect the needs of the target population, helping adults and older adults to increase
their PA, particularly through walking, and to inform UK public health policy. The primary outcome was the
change in average daily step count, measured over 7 days, between baseline and 12 months, assessed
TABLE 3 The PACE-UP practice nurse PA consultations and BCTs included
Sessions Guide to session content aBCTs68
Session1: week 1, first steps
(30 minutes)
l Review health status, current activity, health benefits of PA
l Cost–benefit analysis for increasing PA
l PA guidelines and how to increase PA safely
l Moderate-intensity PA and relating it to number of steps
l Review participant baseline step count
l Teach use of pedometer and recording walks and steps
in diary
l Ideas for increasing steps
l Goal-setting – PACE-UP goals or tailored to the
individual patient
l Use of rewards for effort and for achieving goals
l Summarise and check patient understanding, plan time for
next meeting
l Communication strategies to overcome resistance and
promote patient-led change
1 and 2
2
4 and 21
19
21 and 26
20
7, 9 and 16
12 and 13
37
Session 2: week 5, continuing
the changes (20 minutes)
l Review step count and walking diary
l Encourage progress in increasing walking and achieving step
count goals
l Troubleshoot any problems with pedometer or diary
l Review target and agree goals for next stage
l Barriers to, and facilitators of, increasing PA, overcoming
barriers, encouraging support
l Pacing and avoiding boom and bust
l Check confidence levels, build confidence to make change
l Summarise and check patient understanding, plan time for
next meeting
l Communication strategies to overcome resistance and
promote patient-led change
10 and 19
12 and 13
8
7, 9 and 16
8 and 29
9 and 35
18, 29 and 36
37
Session 3: week 9, building
lasting habits (20 minutes)
l Review step count and walking diary
l Review overall progress over the sessions
l Encourage progress in increasing walking and achieving goals
l Preparing for setbacks
l Building habits: discuss methods of maintaining lasting
change, including repetition, if-then rules and support
l Setting goals: maintaining current activity or
increasing further?
l Reminder regarding contact with research assistant in
3–4 weeks
l Communication strategies to overcome resistance and
promote patient-led change
10 and 19
11 and 17
12 and 13
35
7, 23, 29 and 35
7, 9, 16 and 26
37
a 1 provide general information on behaviour-health link; 2 provide information on consequences to individual; 4 provide
normative information about others’ behaviour; 7 action-planning; 8 barrier identification; 9 set graded tasks;
10 prompt review of behavioural goals; 11 prompt review of outcome goals; 12 prompt rewards contingent on effort;
13 prompt rewards contingent on successful behaviour; 16 prompt self-monitoring of behaviour; 17 prompting
self-monitoring of behavioural outcome; 18 prompting focus on past success; 19 provide feedback on performance;
20 provide information on when and where to perform the behaviour; 21 provide instructions on how to perform the
behaviour; 23 teach to use prompts/cues; 26 prompt practice; 29 plan social support/social change; 35 relapse
prevention/coping planning; 36 stress management/emotional control training; and 37 motivational interviewing.
This table has been adapted from Harris et al.70 This article is published under license to BioMed Central Ltd. This is an
Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/
licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/)
applies to the data made available in this article, unless otherwise stated.
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objectively by accelerometry (GT3X+; ActiGraph LLC, Pensacola, FL, USA). Secondary outcomes were as
follows: changes in step counts between baseline and 3 months; changes in time spent weekly in MVPA in
≥ 10-minute bouts between baseline and 3 months, and between baseline and 12 months; and time spent
sedentary between baseline and 3 months, and between baseline and 12 months. All of these secondary
outcomes were also assessed objectively by accelerometry. Cost-effectiveness was also a secondary outcome
in our protocol [incremental cost per change in step count and per quality-adjusted life-year (QALY)]; this is
presented in Chapter 4.
FIGURE 1 A summary of the PACE-UP walking programme. Adapted from Harris et al.70 This article is published
under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons
Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made
available in this article, unless otherwise stated.
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Ancillary outcomes
l Change in self-reported PA, measured over the same 7 days as accelerometry using the short
International Physical Activity Questionnaire (IPAQ)72 and the General Practice Physical Activity
Questionnaire [(GPPAQ)73 as part of the 7-day PA questionnaire; see Appendix 1].
l Change in other patient-reported outcomes (from the health and lifestyle questionnaires at baseline,
3 months and 12 months; see Appendix 1): confidence in ability to do PA, as measured by exercise
self-efficacy;74 anxiety and depression, as measured by the Hospital Anxiety and Depression Scale (HADS);75
perceived health status (health-related quality of life), as measured by the EuroQol-5 Dimensions, five-level
version (EQ-5D-5L);76 and self-reported pain, measured by two items from the Medical Outcomes Study
36-item short-form health survey.77
l Change in anthropometric measurements (weight, BMI, waist circumference, body fat; see
Ascertainment of outcomes, Anthropometry, for measurement details).
l Adverse outcomes [falls, fractures, injuries, exacerbation of pre-existing conditions, major cardiovascular
events and deaths from serious AEs (SAEs)] were collected as part of safety monitoring for the trial, by
questionnaire self-report items designed by us at 3 and 12 months, and from primary care records after
the 12-month follow-up period, for those giving consent.
l Health service use for those giving consent to primary care record access for the 12-month trial period,
numbers of the following occurrences were collected for health economic evaluations (see Chapter 4):
primary care consultations, accident and emergency (A&E) attendances, emergency and elective
hospital admissions and outpatient referrals.
Ascertainment of outcomes
See Figure 2 for the schedule for outcome assessments and measures.
Accelerometry
Participants were asked to carry on with their usual PA levels and to wear an accelerometer (GT3X+,
ActiGraph LLC) on a belt over one hip, during waking hours (from rising until going to bed) for 7 days,
only removing it for bathing, at baseline, 3 months and 12 months. Participants were offered the option
of text messaging to remind them to wear the accelerometer each day and to return it after the 7 days.
A diary was provided to record what activities were done and for how long. The monitor, belt and diary
were posted back on completion. Once returned, the participants received a £10 gift voucher.
Anthropometry
At the baseline and 12-month face-to-face assessments, the following measurements were taken: height
(measured in bare feet to the nearest 0.5 cm using a stadiometer), weight (measured to the nearest
0.1 kg), body fat, bioimpedence [using the Tanita body composition analyser BC-418 MA (Tanita
Corporation, Tokyo, Japan)] and waist and hip circumference (using a standard technique and tape
measure with a clear plastic slider).
Questionnaire measures
Questionnaire measures were collected using validated tools (detailed under Outcome measures, Ancillary
outcomes), as part of self-completed questionnaires at 3 months and 12 months.
In terms of the self-reported PA in the previous week, for the IPAQ72 we used the measure of MVPA
(total minutes of vigorous and moderate PA weekly) and the measure of walking (total minutes of walking
weekly). The GPPAQ73 provides a PA index (PAI), which is calculated from a combination of PA from both
work and leisure activities. Active individuals are those who self-report ≥ 3 hours of MVPA per week on
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the PAI. However, walking is not included in the calculation of the PAI, although it is asked about in the
questionnaire. Analysis of similar GPPAQ data compared with objective accelerometry in our earlier PACE-
LIFT trial21 demonstrated that a modified PAI, which also included walking at a brisk pace for at least
3 hours per week, improved validity and repeatability compared with the standard GPPAQ.78 A modified
index, GPPAQ-Walk, was therefore generated.
In addition, the following were also recorded at baseline: demographic information, based on 2011 census
questions79 (e.g. marital status, ethnic group, occupation, employment, household composition, home
ownership); a list of common self-reported chronic conditions (e.g. heart disease, lung disease, arthritis,
stroke, diabetes mellitus, depression); disability, as measured by the Townsend score;80 limiting long-
standing illness;79 current medications; smoking; and alcohol consumption.
Several other questionnaire variables were collected at all three time periods, but were not considered
to be ancillary trial outcomes in the trial protocol:70 loneliness, measured by a single item;81 risk of falls,
measured using the Falls Risk Assessment Tool,82 was assessed using a combination of both self-reported
items and direct observation of the ability to rise from a chair without using arms; and self-reported usual
PA, as measured by the modified Zutphen Physical Activity Questionnaire.83 Data from these variables are
not presented in this report.
All study groups were asked about falls, injuries, fractures, exacerbation of any pre-existing conditions and
the costs of any treatments in the 3- and 12-month questionnaires. Questions on the financial costs of
participating in walking and other PAs were asked in the 3- and 12-month questionnaires.
Primary care computerised record measures
For participants who gave written consent, the following data were collected from their electronic primary
care records, for the 12-month duration of the trial, after the 12-month follow-up:
l adverse events potentially relating to trial participation [Read codes relating to falls, fractures, injuries,
cardiovascular events (myocardial infarction, coronary artery bypass graft, coronary angioplasty,
transient ischaemic attack, stroke) and death]
l health service use – GP consultations, practice nurse consultations (excluding those for the trial), A&E
attendances, emergency and elective hospital admissions and outpatient referrals.
These data were downloaded and pseudoanonymised before removal from the practice.
Baseline and follow-up data collection
Baseline data collection
At baseline, a face-to-face assessment with the research assistant occurred at the participant’s general
practice, and questionnaire and anthropometric data were collected (see Ascertainment of outcomes).
Participants were then given a belt with an accelerometer (GT3X+, ActiGraph LLC) and a blinded
pedometer (Yamax Digiwalker CW200) on it, and asked to wear this for 7 days. The CW200 pedometer
model was used to enable the baseline target-setting of the pedometer step count, because of its 7-day
memory of consecutive daily steps. However, it is bulky to wear and complicated to use, so this model
was not used for the intervention.
Follow-up data collection
Follow-up data collection was conducted in the same way for all trial groups (Figure 2): (1) 3 months
(postal) after randomisation (questionnaires and accelerometry) and (2) 12 months (face to face) after the
baseline assessment (questionnaires, accelerometry and anthropometry). Participants were also contacted
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by the research assistant at 6 and 9 months after randomisation by telephone or e-mail to check on
falls for trial safety reporting and contact details. For those in the intervention groups, a replacement
pedometer or batteries were offered at each contact point, if required. The intervention groups were
asked to return their 12-week step count diary following the intervention at 3 months. This was then
photocopied and sent back to participants.
Accelerometer data reduction
The accelerometer measured vertical accelerations in magnitudes from 0.05 to 2.0 g sampled at 30 Hz,
then summed over a 5-second epoch time period. ActiGraph data were reduced using Actilife software
(v 6.6.0; ActiGraph LLC, Pensacola, FL, USA), ignoring runs of ≥ 60 minutes of zero counts.70 Vertical
counts were used, as these are the basis of the validated step count and MVPA algorithms. The analysis
summary variables used were step counts, accelerometer wear time, time spent in MVPA (≥ 1952 counts
per minute, equivalent to ≥ 3 metabolic equivalents),84 time spent in ≥ 10-minute MVPA bouts and time
spent being sedentary (≤ 100 counts per minute, equivalent to ≤ 1.5 metabolic equivalents).85
Adverse events and serious adverse events
An AE was defined as any unfavourable and unintended sign, symptom, syndrome or illness that
developed or worsened during the observation period of the trial. This included:
l exacerbation of a pre-existing illness
l an increase in frequency or intensity of a pre-existing condition
l a condition detected or diagnosed after the trial started (but which might have been present
at baseline)
l a persistent disease or symptoms present at baseline that worsened following the start of the trial.
Type of contact with research
assistant
Seven-day objective PA
accelerometer assessment
Questionnaire health and
lifestyle measures (including the
EQ-5D-5L, self-efficacy, pain,
anxiety, depression)
Questionnaire 7-day PA recall
(self-report: IPAQ short version 
and GPPAQ)
Anthropometric measures
(weight, BMI, waist circumference 
and body fat percentage)
Baseline
Face to face at
practice and post
3 months
Telephone and
post
12 months
Face to face at
practice and post
FIGURE 2 Schedule of outcome assessment measures used in the PACE-UP trial.
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A SAE was defined as any AE occurring during the trial for any of the three groups that resulted in any of
the following outcomes:
l death
l a life-threatening AE
l inpatient hospitalisation or prolongation of existing hospitalisation
l a new disability/incapacity.
All AEs were assessed for seriousness, expectedness and causality. All AEs were recorded and closely
monitored until resolution or stabilisation, or until it had been shown that the study intervention was not
the cause. Participants were asked to contact the trial site immediately in the event of any SAE. The chief
investigator was informed immediately and determined seriousness and causality in conjunction with two
other medically trained trial investigators. A SAE that was determined to be directly or possibly trial related
was reported, within agreed time frames, to the TSC and the ethics committee. All SAEs were reported
annually to the TSC, ethics committee and the trial sponsor.
Although it was important to record AEs contemporaneously for trial safety monitoring during the trial,
there was a risk of bias in their reporting, with those having nurse contact having more opportunities for
reporting falls, injuries and illnesses. For analyses and reporting, we therefore concentrated on measures
for which there were fewer risks of bias between groups: (1) spontaneously reported SAEs, (2) falls,
fractures and injuries from questionnaire self-report at 3 and 12 months and (3) falls, fractures, injuries,
cardiovascular events (new episode of any of the following: myocardial infarction, angioplasty, coronary
artery bypass, stroke, transient ischaemic attack, new-onset angina, ischaemic heart disease) and deaths
from primary care records after the 12-month follow-up point.
Sample size
A total of 217 patients in each of the three trial arms would allow a difference of 1000 steps per day to be
detected between any two arms of the trial, with 90% power at the 1% significance level. However, we
planned to randomise households. Assuming an intracluster correlation of 0.5 and an average household
size of 1.6 eligible patients, we needed to analyse 282 patients per trial arm. Allowing for approximately
15% attrition, we needed to randomise a total of 993 patients (331 control participants, 331 participants
receiving a pedometer by post and 331 participants receiving a pedometer plus nurse support). We initially
planned on six practices to each recruit approximately 166 patients (approximately 55 participants to each
of the three groups), but to enable target recruitment, a seventh practice was added.
We anticipated a 20% recruitment rate among eligible participants, based on other PA interventions
(including with pedometers) among middle-aged and older adults in primary care, where the recruitment
rate was between 17% and 35%.21,33,86–89 We estimated that, even if our recruitment rate was as low as
10%, we would have enough eligible participants at practices. In fact, the recruitment rate dipped to
below 10%, so a seventh practice was added.
Randomisation, concealment of allocation, contamination and
treatment masking
Randomisation and concealment of allocation
Following completion of the baseline assessment (including providing accelerometry data on ≥ 5 complete
days of ≥ 9 hours/540 minutes), each participant was allocated to a trial group using the King’s College
London clinical trials unit internet randomisation service, to ensure independence of the allocation. If
participants were unable to provide at least 5 days of ≥ 540 minutes wear time on accelerometry, they
were asked to wear the accelerometer for a further 7 days, or they were excluded if this was not possible.
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Randomisation was at a household level. Randomisation of a group household took place only after both
members of the household had completed the baseline assessment. Block randomisation was used within
the practice with randomly sized blocks (2, 4 or 6) to ensure balance in the groups and an even nurse
workload. Participants were informed by telephone which group they had been allocated to.
Contamination
Contamination could occur between partners in a household; we minimised this by ensuring that, if two
household members were recruited, they were allocated to the same group (i.e. randomisation was at a
household level). Contamination would have occurred if the control group used a pedometer to increase
their walking during the 12-month trial follow-up. We tried to discourage participants in the control group
from buying a pedometer, by ensuring that they knew that they would receive one at the end of follow-up.
A question was included in the 12-month questionnaire to ask if they had used a pedometer during the
course of the trial.
Treatment masking
Participants were randomised only after the successful return of accelerometers with 5 days’ recording.
It was not possible to mask participants to their intervention group. The research assistants who carried
out follow-up assessments were not masked to group allocation for pragmatic reasons alone: the study
was funded to support only enough researchers to carry out recruitment and follow-up simultaneously.
However, the main outcome was assessed objectively through accelerometry, and the assessment of the
quality of the outcome data was done blind to intervention group: days with < 9 hours of data were
excluded. Weight and body fat were also assessed objectively using the Tanita scales, which provided
electronic printouts of results, and other outcomes were assessed using standardised measures
(e.g. patient-reported outcomes from questionnaires). The statistician carrying out the primary analyses
was masked to group allocation as far as possible.
Withdrawals, losses to follow-up and missing data
Withdrawals and losses to follow-up
Participants could withdraw from the trial at any point. Participants who withdrew following informed
consent, and prior to randomisation, were replaced with another participant. Participants who withdrew
after randomisation were not replaced and were asked if they were prepared to contribute to further data
collection on outcomes at 3 and 12 months. Participants were made aware that withdrawal from the trial
would not affect future care and that information on those who withdrew or were lost to follow-up that
had already been collected would still be used, unless consent for this was withdrawn.
Procedure for accounting for missing data
Only days with at least 540 minutes of registered time on an accelerometer on a given day were used,
which was consistent with previous work (the PACE-LIFT trial,21 Trost et al.90 and Miller et al.91). Participants
were randomised only if they provided at least 5 such days of accelerometer data at baseline. A multilevel
linear regression model was used, taking account of repeated days within individuals to estimate the
baseline average daily step count for each subject, adjusted for the day of the week and the day order of
wearing the accelerometer. The same approach was used to estimate the average daily step count at
3 months and 12 months. The main covariates – age, sex, practice, month of baseline accelerometry and
whether or not participants were taking part as a couple – were known for all participants, and most
patients had complete data for other measures. To lessen attrition bias, the primary analysis included all
participants with at least 1 satisfactory day of accelerometry recording at 12 months (i.e. a wear time of
≥ 540 minutes). The main analysis assumed that, depending on the model covariates, outcome data were
missing at random. This was likely to be true for missing data as a result of accelerometer failure, and was
plausible for missing days and participants who did not return accelerometers. However, an alternative
plausible assumption is that participants who failed to provide outcome data were less active. Multiple
imputation was used to impute values for those with no accelerometer data at 12 months (see Statistical
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methods, Sensitivity analyses). Further sensitivity analyses examined the impact of assuming that missing
step counts at 12 months in the control group were equal to their baseline values and, in the two
intervention groups, varied between 1500 steps lower and 1500 steps higher than their baseline values.
Statistical methods
The analysis and reporting was in line with the Consolidated Standards of Reporting Trials (CONSORT)
guidelines, with the primary analysis on an intention-to-treat basis. That is, all participants with outcome
data were included, regardless of their adherence to the interventions. All participants were included in
the primary analysis if they had at least 1 satisfactory day of accelerometer recording (≥ 540 minutes) of
registered time during a day, out of 7 days, at 12 months. The adequacy of the randomisation process to
achieve balanced groups was checked by comparing participant characteristics in the three arms (e.g. sex,
age, socioeconomic group, baseline PA level or BMI). Stata®, version 12 (StataCorp LP, College Station,
TX, USA) was used for all analyses.
Primary analysis
The primary outcome measure was change in average daily step count from baseline to the 12-month
follow-up point measured over 7 days. However, to overcome Lord’s paradox,92 the analytic approach
regressed 12-month outcomes on baseline measures, thus allowing for regression to the mean. Eligibility
was defined on the basis of ≥ 5 days with ≥ 540 minutes’ activity at baseline. If the participant was asked
to wear the accelerometer for a second time, the second 7 days was used in the analysis. If there were
> 7 days’ wear on the accelerometer, then the first 7 days were used and later readings were discarded.
The primary analysis used all participants providing at least 1 day of ≥ 540 minutes accelerometry wear
time at 12 months (i.e. a complete-case analysis).
All analyses were carried out using Stata, version 12. The xtmixed procedure was used for regression
models. A two-stage process was used for accelerometry data. Stage 1 estimated the average daily step
count at both baseline and 12 months, using a multilevel model in which daily step counts were regressed
on day of the week and day order of wearing the accelerometer (from day 1 to day 7) as fixed effects,
and with day within individual as the random effect (i.e. level 1 was the day within individual and level 2
was individual). In stage 2, average daily step count at 12 months was regressed on baseline average daily
step count, sex, age, general practice, month of baseline accelerometry and treatment group as fixed
effects, and household as the random effect, to allow for clustering at a household level (i.e. level 1 was
individual and level 2 was household). This method effectively measured the change in step count from
baseline to 12 months, minimising bias and maintaining power. Adjusting for baseline steps controlled for
many factors that predict the number of steps in cross-sectional analyses (e.g. BMI, socioeconomic group,
health status). The reference group for the intervention group comparisons was the control group. The
post-estimation command pwcompare was used to obtain the estimates of change with 95% CIs and
p-values for the difference in change in steps for the postal group versus the control group, the nurse-
support group versus the control group and the nurse-support group versus the postal group. This last
comparison provided information on whether or not the nurse intervention promoted a worthwhile
increase in activity compared with a pedometer alone. It should be noted that, although this estimate can
be obtained from the difference of the first two estimates, pwcompare also provided 95% CIs for this
comparison. Checks were carried out to confirm that the distribution of residuals from the regression
model for change in steps was normally distributed.
Secondary and ancillary outcome analyses
Secondary PA outcome measures from accelerometry were total weekly minutes of MVPA in ≥ 10-minute
bouts, average daily sedentary time at 12 months and steps, MVPA in bouts and sedentary time at
3 months. These data were processed and analysed in the same way as described for the step counts
(see Primary analysis). MVPA was highly positively correlated with step counts and sedentary time was
negatively correlated with step counts.
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Other ancillary outcomes were changes in exercise self-efficacy, anxiety, depression, perceived health
status (health-related quality of life, as measured using the EQ-5D-5L), self-reported pain, anthropometric
measures (weight, BMI, waist circumference, body fat) and self-reported PA from the IPPAQ and GPAQ
questionnaires. Changes in these outcomes from baseline to 3 and 12 months were analysed using
identical models to stage 2, as described in Primary analysis (i.e. level 1 was individual and level 2
was household).
Adverse event analyses
The number of participants who suffered an AE between 0 and 3 months or between 0 and 12 months
(a spontaneously reported SAE or a systematically reported SAE from the 3- or 12-month questionnaire,
or a SAE collected from the primary care record data) was compared between groups using exact tests for
categorical tables.
Subgroup analyses
Sex, age groups (< 60 years or ≥ 60 years), taking part as a couple, socioeconomic subgroups, BMI,
disability, pain and exercise self-efficacy were examined as potential effect modifiers by adding interaction
terms to the regression model for the primary outcome, which was changes in step counts at 12 months.
Sensitivity analyses
Sensitivity analyses were carried out for the primary outcome (change in step counts from baseline to
12 months). The effects of using different criteria for defining satisfactory wear at 12 months were examined
as follows: (1) at least 5 days of ≥ 540 minutes’ wear time, (2) ≥ 1 day of ≥ 600 minutes’ wear time and
(3) ≥ 5 days of ≥ 600 minutes’ wear time. The effect of adjusting for change in wear time between baseline
and 12 months was also examined.
Additional sensitivity analyses assessed whether participants lost to follow-up or who failed to provide a
single adequate day’s recording might have introduced bias. This was first done by assuming that outcome
data were missing at random, depending on the model covariates, using the Stata procedure mi impute.
The first model used the standard model covariates to impute missing step counts at 12 months (treatment
group, baseline steps, sex, age, general practice, month of baseline accelerometry and household as
a random effect) and the second model added in the National Statistics Socio-economic Classification
(NS-SEC), self-reported pain and fat mass as additional covariates. Further analyses explored the possible
impact of outcomes not being missing at random, using the following assumptions: among those with
missing data in the control group, the change in mean steps from baseline to 12 months was 0, and
among those with missing data in each of the intervention groups, the change in mean steps from
baseline to 12 months was –1500, 0 or +1500.
Ethics approval and research governance
Ethics approval was granted for the trial from London, Hampstead Research Ethics Committee (reference
number 12/LO/0219). The NHS Research and Development approval was granted by the Clinical
Commissioning Groups in south-west London, through the Primary Care Research Network, to cover
all the practice sites.
Management of the trial
The trial progress, including recruitment, safety, finance and data management, was reviewed regularly
by the trial management group (TMG). This was made up of the chief investigator, two trial investigators,
the trial statistician and the trial manager. The TMG met on a monthly basis. All of the trial investigators
met as a group (the trial investigator group) on a biannual basis, and the TSC met prior to participant
recruitment, and then annually or biannually as necessary. Minutes were kept of all TMG, trial investigator
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group and TSC meetings. The TSC included a patient advisor and more details of their role in terms of
patient and public involvement are given in Appendix 1.
Further trial follow-up at 3 years
After the initial trial results were analysed, funding was obtained to follow up the trial cohort at 3 years.
Details of the methods and results for this further follow-up are given in Chapter 8.
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Chapter 3 Results
The main results from the PACE-UP trial are published,93 and are reproduced here under the terms ofthe Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution,
and reproduction in any medium, provided that the original author and source are credited.
Recruitment of participants
The CONSORT diagram of participant flow (Figure 3) shows that of the 11,015 people invited to
participate, 6399 did not respond and 548 were excluded as a result of self-reported PA guideline
achievement; therefore, 1023 out of 10,467 (10%) were randomised.
Baseline characteristics of the study population (Table 4)
Participants recruited to the trial were evenly spread across the age groups. Just over one-third of those
recruited were men, around two-thirds were married and around one-fifth took part in the trial as a
couple. The majority were in full- or part-time employment, mostly in high-level manual, administrative
or professional jobs, with a minority in intermediate or routine and manual occupations. About 80% of
those recruited were of white ethnicity, around 10% were black/African/Caribbean or black British and
approximately 7% were Asian or Asian British. In terms of health factors, just under 10% were current
smokers, around 80% reported their health as being good or very good, the majority had one or more
chronic disease and some self-reported pain, around 60% reported no current disability, around 10% had
a high depression score, around 20% had a high anxiety score, and around two-thirds of participants were
overweight or obese. Recruitment occurred throughout all four seasons, but was slightly higher in summer
and slightly lower in winter. All of these factors were well balanced between the three randomised groups.
In terms of objectively measured baseline PA levels, the nurse-support group had a slightly higher baseline-
adjusted average daily step count [7653 steps, standard deviation (SD) 2826 steps] and minutes spent weekly
in MVPA in bouts of ≥ 10 minutes (105 minutes, SD 116 minutes) than the postal group (7402 steps,
SD 2476 steps; 92 minutes, SD 90 minutes) and the control group (7379 steps, SD 2696 steps; 84 minutes,
SD 97 minutes). A higher proportion of the nurse-support group participants were achieving the guidelines
of ≥ 150 minutes per week of MVPA in bouts of ≥ 10 minutes (26%, 89/346) than participants in the
postal group (20%, 68/339) and those in the control group (18%, 61/338). The three groups were similar
in terms of average daily sedentary time, at around 10 hours per day.
In terms of self-reported PA levels the patterns were different, with the control group reporting the highest
number of weekly minutes of MVPA on the IPAQ, not including walking; however, the nurse-support
group reported higher levels of MVPA if walking was included. A slightly higher proportion of participants
in the control group than those in the intervention groups reported being active on the GPPAQ PAI, both
excluding and including walking.
Losses to follow-up
Figure 3 shows the losses to follow-up. Of the 1023 people randomised, 32 (3%) withdrew and eight
(1%) were unable to be contacted at 12 months. In total, 956 out of 1023 participants (93%) provided
at least 1 day of 540 minutes’ wear time accelerometer data and were included in the 12-month
primary analyses.
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Enrolment
Allocation
Patients randomly selected to be invited
(n = 12,625)
Not randomised
(n = 9992)
Control group participants
(n = 338; 305 households)
Nurse intervention participants
(n = 346; 310 households)
Patients aged 45 – 74 years
from general practice searches
(n = 25,521)
Not randomly selected
(n = 8618)
• Not eligible (READ code), n = 4206
• In residential/nursing homes,
   n = 72Patients eligible to be invited to participate
(n = 21,243)
• Not eligible (GP decision)
Patients invited to participate 
(n = 11,015; 8886 households)
Patients randomised
(n = 1023; 922 households)
Postal intervention participants
(n = 339; 307 households)
3-month follow-up and analysis
Participants analysed 
(287 households) with complete 
accelerometer data
(n = 318)
Participants analysed 
(289 households) with complete 
accelerometer data
(n = 317)
Participants analysed 
(286 households) with complete 
accelerometer data
(n = 319)
12-month follow-up and analysis
Participants analysed 
(292 households) with complete 
accelerometer data
(n = 323)
Participants analysed 
(283 households) with complete 
accelerometer data
(n = 312)
Participants analysed 
(289 households) with complete 
accelerometer data
(n = 321)
Excluded
(n = 4278)
Excluded
(n = 1610)
• No response, n = 6399
• Did not wish to take part, n = 2918
• Too active, n = 548
• Recruited not randomised, n = 127
  • Withdrawn, n = 1
  • Not able to be contacted, n = 2
  • Inadequate accelerometry, n = 17
  • Withdrawn, n = 3
  • Not able to be contacted, n = 3
  • Inadequate accelerometry, n = 9
• Withdrawn, n = 3
• Not able to be contacted, n = 1
• Inadequate accelerometry, n = 18
  • Withdrawn, n = 12
  • Not able to be contacted, n = 4
  • Inadequate accelerometry, n = 11
  • Withdrawn, n = 17
  • Not able to be contacted, n = 1
  • Inadequate accelerometry, n = 7
  • Withdrawn, n = 8
  • Not able to be contacted, n = 3
  • Inadequate accelerometry, n = 16
FIGURE 3 The PACE-UP trial CONSORT flow diagram. Adapted from Harris et al.93 This is an open access article
distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits
others to distribute, remix, adapt and build upon this work, provided the original work is properly cited.
See: http://creativecommons.org/licenses/by/4.0.
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TABLE 4 Baseline characteristics of the 1023 randomised subjects
Characteristic
Trial arm
Control
(N= 338)
Postal
(N= 339)
Nurse
(N= 346)
Age (years) at randomisation, n (%)
45–54 101 (30) 118 (35) 121 (35)
55–64 138 (41) 125 (37) 124 (36)
65–75 99 (29) 96 (28) 101 (29)
Sex (male) , n (%) 115 (34) 124 (37) 128 (37)
Marital status (married), n (%) 213 (64) 215 (65) 230 (68)
Randomised as a couple,a n (%) 66 (20) 68 (20) 73 (21)
Employment status,79 n (%)
In full- or part-time employment 190 (57) 193 (59) 190 (56)
Retired 102 (31) 96 (29) 101 (30)
Other 39 (12) 39 (12) 50 (15)
NS-SEC (current or previous job),79 n (%)
High-level managerial, administrative, professional 199 (62) 191 (60) 184 (56)
Intermediate occupations 70 (22) 85 (27) 95 (29)
Routine and manual occupations 51 (16) 44 (14) 52 (16)
Ethnicity,79 n (%)
White 253 (78) 270 (83) 267 (80)
Black/African/Caribbean/black British 30 (9) 31 (10) 40 (12)
Asian/Asian British 26 (8) 20 (6) 22 (7)
Other 15 (5) 4 (1) 6 (2)
Current smoker, n (%) 27 (8) 29 (9) 26 (8)
General health:79 very good or good, n (%) 265 (80) 277 (84) 277 (82)
Chronic diseases, n (%)
None 129 (39) 135 (41) 117 (35)
One or two 183 (55) 171 (51) 188 (55)
≥ 3 21 (6) 27 (8) 34 (10)
Presence of self-reported pain,77 n (%) 220 (66) 236 (71) 234 (70)
Limiting long-standing illness,79 n (%) 76 (23) 73 (22) 74 (22)
Townsend disability score,80 n (%)
None (0) 190 (57) 196 (59) 210 (62)
Slight or some disability (1–6) 127 (38) 130 (39) 124 (36)
Appreciable or severe disability (7–18) 15 (5) 8 (2) 7 (2)
HADS depression score:75 borderline or high, n (%) 36 (11) 33 (10) 42 (12)
HADS anxiety score:75 borderline or high, n (%) 65 (19) 64 (19) 71 (21)
Low self-efficacy score,74 n (%) 102 (31) 96 (29) 117 (35)
continued
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TABLE 4 Baseline characteristics of the 1023 randomised subjects (continued )
Characteristic
Trial arm
Control
(N= 338)
Postal
(N= 339)
Nurse
(N= 346)
Month of baseline measure, n (%)
March–May 80 (24) 75 (22) 76 (22)
June–August 105 (31) 106 (31) 110 (32)
September–November 88 (26) 82 (24) 92 (27)
December–February 65 (19) 76 (22) 68 (20)
Physical characteristics
Overweight/obese: BMI of ≥ 25 kg/m2, n (%) 227 (67) 221 (65) 233 (67)
Fat mass (kg), mean (SD) 26 (10) 27 (11) 26 (11)
Waist circumference (cm), mean (SD) 93 (14) 94 (14) 93 (13)
PA data
Accelerometry
Adjusted baseline step count per day, mean (SD) 7379 (2696) 7402 (2476) 7653 (2826)
Total weekly minutes of MVPA in ≥ 10-minute bouts, mean (SD) 84 (97) 92 (90) 105 (116)
Average daily sedentary time (minutes), mean (SD) 613 (68) 614 (71) 619 (78)
Average daily wear time (minutes), mean (SD) 789 (73) 787 (78) 797 (84)
150 minutes of MVPA in ≥ 10-minute bouts (yes), n % 61 (18) 68 (20) 89 (26)
IPAQ score72
IPAQ MVPA score: total weekly minutes of MVPA in ≥ 10-minute
bouts (N= 909), mean (SD)
197 (314) 147 (256) 172 (279)
IPAQ walking score: total weekly minutes of walking in ≥ 10-minute
bouts (N= 888), mean (SD)
333 (333) 330 (338) 312 (277)
150 weekly minutes of IPAQ MVPA score (N = 909): yes, n (%) 110 (37) 91 (30) 109 (35)
150 weekly minutes of IPAQ walking score (N= 888): yes, n (%) 193 (65) 190 (66) 208 (69)
GPPAQ score,73 n (%)
PAI score (N = 973)
Inactive 159 (49) 153 (48) 156 (47)
Moderately inactive 69 (21) 66 (21) 83 (25)
Moderately active 50 (16) 63 (20) 60 (18)
Active 44 (14) 36 (11) 34 (10)
PAI score, including walking (GPPAQ walking score; N = 973)
Inactive 129 (40) 134 (42) 133 (40)
Moderately inactive 57 (18) 56 (18) 63 (19)
Moderately active 43 (13) 49 (15) 47 (14)
Active 93 (29) 79 (25) 90 (27)
SD, standard deviation.
a Two and one participants in the postal and nurse groups, respectively, were randomised and took part in the trial as a
couple, although their partner was excluded before randomisation because of a lack of wear time.
Adapted from Harris et al.93 This is an open access article distributed in accordance with the terms of the Creative
Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work,
provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0.
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Data completeness for accelerometry
Accelerometer wear time was similar between the groups at baseline, the 3-month follow-up point
and the 12-month follow-up point (see Tables 4 and 5). Over 90% of all groups provided ≥ 5 days of
≥ 540 minutes’ wear time at 12 months (see Appendix 2, Table 23).
Effect of the intervention on accelerometer-assessed physical activity
outcomes (Table 5)
Three-month (interim) outcomes
There were significant differences for the change in average daily step counts from baseline to 3 months
between intervention groups and the control group: additional step counts (steps per day) were 692 steps
(95% CI 363 to 1020 steps; p < 0.001) for the postal group and 1173 steps (95% CI 844 to 1501 steps;
p < 0.001) for the nurse-support group, and the difference between the intervention groups was statistically
significant (481 steps, 95% CI 153 to 809 steps; p = 0.004). Findings for the change in time in MVPA levels
showed a similar pattern: additional MVPA in bouts of ≥ 10 minutes (minutes per week) was 43 minutes
(95% CI 26 to 60 minutes; p < 0.001) for the postal group and 61 minutes (95% CI 44 to 78 minutes;
p < 0.001) for the nurse-support group, and the difference between intervention groups was 18 minutes
(95% CI 1 to 35 minutes; p = 0.04). There was no difference between the groups for the change in
sedentary time. Summary data for the 3-month PA outcomes are shown in Appendix 2, Table 24.
TABLE 5 Primary and secondary accelerometry outcome data
Outcome
Comparison between trial arms
Postal vs. control Nurse support vs. control Nurse support vs. postal
Effect (95% CI) p-value Effect (95% CI) p-value Effect (95% CI) p-value
Daily step count
3 months 692 (363 to 1020) < 0.001 1173 (844 to 1501) < 0.001 481 (153 to 809) 0.004
12 months 642 (329 to 955) < 0.001 677 (365 to 989) < 0.001 36 (–277 to 349) 0.82
Total weekly minutes of MVPA in ≥ 10-minute bouts
3 months 43 (26 to 60) < 0.001 61 (44 to 78) < 0.001 18 (1 to 35) 0.04
12 months 33 (17 to 49) < 0.001 35 (19 to 51) < 0.001 2 (–14 to 17) 0.83
Daily sedentary time (minutes)
3 months –2 (–12 to 7) 0.59 –7 (–16 to 3) 0.16 –4 (–13 to 5) 0.38
12 months 1 (–8 to 10) 0.83 –0.2 (–9 to 9) 0.96 –1 (–10 to 8) 0.79
Daily wear time (minutes)
3 months 2 (–8 to 12) 0.69 4 (–6 to 14) 0.40 2 (–8 to 12) 0.65
12 months 9 (–1 to 19) 0.08 9 (–0.8 to 19) 0.07 0.3 (–10 to 10) 0.96
Notes
Accelerometry data were available in the control, postal and nurse groups for 318, 317 and 319 participants at 3 months,
respectively, and for 323, 312 and 321 at 12 months, respectively.
All models include practice, sex, age at randomisation and month of baseline accelerometry as fixed effects and household
as a random effect in a multilevel model.
The xtmixed command in Stata was used, followed by the post-estimation command pwcompare, to generate the pairwise
estimates of effect and their CIs.
Adapted from Harris et al.93 This is an open access article distributed in accordance with the terms of the Creative
Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work,
provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0.
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Twelve-month (main) outcomes
Both intervention groups increased their step counts between baseline and 12 months compared with the
control group: additional step counts (steps per day) were 642 steps (95% CI 329 to 955 steps; p < 0.001)
for the postal group and 677 steps (95% CI 365 to 989 steps; p < 0.001) for the nurse-support group,
with no statistically significant difference between intervention groups (36 steps, 95% CI –277 to 349
steps; p = 0.82). Time spent in MVPA in bouts showed a similar pattern, that is, both intervention groups
increased at 12 months compared with the control group: additional MVPA in bouts (minutes per week)
was 33 minutes (95% CI 17 to 49 minutes; p < 0.001) for the postal group and 35 minutes (95% CI 19 to
51 minutes; p < 0.001) for the nurse-support group, with no statistically significant difference between the
two intervention groups (2 minutes, 95% CI –14 to 17 minutes; p = 0.83). Again, there was no difference
between the groups for the change in sedentary time. Summary data for the 12-month PA outcomes are
shown in Appendix 2, Table 24.
Residuals from the 12-month models for steps and weekly MVPA in ≥ 10-minute bouts were plotted, and
the distribution of residuals from both models was normally distributed (see Appendix 2, Figure 18).
Effect of the intervention on self-reported physical activity outcomes at
12 months (Table 6)
At 12 months, the IPAQ weekly minutes of MVPA (not including walking) did not show any effect of the
intervention for either intervention group compared with the control group. However, weekly minutes of
walking from the IPAQ at 12 months compared with baseline showed significant increases for both groups
compared with controls: 69 minutes (95% CI 19 to 119 minutes) in the postal group and 55 minutes
(95% CI 5 to 105 minutes) in the nurse-support group; there was no difference between the intervention
groups (–14 minutes, 95% CI –64 to 37 minutes). This was also reflected in the odds ratio (OR) for
achieving ≥ 150 minutes of activity in a week, conditional on the baseline state, which was not significant
for IPAQ MVPA for either intervention group, but was for IPAQ walking (postal group vs. control group:
OR 2.1 minutes, 95% CI 1.3 to 3.3 minutes; nurse-support group vs. control group: OR 1.7 minutes,
TABLE 6 Effect estimates for self-report questionnaires (IPAQ and GPPAQ) at 12 months
Questionnaire outcome
Comparison between trial arms
Postal vs. control Nurse support vs. control Nurse support vs. postal
Effect (95% CI) p-value Effect (95% CI) p-value Effect (95% CI) p-value
IPAQ72
Change in weekly minutes of activity
Vigorous and moderate
activity (n = 775)
–10 (–58 to 38) 0.67 –32 (–80 to 16) 0.19 –22 (–70 to 27) 0.38
Walking (n= 750) 69 (19 to 119) 0.01 55 (5 to 105) 0.03 –14 (–64 to 37) 0.59
OR for achieving ≥ 150 minutes of activity in a week at follow-up, conditional on baseline state
Vigorous and moderate
activity (n = 775)
1.0 (0.5 to 2.0) 0.99 0.6 (0.3 to 1.3) 0.18 0.6 (0.3 to 1.3) 0.19
Walking (n= 750) 2.1 (1.3 to 3.3) 0.001 1.7 (1.1 to 2.6) 0.01 0.8 (0.5 to 1.3) 0.41
GPPAQ73
OR for being active at follow-up, conditional on baseline state
PAI (n= 892) 1.2 (0.7 to 2.1) 0.46 0.9 (0.5 to 1.6) 0.80 0.8 (0.4 to 1.3) 0.32
PAI, including walking
(n= 892)
1.1 (0.6 to 1.8) 0.81 0.9 (0.5 to 1.5) 0.64 0.8 (0.5 to 1.4) 0.48
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95% CI 1.1 to 2.6 minutes); there was no difference between the intervention groups (OR 0.8 minutes,
95% CI 0.5 to 1.3 minutes).
For the GPPAQ, the OR for being active at the 12-month follow-up, conditional on the baseline state,
did not show a significant effect for either of the intervention groups compared with the control group,
whether or not walking was included in the GPPAQ PAI.
Summary data for the effect of the intervention on the IPAQ and the GPPAQ are given in Appendix 2,
Table 25.
Effect of the intervention on other health-related outcomes (Table 7)
Fat mass was slightly reduced at 12 months in both intervention groups, but this did not differ significantly
from the control group. There was no change in BMI or waist circumference between baseline and 12 months.
The interventions had no significant effects on anxiety, depression, quality of life (EQ-5D-5L) or pain scores
at either 3 months or 12 months. The exercise self-efficacy score significantly increased in both intervention
groups at 3 months compared with the control group, and there was a greater effect in the nurse-support
group than in the postal group. By 12 months, the self-efficacy score was significantly higher in the nurse
group than in the control group, and the postal group was intermediate between, but not significantly
different from, either of the other groups.
Effect of the intervention on adverse events and serious adverse events
(Table 8)
The number of total AEs did not differ between the groups at either 3 months or 12 months, whether
using higher numbers of events self-reported from the patient questionnaire (falls, fractures, sprains or
injuries) or lower numbers of events from primary care records (any AE – cardiovascular, fracture, sprains/
injuries, falls or pain from back or lower limb). There was also no between-group difference in trial SAEs
reported for safety monitoring. Self-reported falls were lower in the nurse-support group at 12 months
(43/318, 14%) than in the postal group (57/310, 18%) or the control group (71/318, 22%; p = 0.02).
Falls reported in primary care records over 12 months were fewer in number, but also in the same direction,
although the differences were non-significant (p = 0.13). Primary care-recorded cardiovascular events over
0–12 months were lower in the nurse-support group (2/340, 0.6%) and the postal group (1/331, 0.3%)
than in the control group (8/334, 2.4%; p = 0.04).
Subgroup analyses (Figure 4)
There was no evidence of effect modification on the change in step count at 12 months for either of the
intervention groups versus the control group for any of the following: age, sex, taking part as a couple,
BMI, disability, pain, socioeconomic group and exercise self-efficacy.
Sensitivity analyses and imputations (see Appendix 2, Table 26)
The sensitivity analyses on the primary outcome measure (change in average daily step count at
12 months), restricted to those with ≥ 600 minutes’ daily wear time, increased the effect size for both
intervention groups versus the control group, but did not change the interpretation (both intervention
groups had a significant effect compared with the control group, but there was no significant difference
between the interventions). Similarly, imputations with both missing-at-random and missing-not-at-random
assumptions made some difference to the effect sizes for both interventions compared with the control
group and with each other, but, again, made no difference to the overall interpretation.
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TABLE 7 Effect estimates for other health-related outcomes
Health-related outcome
Comparison between trial arms
Postal vs. control Nurse support vs. control Nurse support vs. postal
Effect (95% CI) p-value Effect (95% CI) p-value Effect (95% CI) p-value
BMI (kg/m2)
12 months –0.1
(–0.3 to 0.1)
0.24 –0.03
(–0.2 to 0.1)
0.71 0.07
(–0.1 to 0.3)
0.42
Fat mass (kg)
12 months –0.4
(–0.8 to 0.07)
0.10 –0.2
(–0.7 to 0.2)
0.30 0.1
(–0.3 to 0.6)
0.54
Waist circumference (cm)
12 months –0.04
(–0.8 to 0.7)
0.92 0.08
(–0.6 to 0.8)
0.23 0.1
(–0.6 to 0.8)
0.74
HADS anxiety score75
3 months –0.3
(–0.7 to 0.1)
0.13 –0.3
(–0.7 to 0.1)
0.16 0.01
(–0.4 to 0.4)
0.94
12 months –0.2
(–0.6 to 0.2)
0.28 –0.2
(–0.6 to 0.2)
0.28 0.0006
(–0.4 to 0.4)
1.00
HADS depression score75
3 months –0.2
(–0.6 to 0.1)
0.12 –0.2
(–0.5 to 0.1)
0.19 0.04
(–0.3 to 0.3)
0.82
12 months –0.1
(–0.5 to 0.2)
0.44 –0.02
(–0.4 to 0.3)
0.91 0.1
(–0.2 to 0.5)
0.51
EQ-5D-5L score76
3 months –0.005
(–0.02 to 0.01)
0.60 –0.01
(–0.03 to 0.01)
0.26 –0.006
(–0.03 to 0.01)
0.54
12 months –0.01
(–0.03 to 0.01)
0.30 –0.01
(–0.03 to 0.01)
0.23 –0.002
(–0.02 to 0.02)
0.87
Exercise self-efficacy score74
3 months 1.1
(0.2 to 2.0)
0.01 2.3
(1.4 to 3.2)
< 0.001 1.2
(0.3 to 2.1)
0.01
12 months 0.6
(–0.3 to 1.6)
0.20 1.2
(0.3 to 2.2)
0.01 0.6
(–0.4 to 1.5)
0.22
Self-reported pain score
3 months 0.05
(–0.06 to 0.17)
0.37 0.05
(–0.07 to 0.16)
0.42 –0.004
(–0.12 to 0.11)
0.94
12 months 0.05
(–0.06 to 0.17)
0.35 0.02
(–0.10 to 0.13)
0.76 –0.04
(–0.15 to 0.08)
0.53
Notes
At baseline, data were available for all participants for BMI and waist circumference, and for 335, 337 and 346 participants
in the control, postal and nurse-support groups, respectively, for fat mass.
At 12 months, data were available in the control, postal and nurse-support groups for 323, 314 and 321 participants,
respectively, for BMI and waist circumference, and for 319, 308 and 320, respectively, for fat mass.
Questionnaire data were available for varying numbers of participants at baseline, 3 months and 12 months.
All models include practice, sex, age at randomisation and month of baseline accelerometry as fixed effects and household
as a random effect in a multilevel model.
Adapted from Harris et al.93 This is an open access article distributed in accordance with the terms of the Creative
Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work,
provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0.
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TABLE 8 Adverse events
AEs
Time frame in each trial arm
0–3 months 0–12 months
Control,
n (%)
Postal,
n (%)
Nurse
support,
n (%) p-valuea
Control,
n (%)
Postal,
n (%)
Nurse
support,
n (%) p-valuea
AEs reported on the
questionnaire (N = 931) (N = 946)
Fall, fracture, sprain or
injury
59/313
(19)
70/310
(23)
65/308
(21)
0.51 113/318
(36)
99/310
(32)
96/318
(30)
0.34
Fall 25 (8) 24 (8) 24 (8) 0.99 71 (22) 57 (18) 43 (14) 0.02
Fracture 3 (1) 3 (1) 7 (2) 0.28 15 (5) 10 (3) 11 (3) 0.57
Sprain or injury 49 (16) 54 (17) 47 (15) 0.74 66 (21) 68 (22) 63 (20) 0.81
(N = 911) (N = 924)
Deterioration in health
problems already
present since the start
of the study
33/311
(11)
30/303
(10)
39/297
(13)
0.42 68/313
(22)
67/300
(22)
65/311
(21)
0.91
AEs from primary
care recordsb (N = 1005) (N = 1005)
Any AE 29/334
(8.7)
23/331
(7.0)
20/340
(5.9)
0.36 85/334
(25.5)
75/331
(22.7)
77/340
(22.7)
0.62
Cardiovascularc 2 (0.6) 0 1 (0.3) 0.55 8 (2.4) 1 (0.3) 2 (0.6) 0.04
Fracture 4 (1.2) 2 (0.6) 2 (0.6) 0.68 11 (3.3) 4 (1.2) 4 (1.2) 0.11
Sprain/injury 2 (0.6) 1 (0.3) 2 (0.6) 1.00 8 (2.4) 4 (1.2) 5 (1.5) 0.51
Fall 0 0 0 8 (2.4) 4 (1.2) 2 (0.6) 0.13
Pain (back or lower
limb)
23 (6.9) 20 (6.0) 16 (4.7) 0.48 65 (19.5) 65 (19.6) 70 (20.6) 0.93
SAE spontaneously
reportedd (N = 1023) (N = 1023)
SAE 3/338
(0.9)
1/339
(0.3)
3/346
(0.9)
0.65 10/338
(3.0)
5/339
(1.5)
11/346
(3.2)
0.30
a Chi-squared tests or Fisher exact tests were carried out to assess the statistical significance of the overall differences
between the three groups.
b A total of 1005 participants gave permission at randomisation for their primary care records to be accessed
and downloaded.
c Cardiovascular events recorded in primary care records included a new episode of any of the following: myocardial
infarction, coronary artery bypass graft, angioplasty, ischaemic heart disease, angina, transient ischaemic attack
and stroke.
d Information on spontaneously reported SAEs was collected for the entire cohort (i.e. n= 1023). SAEs were recorded for
safety purposes contemporaneously in the trial, and included the following: deaths, hospital admission and new-onset
disability. All of the SAEs reported during the 0- to 12-month trial follow-up were emergency hospital admissions.
Adapted from Harris et al.93 This is an open access article distributed in accordance with the terms of the Creative
Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work,
provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0.
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Summary of the main trial findings
Overall, 10% (1023/10,467) of those invited participated in the trial, and we had primary outcome data on
93% (956/1023) of participants at 12 months. Although the nurse-supported intervention had a greater
effect on objective PA outcomes at 3 months, by the main 12-month outcome, both the postal and
nurse-supported pedometer interventions significantly increased step counts by around 10%, and time in
MVPA in bouts by around one-third compared with the control group, with no statistically significant
difference between the interventions. There was no significant effect of the interventions on sedentary
time or anthropometric measures. In terms of the effects on self-reported PA levels, the IPAQ MVPA
questions did not show any intervention effect, but both the nurse-supported intervention and the postal
intervention showed a significant effect on the IPAQ walking question. The GPPAQ score did not show an
intervention effect, even when walking was included in the score. The interventions had no effect on most
other patient-reported outcomes, except that exercise self-efficacy was increased in both intervention
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FIGURE 4 Subgroup analyses. (a) Postal group and control group; and (b) nurse-support group and control group.
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groups at 3 months, and in the nurse-support group at 12 months, compared with the control group. AEs
were not increased by the interventions; some individual AEs were lower in the intervention groups, but
this was based on small numbers of events. No important subgroup effects were demonstrated, and the
sensitivity analyses and imputations did not change the interpretation of the trial results.
The following chapters present the results relating to other aspects of the trial: the economic evaluation
(see Chapter 4), generalisability and representativeness (see Chapter 5), the process evaluation (see Chapter 6),
the qualitative evaluation (see Chapter 7) and the 3-year trial follow-up (see Chapter 8). Chapter 9 discusses
the trial findings in detail.
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FIGURE 4 Subgroup analyses. (a) Postal group and control group; and (b) nurse-support group and control group.
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Chapter 4 Economic evaluation
Introduction
Evidence on the short- and long-term cost-effectiveness of pedometer-based interventions could support
the development of policy and practice encouraging increased PA. Calls for evidence on ‘what works’
have been made, in both primary and secondary prevention policy documents, along with appeals to link
interventions to clear health outcomes and ensure that resources are used most efficiently.94,95
To date, only one published estimate of the cost-effectiveness of pedometer programmes for the UK was
based on primary evidence.58 A small (n = 79), highly selected (80% of women from one GP practice in
Glasgow) sample was used. A ‘maximal’ pedometer-based walking programme, which included two
30-minute consultations (based on the transtheoretical model of behaviour change), was compared with a
waiting list control group, which was asked to wait for 12 weeks, after which the group members received
a ‘minimal’ walking programme, which included a pedometer and two 5-minute slots of brief advice.45,96
Compared with the 12-week waiting list control group, it cost an additional £92 per person to achieve an
additional eight people meeting the target of 15,000 steps per day over a 12-week period. Comparing
the maximal walking programme with the minimal walking programme, it cost a further £591 for one
additional person to achieve the same target. No data were collected on QALYs, and long-term
cost-effectiveness was not modelled.
Elsewhere, in Australia, New Zealand and the Netherlands, evidence on the benefits of pedometer-based
interventions for primary prevention has been assessed for community-based adults with low PA levels.97–99
Interventions such as pedometer prescriptions and pedometer-based telephone coaching were compared
with time-based activity prescriptions or usual practice. Evidence suggests that pedometers may be cost-
effective in the long term, but estimates vary widely (from being cost-saving and having fewer disability-
adjusted life-years in Australia in the long term to €11,110 per QALY gained). The generalisability of results
to other contexts has also not been considered.100
This chapter examines the short- and long-term cost-effectiveness, from the NHS perspective, of alternative
pedometer-based walking programmes to increase PA levels using PA outcomes for comparison with
other PA programmes and QALYs to aid decision-making beyond PA programmes. The interventions are
compared against usual practice, in inactive adults aged 45–75 years from south London, and are as
described in Chapter 2:
1. provision, by post, of pedometers with written instructions
2. pedometers provided with tailored support from a practice nurse.
This chapter is structured into two sections: (1) a within-trial analysis with a time horizon of 1 year, and
(2) beyond-trial modelling that takes a lifetime perspective. In each section, the methods and results are
presented. This is followed by a discussion of the findings in the context of the strengths and weaknesses
of the study, as well as current literature.
Within-trial cost-effectiveness analysis
The population, interventions and comparator are identical to Chapter 2. Harris et al.70 set out the protocol
for methods, including for the economic evaluation. This section covers methods used to measure, value and
aggregate costs and outcomes, the treatment of missing data and methods of assessing cost-effectiveness.
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Methods
Identification, measurement, valuation and aggregation of cost
To identify NHS resource use, meetings with the trial team established ‘who did what, to whom and how
often’,101 accounting for events that are likely to have high unit costs, be frequent or differ between trial
arms, and excluding research-focused costs. NHS resources identified for collection included:
l Set-up of service (e.g. design, setting up the intervention in GP practices and staff training, but
excluding trial set-up; see Appendix 3, Table 27).
l Delivery of service, including, for example, pedometers, post/telephone services, handbooks and staff
time; all costs fell within months 0–3, except research assistant contacts with participants (4–12 months;
see Appendix 3, Table 28).
l Health service use in primary care (GP and nurse consultations, excluding nurse PA consultations
undertaken as part of the trial) and secondary care (hospital admissions, A&E, outpatients), as changes
could occur from treating AEs and changes in lifestyle (see Appendix 3, Table 29); the health service
data were available on the 1005 out of 1023 randomised participants who gave written informed
consent for their primary care data to be downloaded. Of these, 956 participants (323 in the control
group, 312 in the postal group and 321 in the nurse-support group) also had 12-month outcome data
and, therefore, were included in the health economic analyses relating to health service use.
Resource use was measured using administrative/trial management records, electronic diaries and
interviews of the trial manager and the principal investigator. Participant-level health service use (e.g.
GP visits, referrals) was collected through a one-time download of GP records, for those who gave explicit
consent for this, at the end of the trial (see Appendix 3, Tables 27–29).
NHS resources were valued using national costs102,103 (see Appendix 3, Tables 27–33) to increase
generalisability. Where national unit costs were not available, local unit costs from St George’s Hospital,
London, were used. All costs were expressed in 2013–14 pounds sterling, inflated to the same base year
when appropriate, using the Hospital and Community Health Service inflation index.103 As the study covers
1 year, costs and outcomes were not discounted. All resources and costs were collected at, or apportioned
to, the trial participant level. The total cost per participant was the sum of each resource use multiplied by
the relevant unit cost over 0–3 and 4–12 months, with costs censored at 12 months.
To support a sensitivity analysis of an alternative wider viewpoint that included participants, as participation
can be affected by economic barriers, three types of costs borne by participants were collected: participation
in the intervention (e.g. time and money spent accessing the intervention for months 0–3; see Appendix 3,
Table 30), money shown to contribute to the costs of ‘walking’ and other PA (e.g. membership/event fees,
shoes/clothing, food/drink)104 and money spent as a result of falls/fractures/sprains/injuries. These data were
collected for months 1–3 using participant-completed questionnaires at 3 months and for months 10–12
using the participant-completed questionnaires at 12 months (see Appendix 1). As the data for months
10–12 were follow-up data beyond the intervention, costs from months 10–12 were multiplied by three
(to approximate annual costs when added to the cost from months 1–3) and added to the costs from
months 1–3 for an annual participant cost.
Measurement, valuation and aggregation of outcomes
The economic analysis uses indicators of PA outcomes. The use of cost per additional step aids comparison
of inputs with directly intended and objectively measured outputs, which the trial was specifically powered
to detect, and which therefore relates the economics to the main trial outcome. As objectively measured
weekly minutes of MVPA in bouts of ≥ 10 minutes were statistically significantly different, have important
health impacts, provide a second point of comparison to other studies and link directly to the longer-term
model, these were also included as an additional outcome measure for assessing cost-effectiveness.
ECONOMIC EVALUATION
NIHR Journals Library www.journalslibrary.nihr.ac.uk
36
To facilitate the comparison of the PACE-UP trial with other health interventions using the quality-of-life
measure recommended for evaluating health interventions in England, participants also completed the
EQ-5D-5L questionnaire at baseline, 3 and 12 months. The EQ-5D-5L, rather than the EQ-5D-3L (EuroQol-5
Dimensions, three-level version), was selected as the EQ-5D-3L is known to suffer from ‘ceiling effects’ and
the five-level version was expected to be more sensitive to differences in health among healthier people
and, therefore, less subject to suffer from ceiling effects. This has been subsequently shown to be the case
in England, especially for older populations, and, therefore, the EQ-5D-5L has been recommended for use
in general population surveys (despite the ceiling effects of dimensions ranging from 58–90%).105 Utility
weights were assigned at each time point, based on an interim scoring ‘cross-walk’ function106 linked to
the standard UK-based weights.107 EuroQol-5 Dimensions (EQ-5D) utilities were converted to QALYs over
the trial period using the ‘area under the curve’ method.108
Methods of analysis
Missing data
Data were investigated for patterns of missingness.109 Mean imputation was used when the proportion of
missing data was ≤ 5%.110,111 Missing EQ-5D-5L data were replaced using an index, rather than domain
imputation, as the sample size was > 500.112 Multiple imputation by chained equations was fitted to replace
item non-response. In line with Rubin’s rules113 and other recommendations,114,115 the point estimate for
imputations was derived by averaging estimates of the imputed data based on results from five imputations.
The point estimate for categorical data was rounded up to the nearest decimal point. The imputation
model included variables used in the main model for the analysis, while also including the predictors of
missingness. The dependent variable was included in the imputation model to ensure that the imputed
values have the same relationship to the dependent variable as the observed values.116
Incremental cost-effectiveness analyses
Incremental cost-effectiveness analyses were based on multiple regression models to adjust for variations
not accounted for by randomisation, and to provide more robust estimates. Generalised linear models
(GLMs) were fitted separately for costs and QALYs,117 accounting for the cluster effect (identified as
household identifier) via clustered standard errors.118 Models used for step count and MVPA have been
described in Chapter 2. The cost models used the Poisson distribution and the QALY models used the
binomial 1 family, equivalent to beta regression.119 Although the generalised linear models do not account
for the correlation between costs and QALYs, the efficiency loss (i.e. higher standard errors) will be
minimal, as the inclusion of the cluster effect provides robust standard errors and mitigates the effects of
potential inaccuracies in the family distribution used. The choice of distributional family rested on the
modified Park test120 and the comparison of observed and predicted values. Covariates included the
baseline level (for QALY-based models), as recommended,116 practice and variables found to be correlates
of PA-related outcomes – that is, demography (age, sex, ethnicity, marital status, education, employment,
socioeconomic status, cohabitation), health (number of disease conditions) and other lifestyle behaviours
(smoking and alcohol intake).121 Reduced models were generated using Wald tests to examine the joint
significance of variables found to be insignificant in the base model. Significance levels were set at 5%.
To provide more precise estimates of uncertainty, the ‘margins method’ was used to generate sample
means for trial arms and incremental point estimates for costs and QALYs.116,122 A different standard error
and calculated CIs123 accounted for the cluster design.
Sensitivity analyses
To reflect the stochastic uncertainty surrounding the mean incremental cost-effectiveness, cost-effectiveness
planes and cost-effectiveness acceptability curves (CEACs) were constructed using 2000 non-parametric
samples from the base-case estimates. Bootstrapping used a new unique identifier for the clusters in
addition to the original cluster identifier (household ID).116
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Deterministic sensitivity analyses performed included:
l all randomised participants (not only those who provided accelerometry data)
l varying exclusion of costs of health service use beyond the immediate intervention
l a method of accounting for AEs
l only spontaneously self-reported SAEs
l only GP data relating to AEs; these were predefined by GP investigators and collaborators (TH, SI, SDW, JI)
as possibly being related to increased walking, and included musculoskeletal events (falls requiring medical
attention, fractures, sprains or injuries, pain in back or lower limb) and cardiovascular events [myocardial
infarction, coronary artery bypass graft, angioplasty, stroke, transient ischaemic attack or new-onset
ischaemic heart disease (angina)]
l a perspective of analysis (i.e. NHS with or without users)
l variation in the length of the life of a pedometer (between 1 and 4 years)
l scenario combinations (excluding all health service use costs, and including participant costs related
to participation in PA and interventions, except the health service use cost borne by participants),
to ensure that the long-run model could use evidence of ‘worst-case’ findings.
Results
Table 9 summarises the data on costs, EQ-5D-5L utility scores and quality of life (see Appendix 3,
Tables 31–35). At 3 months, the average cost per participant was highest in the nurse group (£249),
followed by the postal group (£122) and the control group (£107). The mean cost and distribution is
affected considerably by the inclusion of health service use, which resulted in the control group costing
£36 more per participant than the postal group and £12 more than the nurse-support group. QALYs
varied marginally, with the gap being the greatest between the control and postal groups at +0.002.
At 12 months, the average cost per participant was highest in the nurse group (£603), followed by the
control group (£461) and the postal group (£375). The inclusion of health service use resulted in the control
group costing £86 more per participant than the postal group, but £142 less than the nurse-support group.
QALYs were marginally higher in the postal group (0.843 QALYs) than in the control group (0.837 QALYs)
and the nurse-support group (0.836 QALYs) group.
The main results (Table 10), which are adjusted for baseline differences, show that, at 3 months, the cost
of the nurse-support group was statistically significantly higher than that of the control group (£135,
95% CI £99 to £171), whereas this was not the case for the postal group (£15, 95% CI –£15 to £45).
Table 10 also shows that there was a statistically significant increase in daily steps and minutes of MVPA in
≥ 10-minute bouts for the intervention groups compared with the control group. The ICER per additional
minute of MVPA in ≥ 10-minute bouts was £0.35 for the postal group and £2.21 for the nurse-support
group, compared with the control group. However, both intervention groups accrued slightly fewer QALYs
than the control group (postal group: –0.0005 QALYs; nurse-support group –0.0004 QALYs), although this
difference was not statistically significant. Nevertheless, it contributed to the dominance (lower costs and
more QALYs) of the control group compared with both intervention groups at 3 months.
Comparing the two interventions at 3 months (see Table 10) shows that the nurse group achieved 481
more steps (95% CI 153 to 809 steps) and 18 more minutes of MVPA (95% CI 1 to 35 minutes) per
person than the postal group, at a statistically significant additional cost of £120 (95% CI £95 to £146).
The estimated cost per additional step and additional MVPA minute (in bouts of ≥ 10 minutes) was
£0.25 and £6.67, respectively. The nurse-support group had slightly fewer QALYs, although this was not
significantly different (0.0004 QALYs, 95% CI –0.0026 to 0.0018 QALYs); however, it contributed to the
nurse-support group being dominated (higher costs and fewer QALYs) by the postal group.
The main results at 12 months (see Table 10) were somewhat different from those at 3 months. Although
the mean costs were lower for the postal group (–£91, 95% CI –£213 to £33) and higher for the
nurse-support group (£126, 95% CI –£37 to £290) than the control group, neither was statistically
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TABLE 9 Average costs and QALYs per participant, by trial arm (£2013–14, base case, with missing values imputed)
Cost and quality of life (EQ-5D-5L)
Trial arm, mean (SD)
Control Postal Nurse support
0–3 months (N = 318) (N = 317) (N = 319)
Costs (£)
Total cost 107 (254) 122 (107) 249 (215)
Set-up cost 0 (0) 45 (0) 105 (0)
Delivery of intervention 0 (0) 7 (0) 50 (18)
Health service use 107 (254) 71 (107) 95 (214)
Quality of life
EQ-5D-5L scores at baseline 0.839 (0.14) 0.853 (0.12) 0.851 (0.12)
EQ-5D-5L scores at 3 months 0.844 (0.14) 0.848 (0.14) 0.841 (0.14)
QALYs, 0–3 months 0.194 (0.03) 0.196 (0.03) 0.195 (0.03)
0–12 months (N = 323) (N = 312) (N = 321)
Costs (£)
Total cost 461 (916) 375(611) 603 (987)
Set-up cost 0 (0) 45 (0) 105 (0)
Delivery of intervention 0 (0) 10 (0) 52 (18)
Health service use 461 (916) 320 (611) 447 (987)
Quality of life
EQ-5D-5L scores at baseline 0.837 (0.14) 0.850 (0.12) 0.849 (0.13)
EQ-5D-5L scores at 3 months 0.840 (0.14) 0.847 (0.13) 0.837 (0.14)
EQ-5D-5L scores at 12 months 0.833 (0.15) 0.836 (0.13) 0.831 (0.14)
QALYs, 0–12 months 0.837 (0.13) 0.843 (0.11) 0.836 (0.13)
TABLE 10 Costs, effects and cost-effectiveness at 3 and 12 months (£2013–14; base case, adjusted for baseline
differences)
Cost, effects or
cost-effectiveness
Trial arm, mean (95% CI)
Control Postal deliverya Nurse supporta
Nurse support vs.
postal delivery,
mean (95% CI)
Costs and effects over 3 months
Total cost per participant (£) 108
(80 to 136)
123
(111 to135)
244
(221 to 266)
–
Incremental cost (£) – 15
(–15 to 45)
135
(99 to 171)
120
(95 to 146)
Total QALYs per participant 0.1957
(0.1936 to 0.1978)
0.1952
(0.1930 to 0.1974)
0.1948
(0.1926 to 0.1970)
–
Incrementala QALYs – –0.0005
(–0.0027 to 0.0016)
–0.0009
(–0.0031 to 0.0012)
–0.0004
(–0.0026 to 0.0018)
continued
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significantly different. However, the increase in the cost of moving from postal delivery to nurse-support
delivery was statistically significantly higher (£217, 95% CI £81 to £354). Although both interventions
were associated with a statistically significant increase in both step count and weekly minutes of MVPA in
≥ 10-minute MVPA bouts compared with the control group, the difference between intervention groups
was not statistically different at 12 months. The postal group took more steps on average (+ 642 steps)
TABLE 10 Costs, effects and cost-effectiveness at 3 and 12 months (£2013–14; base case, adjusted for baseline
differences) (continued )
Cost, effects or
cost-effectiveness
Trial arm, mean (95% CI)
Control Postal deliverya Nurse supporta
Nurse support vs.
postal delivery,
mean (95% CI)
Incremental daily steps – 692
(363 to 1020)
1172
(844 to 1501)
481
(153 to 809)
Incremental weekly minutes of
MVPA in bouts of ≥ 10 minutes
– 43
(26 to 60)
61
(44 to 78)
18
(1 to 35)
Costs and effects over 12 months
Total cost per participant (£) 467
(365 to 569)
376
(307 to 445)
593
(473 to 714)
–
Incremental cost (£) – –91
(–215 to 33)
126
(–37 to 290)
217
(81 to 354)
Total QALYs per participant 0.842
(0.832 to 0.853)
0.838
(0.827 to 0.849)
0.836
(0.824 to 0.847)
–
Incremental QALYs – –0.004
(–0.017 to 0.009)
–0.007
(–0.020 to 0.007)
–0.002
(–0.016 to 0.011)
Incremental daily steps – 642
(329 to 955)
677
(365 to 989)
36
(–227 to 349)
Incremental weekly minutes of
MVPA in bouts of ≥ 10 minutes
– 33
(17 to 49)
35
(19 to 51)
2
(–14 to 17)
ICERa at 3 months
Cost per additional QALY (£) – Postal delivery
dominated by
control
Nurse support
dominated by
control
Nurse support
dominated by
postal delivery
Cost per additional step count (£) – 0.02 0.12 £0.25
Cost per additional minute of
MVPA in a bout of ≥ 10 minutes (£)
0.35 0.35 2.21 £6.67
ICERa at 12 months
Cost per additional QALY (£) – Postal delivery is
less costly but has
fewer QALYs.
£21,162 saved per
QALY lost
Nurse support
dominated by
control
Nurse support
dominated by post
Cost per additional step count (£) – Postal delivery
dominates control
0.19 6.03
Cost per additional minute of
MVPA in a bout of ≥ 10 minutes (£)
– Postal delivery
dominates control
3.61 109.00
a For incremental analyses, the comparisons are postal delivery vs. control and nurse support vs. control.
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and cost less on average (–£91) than the control group, and dominated the control group in terms of the
PA outcomes. Compared with the control group, the nurse-support group cost an additional £0.19 per
step and £3.61 per additional minute of MVPA in bouts of ≥ 10 minutes. None of the small decrements
in QALYs at each incremental comparison (–0.0009 QALYs for the postal group vs. the control group,
–0.0007 QALYs for the nurse-support group vs. the control group and –0.0004 QALYs for the nurse-support
group vs. the postal group) was statistically significantly different. Compared with the control group, the
postal group had fewer QALYs (although this was not statistically significantly different) and lower costs
(also not statistically significantly different). However, the magnitude of the cost-savings is such that they
outweigh the forgone QALYs at a threshold of £20,000 per QALY, and would be considered cost-effective.
Using QALYs, the nurse-support group is dominated by both the control group and the postal group.
Comparing the two interventions at 12 months (see Table 10) shows that the estimated cost per
additional step and additional MVPA minute was £6 and £109, respectively, and that, in terms of QALYs,
the nurse-support group was still dominated by the postal delivery group.
The cost-effectiveness planes (Figures 5 and 6; see also Appendix 3, Figure 19) broadly confirm the
findings that the postal delivery group had a strong likelihood of lower costs, but also fewer QALYs,
and that the nurse-support group tended to have fewer QALYs and higher costs than the control group.
However, different levels of uncertainty surround these mean estimates, as reflected in the CEACs
(Figure 7; see also Appendix 3, Figure 20). At £20,000 per QALY, the postal delivery group has a 50%
chance of being cost-effective compared with the control group, which falls to 42% at £30,000 per QALY.
This is because, as the willingness-to-pay threshold increases (and, therefore, the higher the value that is
placed on forgone QALYs), the value of QALYs lost begins to outweigh the cost-savings (see Figure 9).
This is reflected in the CEAC, on which the probability moves towards zero. The nurse-support group
had only a 5.5% chance of being cost-effective compared with the control group at a willingness-to-pay
threshold to gain, or give up, a QALY of £20,000, and this fell to 4.9% when compared with the postal
delivery group.
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FIGURE 5 Cost-effectiveness plane for the postal delivery group vs. the control group at 12 months.
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The deterministic sensitivity analyses (see Appendix 3, Table 36) show that, with the exceptions of
(1) using health service use including only self-reported serious adverse effects, (2) excluding all health
service costs, (3) changing perspective (including all participant costs) and (4) the worst-case ‘combined
scenario’, the sensitivity analyses produced results that were consistent with the base-case findings. For
the exceptions, the postal delivery group was dominated by the usual-care control group at 12 months.
Beyond-trial modelling
Systematic reviews have indicated the positive influence that PA has on primary prevention for a range
of conditions, including coronary heart disease (CHD), stroke, type 2 diabetes mellitus and cancers, 124–128
and, more recently, for improving cognition in older adults.129 Carlson et al.5 have separately shown that
increasing amounts of leisure time PA is associated with decreasing health expenditure. Therefore, by
reducing the risk of disease, increased PA can increase future QALYs, as well as lower future costs. The
next section provides the methods used to estimate the long-term cost-effectiveness of the PACE-UP trial.
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FIGURE 6 Cost-effectiveness plane for the nurse-support group vs. the control group at 12 months.
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FIGURE 7 Cost-effectiveness acceptability curve for the postal delivery and nurse-support groups (vs. the control
group) at different willingness-to-pay-per-QALY thresholds.
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Methods
An existing Markov model,130 designed to assess the cost-effectiveness of PA interventions, was used.
This model has evolved from assessing the cost-effectiveness analysis of exercise referral schemes131–133 to
brief interventions129 and beyond.134 It has been used by NICE to update national guidance (PH44 on brief
interventions, PH2 on exercise referral schemes guidance)36,135 and is the basis for the NICE Return on
Investment Tool136 used by local authorities.
The model is driven by evidence of the impact that PA interventions have on the proportion of people
meeting the recommended PA levels, short-term quality-of-life gains (associated with meeting the
recommended PA levels) and the impact of PA on future rates of CHD, stroke and type 2 diabetes mellitus.
Figure 8 shows the pathways within the model. In the original Markov model,129 a cohort of 100,000
33-year-old people were followed in annual cycles over their lifetime. At the end of the first year of the
model, the cohort would be either ‘active’ (doing 150 minutes of MVPA per week) or ‘inactive’, and could
have had one of three events (non-fatal CHD, non-fatal stroke, type 2 diabetes mellitus), remain event free
(i.e. without CHD, stroke or diabetes mellitus) or die, either from cardiovascular disease (CVD) or from
non-CVD-related causes. Active individuals have a better life expectancy and quality of life, attributable to
lower risks of developing CHD, stroke and type 2 diabetes mellitus. People who become active in the first
year (irrespective of the trial arm) accrue a one-off utility gain associated with achieving the recommended
level of PA. QALYs reflect the health outcomes from a reduced risk of disease. A discount rate of 3.5% per
annum is used for costs and QALYs, as recommended by NICE, and the analysis is conducted from a NHS
perspective. Full details of the model are provided in Appendix 3 and elsewhere.130
Run-in period
(1 year)
Cohort of 100,000 healthy but
inactive people (aged 59 years)
Remained inactive Became inactive
Event free
Stroke Type 2
diabetes mellitus
Non-fatal
stroke
Non-fatal
CHD
Death resulting from
CVD-related causes
Death resulting from
non-CVD-related causes
CHD event
Remaining
lifetime
Fa
ta
l
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FIGURE 8 Illustration of pathways within the long-term cost-effectiveness model.130
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The model by Anokye et al.130 was adapted for use in five ways:
1. The population begins with the mean age of the trial population (i.e. 59 years rather than 33 years) and
was followed to 88 years (average life expectancy at 59 years in the UK).137 This change was also
reflected in the age-specific estimates used.
2. The intervention was either pedometer plus nurse support or a posted pedometer.
3. Within-trial costs were used, with a second year of annuitised values added for the intervention arms
(£5.03 per person for the postal delivery group and £4.14 per person for the nurse-support group –
the number of pedometers to the postal delivery group was relatively higher as a result of more
replacements), as the trial analysis had assumed pedometers lasted 2 years.
4. Effectiveness estimates from the PACE-UP trial were used as follows: the probability of moving from
an inactive to an active state was based on estimated relative risks (RRs) for achieving 150 minutes of
MVPA in ≥ 10-minute bouts over 7 days at 12 months. RRs of achieving ≥ 150 minutes of MVPA in
≥ 10-minute bouts at 12 months were estimated from ORs using the formula OR/[(1 – Pref) + (Pref × OR)],
in which Pref is the proportion of all subjects achieving 150 minutes of MVPA in ≥ 10-minute bouts at
baseline (i.e. 218/1023 = 0.21). The OR was derived from a logistic regression model in which achieving
150 minutes of MVPA in bouts of ≥ 10 minutes at 12 months was regressed on baseline minutes of
MVPA in bouts of ≥ 10 minutes, month of baseline accelerometry, age, sex, general practice and
treatment group, with household as a cluster.
5. The short-term psychological benefits associated with achieving 150 minutes of MVPA per week used
trial data; incremental EQ-5D-5L scores (at 12 months) for active people were regressed, via beta
regression, on EQ-5D-5L scores at baseline, ethnicity, education, employment status, intervention
group, practice and disability.
Other parameters were informed by estimates from the original model. Cost and utility estimates for
disease conditions were originally sourced from literature reviews of economic evaluations conducted for
NICE on CVD and diabetes mellitus.5 Estimates for the health impacts of PA were taken from national/
international evidence-based guidance on PA and health, such as the US Physical Activity Guidelines
Advisory Committee Report, 2008.138 Appendix 3, Table 37 details all parameter values.
The probabilistic sensitivity analysis (PSA) addressed the uncertainties around all parameters in the model
(except for baseline mortality, as the mortality census data have little uncertainty). A total of 10,000 Monte
Carlo simulations were used to generate stable estimates. Given that the within-trial sensitivity analysis
showed the decisional influence of some assumptions, a deterministic sensitivity analysis using the lifetime
model explored two alternative, conservative scenarios:
l Scenario 1 – combined exclusion of all health service use costs during the trial period (year 1 of the
model), with no short-term QALY gain associated with achieving the recommended level of PA. This
was considered as a result of the uncertainty around short-term changes to health service use, and
because previous studies found the exclusion of short-term QALY gain associated with being physically
active to the recommended level to be decisional.5,129
l Scenario 2 – scenario 1 plus user costs related to participation in PA and the interventions. This
combination represented a ‘worst-case’ scenario in the trial. Although this perspective is not one
adopted by NICE, it represents the most conservative scenario based on this evidence.
Results
Table 11 shows that the postal delivery group dominated both usual practice and the nurse-support
group, as the lifetime costs were lower and the number of QALYs was greater. The stochastic uncertainty
associated with the mean ICER (Appendix 3, Figure 21) indicates that these findings are robust, as there is
a 100% likelihood, at a willingness-to-pay threshold of £20,000 per QALY, that the postal delivery group
is cost-effective compared with the control group and with the nurse-support group (Figure 9). This is
consistent with the net monetary benefit estimates, which show that, although we can be 95% confident
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that the postal delivery group is better than the control group and the nurse-support group, we cannot be
95% confident that the nurse-support group is better than the control group.
The results for scenario 1 of the sensitivity analyses for the 100,000 cohort were as follows:
l postal delivery group versus control group – postal delivery moved from a dominant position to being
a more expensive option (+£4M) with greater QALY gains (+609 QALYs) and an ICER of £6100
l nurse-support group versus control group – the ICER increased from £16,000 to £26,000 (+£14M,
+538 QALYs)
l nurse-support versus postal delivery group – the nurse-support group remained dominated by the
postal delivery group (+£10M, –87 QALYs).
TABLE 11 Costs, effects and cost-effectiveness over a lifetime (cohort of 100,000)
Costs, effects and
cost-effectiveness
Trial arm, mean (95% CI)
Control Postal deliverya Nurse supporta
Nurse support vs.
postal delivery
Cost
Lifetime total cost (£M)b 340 (307 to 371) 329 (296 to 361) 351 (318 to 384) –
Lifetime incremental cost
(£M)
– –11 (–12 to –10) 11 (10 to 12) 22 (21 to 23)
QALYs
Lifetime total QALYs (million) 1.07 (0.88 to 1.30) 1.07 (0.88 to 1.30) 1.07 (0.89 to 1.30) –
Lifetime incremental QALYs – 759 (400 to 1247) 671 (346 to 1071) –108 (–223 to –10)
Lifetime ICER for QALYs (£) – Postal delivery
dominates control
16,368 Postal delivery
dominates nurse
support
Lifetime incremental
net monetary benefit
(£M, @ £20,000 per QALY)
– 26 (18 to 36) 2 (–5 to 11) –24 (–27 to –21)
a For the incremental analyses, the comparisons are postal delivery vs. control and nurse support vs. control.
b £46.7M, £37.6M and £59.3M of the total costs are attributed to the costs of the control, postal delivery and
nurse-supported interventions, respectively, estimated from the within-trial analysis.
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FIGURE 9 Cost-effectiveness acceptability curve showing the probability of lifetime cost-effectiveness for the postal
delivery group and the nurse-support group (vs. the control group) at different willingness-to-pay threshold levels.
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For scenario 2, the sensitivity analyses for the 100,000 cohort showed the following:
l postal delivery group versus control group – the postal delivery group moved from a dominant position
to being more expensive (+£16M) with greater QALY gains (+609 QALYs) and an ICER of £26,600
l nurse-support group versus control group – the ICER increased from £16,000 to £25,400 (+£13.7M;
+538 QALYs)
l nurse-support group versus postal delivery group – the nurse-support group moved from a dominated
position to a cost-effective position (–£2M, –87 QALYs).
Discussion
The within-trial analysis shows that, at 3 months, compared with the control group, both interventions cost
something to achieve increases in PA. Compared with the control group, the postal delivery group cost an
additional £0.02 per additional step gained to an average of + 692 steps per day, which was a cheaper
buy than the nurse-support group (at £0.12 per additional step). However, the nurse-support group achieved
more steps on average, and the additional 448 steps were achieved at an incremental cost of £0.25 per step.
Although this pattern of results was replicated for additional minutes of MVPA (in bouts of 10 minutes),
the results for QALYs were very different as both intervention groups were dominated by the control group
(i.e. the control group cost less and had more QALYs).
The main results at 12 months were different, leaning more favourably towards the postal intervention.
Compared with the control group, the postal delivery group achieved statistically significantly better PA
outcomes, and did so at a lower cost. This was much better than the results for the nurse-support group,
and the insignificant difference in PA outcomes between the nurse-support and postal delivery groups
at 12 months implied very high costs per additional step (£6.00). The analysis of the costs per QALY
confirmed that the nurse-support group was not a cost-effective alternative. It also showed that, although
the postal delivery group has fewer QALYs (although not statistically different) and lower costs (with costs
saved higher than £20,000 per QALY), the postal delivery group could be considered to be cost-effective.
Assuming a value of £20,000 per QALY, there was a 50% probability that the postal delivery group was
cost-effective compared with the control group, and a 5% probability that the nurse-support group was
cost-effective compared with the control group or the postal delivery group at 1 year. The sensitivity
analyses did not change the conclusions, except in three cases (using self-reported SAEs, excluding health
service use, but including all participant costs), when the postal delivery group was dominated by the
usual-care control group.
The lack of evidence on effectiveness in terms of quality-of-life outcomes is not necessarily evidence of
no effect, as the trial was not powered to detect a change in quality of life. The results indicate a lot of
variation around the change in QALYs (95% CI –0.017 to 0.009 QALYs) and we are aware of some ceiling
effects at baseline (98% self-care, 83% usual activities, 79% mobility, 73% anxiety, 43% pain). Although
this might contribute to raising questions about the relevance of general quality-of-life measures for
capturing the quality-of-life impacts of public health interventions within the first year, it also serves to
highlight the importance of capturing the QALY impact of public health interventions on disease avoidance
in longer-term economic models. Cost-per-QALY results from short-term public health trials have the
potential to mislead decision-makers on the efficiency of investments in the context of changes that lead
to longer-term reductions in the risk of disease.
A lifetime cost-effectiveness model characterised the long-term impact of PA interventions on CHD, stroke
and type 2 diabetes mellitus.129 This showed that the postal delivery group would dominate both the
control group and the nurse-support groups, as quality-of-life gains (759 QALYs, 95%CI 400 to 1247
QALYs) add to increased cost-savings (–£11M, 95% CI –£12M to –£10M), resulting in an incremental net
monetary benefit of £26M (95% CI £18M to £36M) for a 100,000 cohort. There was a 100% likelihood
that the postal intervention was cost-effective compared with the control group and the nurse-support
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group. The conservatively framed deterministic scenario analyses showed that excluding both the
short-term reduction in health service use and the utility gain seen in the trial would not alter the main
conclusion that the postal delivery group would be an extremely cost-effective intervention (ICER of £6100
per QALY). Even taking the unusual step of including participant costs did not raise the ICER beyond a
threshold value of £30,000 per QALY.
Strengths and weaknesses
To our knowledge, this is the first published study of short- and long-term costs and effects of a pedometer
intervention. Its strengths are the use of detailed individual-level cost and effectiveness data from a
well-designed population-based RCT, which had nearly complete (93.4%) follow-up data to 1 year, to
estimate the cost per QALY at 1 year, and also to input into a lifetime model of cost-effectiveness. It also
included both provider and user perspectives in costing service provision and participation, which allowed
the impact of perspective to be investigated, and which provides a basis for further investigation of the role
of cost in its association with participation in PA. The estimates of uncertainty extended commonly used
techniques to account for increased precision in the context of clustered data. The sensitivity analysis pushed
both the short- and long-term analyses to very conservative outcomes given the trial data and, therefore,
provides a good indication of the robustness of findings based on the current evidence.
The weakness of the within-trial cost-effectiveness study connects to the cost of health service use
over the period of the trial; no information was available on the severity or procedures used for hospital
admissions, or cause of admission to the A&E department. We relied on the principal investigator’s ‘best
guess’ or ‘nearest appropriate code’ (while blind to the treatment group) and on averaging across elective/
non-elective admissions and we therefore explored alternative assumptions in our sensitivity analyses.
There was considerable variation in costs in each trial arm, and the trial was not powered to detect a
difference. Data were also not collected on costs to participants for months 4–9, and the last 3 months
were multiplied to represent the missing data. These may have over- or underestimated participant costs
and, if significantly underestimated, could be decisionally important. With respect to the long-term
modelling, the model assumes that people would revert to PA patterns observed in long-term cohort
studies. This estimate could be improved with longer-term trial data. All the challenges set out in previous
work130 are also relevant here (e.g. some diseases, such as cancer and AEs, are not accounted for, which
could lead to either over- or under-estimation of cost-effectiveness).
The study feeds into an area sparse of primary data139,140 populated only by small studies.95,96 Leung et al.97
showed a 95% likelihood that pedometers would be a cost-effective addition to green prescriptions
(in New Zealand) at 12 months, which is much higher than the 50% likelihood that we found. Our study
also provides long-term estimates based on the population-level primary data for comparison with the
larger body of cost-effectiveness estimates134 from decision models.97,98,141,142 Some have identified cost-savings
and an improved quality of life at a population level from pedometers in the long term.98,137 Others97,138 have
indicated high probabilities that pedometers will be cost-effective in the long term, with Brennan et al.142
indicating that, even with long-term support at £25 per year (for monitoring and support), ICERs fell well
below £10,000 per QALY gained. Our study provides further support to indicate that pedometer-based
programmes are a cost-effective method of improving health.
Conclusion
A range of sensitivity analyses of both short- and long-term cost-effectiveness confirmed the view that
postal delivery of pedometer interventions to people aged 45–75 years through primary care has a high
chance of being cost-effective in the long term and has a 50% likelihood of being cost-effective, through
resource-savings from changes in health service use, within 1 year. Further research is needed to ascertain
the level of maintenance of PA beyond 1 year and the impact of PA on quality of life and general health
service use in both the short term and long term.
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Chapter 5 Generalisability
Introduction
Although the numbers of adults achieving the recommended PA levels are generally low,9 there are
marked differences between groups, with lower PA levels in women, older people and those from
socioeconomically deprived areas and of Asian ethnicity.9,143 Walking interventions aiming to increase PA
levels ideally need to try to ensure that these groups are well represented. When participation rates are
low,144–146 there may be systematic differences between those who participate and those who do not,
but to whom the intervention could reasonably be applied. Failure to include certain groups of people for
whom PA levels are lower may lead to the implementation of interventions that are likely to increase
health inequalities. When there are differences between participants and non-participants, exploring the
reasons for non-participation using a qualitative approach can be instructive.
The population-based sampling frame used in this study provided an opportunity to assess whether or not
there were differences in terms of age, sex, ethnicity and area-level deprivation between general practice
patients who replied to the invitation letter compared with those who did not. We also compared the health,
lifestyle, education and social factors of those who agreed to participate in the trial with those who agreed
to complete a questionnaire, but who did not wish to participate (see Appendix 4 for the non-participant
questionnaire). These findings are now published.147 Qualitative interviews with a sample of this latter group
allowed us to investigate the reasons for non-participation in the trial, and these findings are also published.148
Methods
Data collection for quantitative comparisons
The sex, age and IMD score of all those invited were collected from general practice records. The IMD score
is an anonymised measure of deprivation based on postcode.71 To avoid the possibility of individuals being
identified, aggregated practice-recorded ethnicity was exported from the practice in 10-year age bands for
all batches where everyone was mailed, less exclusions (n = 10,155). Those not wanting to participate in
the trial were asked in their invitation letter if they were willing to complete a shortened version of the trial
baseline questionnaire, including questions on demographics, health, PA levels and a question on reasons
for not participating. The following categories were offered, based on previous research, with space to add
other reasons for trial non-participation: (1) I do not have time, (2) I cannot increase my PA, (3) I am not
interested in increasing my PA, (4) I am already very physically active, (5) I am not interested in research
and (6) I do not want to be put in a group by chance.
Comparison groups
Individuals whose invitation letters were ‘returned to sender’ were excluded from the analyses before
calculating response rates. ‘Responders’ are defined as those who replied to the invitation letter, regardless
of whether or not they wanted to take part. Individuals could respond by post, e-mail or telephone.
‘Participants’ are those who completed the baseline assessment, although not all were randomised as some
provided inadequate accelerometry data. ‘Non-participants’ are those who completed a questionnaire but
did not wish to participate in the trial (Figure 10).
As the PACE-UP trial targeted inactive adults, participants who attended a baseline appointment were
selected on the basis of their low PA levels. Non-participants were not selected in this way. In order to
minimise selection bias, the quantitative analysis of participants and non-participants was therefore
restricted to those categorised as ‘not active’ according to a self-reported primary care PA questionnaire,
the GPPAQ,73 which was the only PA measure available for both groups.
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Statistical analysis
Age- and sex-standardised rates were used to compare IMD quintiles for responders. Similarly, sex-standardised
rates were used to compare age groups and age-standardised rates were used to compare sexes. The full
population of invitees was used as a standard population throughout. No further analysis on non-responders
was possible because they did not provide any questionnaire data on ethnicity or other factors.
Analysis of non-responders
Analysis of participants and non-participants
Non-participants
Completed a questionnaire
(n = 1139; 10%)
Participants
Completed a questionnaire
(n = 1150; 11%)
Did not complete questionnaire
(n = 1573)
Responders
Sent a reply to invitation
(n = 4572; 42%)
Wanted to take part in trial
(n = 1860; 17%)
Sent invitation letter
(n = 11,015)
Non-responders
No reply to invitation
(n = 6355; 58%)
Did not want to take part in trial
(n = 2712; 25%)
• Not randomised, n = 710
• Excluded as too active, n = 548
• No baseline assessment, n = 162
Invitees
Age and sex matched with GP records
(n = 10,927)
Unable to match for age 
and sex
(n = 88)
Selected for study
(n = 12,625)
• GPPAQ active, n = 118
• GPPAQ missing, n = 108
• GPPAQ active, n = 388
• GPPAQ missing, n = 36
• Excluded (GP decision), n = 1421
• Returned to sender, n = 189
Not active non-participants
(n = 715)
Not active participants
(n = 924)
FIGURE 10 Flow chart to show the recruitment process in the PACE-UP trial. All percentages are out of all of those
whose age and sex were matched with GP records (n= 10,927).
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Practice ethnicity data were available in 10-year age bands for 10,155 invitees, which was effectively a
random sample of the 11,015 people invited to participate. The proportion of patients belonging to each
ethnicity category within each age band and within each practice was calculated, and the number of invitees
in each ethnicity in each practice and age band was estimated. Overall, 1903 invitees had ethnicity recorded
as ‘unknown’. These are assumed to be missing at random in the main results, but sensitivity analyses were
performed assuming that these were all white people or all non-white people. Age-standardised participation
rates for not-active participants and non-participants completing questionnaires were calculated, assuming that
invitees gave the same ethnicity on the questionnaire as was recorded in their practice records. Participation
rates by age, sex and IMD score were calculated for not-active participants versus not-active non-participants
completing questionnaires, as in the analysis of responders.
Not-active participants and non-participants completing the questionnaire were compared for additional
demographic and social characteristics, and health and lifestyle factors, using logistic regression. All data
came from the questionnaires. Models were adjusted for clustering by practice and household, by
including fixed effects for practice and using robust standard errors for household.
Methods for the interview study of non-participants
This is fully described elsewhere.148 Non-participants completing the questionnaire were asked if they could
be contacted to discuss their reasons in more detail. A purposive sample of those willing to be contacted
was selected to provide men and women of varying ages, ethnicities and employment status from the
initial six participating practices. To maximise participation, we used focused telephone interviews; permission
was gained for interviews to be audio-recorded. The topic guide was developed from the literature, from the
previous PACE-LIFT trial qualitative evaluation21,149 and discussions between the authors, and is published148
and provided in Appendix 4. Approximately 30 interviews were planned, with recruitment continuing until
no new themes were identified and a demographically balanced sample had been achieved. Open questions
were asked about what influenced their decision not to participate and their opinions on the trial information
received. Responses given on the completed questionnaires were used as a starting point to further explore
their reasons. They were asked general questions about the perception of the trial design and were invited to
make any final comments.
Methods for analysing interviews
Audio-recordings were transcribed verbatim and checked for accuracy. After 10 interviews, researchers
(Rebecca Holmes, TH and CV) read the transcripts and discussed the interviews. The interview technique
was then modified slightly to ensure that interviewees understood the trial randomisation process, as
several participants had appeared not to understand the question about whether or not being put in a
group by chance had influenced their decision not to participate. On completion of the interviewing, the
transcripts were read and re-read for familiarisation by the researchers, who assigned codes (RN and TH),
before a thematic framework was produced.150 Coding discrepancies between researchers were resolved
by discussion. The framework produced was informed both by a priori issues, mostly related to trial design,
and by emerging themes. Themes were refined further by discussion between authors (Rebecca Holmes,
TH, RN and CV), and broader categories, encompassing several subthemes, were generated. Reasons for
declining given by all non-participants were also compared with those given at interview, to put our
findings in a wider context and assess the generalisability to all of those actively declining.
Results
Results from quantitative comparisons
Of the 12,625 individuals selected for screening (see Figure 10), 1421 (11.3%) were excluded by practice
staff and 189 (1.5%) had invitation letters that were returned, as they had moved away; both of these
groups were classified as ‘not invited’. In the 44 households where one person refused the invitation
and the other did not respond, it was impossible to match the response to individual invitees within the
household, so age and sex are unknown. These 88 people have been excluded from further analyses.
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Of the remaining 10,927, 4572 (42%) responded to the invitation letter, mainly by post, and 1150 (11%)
completed the baseline assessments.
Of all invitees, 5229 (48%) were aged 45–54 years. Although all quintiles of deprivation were represented,
only 7% were in the most deprived quintile. Response rates were higher in older people, women and
those living in less deprived areas (Table 12). As individual ethnicity was available only for the participants
and non-participants who completed a questionnaire, it was not possible to estimate response rates by
ethnicity for all responders.
Although the GPPAQ was not used to assess PA levels for trial inclusion, it was the only PA measure
available for both participants and non-participants. A total of 118 participants and 388 non-participants
were classified as active by the GPPAQ, and 134 people did not complete the GPPAQ. These people were
excluded from further analysis, leaving 924 participants and 715 non-participants.
Similar to the response rates, participation rates were higher in older people, women and those living in
less deprived areas. (Table 13). Ethnicity was extracted from the practice for 10,155 invitees. Of these,
5991 were recorded as white (59%), 893 (9%) were recorded as Asian or British Asian and 915 (9%)
were recorded as black Caribbean, black British or black African. A total of 1903 (18.7%) were recorded
as ‘unknown’. The percentage of people with ‘unknown’ ethnicity varied by practice from 3% to 48%.
Table 13 shows the estimated number in each ethnicity category for all 10,927 invitees, assuming that
those for whom ethnicity was recorded as ‘unknown’ and those for whom we were not able to collect
ethnicity have the same ethnicity distribution as the group with known ethnicity.
TABLE 12 Responders to the invitation letter by age, sex and IMD quintile
Characteristic
All invitees
(N= 10,927), n (%)
Responders to the invitation (N= 4572)
n
Standardised
percentage
responsea (95% CI)
Ratio of response
rates (95% CI)
Age (years)
45–54 5229 (47.8) 1698 33.4 (32.1 to 34.7) 0.57 (0.54 to 0.60)
55–64 3367 (30.8) 1535 46.2 (44.5 to 47.9) 0.79 (0.76 to 0.84)
65–75 2331 (21.3) 1339 57.8 (55.8 to 59.8) 1.00
Sex
Female 5604 (51.3) 2638 46.7 (45.4 to 48.0) 1.00
Male 5323 (48.7) 1934 36.8 (35.5 to 38.1) 0.80 (0.76 to 0.84)
IMD national quintileb
1 (most deprived) 712 (6.8) 207 29.5 (26.2 to 32.8) 0.55 (0.50 to 0.61)
2 2768 (26.4) 995 36.1 (34.4 to 37.9) 0.67 (0.63 to 0.72)
3 2960 (28.2) 1242 41.2 (39.8 to 43.2) 0.77 (0.73 to 0.82)
4 2328 (22.2) 1060 45.6 (43.6 to 47.5) 0.85 (0.80 to 0.90)
5 (least deprived) 1711 (16.3) 914 53.4 (51.4 to 56.0) 1.00
a Age percentages were standardised for sex, sex percentages were standardised for age, and IMD percentages were
standardised for age and sex. Percentages are of all those invited.
b A total of 448 people are missing IMD quintile, primarily because of certain postcode areas not being included in the
look-up table.
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TABLE 13 Completion of the baseline assessment and questionnaires in participants and non-participants who are
not active on the GPPAQ, by age, sex, IMD quintile and ethnicity
Characteristic
All invitees
(N= 10,927), n
Participants (N= 9241)a Non-participants (N= 7152)b
n
Standardised
completion
ratea (95% CI)
Ratio of
completion
rates (95% CI) n
Standardised
completion
ratec (95% CI)
Ratio of
completion
rates (95% CI)
Age (years)
45–54 5229 331 6.4
(5.7 to 7.1)
0.60
(0.51 to 0.71)
231 4.6
(4.0 to 5.1)
0.41
(0.34 to 0.49)
55–64 3367 342 10.1
(9.1 to 11.1)
0.94
(0.81 to 1.10)
213 6.3
(5.5 to 7.1)
0.56
(0.47 to 0.67)
65–74 2331 251 10.8
(9.4 to 11.9)
1.0 264 11.2
(10.0 to 12.6)
1.00
Sex
Female 5604 597 10.6
(9.8 to 11.4)
1.0 408 7.2
(6.5 to 7.9)
1.00
Male 5323 327 6.2
(5.6 to 6.9)
0.59
(0.52 to 0.67)
308 5.9
(5.2 to 6.5)
0.82
(0.71 to 0.94)
IMD national quintiled
1 (most
deprived)
712 40 5.5
(3.8 to 7.2)
0.52
(0.39 to 0.70)
31 4.5
(3.0 to 6.0)
0.51
(0.37 to 0.70)
2 2768 183 6.7
(5.7 to 7.6)
0.63
(0.52 to 0.78)
128 4.6
(3.8 to 5.4)
0.52
(0.41 to 0.66)
3 2960 288 9.6
(8.6 to 10.7)
0.92
(0.77 to 1.10)
213 7.1
(6.2 to 8.0)
0.80
(0.65 to 0.98)
4 2328 206 8.8
(7.7 to 10.0)
0.84
(0.69 to 1.02)
172 7.4
(6.3 to 8.4)
0.83
(0.67 to 1.03)
5 (least
deprived)
1711 179 10.5
(9.1 to 11.9)
1.0 150 8.9
(7.5 to 10.2)
1.00
Ethnicity
White 81,295e 709 8.7
(8.1 to 9.3)
1.0 638 7.9
(7.3 to 8.4)
1.00
Asian 11,315e 61 5.4
(4.1 to 6.7)
0.62
(0.50 to 0.76)
27 2.4
(1.5 to 3.3)
0.31
(0.24 to 0.38)
Black 10,845e 90 8.5
(6.7 to 10.2)
0.97
(0.79 to 1.20)
20 1.9
(1.1 to 2.8)
0.24
(0.19 to 0.31)
Other 5835e 22 3.8
(2.2 to 5.4)
0.44
(0.33 to 0.59)
20 3.9
(2.2 to 5.6)
0.59
(0.36 to 0.68)
a Participants completed the baseline health and lifestyle questionnaire and the baseline assessment.
b Non-participants completed the non-participant questionnaire.
c Age percentages were standardised for sex, sex and ethnicity percentages were standardised for age, and IMD
percentages were standardised for age and sex. Percentages are of all those invited.
d A total of 448 people are missing IMD quintile data, primarily because of certain postcode areas not being included in
the look-up table.
e Number of invitees estimated from practice summary data.
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Of the white invitees, 709 (8.7%) agreed to participate in the trial and were not active, and a further 638
(7.9%) completed a non-participant questionnaire and were not active. Both Asian and black invitees had
very low non-participant questionnaire completion (2.4% and 1.9%), but black invitees were as willing
to participate as white invitees (8.5% vs. 8.7%), whereas only 5.4% of Asian invitees participated. The
sensitivity analyses assuming that all ethnicities recorded as ‘unknown’ were white or non-white people
showed similar results, and the same patterns were also seen in practices with nearly complete ethnicity
coding.
Those providing questionnaire data were more likely to be working part-time, married or living with a partner,
and less likely to have finished their education aged ≤ 16 years (Table 14). Participation was associated with
recent primary care contact and with some degree of health problems (general health, long-standing illness
and comorbidities), although those more severely affected were less likely to participate (see Table 14). This
is consistent with the EQ-5D-5L (health-related quality-of-life) domains, whereby participants were more
likely to have problems with pain and mobility, but less likely to have problems with self-care, which is likely
to indicate greater disability. Forty-five per cent of the sample gave insufficient time (n = 327) or already
being physically active (n = 325) as reasons for non-participation, even though those classified on the
GPPAQ as active were excluded from this analysis. Less commonly, 152 (21%) people answered that they
could not or were not interested in (n = 122, 17%) increasing their PA. Randomisation was cited as a
reason for non-participation only by 88 respondents (12%).
TABLE 14 Participants and non-participants who completed questionnaires and were not active on the GPPAQ:
demographics and health and lifestyle factors
Variables
Participants with
baseline information
(N= 924),a n (%)
Non-participants
who completed
a questionnaire
(N= 715),a n (%)
OR for participation
adjusted for
clustering (95% CI)b
OR for participation
adjusted for clustering,
age and sex (95% CI)
Demographic factors
Invited as a couple 393 (42.3) 314 (43.9) 0.98 (0.79 to 1.21) 0.99 (0.79 to 1.23)
Married/living
together as a
couple
595 (65.8) 439 (62.5) 1.20 (0.96 to 1.49) 1.25 (1.01 to 1.56)*
Age (years) finished full-time education
≤ 16 238 (26.4) 246 (35.6) 0.64 (0.49 to 0.83) 0.67 (0.51 to 0.87)
17 or 18 204 (22.6) 122 (16.2) 1.39 (1.10 to 1.76) 1.23 (0.93 to 1.64)
≥ 19 334 (48.3) 334 (48.3) 1.0** 1.0**
Employment status
Full-time 334 (37.1) 248 (35.4) 1.0*** 1.0**
Part-time 175 (19.4) 83 (11.8) 1.60 (1.17 to 2.19) 1.57 (1.13 to 2.18)
Retired 274 (30.4) 269 (38.4) 0.77 (0.60 to 0.99) 0.87 (0.63 to 1.21)
Other 118 (13.1) 101 (14.4) 0.87 (0.64 to 1.19) 0.85 (0.62 to 1.17)
Residential status
Home owner 734 (82.7) 587 (84.2) 0.92 (0.69 to 1.23) 0.91 (0.68 to 1.21)
Health and lifestyle factors
Contact with GP
or nurse in the
last 3 months
591 (65.4) 409 (59.3) 1.31 (1.61 to 1.06)* 1.34 (1.09 to 1.65)**
Current smoker 74 (8.4) 62 (9.0) 0.90 (0.63 to 1.29) 0.87 (0.60 to 1.24)
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TABLE 14 Participants and non-participants who completed questionnaires and were not active on the GPPAQ:
demographics and health and lifestyle factors (continued )
Variables
Participants with
baseline information
(N= 924),a n (%)
Non-participants
who completed
a questionnaire
(N= 715),a n (%)
OR for participation
adjusted for
clustering (95% CI)b
OR for participation
adjusted for clustering,
age and sex (95% CI)
General health level
Very good/good 727 (81.0) 579 (84.0) 1.0* 1.0*
Fair 154 (17.2) 88 (12.8) 1.34 (1.01 to 1.79) 1.40 (1.05 to 1.86)
Poor/very poor 16 (1.8) 22 (3.1) 0.54 (0.28 to 1.04) 0.56 (0.29 to 1.09)
Limiting long-standing illness
Yes, a lot 24 (2.7) 46 (6.7) 0.40 (0.24 to 0.66) 0.41 (0.24 to 0.70)
Yes, a little 194 (21.7) 113 (16.4) 1.35 (1.04 to 1.77) 1.40 (1.07 to 1.84)
No 678 (75.7) 528 (76.9) 1.0*** 1.0***
One or more
comorbidities
568 (58.6) 401 (41.4) 1.23 (1.01 to 1.51)* 1.29(1.05 to 1.59)*
One or more
different
medications taken
per day
517 (57.6) 384 (55.5) 1.07 (0.87 to 1.31) 1.17 (0.95 to 1.46)
EQ-5D measurements
Mobility – some
problems
202 (22.4) 122 (17.4) 1.36 (1.05 to 1.76)* 1.44 (1.10 to 1.87)**
Self-care – some
problems
23 (2.6) 31 (4.4) 0.53 (0.30 to 0.93)* 0.56 (0.32 to 0.99)*
Usual activities –
some problems
163 (18.3) 121 (17.2) 1.06 (0.81 to 1.38) 1.09 (0.83 to 1.43)
Pain/discomfort –
some problems
522 (58.0) 326 (46.4) 1.61 (1.31 to 1.97)*** 1.62 (1.32 to 2.00)***
Anxiety/depression
some problems
247 (27.8) 169 (24.0) 1.20 (0.96 to 1.52) 1.19 (0.94 to 1.50)
Health factors relating to exercise
Balance problems 106 (11.7) 64 (9.3) 1.26 (0.91 to 1.76) 1.27 (0.90 to 1.78)
One or more falls
in the past year
157 (17.5) 123 (18.0) 0.97 (0.74 to 1.26) 0.98 (0.75 to 1.27)
Brisk/fast walking
pace
256 (27.9) 342 (48.2) 0.42 (0.34 to 0.51)*** 0.39 (0.32 to 0.49)***
Someone to walk
with
Sometimes/often/
always
791 (87.2) 600 (84.2) 1.25 (0.93 to 1.69) 1.20 (0.88 to 1.63)
*p < 0.05, **p< 0.01, ***p< 0.001, from the Wald test p-value for the inclusion of the variable in the logistic model,
used to assess the significance of inclusion of categorical variables with more than two categories.
a Total number in each group. Some questions have missing data.
b ORs are from models with fixed effects for practice and robust standard errors for clustering by household.
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Results from qualitative comparisons
Fifty-five trial non-participants were telephoned from March to July 2013: 21 could not be contacted and
four declined to be interviewed. Thirty trial non-participants representing the six initial participating practices
were interviewed. Data saturation was achieved prior to completing 30 interviews, but we continued to
30 to ensure a more ethnically diverse sample. The demographic details of interviewees and their main
reasons for non-participation are published.141 Those interviewed were not selected on the basis of inactivity,
and a slightly higher percentage (67%; 20/30) reported being too active as a reason for non-participation
compared with those who were included in the main quantitative analysis.
Most interviewees gave one primary reason for declining participation, consistent across sex, ethnicity and
age groups. The majority (n = 18) said that they were too active either because they felt that their activity
exceeded the trial’s target levels or because others would benefit more. Less frequently cited main reasons
included existing medical problems (n = 4), travel from home (n = 3), work/other commitments (n = 3),
concerns about potential equipment problems (n = 1) and reluctance to be randomised (n = 1). To further
understand the reasons for non-participation, we categorised the emerging themes into three domains:
internal, external and trial related. Short quotations illustrating all of these reasons are shown in Table 15
and more detailed quotations are given in our published paper.148
TABLE 15 Summary of categories and themes: barriers to participating
Category Subcategory Theme Quotations with non-participant (NP) number
Internal Already active Personal activity I tend to walk quite a lot anyway, so I didn't think a
pedometer would probably be likely to increase my
walking at all really.
NP12
Work activity I actually work as a postman, so I do a hell of a lot of
walking . . . and that was basically the reason that I
didn’t think I’d need to actually join the programme.
NP06
Medical problems Stroke I had the stroke in ‘94. So that limited my walking.
NP07
Pain If I walk for more than half an hour at a time, I get
incredibly stiff and painful.
NP16
Heart condition I’m always at the hospital seeing a cardiologist.
NP18
Multiple medical
problems
I don’t need anything else going on to do with health
. . . I certainly would have thought . . . that they would
have thought, oh, she would not want to do this
because she’s got lots of other problems.
NP18
No wish to increase
activity
Not interested/does
not like PA
And I do not really like running . . . and I certainly will
not join a gym. I hate exercising.
NP02
Already doing
enough
No, I think I do enough. I’m fine with what I do.
NP17
Not interested in
walking
‘More interesting
than walking’
Cycling’s nice, swimming . . . any form of recreation
thing, like ice skating or horse riding or bicycle riding,
anything like that . . . Walking’s quite boring.
NP02
Team sport Well, it would be hard for you to organise team sports
I should think wouldn’t it? I mean I used to play
badminton quite a lot which I enjoyed.
NP19
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TABLE 15 Summary of categories and themes: barriers to participating (continued )
Category Subcategory Theme Quotations with non-participant (NP) number
Running If anybody’s doing research into people who have had
heart attacks and then trying to get back into running,
that I’d be extremely interested in.
NP24
Not the right person For younger people You get to a stage in your life and you think, that’s it
. . . I’m relaxing now. I exercise my mind instead.
NP02
For lonely people These sort of things people take them up if they are
lonely and I’m not lonely.
NP18
For overweight
people
Unless you were a really fat person, which I’m not.
NP18
Altruism . . . an opportunity for someone else, you know, that it
may be more useful to.
NP13
External Work commitments It’s bad enough trying to get . . . a day off for a
normal appointment.
NP02
I just did not think I’d have time. . .because I know
how important walking is, and I love walking, and if I
have an hour or two free, I would prefer to walk than
talk to the nurse.
NP21
Travel difficulties If I had time, I’d love to be part of your research and
go to the surgery and all the rest of it, but I think,
actually . . . the awkwardness of the journey . . .
NP22
Other commitments Travel from home I’m going away so much, I could not really tie myself
down to anything like that.
NP01
Caring for family
member
I’m a carer for my father. I think most of it is just
being there.
NP04
Chores/’life’ I’ve got grandchildren. I’ve got a husband. I like to do
my gardening. I’ve got a four bedroom house to keep
clean. I feel my load is more than enough to keep
me going.
NP08
Advice from others I did mention it to my daughter actually and she said
that sounds crazy! She said it’s not for me, so I did
not go any further.
NP07
Trial
related
Length of programme It does sound a bit on the lengthy side does not it
really . . . some people could be put off by that.
NP10
Trial material Too long . . . there was a lot to read. Bullet points are good.
Just make it simple.
NP19
Aimed at older
people
I just remember thinking, actually, I do not think I’m in
that age group yet. It kind of seemed to be geared to
people who really were in their 70s and over.
NP09
continued
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Internal reasons for non-participation included already being active, medical problems (pain, heart conditions,
stroke and multimorbidity), no wish to increase activity, no interest in walking, feeling incorrectly ‘targeted’
and altruistic reasons. The dominant reason in this category was a belief in already being sufficiently active.
When explored in more depth, it seemed that, on self-report, many were achieving, with some significantly
exceeding, the recommendations. This is supported by the finding that non-participants were found to
be more active on the GPPAQ. Of those citing medical reasons, it was less clear whether or not these
problems constituted a definite contraindication, especially as those with predefined medical conditions
contraindicating an increase in walking should have been excluded. A small number of people suggested
that they did not enjoy PA, were not interested in walking or suggested a different activity or a team sport.
TABLE 15 Summary of categories and themes: barriers to participating (continued )
Category Subcategory Theme Quotations with non-participant (NP) number
Equipment problems Pedometer/
accelerometer
Well I mean I have actually used a pedometer but I
would not sort of particularly want to do it for
a week.
NP09
Randomisation Did not like concept I think if you’re doing research then you should be
able to choose . . . within reason . . . what club you’re
willing to join really.
NP13
Did not want to be in
nurse-support group
. . . I could probably commit to the other two groups,
but possibly not to the nurse support.
NP09
Did not want to be in
the control group
Well . . . I could not see the point of being in a group
that did nothing.
NP04
Venue Fitness-related venue
better
If you’re going to do a fitness programme, you should
do it in a fitness venue.
NP04
Does not like the GP
surgery
I have to go there when I’m not well. I certainly am
not going to go to the surgery when I’m well.
NP18
Walking environment Boring Walking’s quite boring. Unless you’re walking
somewhere on an outing somewhere, you know, in
the country or something, seaside. You should have
more trips.
NP02
Wrong season As the weather gets better, then I might go for a walk
in the evening . . . it was really due to the seasons
as well.
NP28
Preferred group I think you get more encouragement if you are in
a group.
NP05
Trial design . . . that is not something I wanted to be part of I think
I’d have found it incredibly boring.
NP18
Adapted from Normansell et al.148 This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication
waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless
otherwise stated.
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The external theme related to factors ‘external’ to the potential participant, including work and other
commitments, travel problems, being a carer and advice from others. Work and work-related travel were
frequently given as reasons for not participating and many feared that they could not commit to the trial.
Family and home life commitments were also important barriers to increasing activity, including being a
full-time carer for family members. We were interested in finding out whether or not advice from friends
or family affected the decision not to participate. Very few interviewees discussed participation; for those
who did, it did not influence their decision, except for one interviewee whose daughter strongly agreed
that she should decline.
Reasons related to trial design included programme length, trial material, equipment problems, being
randomised, the venue, the walking environment, the nurse interaction and the overall trial design. For some
interviewees, the trial duration, at 3 months, was too long and it was difficult to commit for this period. One
interviewee reported a previous negative experience with pedometers as her primary reason for declining.
Several felt that not being able to choose their allocated group was a disadvantage. Two interviewees expressed
concern about the trial promoting walking as an exercise, because the local walking environment was ‘boring’,
and another stated that it was ‘the wrong season’ for walking outdoors; however, most interviewees thought
that walking was an appropriate and inclusive activity. Some expressed interest in a group intervention rather
than one to one with a nurse, feeling that this would improve motivation and sociability; however, others felt
that interacting directly with a nurse was preferable to being in a group. Most interviewees approved of the
choice of their GP surgery as the location for a PA intervention, describing their surgery as ‘lovely’, ‘pleasant’,
‘convenient’ and ‘appropriate’. Many interviewees expressed a positive attitude towards PA and research, and
regretted not being able to participate.
Summary of the findings
The PACE-UP trial recruited 11% of patients aged 45–75 years who were invited by post from their registered
general practice, although not all were randomised because of failure to provide adequate accelerometry
data. Those not replying were younger and more likely to be male and from deprived postcode areas. Asian
patients were less likely to participate. Participation was associated with mild or moderate health impairment,
although those with more severe problems were less likely to participate. Not having enough time and being
already physically active were the most common reasons for non-participation, even among patients who
were classified as not active. Interview findings supported the questionnaire findings and gave more detail
about the reasons behind the lack of time (work, travel, family, caring commitments, etc.) and the type of
health impairments that stopped people from taking part. Despite not wanting to participate, almost all
interviewees were positive about the trial, aware of the benefits of PA and the importance of research, and
supported primary care as a venue for such programmes. The design of the trial and intervention was not
stated as a key reason for declining to participate.
Strengths and limitations
The PACE-UP trial is a large trial recruiting from a clearly defined invited population, based on GP lists,
enabling us to assess the potential reach of the intervention in terms of age, sex and deprivation. Our
estimate of 11% participation may underestimate the true rate, particularly in areas of high mobility where
patients may have moved away and not informed the practice, inflating the number of patients counted as
invited. Although based on limited data, the PACE-UP trial offers a rare opportunity to examine demographic
differences between participants and non-participants. We were able to estimate participation within
different ethnicities using pooled data. However, we were not able to match at an individual level and some
participants may have categorised themselves in a different ethnic group to that on the GP register. Ethnicity
was also poorly recorded in some practices and we needed to make assumptions about whether or not
those with ‘unknown’ ethnicity were similar to those with recorded ethnicity. In a sensitivity analysis, even
under extreme assumptions, the difference between Asian and black ethnic groups persisted. The trial
excluded individuals who self-reported being active, but the non-participants were not selected in this way.
Our quantitative analysis attempted to mitigate this difference by restricting analysis to all those who
self-reported as not being active. However, some residual bias may remain.
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The interview study represents an innovative attempt to systemically explore the reasons for non-participation
with a purposive sample of those who were invited but declined. Our aim was to further understand the
perceived barriers to participation to enhance recruitment to future trials and exercise programmes. We were
also able to explore non-participants’ perception of the trial design and research in general. This sample
spanned six out of seven of the practices involved and included both sexes, a range of ages, ethnicities,
employment and educational backgrounds. The telephone interviews allowed in-depth exploration of the
barriers to participation not possible from a questionnaire alone and allowed us to compare the interview
findings with the non-participant questionnaire responses. The main limitation of the interview study is that
this was based on a self-selected group of people who both returned the non-participant questionnaire and
agreed to be interviewed. It is possible that some of our sample would have been excluded in any case on
the basis of their pre-existing activity levels and, therefore, their decision to decline may have been entirely
appropriate. In addition, despite our attempt to sample interviewees from non-white British backgrounds,
these groups were under-represented when compared with the ethnic diversity of the population invited.
Comparisons with previous work
A systematic review of 47 studies of walking interventions151 showed that recruitment methods and
participation rates were poorly reported. Of 25 RCTs, participation rates could be calculated for only five.
We recruited by post to reduce the burden on practice staff and to obtain response rate data. Postal
invitations are used in primary care for other preventative activities, making this a pragmatic approach.152
Other walking intervention trials using postal invitations in primary care33,48,144,153 had similar response rates
of 10–20%; those with higher rates (37% and 39%)154,155 recruited individuals who were older and more
frequent attenders in primary care, and invited individuals in the primary care consultation, as well as by
post. Our previous trial21 used similar recruitment strategies to the PACE-UP trial, but, unlike other trials,
included active people. This trial had a recruitment rate of 30%, but was conducted among older people
in an affluent setting with few non-white residents.
Non-responders were followed up with one reminder letter, but because of data protection constraints
we were unable to contact patients by telephone. Although only 1% of invitation letters were returned to
sender, this may underestimate those who did not receive the letter as we did not use registered post.
A previous London study using registered post found that 26% of letters were not delivered.156 Our findings
of greater participation in women,157,158 older people158 and those in affluent areas157 are supported by other
studies. Attwood et al.158 found no association with deprivation or ethnicity, but this trial was based in an
area of high deprivation with few non-white patients. Among Asian patients, our response rate was similar
to postal invitations in the PODOSA (Prevention of Diabetes and Obesity in South Asians) trial (5.2%), in
which community-based approaches,159 through partnership with local South Asian groups, were found to
be more effective. Wilbur et al.160 found that social networking was the most effective method for recruiting
African American women from low-income areas.
The finding that declining participation in this PA trial was attributable to interviewees considering
themselves to be already sufficiently active is in line with other literature.157,161–163 Importantly, objective
measurement of PA reveals that most people overestimate their activity levels,9 and that their assessment
of their personal activity levels is likely to be influenced by a social context.161 However, this interview series
allowed activity levels to be explored in more detail and revealed that, at least on self-report, this was a
relatively active cohort for some of whom the trial may not have been appropriate.
Our finding that participation was associated with some degree of health problems, but that severe
impairment reduced participation, is more nuanced than previous work, which has suggested that declining
participation in PA programmes or trials is attributable to medical problems, including pain,157,161,162,164
particularly in studies with older participants.165 Lack of time because of work and other commitments has also
been identified as an important barrier,157,161–163,166,167 particularly in younger and middle-aged participants.165
A lack of interest in PA has also been reported in the literature,157,161–163,166 but travel away from home has not
been reported prominently. This may reflect the high proportion of our interviewees still in full- or part-time
work and the seasonal migration of the diverse south-west London population.
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Implications
Guidelines published by NICE36 concluded that more research was needed to determine which
interventions are effective and cost-effective in increasing activity levels among lower socioeconomic and
high-risk groups, and that there is little evidence on differential effects of interventions. In our trial, those
groups for which more evidence is required tended to be those with the lowest recruitment rates, such
as Asians and those in more deprived areas.143 It has been suggested168 that specific cultural groups may
respond better to interventions directly targeted at their needs, rather than to universal interventions.
Reasons for non-participation were often related to individuals not wanting to increase activity or feeling
that they were sufficiently active. It is likely that such resistance will similarly apply to any intervention
roll-out and may apply more widely to other public health interventions. Low participation rates mean that
policy-makers should be cautious about the intervention’s potential reach and the possibility that it could
increase activity inequalities, but these are not a reason not to implement an intervention shown to be
effective in 11%93 of the population. We were successful in recruiting older people, women and those
with comorbidities or some degree of health limitation. These groups have lower PA levels and are likely to
benefit more from increased PA. However, those with more severe disability, people who have had falls
and those with a fear of falling were not over-represented, indicating a rational choice by individuals.
Only 12% of non-participants cited randomisation as a factor for not participating, whereas 45% cited
time constraints. The nurse intervention required three additional visits to the practice on top of the three
data collection visits, which may deter working people or those with child-care and other commitments.
However, the PACE-UP trial showed that both the nurse-support and postal delivery groups performed
similarly at the main 12-month outcome.93 An intervention offering pedometers with brief advice, without
the need to provide research data, may be more acceptable.
Both the PACE-LIFT and the PACE-UP trials recruited to target, achieved follow-up rates of over 90% and
demonstrated that the interventions were effective in increasing PA levels.21,93 However, considerably more
research effort was required (e.g. more contacts from research assistants) per randomised participant in the
PACE-UP trial than in the PACE-LIFT trial, resulting from a lower uptake rate. In spite of the effort, we still
had limited power to investigate ethnic and socioeconomic subgroups. Trials with greater reach are likely
to be more expensive in terms of recruitment, and gains in generalisability need to be balanced with
greater costs. Our findings have important implications for those planning PA trials, as well as for those
commissioning community PA programmes. As the cohort we interviewed appeared to be relatively
physically active, it may be necessary to tailor some interventions to maintaining, rather than increasing,
activity; this may also be important to mitigate the decrease in PA levels that often occurs with ageing.
Equally, education about the levels of activity that optimise health gain may prevent potential participants
from declining because of overestimation of their actual levels of activity. Measurements using pedometers
or accelerometers provide an easy approach to validating PA levels.
Lack of time was an important barrier, so it may be helpful to reiterate that activity can be broken up
into 10-minute bouts throughout the day (this can also help those individuals limited by pain or disability).
Tailoring interventions to an individual’s travel and work commitments and for their specific health
problems may also increase uptake. Promotional material should be inclusive and explicitly state that
pre-existing medical conditions do not necessarily prevent participation and dispel myths about the risks
of moderate-intensity exercise. Information about the value of PA, particularly walking, for many different health
conditions1 should be emphasised in the invitation to participate. RCTs inevitably involve randomisation, but
emphasising that, in some trials (including the PACE-UP trial), the control group can receive the intervention
after the trial may help recruitment. Most interviewees felt that primary care was an appropriate, convenient
location for delivering a walking-based PA intervention, indicating that further primary care-based trials and
programmes are likely to be well received.
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Conclusions
Participation in an effective PA trial among adults and older adults in a socially and ethnically diverse
population was only 11%, with lower rates in more deprived and Asian subgroups, limiting the trial’s
ability to investigate differential effects in these important subgroups. Trials with greater reach are likely to
be more expensive in terms of recruitment, and gains in generalisability need to be balanced with greater
costs. Differential uptake of interventions found to be successful in trials may increase inequalities in PA
levels and should be monitored.
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Chapter 6 Process evaluation
Introduction
Why is process evaluation necessary in the PACE-UP trial?
The PACE-UP RCT is a complex intervention comprising multiple interacting components (pedometer,
handbook, diary, practice nurse PA consultations and BCTs – as part of both written materials and
consultations). Although the RCT design is able to establish the effectiveness of the intervention (see
Chapter 3), it does not provide information on how it works, or whether or not there are contextual
factors that could be associated with variation in outcome in different settings.169 Conducting a process
evaluation of the PACE-UP trial enables a detailed examination of the mechanisms of change by gaining
an understanding of how the intervention was delivered and received and how this may have affected the
variation in outcomes. The process evaluation investigates the relationship between the fidelity and quality
of implementation, the context of the intervention and the main trial outcomes. The evaluation also helps
to draw conclusions on the replicability and generalisability of the intervention. The main findings from the
process evaluation are published170 and are reproduced here under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/4.0).
Medical Research Council’s guidance on process evaluations in complex interventions
In 2014, the Medical Research Council (MRC) published new guidance for process evaluations of complex
interventions.169 The guidance draws on the experiences of researchers and wider stakeholders who have
conducted process evaluations within trials of complex public health interventions. We have used the
guidance to provide the framework for the process evaluation of the PACE-UP trial. Process evaluation is
accomplished through investigating aspects such as implementation, mechanisms of impact and context,
and the relations between these, as described in Figure 11.
Implementation refers to the structures, resources and methods through which delivery is realised, and
comprises the following factors: implementation process, reach, fidelity, dose and adaptations. The
implementation process describes how the delivery is achieved, through training, support, resources, etc.
Reach refers to coverage and the degree to which the intervention is delivered to those for whom it was
intended, that is, who receives the intervention. The other aspects of implementation are related to what is
delivered. Fidelity is the degree to which the intervention was delivered as intended (content) and includes
assessment of the quality of the intervention. Dose denotes the quantity of the intervention implemented.
Adaptations are participant and implementer adjustments, which may impede or strengthen the intervention
and which arise in response to the intervention itself.
Mechanisms of impact refer to how the intervention activities and participants’ responses to them cause
change and adaptations.
Context refers to external factors which may influence, and be influenced by, implementation mechanisms
and outcomes.
The first stage of designing the process evaluation was to describe the intervention and to clarify casual
assumptions, which was accomplished through the use of a logic model, shown in Figure 12.
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Mechanisms of impact
• Participant responses to and
   interactions with the intervention
• Mediators
• Unanticipated pathways and
   consequences
How delivery is achieved – implementation process – training,
resources
Who it is delivered to – reach
What is delivered
• Fidelity
• Dose
• Adaptations 
Outcomes
Description of
intervention
and its causal
assumptions
• Contextual factors that shape theories of how the intervention works
• Contextual factors that affect (and may be affected by) implementation, intervention mechanisms and outcomes
• Causal mechanisms present within the context that act to sustain the status quo or enhance effects
Context
Implementation
FIGURE 11 The key functions of process evaluation and the relationships between these. Green boxes represent the components of process evaluation, which are informed by
the causal assumptions of the intervention, and inform the interpretation of outcomes. Adapted from Moore et al.169 This is an Open Access article distributed in accordance
with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use,
provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
PRO
CESS
EVA
LU
A
TIO
N
N
IH
R
Journals
Library
w
w
w
.journalslibrary.nihr.ac.uk
64
Problem Evidence base Resources Activities Short-term outcomes Longer-term
12-month (main)
outcomes
Most adults
and older
adults lead
sedentary
lifestyles
and do not
do enough
PA for
health
benefits
Being physically
active reduces
the risk of
overall mortality
and prevents or
reduces
complications
from > 20 health
conditions
Grant funding
Nurse-support 
group: 12-week
programme, three 
PA consultations
with nurse,
pedometer,
handbook, diary
Trained nurses
demonstrate
competence and
confidence in PA
consultations
Accelerometry-
measured change
in step count, time
in MVPA, time spent 
being sedentary
from baseline
Increasing
walking can
safely increase
moderate-
intensity PA 
Pedometers and
step count goals
can help adults
and older adults to
increase walking
BCTs help
people to change
behaviour and
maintain changes
Seven general
practices and
practice nurses
Multidisciplinary
research team
including GPs,
epidemiologists
statisticians,
health
economists,
psychologists,
public health,
PA and
qualitative
experts, BCT
trainers, trial
manager, research
assistants
Equipment
(pedometers,
accelerometers)
Patient
resources
(diaries,
handbooks, etc.)
Nurse training
in BCTs, PA
promotion,
pedometers,
safety-reporting
Postal delivery 
group: 12-week
programme,
pedometer,
handbook, diary
Control group:
offered nurse-
supported or 
postal intervention
after 12 months
follow-up
Medium-term
3-month (interim)
outcomes
Accelerometry-
measured change
in step count, time
in MVPA, time spent 
being sedentary 
from baseline
Participants in both
intervention groups
use pedometers to
record steps in
diaries and work
towards individual
walking targets Anthropometric
changes since
baseline (BMI,
waist circumference,
body fat)
Change in 
patient-reported
outcomes from
baseline: health-
related quality of
life, depression and 
anxiety scores, pain, 
exercise self-efficacy
Change in 
patient-reported
outcomes from
baseline: health-
related quality of
life, depression and 
anxiety scores, pain, 
exercise self-efficacy
Increase in time
spent walking –
change in walking
habits
Increase in time
spent walking –
change in walking
habits and 
longer-term health 
benefits
Assessment of
PA and other
outcomes at
baseline and
12 months
(face to face)
and 3 months
(postal)
FIGURE 12 Logic model for the PACE-UP (Pedometers and Consultation Evaluation – UP) PA trial.
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Methods and results
The PACE–UP trial process evaluation was conducted alongside the effectiveness evaluation, included both
qualitative and quantitative components and was undertaken by the same team that carried out the
effectiveness evaluation.
In accordance with the MRC guidance, the methods were selected through following the key functions model
(see Figure 11) and are summarised in Table 16, which details the process evaluation components, the data
sources, the trial group to which they refer and the measures used. The nurse-supported intervention was the
most complex to deliver as it involved eight nurses from seven practices delivering three consultations over a
3-month period. Most of the process evaluation was therefore designed to evaluate the nurse-supported
intervention group. When process evaluation occurred for other groups, this is clearly described.
TABLE 16 Summary of the PACE-UP trial process evaluation data sources, evaluative groups and reported measures
Process
evaluation
component Data source
Trial groups
evaluated Measures
Implementation
Implementation
process
How was it
delivered?
Training:
l Nurse training day agendas
l BCT trainer telephone feedback
records (generated from
audio-recordings of nurse
intervention sessions)
l Trial administrative records
Nurse-support
group
Time spent on training activities
Resources:
l Trial administrative records
(see Chapter 4)
Nurse-support
and postal
delivery groups
Cost of delivering intervention
components
Reach
Who was it
delivered to?
l Trial recruitment records
(see Chapter 2)
l Data collection on non-responders
and non-participants, including
non-participant interviews
(see Chapter 5)
All groups and
non-participants
l Recruitment frequencies
and percentages
l Qualitative themes and subthemes
from non-participant interviews
Fidelity (content
and quality)
What was
delivered?
l Nurse session checklists
(see Appendix 5)
l Patient alliance questionnaire
(see Appendix 5)
l Nurse alliance questionnaire
(see Appendix 5)
l BCT trainer feedback sheets
(generated from audio-recordings of
nurse intervention sessions)
Nurse-support
group
l Content – number of items delivered
(mean and SD)
l Quality of delivery (frequencies
and percentages)
l BCT competency scores, measures of
quality of delivery (mean, SD and
range)
l PA diaries
l Participant interviews and nurse-
support focus groups and interviews
(see Chapter 7)
l Pedometer use questionnaire
(see Appendix 5)
Nurse-support
and postal
delivery groups
l Completed diary return and weekly
target achievement (frequencies
and percentages)
l Participant and nurse quotations,
qualitative themes and subthemes
l Pedometer use (frequencies
and percentages)
Dose
What was
delivered?
l Nurse session checklists
(see Appendix 5)
l Audio-recordings of nurse
intervention sessions (used to
generate BCT trainer
feedback sheets)
Nurse-support
group
l Sessions attended (frequencies
and percentages)
l Consultation durations (mean SDs,
medians and interquartile ranges)
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To reduce duplication, and for ease of reading, the methods and results for each aspect of the process
evaluation are presented together. The main results are summarised in a further key functions model after
all of the results have been presented (Figure 13). Several aspects of the process evaluation are dealt with
appropriately in other chapters of this report, such as reach in Chapter 5 and participant responsiveness in
Chapter 7. They are referred to in Table 16 for completeness and the relevant chapter in which the
methods and results for this aspect are presented are clearly shown.
We have selected three quantitative aspects of the process evaluation to relate directly to PA outcome
measurements at 12 months (change in step counts and change in time in MVPA in bouts): the number of
nurse appointments attended whether or not completed step count diaries were returned by participants at
3 months in the nurse-support and postal delivery groups, and the use of pedometers in the nurse-support
and postal delivery groups during the 12-week intervention. These analyses relating process to outcome
measures are described at the end of Methods and results.
Implementation
Implementation process
Training
Nurses delivering the intervention were provided with training in PA guidance (1 hour and 25 minutes),
trial protocols (4 hours), safety reporting (1 hour and 10 minutes) and BCTs (9 hours and 25 minutes)
across the duration of the trial (see Appendix 5, Table 38). Data on nurse training were obtained from
training-day agendas and BCT trainer telephone feedback records and trial administrative records. The
total training time was approximately 16 hours; most of this was allocated to delivering BCTs as the active
ingredient in the intervention.
TABLE 16 Summary of the PACE-UP trial process evaluation data sources, evaluative groups and
reported measures (continued )
Process
evaluation
component Data source
Trial groups
evaluated Measures
Adaptations
What was
delivered?
l Nurse training session records
l PA diaries
Nurse-support
group
l Comments made by nurses
l Alteration of targets (frequencies
and percentages)
l Participant and nurse quotationsl Participant interviews and nurse
focus groups and interviews
(see Chapter 7)
Nurse-support
and postal
delivery groups
Mechanisms of impact
Participant
responsiveness
l Patient alliance questionnaire
(see Appendix 5)
l Nurse alliance questionnaire
(see Appendix 5)
Nurse-support
group
l Measures of responsiveness
(frequencies and percentages)
l Participant and nurse quotations
l Participant interviews and nurse
focus groups and interviews
(see Chapter 7)
Nurse-support
and postal
delivery groups
Qualitative themes and subthemes
Context
Contextual
factors
Nurse training session records Nurse-support
group
l Comments made by nurses
l Qualitative themes and subthemes
l Participant and nurse quotations
Participant interviews and nurse focus
groups and interviews (see Chapter 7)
Nurse-support
and postal
delivery groups
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Participant responsiveness
• 90% of participants felt that the pedometer
   used in the PACE-UP trial was helpful
• 83% of participants felt that the number of
   nurse appointments was just right
• ‘PACE-UP has changed my life . . .’
• Process – training – 16 hours mainly BCTs, also
   PA, protocol and safety
• Reach – 10% of those invited participated in the trial
• Fidelity – content well covered. 80% returned
   completed PA diaries
• Fidelity – quality – 90% of participants felt understood
   and respected. Nurses were competent, proficient or
   expert at BCT delivery
• Dose – 74% attended all three nurse sessions
• Adaptations (often related to context) – for
   health limitations, pain, weather, religious
   observances, holidays and couples
• Significant increases in
   average daily step count
   and average weekly
   MVPA in bouts in 
   nurse-support and 
   postal delivery groups
   compared with control
   (no difference between
   intervention groups)
• Nurse-support group 
   increased self-efficacy 
   compared with control
• No change in other
   outcomes
• Significant associations
   between implementation
   measures (diary return,
   pedometer use and nurse
   sessions attended) and
   PA outcome measures
Description of
intervention and its
causal assumptions
• Primary care
   pedometer-based
   12-week walking
   intervention, with
   and without practice
   nurse support
   (postal or nurse
   supported by three 
   PA consultations)
• Assumption that
   providing a
   pedometer,
   individual walking
   target and
   handbook based on
   behaviour change
   techniques will
   increase PA levels
Context
Implementation
Mechanisms of impact
Factors affecting (and affected by) implementation of this walking intervention: season / weather (effect of rain, ice and snow on walking),
environment (easier to walk in nearby park than in built-up area), health issues (walking making pain worse and pain improved by walking) and
employment (retired people having more time for walking, some occupations providing walking opportunities), observance of religious events
(difficulty achieving PA targets during Ramadan and Christmas) and social factors (walking with partner/friend/family / grandchildren, or not 
having anyone to walk with). Contextual factors often led to adaptations by nurses or participants
Outcomes
12-month outcomes
FIGURE 13 The key functions of process evaluation and the relationships between them for the PACE-UP trial. Green boxes represent components of process evaluation, which
are informed by the causal assumptions of the intervention and inform the interpretation of outcomes. Adapted from Moore et al.169 This is an Open Access article distributed
in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for
commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/.
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Resources
Resources for the trial include the trial materials [patient handbooks and diaries, see the NIHR Journals
Library website: www.journalslibrary.nihr.ac.uk/programmes/hta/103202/#/ (accessed 25 May 2018)], trial
equipment (pedometers and accelerometers) and payment of nurse time and room hire. These are all fully
costed in Chapter 4 and are not further commented on in this chapter.
Reach
The overall trial recruitment rate was 10% (1023/10,467). Details on how practices and participants were
selected and recruited is described in Chapter 2. The methods for assessing trial representativeness and
generalisability, by comparison of non-responders, non-participants and participants, and by interviews of
non-participants, are described in Chapter 5.
Fidelity (content and quality)
Content
Nurse sessions
Nurse session attendance and session content delivered was recorded by the nurses after each session
(see Appendix 5). There were 11 compulsory items to be covered in session 1 and six items to be covered
in sessions 2 and 3. The level of nurse session attendance was high; approximately three-quarters of
participants attended all three sessions (n = 255/346; 74%). Adherence to content delivered was high in all
sessions; the mean number of items delivered in each session was 11 (range 10–11) and six (range 5–6) in
sessions 2 and 3, respectively. Of those participants who attended session 3, most reported still using the
pedometer and diary (n = 258/263; 98%) (Appendix 5, Table 39).
Physical activity diaries
Physical activity diaries (see Appendix 5, Table 40) returned by participants after the intervention provided
data on the achievement of weekly walking targets for the intervention groups. Eighty per cent of
participants (n = 549) returned completed diaries; there was similar return across both groups. One-third of
participants in the nurse-support group altered their step count targets (89/346; 32%) and the majority
were decreased (n = 80). In comparison, just four participants in the postal delivery group altered their step
count targets and all were decreased. The relationship between diary return at 3 months and the trial
outcome measures was explored (see the association between the process evaluation measures and the
trial outcomes at the end of Methods and results).
Pedometer use
All participants were asked about their pedometer use during the 12-week intervention period (see
Appendix 5, Table 41). During the 12-week intervention, a high proportion of both the postal delivery and
nurse-support groups reported using their pedometer either every day or most days: 238 out of 294 (81%)
in the postal delivery group and 269 out of 303 (89%) in the nurse-support group. The relationships
between pedometer use during the intervention and the trial PA outcomes at 3 and 12 months were
explored for both intervention groups (see the association between the process evaluation measures and
the trial outcomes at the end of Methods and results).
Quality
Nurse and patient alliance questionnaire
Following the intervention, both the nurse and the participant independently completed a 12-item nurse
and patient alliance questionnaire (see Appendix 5) covering different intervention aspects (e.g. working
together and goal-setting, number of appointments). The questionnaires were developed by BCT trainers
and trial investigators, and questions 1–11 were adapted from the Working Alliance Inventory,171,172 which
is a validated alliance measure used in cognitive–behavioural therapy-based studies, and the Outcome
Rating Scale.173 Item 12 was added to specifically ask about the number of PACE-UP trial appointments.
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The questionnaire was posted to the participant and returned to the researcher, so that the nurse was
blind to participant responses. Three directly comparable items (questions 1, 3 and 4) from both the
patient questionnaire and the nurse questionnaire provided data on the quality of intervention delivery
(Table 17). Seven directly comparable items directly relate to participant responsiveness (questions 5, 6, 8,
9, 10, 11 and 12). Two items (questions 2 and 7) were discounted as they did not relate to quality of
participant responsiveness.
The questionnaires were completed by 295 out of 346 participants (85%) in the nurse-supported
intervention group and by the nurses for 251 out of 346 nurse-support group participants (73%).
There was strong agreement between the participant and nurse results for all of the items relating to
quality and 80% or more of both nurses and participants agreed or strongly agreed with all of these
statements, suggesting high quality of delivery.
TABLE 17 Quality of delivery and participant responsiveness data from the nurse and patient alliance
questionnaires
Delivery and responsiveness
Questionnaire
Patient alliance Nurse alliance
N
‘Agree’ or
‘strongly
agree’, n (%)
Missing
items N
‘Agree’ or
‘strongly
agree’, n (%)
Missing
items
Quality of delivery
Q1: the patient and I worked together on
setting goals that were important to the patient
287 231 (80) 8 250 221 (88) 1
Q3: the patient felt heard, understood and
respected
287 259 (90) 8 249 234 (94) 2
Q4: in our meetings together, the patient
discussed everything they wanted to discuss
285 267 (94) 10 249 234 (94) 2
Participant responsiveness
Q5: the patient understands how to make
lasting changes in activity levels
289 259 (90) 6 249 215 (86) 2
Q6: the approach to making change suited the
patient
287 247 (86) 8 249 182 (73) 2
Q8: the patient feels confident to continue to
make positive changes in PA on their own
288 238 (83) 7 246 191 (78) 5
Q9: the patient feels confident about
overcoming obstacles to increasing activity levels
in the future
257 169 (66) 38 190 124 (65) 70
Q10: the pedometer used in the PACE-UP study
was helpful to the patient
288 260 (90) 7 246 209 (85) 5
Q11: the diary used in the PACE-UP study was
helpful to the patient
284 229 (81) 11 247 203 (83) 4
Q12: the number of appointments with the PA
nurse was just right . . .
278 232 (83) 17 241 178 (74) 10
Notes
Missing items were excluded from the percentage calculations.
Q9 on the nurse alliance questionnaire was printed blank on the Likert scale for answers, so a high number of responses
were missing.
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The following are some examples of participant and nurse comments relating to quality from the
questionnaires:
Nurse was encouraging, supportive. Encouraged me to set goals that were achievable for me and not
to put too much pressure on myself.
Female, aged 47 years, nurse-support group
My nurse was lovely and encouraged me all the way through, even when some days I couldn’t do
what I needed, we discussed alternatives. My nurse was a diamond. Thanks to PACE-UP and the nurse
my walking has really improved.
Female, aged 47 years, nurse-support group
Client pleased with programme. Learning curve. Would recommend to others.
Practice nurse
Enjoyed patient, good discussions and understanding around increasing exercise.
Practice nurse
Audio-recordings from nurse sessions
Nurses were asked to audio-record a sample of their sessions so that these could be listened to by the
BCT trainer and rated according to their skill in six different communication skill competencies. Ratings
were made by the BCT trainer against a primary care consultation rating scale (range 0–6) in six domains
(Figure 14) and used for both fidelity (quality) evaluation and supervision purposes. The rating scale used
was developed from the Cognitive Behavioural Therapy Techniques for Palliative Care Practitioners Rating
Scale174 and the Department of Health and Social Care’s The Ten Essential Shared Capabilities – A
Framework for the Whole of the Mental Health Workforce.175 The nurses were each asked to provide
three audio-recorded sessions, one each for sessions 1, 2 and 3. They were asked to try to ensure that one
of the recorded sessions was from a session where a couple were seen together. The mean scores and
ranges for all nurses are shown across all domains in Table 18.
The range of scores illustrates that even the lowest ratings were competent, and the highest scores were
expert, across all six competencies. The lowest scoring competency was given for empowering explanations
(mean score 4.7), whereas all the other competencies had mean scores above 5, demonstrating proficiency,
with very good features.
Competence level Examples
0 Absence of feature, or highly inappropriate performance
Incompetent
1 Inappropriate performance, major problems evident
Novice 2 Evidence of competence, but numerous problems and lack of consistency
Advanced
beginner
3 Competent, but some problems and/or inconsistencies
Competent 4 Good features, but minor problems or inconsistencies
Proficient 5 Very good features, minimal problems and/or inconsistencies
Expert 6 Excellent performance, or very good even in the face of patient difficulties
FIGURE 14 Behaviour change technique competency level.
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Qualitative perspective
Semistructured individual interviews with participants and focus groups with nurses provided a qualitative
perspective of the intervention, including the quality of delivery; this is presented in detail in Chapter 7.
Overall, the nurses and participants described the intervention in a positive manner, as highlighted by the
following quotations:
. . . they kept saying how well I was doing, and all this sort of thing, so it made me want to continue.
I think it was . . . a part motivation, yes, because I knew I had to face somebody and I didn’t want
to fail.
Female, aged 63 years, nurse-support group
. . . if you had, in your drawer, you had like a set . . . a package, programme, you could do, and if
through the NHS Health Check you identified someone who was suitable, you could then discuss it
with them and say, ‘Would this be something you’d be wanting to look at? . . . and go from there.
Practice nurse
Dose
For the purpose of the PACE-UP trial, the dose delivered to the postal delivery group was fixed, as they all
received the same handbook, diary and pedometer. The dose could vary for the nurse group according to
the number of sessions attended and the length of each of the sessions. Nurses were required to complete
checklists at the end of each session (see Appendix 5, Table 39), providing details on attendance and the
duration of sessions. The duration of sessions was also captured from the audio-recorded sample of
intervention sessions; this allowed a comparison with session durations calculated from nurse checklists.
Overall, three-quarters of participants in the nurse-support group attended all three sessions. Ninety-five per
cent of participants (330/346) attended session 1, 86% (296/346) attended session 2 and 76% (263/346)
attended session 3. The relationship between the number of sessions attended and trial PA outcomes was
also explored (see the association between process evaluation measures and trial outcomes at the end of
Methods and results).
Trial protocols detailed the following approximate duration of each nurse intervention session: 30 minutes
for session 1 and 20 minutes each for sessions 2 and 3. A summary of nurse intervention session durations
from nurse self-report and audio-recordings is available in Appendix 5, Table 42 (19 recordings, relating to
22 participants, as some were couples). There was good agreement between the planned protocol session
length and the nurse self-report durations: mean of 30 minutes (SD 4 minutes) for session 1, mean of
24 minutes (SD 3 minutes) for session 2 and mean of 22 minutes (SD 4 minutes) for session 3. The duration
of consultations from audio-recordings was based on much smaller numbers (n = 22 participants) but had a
shorter mean duration: mean of 21 minutes (SD 6 minutes) for session 1, mean of 21 minutes (SD 7 minutes)
for session 2 and mean of 14 minutes (SD 5 minutes) for session 3.
TABLE 18 Fidelity: quality scores of performance for audio-recordings of nurse sessions by BCT trainer
Scores
Communication skill competency
1. Framing,
pacing,
focus and
use of time
2. Empowering
explanations
3. Collaboration
and active
listening;
interpersonal
effectiveness
4. Setting goals,
agreeing actions
and motivational
techniques
5. Feedback,
reviewing and
summarising
6. Building
self-efficacy
Average (mean)
score
5.3 4.7 5.0 5.2 5.3 5.2
Range of
scores
3–6 3–6 4–6 4–6 5–6 4–6
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Adaptations
Details of nurse and participant adaptations made to the intervention were provided from nurse training
session records. There were many examples presented relating to step count target adaptation and tailoring
the intervention to individual circumstances. Adjustments were made to the intervention to accommodate
religious observances, such as Ramadan and Christmas. Step count targets were adapted to be more
achievable to reflect participants’ reduced energy/activity levels in advance of holidays, when there were
expected to be reductions or increases in PA, during periods of participant illness and pain and in response
to changing weather conditions. Nurses also explained the need for flexibility with participants who
experienced difficulties with equipment use; for example, a small number of participants who did not like
using the pedometer were advised to use time to measure their walking, rather than measuring step count
(e.g. extra walks of 10–15 minutes per day, rather than an extra 1000–1500 steps per day). At the second
training session, it became clear that the nurses did not find the optional handouts provided for use in
consultations to supplement the patient handbook helpful and, as a consequence, were not using them.
From these discussions, it was decided that these materials would be discontinued. Another adaptation
revealed by the nurses was adapting targets and advice for participants taking part as a couple, particularly
if they had very different PA levels and targets; this sometimes related to one individual of the couple having
health problems that had an impact on mobility. Nurses adapted the intervention to encourage both
participants to meet their targets, often encouraging a mixture of walking together and walking apart to
achieve this.
Physical activity diaries also provided data on adaptions to the prescribed intervention through alterations
of participants’ walking targets (see Appendix 5, Table 40). Few participants in the postal intervention
group altered their targets in the diary (1%; 4/339), whereas 32% (89/346) of the nurse-supported
intervention group altered their walking targets, mainly by decreasing the target [29% (80/346)].
Additional details of nurse and participant adaptations to the intervention by both intervention groups,
obtained as part of the qualitative evaluations of the trial, are presented in Chapter 7. Some examples are
given here.
The nurse quotations below illustrate the flexibility in intervention delivery during Ramadan and also during
bad weather:
. . . they couldn’t walk or increase on their walking at that time because they hadn’t eaten and then
they weren’t feeling too good, and all that, so we did it a different way then, and what I did with
them was we relaxed it and then I said to them, when Ramadan’s over, we made the appointment
so that their actual trial went on a bit longer.
Practice nurse
. . . if the weather was bad, or it was cold, or there were obstacles that got in the way . . . they would
do things like, you know . . . activities indoors where they could not always go outside.
Practice nurse
Mechanisms of impact
Participant responsiveness
Seven items reflecting participant responsiveness were identified in both the patient alliance questionnaire
and the nurse alliance questionnaire (see Table 17). There was a good degree of consistency between
participant and nurse responses for all of the items relating to participant responsiveness and high levels
of agreement with all of the statements. For example, 90% of participants said that the pedometer was
helpful and 83% said that the number of nurse appointments was just right, suggesting that there was
a good level of participant responsiveness to the intervention.
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Some examples of both participant and nurse comments relating to participant responsiveness from the
alliance questionnaires are shown below:
PACE-UP has changed my life. I use the car less when I go about. Although I drive to work I park
about 1 km away from work, then walk all the way to and from.
Female, aged 47 years, nurse-support group
Wearing the pedometer really raised my awareness of how far I walked each day. I will continue to
use it.
Female, aged 68 years, nurse-support group
Positive, liked study book. Was a very reflective/honest person regarding his exercise. Positives/
negatives easily identified by patient.
Practice nurse
Patient has own excel monitor of readings/pedometer count. Also converts to miles daily.
Practice nurse
Information about participant responsiveness also came from the qualitative evaluations of participants
from both the postal delivery and the nurse groups (from individual interviews) and from practice nurses
(from a focus group and individual interviews), and is presented in Chapter 7.
The following quotations from the qualitative evaluation illustrate participant responsiveness and
engagement from a nurse and participant perspective:
. . . the only other thing I’d say about the diary is that the people that really liked filling it in found it
a really good motivator. When they came to the last appointment, they wanted another one.
Practice nurse
There’s nothing like the fact that you know you’re going to meeting someone and talk about it to
make you do it, you know, . . . It’s basically the routine of being checked up on by someone else . . .
Male, aged 61 years, nurse-support group
. . . well having something which counts the steps makes one conscious of it and filling out a little
booklet every day, likewise, it just creates some personal pressure.
Male, aged 59 years, postal delivery group
Context
Comments made by nurses during training sessions relevant to contextual factors were noted down. There
was overlap with the factors mentioned in the section on adaptation of the intervention, as contextual
factors often required the nurses to consider adapting the intervention or targets after discussion with
participants. Examples of contextual factors mentioned are as follows: the difficulty of walking in bad
weather, the effect of taking part in the intervention as a couple, health issues that required a slower,
more gradual approach and undertaking the intervention during Ramadan or Christmas.
How contextual factors may have affected (and been affected by) the implementation, such as season,
environment, health status, employment and social and religious factors, were explored as part of the
qualitative evaluation of participants (from individual interviews) and nurse perspectives (from focus group
and individual interviews), and are described more fully in Chapter 7. The following factors were described:
season/weather (problems with rain or snow and ice), environment (ease of walking in parks, more difficult
in built-up areas), health issues (examples both of pain getting worse with walking and of walking improving
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pain), employment (retired people saying they have increased time for walking, some occupations providing
the opportunity for walking or at least walking to work), religious factors (difficulty with walking during
Ramadan when fasting and having low energy levels) and social factors (walking with family/grandchildren,
etc. or not having anyone to walk with). This last factor is illustrated by the following quotation taken from
the qualitative evaluation:
. . . it’s something I want to keep up, because I just felt that it was such a benefit, and even the kids
would come out with me sometimes.
Nurse-support group participant
Association between process evaluation measures and trial
outcome measures
Although the trial was powered only for analysis of the difference in outcome measures between the
three groups, and not for exploration of the effect of process evaluation measures, we felt that it was
interesting to explore if there was any relationship between adherence to the intervention and the change
in outcomes. We have focused on three quantitative measures of process evaluation in relation to the PA
outcome measures at 3 months and 12 months (changes in average daily step count and weekly time in
MVPA in bouts). The three measures were all to do with the implementation of the intervention:
1. Dose – nurse session attendance (0, 1, 2 or 3 sessions attended; nurse-support group).
2. Fidelity – return of completed diaries after the 3-month intervention (yes/no; postal delivery and
nurse-support groups).
3. Fidelity – pedometer use – how often did you wear the pedometer? Every day or most days (yes/no;
postal delivery and nurse-support groups) during the 12-week intervention (0–3 months).
All measures described were considered as independent variables in the models, with (1) change in
average daily step count and (2) change in total weekly MVPA in bouts as outcomes. All analyses were
adjusted for age, sex, practice, month of baseline accelerometry, household identifier (to account for
clustering by household) and trial group (as in the main trial analyses; see Chapter 2). Table 19 shows the
results of the models.
Nurse session attendance and physical activity outcomes
In the nurse group at 3 months and 12 months there was a positive association between the number of
sessions attended and the PA outcomes. Participants attending all three sessions increased their step count
and their time in MVPA in bouts at 3 and 12 months by significantly more than those attending between
0 and 2 sessions.
Diary return and physical activity outcomes
In the postal delivery group, there was a strong positive association between returning a diary and on both
change in steps and MVPA in bouts at both 3 and 12 months compared with those in the postal delivery
group, who did not return a diary. In the nurse-support group, there was a positive association between
returning the diary and on change in step count and MVPA at 3 months, compared with those in the
nurse-support group who did not return a diary. However, by 12 months, there was no significant
association for either PA outcome of returning a diary within the nurse-support group.
Pedometer use and physical activity outcomes
In the postal delivery group, reported use of a pedometer every day or most days during the 12-week
intervention period was associated with a significant change in step count at 3 months and 12 months,
and with change in MVPA at 3 months (borderline effect at 12 months).
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Within the nurse-support group, there were no significant associations between regular pedometer use
during the 12-week intervention and change in step count or MVPA at 3 months and 12 months. This lack
of significant effect could be explained by the very small numbers of participants in the nurse-support group
who reported not having used a pedometer regularly during the 12-week intervention (n = 34; 11%).
Overall, the analysis of the association between process measures and PA trial outcomes exhibits a clear
pattern of positive associations (i.e. increased nurse appointments, diary return and pedometer use were
associated with increased objective PA levels). This provides clear evidence of the engagement with the
trial process and outcomes, but cannot be interpreted as causality.
Discussion
Main findings
Figure 13 summarises the key findings from the PACE-UP trial process evaluation, which followed the
MRC guidance for process evaluation of complex interventions.169 We gathered a number of positive data
on implementation, suggesting good-quality intervention delivery and adherence to the protocol, despite
the low reach of the trial. Nurse training was an important element of the trial, with nurses receiving
approximately 16 hours of training, predominantly around delivery of BCTs. We demonstrated good
TABLE 19 The PACE-UP trial modelling results: relating nurse session attendance, step count diary return and
pedometer use to PA outcomes
Intervention
components
PA outcome
Daily step count
Total weekly minutes of MVPA in
≥ 10-minute bouts
3 months 12 months 3 months 12 months
Effect
(95% CI) p-value
Effect
(95% CI) p-value
Effect
(95% CI) p-value
Effect
(95% CI) p-value
Nurse session attendance
Attended all
three nurse
sessions: yes vs.
no
1197
(627 to 1766)
<0.001 605
(74 to 1137)
0.03 74
(45 to 103)
<0.001 30
(3 to 57)
0.03
Diary returned
Postal delivery
group: yes vs.
no
1458
(854 to 2061)
<0.001 1114
(538 to 1689)
<0.001 64
(33 to 94)
<0.001 47
(17 to 75)
0.002
Nurse-support
group: yes vs.
no
873
(190 to 1555)
0.01 323
(–278 to 925)
0.29 50
(15 to 85)
<0.001 3
(–27 to 33)
0.89
Pedometer use every day or most days during the 12-week intervention
Postal delivery
group: yes vs.
no
1029
(383 to 1675)
<0.001 606
(22 to 1190)
0.04 40
(6 to 73)
0.02 26
(–2 to 55)
0.07
Nurse-support
group: yes vs.
no
337
(–525 to 1198)
0.44 394
(–321 to 1109)
0.28 24
(–20 to 68)
0.28 10
(–25 to 45)
0.58
Notes
All models include practice, sex, age at randomisation and month of baseline accelerometry as fixed effects and household
as a random effect in a multilevel mode.
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coverage of the proposed session content by the nurses and also good-quality delivery, with the
audio-recording of nurse sessions demonstrating high levels of competency in communication skills.
High-quality delivery was also reflected in comments from participants who felt heard, understood and
respected. Three-quarters of the nurse group attended all three PA consultations, and around 80% of
both the nurse-support and the postal delivery groups engaged with the self-monitoring aspects of the
trial and returned completed step count diaries at 3 months. In terms of the mechanisms of impact, we
demonstrated high levels of participant responsiveness. Context was important and factors affecting
the implementation of the walking intervention were suggested by nurses and participants from both
intervention arms, and included the effects of weather, the environment, health issues, pain, employment,
observance of religious events and social factors. The nurses worked with participants to help them to
make adaptations, either to the intervention or their individual targets, or to encourage participants to
come up with solutions when possible, when there were contextual challenges. Several process evaluation
measures (number of nurse sessions attended, return of a completed diary and regular pedometer use)
showed significant associations with PA outcomes at 3 and 12 months.
Strengths and limitations
Strengths
Despite the PACE-UP trial process evaluation having been designed before the publication of the MRC
guidance,169 we were able to use the data that we collected and fit them into the framework, which has
provided a useful structure for reporting process evaluation findings. We have a number of different data
sources that reflect three different perspectives in the trial: participant, practitioner and observer. This
provided a broader picture of the process than many studies have reported and allowed comparison
of results from different methods (e.g. for consultation duration). We tried to reduce the burden of
participant measurement, trial costs and duplication of effort, by collecting as many routine trial data as
we could for the evaluation (from administrative records, nurse training records, nurse checklists, nurse
audio-recordings from supervision sessions, etc.), but we supplemented this with data collected specifically
for the evaluation (e.g. the nurse and patient alliance questionnaires or the 12-month pedometer use
questionnaire). We have used a mixed-methods approach to the process evaluation, as recommended,
combining quantitative data from key process variables from all participants with in-depth qualitative data
from purposively selected samples.169 The qualitative element is described in full in Chapter 7; however,
we have used relevant quotations in this chapter to illustrate the quality of delivery, adaptations, participant
responsiveness and context, and these have provided a voice to participants and nurses and added a
richness and depth to the evaluation. The data were collected longitudinally and contemporaneously
throughout the trial, which is seen to be the most complete and accurate method of data collection, and
also allows any change in intervention delivery over the course of the trial to be detected.169 The data are
comprehensive, with a high response rate and completeness of data sources, strengthening the robustness
of the findings. The process evaluation analysis was conducted before the outcome analysis to avoid a
biased interpretation of the process data. Only the final analyses examining the effects of process evaluation
variables on outcome data were carried out following the main outcome analyses.
Limitations
The process evaluation was conducted by the trial team while the trial was ongoing. This allowed efficient
data collection in a contemporaneous manner, but could have led to bias in evaluation. We tried to minimise
the bias by using objective instruments when possible (e.g. nurse and patient alliance questionnaires,
12-month pedometer use questionnaires, return of patient diaries). In addition, the qualitative evaluation was
led by Christina Victor, who was not involved in the day-to-day trial conduct. Some process measures were
not filled out by everyone (patient alliance questionnaire: 85% completion; nurse alliance questionnaire: 73%
completion); this could have led to a more positive assessment of statements, if those who felt negatively
about the programme did not reply. Nurses could have selected more positive consultations to audio-record,
inflating the BCT competency levels, although they were encouraged to record cases as they occurred. Not all
of the nurses submitted audio-recorded consultations with couples, meaning that we were unable to look
separately at the quality of these consultations. The content delivery for the nurse consultations was evaluated
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from checklists filled out by the nurses because they may have overestimated what they had achieved. We
tried to compensate for this by collecting additional data from both the participant and observer perspective
to help to corroborate these data; both participant and observer data suggested a high degree of quality in
the consultations. The consultation durations were shorter from observer data than from self-report, but data
on observed consultations were based on a much smaller sample. The study was not powered to look at the
effects of adherence to different aspects of the protocol on trial outcomes; we therefore have reduced power
for these analyses, which limits the interpretation of the findings, which cannot be taken to be casual.
Comparison with other complex intervention process evaluations
A number of studies have examined intervention implementation fidelity, with a large variety of process
structures and methods; therefore, it is difficult to draw direct comparisons. Process evaluations have
become increasingly important, but the purposes and design of studies have been mixed. Many process
evaluations are completed independently of trial data collection and are observations of a random
subsample of participants or practitioners.176,177 The process evaluation of the PACE-UP intervention
provides both participant and nurse perspectives and identifies a link between contextual factors and
adaptations in intervention delivery and acceptance. The study allowed us to look at both perceived and
observed behaviour change in the nurse intervention delivery and participant responsiveness; this is unlike
many other studies, which have tended to focus on only one perspective, which is most often the person
delivering the intervention.176,178–181 Nurse comments collected at training, individual session checklists
and nurse and participant comments from the qualitative work illustrate the intervention delivery and
adaptations in context. The intervention was designed to bring about change at an individual level when
delivered in a primary care environment; we have observed that context influences the delivery and
implementation of the intervention through adaptation. This is similar to findings from other PA and
dietary complex intervention studies with process evaluation.182,183 Specifically, Fitzgerald et al.182 identified
that negotiation and flexibility play an integral role in overcoming the barriers and resistance to change in
a dietary intervention. Previous studies have collected data at an organisational or practice level;176,181 there
are few studies that have captured the evaluation of behaviour change at an individual level and from
two perspectives. A previous study that did look at both patient and practitioner perspectives, however,
reported much greater variations in dose and adherence to protocols than seen in the PACE-UP trial,
therefore making it difficult to establish which elements of the intervention were effective.184 Berendsen
et al.184 reported that many health-care professionals deviated from the protocol of a lifestyle intervention
to accommodate individuals and reduce fallout, which was associated with increased patient satisfaction
for the intervention sessions. This perhaps suggests that adaptations and tailoring of an intervention have
a strong influence on retention, adherence and, possibly, effectiveness in lifestyle and behaviour change
interventions. The PACE-UP intervention allowed nurses to adapt the sessions as necessary to each
individual, while maintaining the key deliverables in each nurse-led session; although we have not looked
at the effect of adaptation on retention, we have seen that dose (nurse session attendance) was associated
with effectiveness of the intervention. This, in turn, promotes the consideration of building adaptations
and flexibility into intervention design. Our finding of an association between the return of a completed
step count diary and a change in PA outcomes is consistent with the findings of a systematic review,31
which suggested that the use of a step count diary was common to many successful pedometer interventions.
Implications of the process evaluation for the interpretation of the PACE-UP trial
We have demonstrated that the PACE-UP trial had good adherence to the protocol, the intervention was
acceptable and was rated positively by both the nurse-support group participants and the postal delivery
group participants, and both groups engaged in self-monitoring using the pedometer and step count
diary. It is not possible to infer causality directly from the process evaluation data, but the high level of
engagement with pedometers and diaries by both intervention groups suggests that these were important
factors in helping people to make the PA changes observed. This is supported by the associations
demonstrated between increased PA levels and the following process measures: number of consultations
attended, return of a completed step count diary and pedometer use. The careful description and
documentation of the trial processes, the collection of additional data for the process evaluation and the
publication of the resources used as appendices mean that our intervention and process evaluation would
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be easy for others to replicate, from training through delivery, to follow-up and evaluation. Use of the
MRC framework gave a logical and coherent structure for reporting,169 which is also easy for others to
follow. The PACE-UP trial had a positive and significant effect on PA outcomes, but had this not been the
case, the positive process evaluation with high levels of fidelity would have enabled us to have confidence
that any negative trial effect would not have been because of poor trial implementation. The trial
demonstrated a stronger effect on the main PA outcomes and on exercise self-efficacy at 3 months in the
nurse-support group than in the postal delivery group, although the effects on PA outcomes were similar
between the groups at 12 months (self-efficacy remained higher at 12 months in the nurse-support group).
The process evaluation demonstrated that the nurses were delivering BCTs in their PA consultations in
accordance with the protocol and with high levels of competence (in addition to the BCTs provided
in the handbook and diary for both groups). This suggests that the nurse-delivered BCT elements of the
intervention have strong short-term effects on PA levels (and, possibly, longer-term effects on self-efficacy).
The possible effects on longer-term maintenance are examined in Chapter 8. The implications of the low
reach of the trial for generalisability and the public health impact have been discussed in Chapter 5 and will
be considered further in the main discussion in Chapter 9. The process evaluation demonstrated important
contextual factors that had an impact on participants’ ability to engage with a walking intervention; these
should be considered in any future roll-out of the programme, particularly regarding how the programme
may need adaptations to be made in these circumstances.
Conclusion
The PACE-UP trial process evaluation demonstrated that the trial was well delivered by the trial team and
well received by participants. The MRC framework was a useful vehicle for reporting the evaluation. An
association between adherence to the trial protocol and main trial PA outcomes has been demonstrated.
Important contextual factors were shown that may need adaptations to be considered in any roll-out of
the intervention.
DOI: 10.3310/hta22370 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 37
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Harris et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
79

Chapter 7 What did the nurses and participants
think about the intervention?
Introduction
It is important, within the delivery of a behaviour change intervention trial, to understand the experiences
of those involved in the delivery and receipt of the intervention. In order to address these important issues,
two qualitative studies were embedded within the trial protocol. In these studies, we sought to gain
insights into two important issues: (1) the views and experiences of the nurses delivering the intervention
and (2) the experiences of trial participants. Summaries of the nurses’ perspectives on the trial185 and the
participants’ evaluation of the trial in helping them to increase their levels of PA162 have been published
and are reproduced here under the terms of the Creative Commons Attribution 4.0 International License
(http://creativecommons.org/licenses/by/4.0). In this chapter, we focus upon the perceptions of the nurses
and participants of the trial; some of the quotations have been published previously in the publications
detailed above.
It is of fundamental importance to understand the perspectives of both those involved in the delivery of
the intervention and those who received the intervention. In Chapter 6, we provided a comprehensive
process evaluation of the trial which described, in detail, the training and support given to the trial nurses.
In Chapter 6, we also addressed issues related to the fidelity of the trial delivery by the nurses. In this
chapter, we focus on the nurses’ perspective on their experience of participating in the trial, with a view
to understanding how we can better plan and deliver primary care-based trials and then implement them
more widely. There is an extensive literature that examines adherence to behaviour change interventions
in adults and which establishes the barriers to, and facilitators of, for example, increasing PA. For example,
Picorelli et al.,186 focusing on older adults, reported that adherence to exercise interventions was associated
with key demographic factors (higher socioeconomic status and not living alone), health status (fewer
health conditions, taking fewer medications and better self-rated health) and psychological factors (fewer
depressive symptoms).186 For trial participants, a novel part of our qualitative study addressed a related,
but much less well researched, issue of trying to understand why the intervention did, or did not, work
as a means of evaluating the individual elements of the intervention in facilitating behaviour change.
Recruiting trial participants for the qualitative study
At initial recruitment into the trial, participants were asked for consent to participate in follow-up
telephone interviews, such as those included in this aspect of the study. The trial statistician prepared a
spreadsheet of all participants who had completed the 12-month follow-up in January 2014 and who
had given consent to be approached to participate in the telephone interviews (this list was updated in
March 2014). We purposely recruited participants who had, and had not, increased their PA levels from
both nurse-supported and pedometer-only intervention groups. We defined an increase as ≥ 200 steps per
day; anyone who either did not achieve this or decreased their PA was defined as a non-improver. This
gave us four interview groups: (1) nurse support/increase, (2) nurse support/no increase, (3) postal delivery/
increase and (4) postal delivery/no increase. We also ensured that we sampled participants with a range of
ages, from both sexes and from all six of the initial participating practices. As noted in Chapter 2, a novel
feature of our trial was the option for participants to take part as a couple and we wanted to ensure their
inclusion in our qualitative study. We purposely targeted potential participants from demographic groups
under-represented in our main sample (e.g. ethnic minority community participants) to ensure that we
explored the widest range of views possible.
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Between February and April 2014, we identified 96 trial participants who had been selected on the
basis of the criteria described above. We made contact with 44 of these participants, of whom only one
declined to be interviewed. We were unable to make contact after three attempts with the remaining
52 participants, who had been initially identified as potential participants. The 43 participants we recruited
broadly approximated to the demographic parameters specified, with 20 participants in the 45- to 59-year-old
age group, 29 participants being female, 21 participants in the nurse-supported intervention group and
23 participants who did not increase their step counts. We interviewed seven participants who took part as a
couple, but we did not interview both partners. In terms of ethnicity, 29 were white British and a further five
were from other white ethnicity groups, with nine participants from black and Asian ethnic minority groups.
Appendix 6, Table 43 shows the demographic and step count details of individual participants.
We used a semistructured interview guide tailored for each group to reflect the nature of the interventions
and the classification of participants as improvers/non-improvers.162 The 43 interviews completed ranged in
duration from 9 to 44 minutes, with an average (mean) duration of 21 minutes. Interviews were recorded
and transcribed verbatim. Full details of the analysis strategy for our qualitative interviews is provided
elsewhere,162 but are briefly summarised here. All transcripts were read by four authors (RN, JS, CV and TH),
codes were assigned independently and discrepancies were resolved by discussion. Codes were grouped
into themes, which were further refined by discussion to produce broader themes, encompassing several
subthemes. Theoretically informed BCTs were an important element of the trial and we were interested in
understanding which of these had been of most use to participants. We performed an additional analysis
of the data to specifically draw out themes relevant to these techniques. We have reported the reasons for
trial non-participation and the barriers to, and facilitators of, increasing PA elsewhere.148,162 We have noted
elsewhere that, although we defined our groups by the quantitative increase in walking, responses from
participants did not demonstrate this distinction. In this, and in our previous qualitative evaluation from
the PACE-LIFT study,149 almost all participants interviewed felt that they had benefited from the trials,
even if this had not been manifested by an increase in their step count. In this chapter, we focus on what
participants told us about their motivation for participating in the trial, their experiences of the various
components of the trial and the longer-term impact of trial participation.
The role of nurses in the PACE-UP intervention
As described in detail in Chapter 6, the trial intervention was delivered by eight nurses across seven
practices. They delivered three PA consultations to participants in their arm of the trial. These took place
in weeks 1, 5 and 9 of the 12-week pedometer-based walking programme. Participants developed an
individualised PA plan with the practice nurses, based around their current level of activity, with the goal of
increasing both step count and time spent in MVPA. The nurses provided each participant with an individual
PA diary, including step count targets for the 12 weeks, based on their own baseline PA measures, but
this could be tailored further in the nurse PA consultations through joint discussions between nurse and
participant. Five PACE-UP trial nurses participated in a focus group that was led by two of the research team
(CB and CV); additionally, two nurses were interviewed individually by Rebecca Normansell (who also
attended the focus group) and one further nurse was not available to participate in this phase of the
research. A further focus group was also carried out with nurses involved in the previous PACE-LIFT trial of a
pedometer-based walking intervention with older people.21 The focus groups lasted for, on average, 106
minutes and the individual interviews lasted for 50 minutes. The published evaluation of nurse experiences of
the interventions includes data from both trials.185 In this chapter, we have limited the results presented to
those from the PACE-UP trial nurses. A semistructured interview guide was used to elicit the nurses’ views on
their participation in the trial (see Appendix 6). The interviews/focus groups were audio-recorded and
transcribed verbatim. Full details of the methods used are available elsewhere,185 but are briefly summarised
here. Coding the transcript themes was guided by thematic analysis for both the group and individual
interviews, and areas of disagreement were discussed to ensure a consensus. Researchers were mindful that
group interviews reflect a generalised understanding, whereas individual interviews provide more personal
views. However, similar interpretations and themes emerged from both types of interview, and referral
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to field notes throughout the process enhanced the trustworthiness of the findings through data
triangulation.185
In the rest of this chapter, we combine the perspectives of both the nurses and the trial participants to
provide an overview of their experiences of being part of the PACE-UP trial. We present our results in
terms of the three key phases of the intervention: preparing for the trial, delivering or receiving the
intervention and after the trial/implementation.
Preparing for the trial
A key theme that emerged from our work with the nurses was the importance of the pre-trial training
programme. As documented in Chapter 6, before the trial was implemented the nurses received training
in the BCTs that underpinned the intervention. Support was then ongoing once the trial had started.
Although these were experienced practice nurses, we could not presume detailed familiarity with all of the
techniques that our study involved. An additional and important feature of the training was the importance
of trial fidelity. One unique element of our trial was the delivery to couples. This is not a familiar service
delivery model for our nurses and so it was one area where we provided specific support/training. As
comprehensively demonstrated in Chapter 6, the consensus from our nurses was that they felt appropriately
trained and prepared to deliver the intervention as per the protocol: ‘all the training was really excellent’
(PACE-UP nurse, focus group).
For participants, the key pre-trial activity focused upon the decision to participate. This is described
in detail in Chapter 5, in which we discuss the recruitment and participation rates. In Chapter 5, and in
Normansell et al.,148 we present both the sociodemographic profile of participants and examine why
individuals opted not to participate in the trial. Although we have details of the sociodemographic profiles
of those who take part in PA trials, we have less information on what motivated participants to take part
in the trial. This was not explicitly explored in our interview, as the focus was on the trial and its impact on
levels of PA. However, some participants talked explicitly about their reasons for taking part in the trial.
Key individually based motivations to participate were concerns about weight and helping to manage existing
long-term conditions (especially diabetes mellitus). Others noted the commitment they were making in signing
up for the intervention, even though they were not aware of which group they were in when they agreed to
participate in the trial: ‘Well I must admit, when I first signed up for it, I was thinking what I have done to
commit myself to this for quite a long time’ (ID30).
Delivering and participating in the trial
Our focus in this chapter is on the experiences of participating in the trial, rather than on the outcomes or
the factors that facilitated changes in PA. Our trial had three arms: usual care (n = 338), postal pedometer
intervention (n = 339) and nurse-supported pedometer intervention (n = 346). Of our 43 interviewees,
21 were in the nurse-supported intervention group and 22 were in the postal delivery group. We first
consider the experiences of participants who were in the nurse-support group and compare these with
the postal delivery group in terms of how they perceived their engagement with the trial.
Perceived value of nurse consultations
The nurse-led consultations were well accepted by the participants in that part of the trial, with 74% (255/346)
attending all three sessions. Overall, those who were allocated to the nurse-supported intervention arm were
very happy with their meetings with the nurse, as illustrated thus:
Yes, the nurse was very helpful . . . it was really good for me.
ID12
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Conversely, those who had not been in the nurse-support group were, overall, confident that they did not
need the support of the nurse:
I think I was happy doing it on my own. I don’t think . . . I mean it was very . . . it was very easy to
follow your instructions and what you wanted us to do and so I don’t think meeting a nurse . . .
ID13
No, I don’t think it [visiting the nurse] would have been useful really.
ID17
Some were sceptical of what advice the nurse could give:
No, not really. What would she say, walk a bit quicker, eat a bit less? It’s common sense, I knew in the
first place.
ID23
I know what I should be doing.
ID8
Others were confident in their own internal motivation:
I think if I’ve agreed to do something, then I will try and achieve that target, whether somebody tells
me face to face or by post, so I think it’s dependent on the individuals maybe, individual choice.
ID38
There were two key caveats to the confidence of the postal delivery group in increasing their PA without
the support of a nurse. These were existing health problems and overcoming barriers. Several participants
in the postal delivery group observed that if they had had a long-standing health problem, they may have
preferred the security and support of the nurse, as illustrated in this comment:
If I did have health problems, I may have wanted to see a nurse, and say, look, I’ve been doing this and
I’ve had an ache and a pain here, shall I stop or . . . you know, if it was that situation, and I think yes,
you might need to speak to someone you know who could advise you medically, but I didn’t need it.
ID13
In addition, some participants in the postal delivery group thought that being able to see the nurse might
have helped them to overcome the difficulties and challenges they experienced when trying to increase
their PA, for example:
I would have found that better [to see a nurse] because, if I’d have talked to her about the steps,
she might have been able to umm introduce something else . . . [participant was concerned that the
target step count was unachievable]. I think if I’d have been seeing the nurse regularly then, during
that summer, umm, we would have found another way I feel, you know.
ID19
Behaviour change techniques
Our intervention included over 20 distinct behaviour change activities, as defined by Michie et al.,68
embedded within the PACE-UP trial handbook and diary (received by both the postal delivery group and
the nurse-support group) and, additionally, within the protocol for the nurse consultations. Reference to
these specific BCTs were then extracted from the interview transcripts to determine what elements of
behaviour change were viewed as being most helpful by the participants.162 There were 152 examples
of these factors in our interviews: 54 in the postal delivery group and 98 in the nurse-support group.
With the exception of self-monitoring, the BCTs were more frequently noted in the nurse-support group
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compared with the postal delivery group. The elements of Michie et al.’s68 typology that were especially
evident in our participants’ comments were (1) the provision of information, (2) monitoring and feedback
and (3) strategies for relapse prevention/overcoming challenges. Rewards, an important element of the
typology, were not seen as being of great importance by our participants. Both of our intervention groups
appreciated receiving information about the link between behaviour and health. However, a key and
important type of information provided, especially in the nurse-support group, was specifically tailored
and personalised information about how, where and when to increase walking, for example:
She gave me a printout of umm . . . some . . . walks that you could do, group walks and things like that.
ID18
In terms of monitoring and feedback, nurses played an important role for their group, as exemplified by
comments such as the following:
She was very encouraging.
ID39
Oh I felt really happy [with the nurse] and she was very happy too with me and I did really like my
nurses, yes. That was one of my reasons because, each week I go, I ask her if they think I am doing
well, am doing well, yes [laughs].
ID12
Importantly, the nurses were seen to provide motivation and encouragement when the ‘novelty’ of the
intervention was waning and participants were at risk of lapsing, for example:
I think there was a point where they sort of said, you know, don’t give up now, or something like
that, you know, at the point where . . . the novelty might have worn off . . .
ID35
The postal delivery group largely felt that they could self-monitor their activity:
I felt like it was enough to know [the step count] . . . I think it was fine, just to sort of keep . . . I was
very good about filling the diary in and it was sort of for me that was enough to keep me going really.
ID43
Adapting the trial protocol versus fidelity
Given that this was a trial, it was essential that the nurses delivered the intervention as per the protocol;
therefore, before the trial started, we provided extensive training to the nurses and emphasised the
importance of adherence to the prescribed protocol:
The equipment was excellent, the pedometers, the accelerometers, excellent, excellent, excellent.
However, given that the trial ran over 12 months, pragmatic adaptations were made by the nurses
(in consultation with the team) in response to the specific circumstances of participants, for example,
working around holiday periods (e.g. Christmas) or periods of religious observance, such as Ramadan:
. . . forget about the 2 months around Christmas . . . you can’t get appointments and they don’t want
to wear it [pedometer].
This serves to remind us that delivering behaviour change interventions in real-world practice requires ‘fine
tuning’ in the delivery to reflect the complexity of people’s daily lives. We assessed fidelity by audio-recording
a minimum of three consultations for each nurse, as described in detail in Chapter 6. However, this also
enabled us to provide specific feedback to the nurses on their use of the BCTs employed. This was universally
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welcomed and improved their practice during the trial, but also provided them with enhanced skills to take
into practice beyond and after the trial:
I actually changed my practice from thereon, so yes, it was exceptionally helpful.
Trial materials and equipment
Both nurses and participants remarked on the materials that supported the trial, namely a pedometer, a PA
diary and a series of optional handouts, as described in Chapter 2. From the participants’ perspective, each
element of the trial had both advantages and disadvantages. However, the focus of the comments about
equipment from the participants’ perspective was upon the accuracy (or otherwise) of the pedometer.
Typical of the more critical comments of the pedometer was:
That day we went for a really long walk round the common, I was really disappointed when I come
back, it didn’t seem to register very many steps. I’ve obviously done a lot more than . . . registered
about ,000 or something, well walked around the whole of Tooting, is a bit more than that I think.
ID7
There were fewer comments about the diary, which was seen as being motivating:
I was very good about filling the diary in and it was sort of for me that was enough to keep me
going really.
ID43
However, for others it was chore:
Like I say, it is an effort, it’s umm . . . you have to know what you are in for, and then really maintain
it. I had to record it every day, yes, you are busy, sometimes you are out and you go for dinner and
then you come home and then you had a few drinks and you can’t remember what day it is.
ID1
Actually writing down the activities and things, it . . . after about the first day, I got bored with that.
ID3
Nurse satisfaction
One feature of the trial noted by the nurses (but not the participants) was the time that they had to devote
to the PA consultations compared with their normal activities, as this comment illustrates:
You know, we don’t have any protected time for health promotion . . . the health promotion is the
add-on. It’s giving us the time, because we don’t have the time.
From the nurses’ perspective, this engagement provided considerable job satisfaction in seeing their
participants embrace change and become more physically active. A feature not experienced prior to
the trial by most of the nurses was delivering the intervention to couples rather than individuals. This
presented a unique challenge for some of the nurses as, in normal practice, it is unusual to be working
with two patients simultaneously. Sometimes the dynamic worked well:
. . . most couples, they enjoy doing it together because they’d go . . . they could go out walking
together and, even if it was through the winter, at least if they were both going, they had each other
. . . they use to encourage each other. So if one didn’t want to go the other one would encourage
them and they’d make sure they went.
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At other times, the problems encountered were a significant barrier:
I’m not actually overly sure how couples worked. I don’t know if I had, I don’t know if it caused more
issues sometimes, in the fact with the pedometers, because they got so focused sometimes on the fact
that their pedometers didn’t match up.
After the trial and implementation
All participants felt that they had benefited, regardless of changes in their objective PA levels, and had
developed skills in terms of embedding PA in their daily lives and routines and by developing strategies to
overcome challenges when they arose:
Yes, everyone in my house now, we don’t drive to the shops, we all walk to the shops . . . it was
easier for me just to jump in to the car, now I have to think twice, do I really have to?
ID21
Yes, setting my own targets and now . . . well, it’s something that I’ve got used to now and I’m
determined to keep it up.
ID11
All of our nurses were very positive about how participation in the trial had developed and enhanced their
knowledge and skills, which they were applying across a wide range of routine lifestyle consultations,
not just related to PA, but also for smoking cessation, weight loss management and the prevention of
chronic diseases. From the perspective of primary care and the nurses specifically, participation in the trial
generated a legacy and the project was, in a small way, able to support the development of expertise in
primary care of the use of BCTs and in working with patients in different ways (e.g. couples).
Our intervention was an individual as opposed to a group-based intervention. Some participants firmly
believed that this was most appropriate:
If it involved each person reporting back on their success or failure at meeting the previous targets,
it might be a bit awkward in a group possibly.
ID2
However, others identified the potential benefits of a group intervention:
When you are with other people, and then you see the same problems they are facing, some of them
might come up with other ideas . . . you can form a team, support network.
ID21
Ultimately, this suggests that we need a repertoire of interventions that mesh with the circumstances and
preferences of the different populations.
There was virtually uniform support for the location of the trial within a primary care context, with many
participants recognising the convenience of getting to their GP surgery:
. . . you wouldn’t want someone to have to travel and people know how to get to their doctors
don’t they?
ID 29
Yes, that was good, because obviously it was very near home so it was ideal.
ID15
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From the nurses’ perspective, although acknowledging that the intervention would be beneficial to their
patients, they observed that within the time constraints of routine practice, they would not be able to
replicate the full intervention as it stood within a routine nurse consultation. The nurses made suggestions
for modifying the intervention to focus on the pedometer and printed materials for use opportunistically
within ‘normal’ practice and, perhaps, to be available on prescription. The suggestion that health advisors,
or a related role, could deliver the intervention that we evaluated was not supported by our nurses.
Discussion
From this phase of our study, several key points arise. Almost without exception, both the nurses and the
participants enjoyed taking part in the study and felt that it had provided them with important and enduring
benefits. For the nurses, these benefits were couched in terms of new skills that they could transfer into their
routine practice. For participants, there was an increase in their awareness of the benefits of walking as a
means of enhancing health by increasing PA. Among our intervention groups, this perceived benefit was
articulated irrespective of the objective changes in PA.
For nurses and intervention group participants, a key feature of the trial was the preparatory work before the
intervention started. This was especially important for the practices who participated and the nurses. We
opted to deliver this trial in ‘ordinary’ general practice settings to test out the potential of the intervention to
be implemented in routine primary care settings. Participants and nurses alike felt that primary care is the
appropriate setting from which to run such interventions. However, the nurses provided a caveat to this with
comments about the constraints of time within ‘real-world’ primary care. Prior to the implementation of the
intervention, the research team and our behaviour change experts worked extensively with the practices and
nurses and provided training in the intervention, feedback on the delivery of the intervention and support
across the trial to the nurses delivering the intervention. One example of a challenge with which some nurses
needed support was in working with couples. This is not something that usually occurs within their general
working regime and support from the research team in dealing with these challenges was important.
The nurses were supported to adapt how materials were introduced and used within the consultations to
make these materials relevant to the participant and thereby personalise the intervention more. This is a
key challenge in effectively delivering standardised interventions, in both trial settings and every day primary
care – how to ensure the consistency of information provision and support, while also making it relevant
to individuals. Empowering nurses, and other primary care staff, to make ‘patient-centred’ adaptations to
standard behaviour change programmes is likely to result in improved outcomes. This links to the important
issue of tailoring support to make changes in health behaviours to match the circumstances and preferences
of individuals. Thus, support needs to be appropriate to external factors, such as seasons or the time of
year, or key events in peoples’ lives, such as retirement, but also reflect individual circumstances such as
preferences for group or individual activities and the relevance of written or other types of digital materials
and current health problems. Our study has included two types of intervention that offered varying levels of
support, both of which generated increased levels of PA. A key challenge for future studies is to determine
which groups would benefit from the ‘minimal support’ pedometer by post-type intervention, and those for
whom the more intense nurse-led intervention is the most appropriate.
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Chapter 8 Three-year follow-up to assess the
maintenance of physical activity levels
Introduction
The PACE-UP analyses showed positive effects on 12-month PA levels (see Chapter 3). We wanted to see if
this effect was maintained at 3 years, as this has important implications for the NHS; specifically, would
any future pedometer programme require a ‘top-up’ after 12 months? Our interventions led to an extra
33–35 minutes weekly of MVPA in bouts (an increase of about one-third from baseline) in a predominantly
inactive cohort. Delivery via three nurse PA consultations had the same effect on 12-month outcomes as the
simpler, cheaper postal delivery. These are exciting findings, as they show that a low-cost postal pedometer
intervention increases PA levels in sedentary adults and older adults. However, it is vital to know whether
12-month effects persist at 3 years or if a further intervention boost is needed. We therefore successfully
applied for additional funding from NIHR’s Health Technology Assessment programme to follow-up the
trial cohort at 3 years (2 years after the previous 12-month follow-up) with both quantitative and qualitative
evaluations. Both the qualitative187 and the quantitative findings188 have been published and are reproduced
here under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0).
To date, little is known about the long-term sustainability of PA interventions. A meta-analysis of
interventions (including pedometers) to increase PA levels in 55- to 70-year-olds included only four trials
with data beyond 12 months (all self-reported). They found a limited evidence base beyond 12 months,
and called for more trials with a longer follow-up period and objective PA measures.26 These findings were
supported by a Cochrane systematic review23 and recent NICE guidance on PA interventions.29 The ProAct
65 + trial189 of a PA intervention found that between-group differences persisted at 2 years post
intervention, but only for self-reported PA.
As well as a lack of long-term objective PA data after interventions, there is also a lack of qualitative evidence
on maintenance. A literature review suggested that PA disengagement usually occurs 6 months after an
intervention has ended, but called for more research to distinguish the factors that lead to successful and
unsuccessful PA maintenance.190 A very small primary care study followed up participants 6 months after a
pedometer-based intervention, and found some useful insights to explain how this pedometer intervention
worked and how it may be developed,44 but further qualitative studies on longer-term effects are lacking.
The PACE-UP trial 3-year follow-up provides evidence on objective PA levels, 2 years after the 12-month
follow-up. After the 12-month follow-up, 212 out of 322 controls (66%) received a pedometer, handbook
and diary by post. They had no further input (unlike the original postal delivery group, who were telephoned
by a research assistant 1 week after being sent the pedometer, to check that it had arrived, and who were
asked to return their completed PA diaries for review at 3 months). The control participants being sent the
pedometer by post mimics what would happen if this simple, pragmatic intervention were to be rolled out
by post through routine primary care, without any further input. As described in our protocol,70 a further
64 out of 322 control participants (20%) attended a single nurse appointment after the main trial, in which
they were given a pedometer, diary and handbook, but, again, received no further contact. The other
intervention groups received no further intervention after the 12-month follow-up [apart from a small
number of the postal delivery group, 50/312 (16%), who had a single nurse PA appointment].
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Anthropometric measures did not show differences at 12 months; therefore, data on these were not
collected at the 3-year follow-up. Therefore, our follow-up study focused on establishing evidence of
effectiveness at 3 years in objective PA measures and had the following objectives:
l to investigate if the original nurse-support and postal delivery groups showed any persistent
intervention effect (change in step count and time in MVPA in bouts) at 3 years, compared with the
baseline levels
l to investigate if there were any differences between the original nurse-support and postal delivery
groups in their change in objective PA levels (step count and time in MVPA in bouts) between baseline
and 3 years
l to investigate if the simple postal pedometer intervention at 12 months increased objective PA levels
(step count and time in MVPA in bouts) in the control group compared with baseline.
We also felt that it was important to explore how participants in the nurse-support and postal delivery
groups felt about the interventions in terms of maintenance of any increase in PA levels, and what factors
might help to encourage this further or to overcome barriers they had to increasing or maintaining their
PA levels. Furthermore, we were interested in how the initial control group felt about the minimalist
intervention that they received. Our qualitative evaluation therefore had the following objectives:
1. qualitative evaluation of both the nurse-support and postal delivery intervention groups to look at
factors affecting PA levels and maintenance of any increase in PA levels at 3 years
2. qualitative evaluation of the control group to see the effect of the minimal intervention on PA levels.
Methods for quantitative physical activity evaluation
The 3-year follow-up focused on collecting the objective PA accelerometry data and other questionnaire-
based self-reported outcomes by post to minimise data collection costs. To allow for seasonal variation
in PA levels, the baseline, 12-month and 3-year outcomes needed to be assessed in the same calendar
month; therefore, follow-up ran from October 2015 to November 2016.
Ethics approval and research governance
Ethics approval for the 3-year follow-up was granted to the trial from London, Hampstead Research Ethics
Committee (reference number 12/LO/0219). NHS local research and development approval was granted to
cover all of the practice sites.
Participants eligible for the 3-year follow-up
All trial participants who had not withdrawn from the trial were eligible to be followed up, even if
they had not provided 3- or 12-month follow-up data. Lists of eligible participants were organised by
practice and practices were asked to check whether any participants had died, moved away or developed
a terminal illness or dementia since trial participation. These patients were then excluded.
Contacting participants
Eligible participants were contacted with a letter explaining the trial 3-year follow-up. A participant
information sheet, consent form and a Freepost return envelope were also included, as was information on
the main 12-month trial results. The letter explained that a research assistant would contact the participants
by telephone in around 1 week’s time to discuss the 3-year follow-up. If they were happy to take part
without further discussion, they were invited to post back the signed consent form.
Informed consent
The research assistant contacted participants by telephone approximately 1 week after sending out the
letter about the 3-year follow-up to discuss any questions they might have after reading the participant
information sheet. Part of the consent form included consent to contact participants for an interview to
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discuss their current PA levels in more detail. If the participants were happy to proceed with the 3-year
follow-up, they signed and dated the informed consent sheet and returned the top copy to us.
Data collection
Once the informed consent for follow-up was agreed, the research assistant arranged a time to post out
the accelerometer (GT3X+) to participants to measure their current usual PA levels for 1 week. Instructions
about how to wear the accelerometer were included (on a belt, over one hip) and participants were asked
to wear it for 7 consecutive days, from getting up until going to bed, as they had done previously. A diary
was also provided to record what activities were done and for how long. They were also sent a health and
lifestyle questionnaire to complete (see Appendix 7; this was similar to that completed previously) and a
short questionnaire about self-reported PA levels to complete (the 7-day PA questionnaire used previously)
after they had finished wearing the accelerometer. They were provided with a Freepost return envelope to
send the accelerometer and both questionnaires back. If the accelerometer did not record at least 5 days
with at least 540 minutes per day, participants were asked to rewear it for a further week. The set of
recordings with the greatest number of days with at least 540 minutes per day was included in the analysis.
Once accelerometers with adequate data were received, participants were posted out a £10 gift voucher.
Outcome measures
The main outcome measures (all accelerometry) used to evaluate the 3-year follow-up were as follows:
1. change in average daily step count, measured over 7 days between baseline and 3 years
2. change in time spent weekly in MVPA in ≥ 10-minute bouts between baseline and 3 years
3. change in time spent sedentary weekly between baseline and 3 years.
Although patient-reported outcome measures were collected from the health and lifestyle questionnaire
(e.g. depression,75 anxiety,75 quality of life,76 self-efficacy,74 pain,77 disability80) and from the 7-day PA
questionnaire (IPAQ72 and GPPAQ73), these have not been assessed further as part of this report.
Accelerometer data reduction
ActiGraph data were reduced, as described previously in Chapter 2, for the main trial. Analysis summary
variables were also identical to those used in the main trial, described fully in Chapter 2.
Procedure for accounting for missing data
Only days with at least 540 minutes of registered time on the accelerometer on a given day were used.
The main analysis of effect included all subjects with at least 1 satisfactory day of recording at 3 years.
Statistical methods
Statistical methods for the analysis of the 3-year follow-up are largely as described in Chapter 2 for the
primary analysis at 12 months. Average daily step count at 3 years was computed from a random-effects
model, allowing for day of the week and day order of wearing the accelerometer as fixed effects and
participant as a random effect. The average daily step count at 3 years was then regressed on average
daily step count at baseline with treatment group, age, sex, practice and month of baseline accelerometry
as fixed effects and household as a random effect, in a multilevel model. The same analyses were carried
out for MVPA in ≥ 10-minute bouts and daily minutes of sedentary time.
The primary analyses used the 681 participants who provided accelerometry data at 3 years. Sensitivity
analyses were carried out to assess the effect of missingness:
1. Multiple imputation methods were used to impute outcome data for those missing at 3 years, assuming
that outcomes were missing at random, conditional on variables in the model. We used the Stata
procedure mi impute.
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2. Missing-not-at-random analyses were used when it was assumed that changes in the control group
from baseline to 3 years were missing at random, but the change in each of the intervention groups
was ± 500 and ± 1000 steps from their missing-at-random estimate.
For this analysis, we used a mean score method,191 which has been implemented in a Stata module,
rctmiss, available from Statistical Software Components at https://ideas.repec.org/s/boc/bocode.html
(accessed 25 May 2018).
Methods for qualitative evaluation
Sampling
Participants consented to be contacted for a telephone interview at the same time as they consented to
take part in the 3-year follow-up. In February 2016, the research assistant produced three lists of participants
who had already provided 3-year accelerometry data and who had given consent to be interviewed (one list
for each arm of the trial – nurse support, postal delivery, control). The trial statistician randomly sorted these
three lists ready for the qualitative researchers to start approaching participants for interviews. The interviewers
were blinded to participants’ previous and current PA levels.
One of the aims of the qualitative evaluation was to explore the success, or otherwise, of the minimalist
intervention provided to the control group after the main trial; therefore, the following participants were
excluded from this qualitative evaluation:
l control group participants who had attended a nurse consultation after the main trial
l control group participants who opted not to receive the postal pedometer after the main trial.
At 12 months, participants in the postal delivery group were also offered a nurse consultation. Again,
those who attended the nurse consultation were excluded from the sampling procedure, so that all those
sampled from the postal delivery group had received just the postal intervention.
The aim was to interview approximately 15–20 people from each arm of the trial (45–60 people in total), but
continuing further if required, until saturation was reached. As two researchers (CB and CW) were interviewing
participants, they met regularly to discuss the sampling, interview schedule and any emerging themes.
Interviews were conducted until saturation of new information was reached. By looking at the participants’
demographic information it was possible to ensure that the study group included both males and females and
also represented a range of different ages and ethnicities, to ensure that a wide range of views were explored.
Recruitment and informed consent
Participants were initially contacted via e-mail to arrange an appropriate time to contact them for a telephone
interview. Participants without an e-mail address were called and the interview was either conducted then or
arranged for later. To assess response, a detailed record was kept of when each participant was contacted,
including information on who agreed, who refused and who could not be contacted. Charlotte Wahlich and
Carole Beighton conducted the guided interviews with participants using a topic guide (see Appendix 7).
Before the interview commenced, the participants were reminded of their initial consent to be approached
for an interview; if the participants were happy to go ahead, their consent was then sought for the interview
to be audio-recorded. Once the recording had started, the qualitative researchers stated the participant’s ID
number to ensure confidentiality and anonymity in the subsequent transcript. On interview completion,
the participants were offered a £10 high-street gift voucher to thank them for their time.
Transcribing
Interviews were promptly transcribed verbatim by an external source. Once the transcripts were received
back, they were double-checked against each audio-recording by the qualitative researchers. Transcripts
were also circulated to the research team to ensure consistency between the interviewers and to help
assess when theme saturation had been reached.
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Interview schedule
The interview schedules were developed through discussions with Tess Harris, Charlotte Wahlich, Carole
Beighton, Christina Victor and Rebecca Normansell. Slightly different questions were used for participants
in the intervention groups (postal delivery and nurse support) and participants in the control group (see
Appendix 7). For those in the intervention groups, the aim was to explore participants’ views about PA
maintenance and whether or not a ‘top-up’ intervention was required, whereas for those in the control
group, the aim was to explore their views about the minimalist intervention. The interview schedules were
revised slightly during data collection to ensure that the questions were clear and to include additional
questions to gain a better understanding of the participants’ experiences.
Analysis
All verbatim transcripts were read repeatedly by Charlotte Wahlich and Carole Beighton. Initial line-by-line
coding was conducted independently to assign conceptual ideas to important episodes within the data.
Through discussion with Rebecca Normansell, Tess Harris and Christina Victor, any discrepancies were
resolved; this helped to ensure that the interpretation and categorisation of the data were valid. After
further discussions between Charlotte Wahlich and Carole Beighton, these codes were then refined and
grouped into emergent and anticipated themes.
Results for the quantitative physical activity evaluation
Follow-up rate
Of the 1023 original trial participants, 32 had withdrawn by the end of the 12-month follow-up, a further
two had died between the 12-month and the 3-year follow-up and one was excluded by their practice for
health reasons. Therefore, we approached 988 participants and 681 provided adequate accelerometry data
(≥ 1 day with ≥ 540 minutes wear time) for analysis, giving a 3-year follow-up rate of 69% (681/988).
However, in relation to the initial trial participants providing 3-year outcome data, the 3-year follow-up
rate was 681 out of 1023 (67%). The CONSORT flow diagram with 3-year follow-up data is shown in
Figure 15, by randomised group.
Data completeness
Table 20 shows that 92% of participants (625/681) overall provided ≥ 5 days of accelerometry data at
3 years (88% of control participants, 94% of postal delivery participants and 93% of nurse-support
group participants).
Objective physical activity findings
Table 20 shows the summary measures for all three groups at each time point and Table 21 shows the
estimates of effect for the different groups. For the main trial outcome of steps per day, both intervention
groups were still doing more than the original trial control group: 627 steps (95% CI 198 to 1056 steps)
in the postal delivery group and 670 steps (95% CI 237 to 1102 steps) in the nurse-support group. The
nurse-support and postal delivery groups combined did 648 steps per day (95% CI 272 to 1024 steps).
The pattern was similar for the total weekly MVPA in bouts (minutes per week): 28 minutes (95% CI 7 to
49 minutes) in the postal delivery group and 24 minutes (95% CI 3 to 45 minutes) in the nurse-support
group. The nurse-support and postal delivery groups combined did 26 minutes (95% CI 8 to 44 minutes).
There was no difference between the groups at 3 years for sedentary time or daily wear time.
Missing data analyses
Imputation analyses (see Table 22) presents the results for missing at random, using imputations based on
the different assumptions detailed in the methods section. The imputation analyses show that making
adjustments for missing values has only a small effect on the primary outcome, that is, the step count
estimate, and does not change the interpretation.
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Control group participants
(n = 338; 305 households)
Patients randomised
(n = 1023; 922 households)
Nurse intervention patients
(n = 346; 310 households)
Postal intervention patients
(n = 339; 307 households)
Allocation
3-month follow-up and analysis
Participants analysed 
(287 households) with complete 
accelerometer data
(n = 318)
Participants analysed 
(289 households) with complete 
accelerometer data
(n = 317)
Participants analysed 
(286 households) with complete 
accelerometer data
(n = 319)
12-month follow-up and analysis
Participants analysed 
(283 households) with complete 
accelerometer data
(n = 312)
Participants analysed 
(289 households) with complete 
accelerometer data
(n = 321)
Participants analysed 
(292 households) with complete 
accelerometer data
(n = 323)
3-year follow-up and analysis
Participants analysed 
(216 households) with complete 
accelerometer data
(n = 236)
Participants analysed 
(196 households) with complete 
accelerometer data
(n = 214)
Participants analysed 
(211 households) with complete 
accelerometer data
(n = 231)
  • Withdrawn, n = 1
  • Not able to be contacted, n = 2
  • Inadequate accelerometry, n = 17
  • Withdrawn, n = 3
  • Not able to be contacted, n = 3
  • Inadequate accelerometry, n = 9
  • Withdrawn, n = 11
  • Not able to be contacted, n = 10
  • No follow-up data provided, n = 97
  • Inadequate accelerometry, n = 6
  •  Withdrawn, n = 3
  • Not able to be contacted, n = 1
  • Inadequate accelerometry, n = 18
  • Withdrawn, n = 8
  • Not able to be contacted, n = 3
  • Inadequate accelerometry, n = 16
  • Withdrawn, n = 12
  •  Not able to be contacted, n = 4
  • Inadequate accelerometry, n = 11
  • Withdrawn, n = 17
  • Not able to be contacted, n = 1
  •  Inadequate accelerometry, n = 7
  • Withdrawn, n = 17
  • Withdrawn by GP, n = 1
  • Not able to be contacted, n = 9
  • No follow-up data provided, n = 75
  • Inadequate accelerometry, n = 1
  •  Died, n = 2
  •  Withdrawn, n = 20
  • Not able to be contacted, n = 13
  •  No follow-up data provided, n = 78
  •  Inadequate accelerometry, n = 2
FIGURE 15 The PACE-UP CONSORT flow diagram with 3-year follow-up data.
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TABLE 20 Summary means and SDs for accelerometry data at baseline, 3 months, 12 months and 3 years
Accelerometry data
Randomised group
Control Postal delivery Nurse-support
Baseline 3 months 12 months 3 years Baseline 3 months 12 months 3 years Baseline 3 months 12 months 3 years
Number of participants 338 318 323 214 339 317 312 236 346 319 321 231
Number of participants with
≥ 5 days wear (%)
338 (100) 286 (90) 300 (93) 188 (88) 339 (100) 282 (89) 287 (92) 222 (94) 346 (100) 296 (93) 302 (94) 215 (93)
Daily step count, mean (SD) 7379
(2696)
7327
(2688)
7246
(2671)
7281
(2721)
7402
(2476)
8086
(3014)
8010
(2922)
7896
(2853)
7653
(2826)
8707
(3206)
8131
(3228)
8131
(3410)
Total weekly minutes of
MVPA in ≥ 10-minute bouts,
mean (SD)
84 (97) 87 (101) 89 (94) 94 (102) 92 (90) 136 (125) 129 (124) 132 (124) 105 (116) 164 (154) 138 (141) 138 (161)
Daily sedentary time (minutes),
mean (SD)
613 (68) 614 (70) 616 (72) 615(71) 614 (71) 614 (74) 617 (71) 617 (75) 619 (78) 613 (77) 620 (79) 620 (69)
Daily wear time (minutes),
mean (SD)
789 (73) 795 (78) 791 (76) 789 (78) 787 (78) 798 (84) 800 (80) 798 (86) 797 (84) 805 (85) 807 (89) 805 (81)
Note
Accelerometry data are adjusted for day of the week and day order of wearing the accelerometer as fixed effects and participant as a random effect in a multilevel model.
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The missing-not-at-random analyses make a bigger impact, but only when we assume that there is a strong
differential departure between the non-random effects in the control and treatment groups (solid lines in
Figure 16). Even then, it is only when we assume that the missing data in the treatment groups are 1000
steps below their missing-not-at-random values, while the values in the control group are at their missing-not-
at-random values, that the treatment effects become non-significant; even then, the CI is still largely positive.
Results for the qualitative evaluation
Between March and April 2016, 105 participants were randomly selected, 96 were contacted and all
agreed to participate. Telephone interviews were arranged and undertaken with 60 participants (20 from
each trial arm). Fifty-two participants were white and eight were non-white. Interviews lasted between
4 and 22 minutes (median 10 minutes). One participant who had difficulty hearing was e-mailed the
questions to complete. In the quotations that follow, ID3Y_ refers to the participant’s ID number, F/M
refers to the participant’s sex, the number following this refers to their age and N, P or C refers to whether
the participant is in the nurse-support group, the postal delivery group or the control group, respectively.
TABLE 21 Accelerometry outcome data at 3 months, 12 months and 3 years. Analysed using all available data at
each follow-up. N= 954 at 3 months, N= 956 at 12 months and N= 681 at 3 years
Outcome
Comparison of change from baseline between randomised groups
Postal delivery vs. control Nurse support vs. control
Nurse support and postal
delivery vs. control
Effect (95% CI) p-value Effect (95% CI) p-value Effect (95% CI) p-value
Daily step count
3 months 692 (363 to 1020) < 0.001 1173 (844 to 1501) < 0.001 –
12 months 642 (329 to 955) < 0.001 677 (365 to 989) < 0.001 660 (389 to 930) < 0.001
3 years 627 (198 to 1056) 0.004 670 (237 to 1102) 0.002 648 (272 to 1024) < 0.001
Total weekly minutes of MVPA in ≥ 10-minute bouts
3 months 43 (26 to 60) < 0.001 61 (44 to 78) < 0.001 –
12 months 33 (17 to 49) < 0.001 35 (19 to 51) < 0.001 34 (20 to 48) < 0.001
3 years 28 (7 to 49) 0.009 24 (3 to 45) 0.026 26 (8 to 44) 0.006
Daily sedentary time (minutes)
3 months –2 (–12 to 7) 0.59 –7 (–16 to 3) 0.16 –
12 months 1 (–8 to 10) 0.82 0 (–9 to 9) 0.96 0 (–7 to 8) 0.92
3 years –1 (–12 to 11) 0.90 –2 (–14 to 9) 0.69 –1 (–11 to 8) 0.77
Daily wear time (minutes)
3 months 2 (–8 to 12) 0.69 4 (–6 to 14) 0.39 –
12 months 9 (–1 to 19) 0.08 9 (–1 to 19) 0.07 9 (0 to 18) 0.04
3 years 8 (–5 to 20) 0.23 7 (–6 to 19) 0.32 7 (–4 to 18) 0.21
Notes
All models include treatment group, practice, sex, age at randomisation and month of baseline accelerometry as fixed
effects and household as a random effect in a multilevel model.
The xtmixed command in Stata version 12 was used, followed by the postestimation command pwcompare to generate the
pairwise estimates of effect and their CIs (see Table 22).
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Factors affecting physical activity levels and maintenance at 3 years
A key theme that emerged from our interviews was the impact that the PACE-UP trial had on participants.
Most participants, regardless of what group they were in, reported an increased awareness of PA.
Participants described an increased understanding about the importance of PA for health, as well as an
awareness about the amount of PA required to meet their daily step count target:
It’s made me more aware of the need to actually commit to doing some exercise a day, just strolling
around the house, and going to the shops occasionally doesn’t really make much difference. It doesn’t
meet the sort of threshold that you need to reach to ensure that you lead a healthy lifestyle.
ID3Y27M56P
Participants felt that taking part in the PACE-UP trial and using a pedometer had ‘kick-started’ regular activity:
It was the PACE-UP trial that helped get me started and I think that did make a huge difference to me.
ID3Y47F51N
Participants highlighted different barriers to, and facilitators of, being able to stay physically active in the longer
term. These barriers and facilitators were often the opposite of each other; for example, some participants saw
good weather as a motivator to engage in PA, whereas others saw bad weather as a barrier to being physically
active. Other important facilitators and barriers included health, self-motivation, ageing and social support.
These factors were considered to be important by participants, regardless of which group they were in. For
some participants, they felt that engaging in regular PA helped them to manage their health condition:
The more active I am, the better the arthritis is.
ID3Y25F60P
TABLE 22 Imputation analyses for the 3-year accelerometry outcomes
Missing at random
imputation analyses N
Randomised group(s) vs. randomised group
Postal delivery vs.
control
Nurse support vs.
control
Nurse support and
postal delivery vs.
control
Effect
(95% CI) p-value
Effect
(95% CI) p-value
Effect
(95% CI) p-value
All participants with
follow-up data
681 627
(198 to 1056)
0.004 670
(237 to 1102)
0.002 648
(272 to 1024)
< 0.001
Imputed using treatment group,
baseline steps, sex, age, practice,
month of baseline accelerometry
1023 597
(174 to 1020)
0.006 679
(268 to 1089)
0.001 649
(295 to 1003)
< 0.001
Imputed using treatment group,
baseline steps, sex, age, practice,
month baseline accelerometry,
NS-SEC, baseline self-reported
pain and baseline body fat massa
996 634
(211 to 1057)
0.003 735
(293 to 1178)
0.001 637
(239 to 1034)
0.002
Imputed using treatment group,
baseline steps, sex, age, practice,
month baseline accelerometry
and 12-month stepsb
965 625
(217 to 1033)
0.003 683
(270 to 1095)
0.001 655
(305 to 1005)
< 0.001
a Baseline data for NS-SEC or self-reported pain or body fat mass were missing for 27 participants and imputations were
not available for these 27 participants when including these variables as predictors.
b Twelve-month steps were missing for 58 participants and imputations were not available for these 58 participants when
including 12-month steps as a predictors.
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FIGURE 16 Sensitivity analyses for different values of missing step counts. (a) Postal delivery group vs. control group;
(b) nurse-support group vs. control group; and (c) postal delivery and nurse-support groups combined vs. control group.
The figures show how different values for the missing step counts changes the treatment effects. The starting point
where all missing step counts are replaced by ‘missing-at-random’ estimates in each group is represented by the zero
difference estimate. Estimates in the different groups are then altered differentially over a range of scenarios. Control
group – missing step counts are the same as the 3-year missing-at-random estimates. Treatment groups – missing step
counts are 500 or 1000 steps lower than the 3-year missing-at-random estimates. Control group – missing step counts
are 500 or 1000 steps higher than the 3-year missing-at-random estimates. Treatment group – missing step counts are
the same as the 3-year missing-at-random estimates. Missing step counts are 500 or 1000 steps lower or higher than
the 3-year missing-at-random estimates in all control and treatment groups (see White191 for methods). The vertical
lines are the 95% CIs for the estimated treatment effects. The treatment effect becomes statistically not significant
when the CI crosses the horizontal line at zero.
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Conversely, others felt that having a health condition was a contraindication to PA:
I’ve got an ongoing problem where I get pain, so there’s no way I’m going to be going out walking if I
don’t have to.
ID3Y24F61P
Self-motivation was seen to be an important determinant to PA:
I think it’s got to come from inside.
ID3Y19F62C
Some participants attributed the PACE-UP trial to providing them with this motivation:
Before the PACE-UP trial, I had no incentive. And that really did help me. That put me/gave me the
first steps as it were, got me on the right track.
ID3Y47F51N
On the other hand, a few participants felt that since the PACE-UP trial had ended, their PA levels had
decreased as a result of a lack of self-motivation:
I’m not covering anything like what I was covering when I was on the programme, but I don’t know
how . . . to put myself in that mind set . . .
ID3Y55M68N
Some participants chose to engage in PA as a way to stay young and slow down the ageing process:
I’ve got nieces and a nephew . . . I need to be active to keep up with them because they are young.
I just need to keep up with everyone else really. I don’t want to slow down and become old.
Unfortunately, I’m not really motivated by anything else.
605027F65N
Other participants felt that their age had become a barrier to PA and were less likely to do as much as they
did when they were younger:
If anything I’m getting a bit older and I’m beginning to find it a little bit more of a strain.
ID3Y42F59N
Many participants spoke about the importance of having friends and family to motivate them to participate
in PA. Support from, and accountability to, family and friends were therefore seen as common facilitators
of PA:
Maybe my motivation is not only my health, but having somebody to do it with . . . to maybe be
paired up with somebody who was like-minded . . . if I’ve promised/only promised myself, then I might
find excuses not to do it.
ID3Y50F63N
Lack of social support meant that some participants did not engage in PA:
I haven’t got anyone to walk with.
ID3Y37F67P
Lack of time was the most frequently cited barrier to maintaining PA. Unlike the other factors previously
mentioned, ‘having time’ to engage in PA was not mentioned as a facilitator. The reasons for a lack of
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time included having ‘family responsibilities’ (looking after children, caring for older relatives), ‘work
commitments’ or simply being ‘too busy’:
I’ve got plenty of things that encourage me, it’s just the time I find because I work full time, I just find
it difficult to come home, sort of prepare meals, go to the gym, go for a walk . . . I don’t think I need
any more actual motivation, I just need a bit more time!
ID3Y43F54N
Some participants spoke about strategies they adopted to overcome the barrier of lack of time, either by
incorporating PA into their daily routine or by building up their daily PA in short bouts of activity:
I walk up the escalators to get my little bit of exercise.
ID3Y15M62C
As opposed to the mind set of, oh, I’ve got to do an hour in the gym. Actually 10 minutes solid
walking somewhere, several times a day, actually builds stuff up.
ID3Y56F68N
At the end of the interview, participants were asked for their views on what additional support could be
provided to aid PA maintenance. Participants were offered examples to comment on, which included
regular text messages, online resources, annual nurse appointments and walking groups. Participants had
varying preferences over which additional resources they would find the most beneficial. Although some
participants liked the idea of a regular text message or ‘jolly little reminders’ (ID3Y47F51N) encouraging
PA, others felt that these would be ‘too intrusive’ (ID3Y27M56P). Similarly, some participants liked the idea
of having PA resources online to ‘open at their own time’ (ID3Y9F62C), whereas others felt that obtaining
this information online would require ‘a more proactive’ (ID3Y47F51N) approach. On the whole, walking
groups and nurse appointments were considered to be favourable. Some participants felt that walking
groups would provide ‘more motivation to go out’ (ID3Y17M68C) and a regular nurse or other
appointment would provide ‘external accountability’ (ID3Y52M66N).
As well as providing feedback on suggested possible resources, we proposed that participants also come
up with additional suggestions. These suggestions included holistic appointments with a nurse to discuss
both diet and PA, and more opportunities for older people:
There is not much for people over 60, there’s no real places that are easy on the doorstep.
ID3Y2F64C
One participant spoke about being afraid to increase their PA levels, as they were unsure of whether or
not it was safe. This participant sought more guidance around riskless ways to increase PA levels:
I’m doing quite well with what I’m doing, so what’s the point of sort of having a risk of a heart attack
or something like that, suddenly break in to a stride and start running, so maybe a bit of guidance on
what’s going to happen to you if you do step up your exercise plan.
ID3Y23M67P
The effect of the minimal intervention on physical activity levels of participants in the
control group
Of the 20 control group participants interviewed, 17 received the pedometer, handbook and diary after
12 months. Thirteen of these participants reported using these resources when they first received them;
however, at 3 years, only four participants were continuing to monitor their steps [two with a pedometer,
one with a Fitbit (Fitbit, San Francisco, CA, USA) and one with a mobile phone].
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Although most of the control group participants who were interviewed felt that the PACE-UP trial had not
increased their PA levels, they still stated that the PACE-UP trial had increased their awareness:
It’s made me aware that I do not do as much as I should be doing.
ID3Y20F66C
Some, however, did talk about changes they had made to their daily lives as a result of their increased
awareness:
I’m more likely to walk to work now, rather than going on the bus.
ID3Y11M54C
For those who did not utilise the pedometer, some reported difficulties in using it:
I could not work the pedometer . . . could not get it going.
ID3Y9F63C
A few others who used the pedometer stated that discontinued use was either because it had a negative
impact on them psychologically or because they had fallen out of the habit of using it regularly:
It’s quite distressing to see how little I do.
ID3Y1M58C
. . . there are lots of other things [that] intrude and you tend to slip back to old patterns.
ID3Y5F68C
There was also a suggestion that, as well as the pedometer, you needed to have someone to report
back to:
It always needs to have someone keeping you aware I think.
ID3Y5F68C
Discussion
Main quantitative findings from the 3-year follow-up
We followed up just over two-thirds of the original trial cohort with accelerometry outcome data at 3 years
(and over 90% provided ≥ 5 days of data). Compared with baseline, those in the original nurse-support
and postal delivery groups were still doing significantly more steps per day and weekly time in MVPA in
bouts at 3 years than the control group. There were no significant differences in outcomes between the
postal delivery and nurse-supported intervention groups (as was also the case at 12 months), and there
were no significant differences between the three groups in terms of wear time or sedentary time. Our
sensitivity analyses looking at the potential impact of missing outcome data at 3 years suggest that it is
highly unlikely that missing data have substantially biased our results. Fairly extreme departures from the
missing-at-random analyses were needed to result in non-significant effects and, even then, the 95%
confidence limits were largely positive. This suggests that the trial interventions had a persistent effect on
objectively measured PA levels at 3 years, with no difference between intervention groups. The fact that
the minimal intervention given to the control group at 12 months was not effective at increasing the
participants’ PA levels suggests that the additional support given to the original trial postal intervention
group (with a follow-up telephone call after 1 week and encouragement to return the completed PA diary
after 3 months) was an important component of this group’s success. Both the follow-up telephone call
and the encouragement to return the completed PA diaries after the intervention were not part of the
intended intervention package, but, rather, were research measures as part of the process evaluation to
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ensure fidelity of the intervention delivery. However, this minimal support, which was not provided face
to face or by a health-care professional, seems to have been important to the success of the postal
intervention. The original trial postal delivery group also received the postal pedometer intervention when
they had just been recruited to the PA trial, when motivation may have been higher, and they had step
count targets set for them based on their baseline blinded pedometer use, whereas those receiving the
materials at 12 months needed to wear the pedometer again for 1 week to set their target step count.
These factors may also have been important to the success of the trial postal intervention group.
Main qualitative findings from the 3-year follow-up interviews
A key finding was that most participants discussed their increased awareness of PA, irrespective of which
group they were in and regardless of whether or not they thought that the PACE-UP trial had actually
increased their PA levels. Key barriers to, and facilitators of, maintaining PA were reported that were often
the inverse of one another and included health, weather, self-motivation, ageing and social support. Lack
of time was the most frequently cited barrier. Some participants were able to overcome lack of time by
incorporating PA into their daily routine or by breaking PA down into smaller, more manageable bouts
throughout the day. Participants gave us mixed feedback on how useful they thought text messages and
online resources would be to help to inform future interventions to increase and maintain PA, but walking
groups and nurse or other appointments to provide external accountability were broadly welcomed.
Additional suggestions provided included more holistic appointments with a nurse and more opportunities
for PA for older people. Participants had differing opinions over the resources they would find most
beneficial, emphasising the importance of individual tailoring of some aspects of PA interventions. Only
a few of the control group participants interviewed were continuing to use the pedometer provided at
12 months. Some participants were not sure how it worked, and others felt that, as well as using the
pedometer, it was important to have someone to report back to. This highlights the importance of the
extra contact that participants in the postal delivery group received as part of the main trial: a follow-up
telephone call to check that they knew how to work the device and encouragement to send back their
completed PA diaries with step count recordings after the 12-week programme.
Further discussion of the strengths and weaknesses of both the quantitative and qualitative approaches,
and the implications of the findings for health care and future research, are detailed in Chapter 9.
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Chapter 9 Discussion
Summary of the findings
The PACE-UP trial demonstrated that both the postal delivery and the nurse-supported pedometer
interventions, based on trying to gradually add in ‘3000 steps in 30 minutes’ on most days, increased
objectively assessed PA (step counts by around one-tenth and MVPA in bouts by around one-third) among
predominantly inactive 45- to 75-year-olds at 12 months. Although the nurse-led delivery had a greater
effect than the postal delivery at 3 months, by 12 months this difference was not sustained. The interventions
had no effect on sedentary time, anthropometry or other outcomes and did not increase AEs. No effect
modification was demonstrated (by age, sex, taking part as a couple, self-efficacy, disability, socioeconomic
status, pain or BMI). Questionnaire-based outcome measures tended to support the conclusions of
accelerometer measures, but only if walking was an explicit part of the questionnaire. Thus, the IPAQ
MVPA question did not show any intervention effect, but the IPAQ walking question showed a significant
effect of both the nurse-supported and the postal delivery interventions with no difference between the
interventions, although with less precision than the accelerometry data.
Both interventions were well accepted and the trial had high fidelity; three-quarters of the nurse group
attended all three sessions and around 80% of both the postal delivery and the nurse-support groups
returned completed step count diaries. Increase in step count was positively associated with both nurse
session attendance and completed diary return.
Incremental cost per step was £0.19 and £3.61 per minute in a ≥ 10-minute MVPA bout for the
nurse-support group, whereas the postal delivery group took more steps and cost less than the control
group. The postal delivery group had a 50% chance of being cost-effective at a £20,000 per QALY
threshold within 1 year. The QALY-based conclusion changed to the control group dominating the
postal delivery group when four alternative assumptions were made (using the 3-month outcome data,
extending the perspective to participants, excluding health service use and using self-reports of AEs),
although this was not the case for cost-effectiveness ratios based on step count and MVPA. The postal
delivery group was significantly more cost-effective than both the nurse-support group and the control
group in the long term and this finding was robust to changes in assumptions.
Nurses and intervention group participants described the intervention in a positive way and confirmed
that primary care was an appropriate setting. Nurses believed that participating in the trial, especially in
the BCT training, enhanced the quality and delivery of the advice and support they provided within routine
consultations. Participants described important facilitators of increasing PA, including the desire for a
healthy lifestyle, improved physical health, enjoyment of walking in the local environment, having a flexible
routine, appropriate self-monitoring and external monitoring and support from others. Important barriers
included physical health problems, having an inflexible routine, work and other commitments and poor
weather. Several BCTs were highlighted as having an important impact, including self-monitoring and
review of goals and outcomes, planning social support/change and relapse prevention. Although most
participants in the postal delivery group were confident in increasing their PA without nurse support,
two key caveats were existing health problems and overcoming barriers.
The follow-up of over two-thirds of the trial cohort at 3 years demonstrated persistent increases in both step
count and time in MVPA for the nurse-support and postal delivery groups compared with the control group,
with no difference between intervention groups. The postal intervention given to the control group at
12 months, with no follow-up telephone call after 1 week and no requirement to post back the diary to be
reviewed after 3 months, was not effective at increasing participants’ PA levels. This suggests that these
‘minimal support’ components of the postal delivery intervention, which were not face to face or not
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provided by a health-care professional, may have been important to its success. Qualitative evaluation found
that most participants felt that the PACE-UP trial had increased their awareness of the importance of PA,
irrespective of their intervention group and whether or not they felt that their PA had actually increased.
Many of the barriers to, and facilitators of, PA maintenance were the inverse of each other and most were
similar to those found to be important for increasing PA during the actual trial (health conditions, weather,
ageing, social support, time). Participants varied in the resources that they would find most beneficial to help
them maintain their PA levels, emphasising the importance of individual tailoring of some aspects of PA
interventions.
The PACE-UP trial was novel in clearly separating out the effects of pedometer provision and nurse support
in a general population sample of adults and older adults and in demonstrating the effects on both step
counts and MVPA in bouts, thus making the outcome assessment relevant to current national and
international PA guidelines.
Strengths and limitations
Study strengths
The PACE-UP study had many important strengths. It was large and population based with primary care
sampling, allowing response and any bias in response to be assessed, rather than relying on recruiting
volunteers. It was designed to have household randomisation, which allowed two members of a couple to
take part together if they wished to, enabling a comparison of individual and couple effects. It had three
trial arms, allowing the separation of nurse support and pedometer/handbook/diary effects. The intervention
was pragmatic, using practice nurses who worked in the practices to deliver the nurse PA consultations, rather
than external researchers or exercise specialists. There was a very good uptake rate of nurse appointments
and return of completed step count diaries, showing participant engagement with the interventions. The main
PA outcomes were objectively measured and were relevant to the PA guidelines. AEs were measured in a
number of ways to minimise bias, both self-reported from questionnaires and objectively from primary care
records. The trial achieved a follow-up rate of over 90% with complete primary outcome data. The trial also
included embedded process, qualitative and economic evaluations, with the economic evaluations using trial
results in a simulation of long-term cost-effectiveness. An extended 3-year follow-up allowed maintenance
of any intervention effects beyond 12 months to be studied.
Study limitations
There were also some important study limitations. The 10% recruitment into the trial is considered in
detail below, in Generalisability. At the baseline assessment, 218 out of 1023 participants (21%) achieved
the PA guideline targets based on their accelerometry. These participants were not excluded from the trial
because if the intervention were to be rolled out in primary care, self-reported PA levels would define
participation. Our nurse-supported intervention group had slightly higher baseline PA levels; however, the
trial results were not biased, as analyses were based on individual change, controlling for baseline PA level.
It was impossible to mask participants and nurses to the intervention group and, pragmatically, research
assistants recruited and followed up the same participants, so were unmasked to group at the outcome
assessment. However, all the primary and secondary PA outcomes were assessed objectively by accelerometry.
It is possible that participants might have tried harder with their PA when monitored, but this would also have
affected control participants and would be reduced by using a 7-day protocol for data collection.31 In addition,
our intervention groups increased their MVPA in bouts of ≥ 10 minutes, implying that participants made
changes suggested by the programme. Despite recruiting to target and having excellent follow-up, our CIs for
the difference between intervention groups cannot rule out a small 12-month difference. Interpretation of our
3-year follow-up findings was potentially limited by the fact that two-thirds of the control group participants
received a pedometer, handbook and diary, and 20% of them also received a single nurse appointment after
their 12-month follow-up. However, any contamination appears to be minimal, as there was no evidence of a
change in the control group and the intervention estimates at 3 years were very similar to those at 12 months.
These findings are of potential importance as, in combination, they suggest that the minimal contact with the
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postal delivery group after participants were sent their pedometer packs (telephone contact after 1 week and
encouragement to return their completed step count diaries at 3 months) was important in stimulating an
effect. Timing may have been important too; as the control group was offered the intervention 12 months
after the participants had initially expressed an interest in participating in the trial, they would have had to
have worn the pedometer to measure their step count and set targets, whereas the trial postal delivery group
had targets set based on wearing a blinded pedometer at baseline. These added factors may have also been
important to the success of the trial postal delivery intervention group.
Generalisability
Overall, only 10% of people invited to participate in the trial ended up being recruited and randomised.
This is similar to other primary care PA trials,33,192 but lower than the 30% that we achieved in our recent older
adult PA trial.21 However, 10% of a population sample is still a useful percentage to participate in a public
health intervention, and this trial shows the potential of primary care to contribute to PA public health goals,
particularly within an urban context. As well as monitoring overall recruitment, using primary care as a
sampling framework allowed us to look for any selection bias in recruitment to the trial. Primary care record
comparisons showed that participation rates were significantly lower in men, in those aged < 55 years, in
those who were living in the most socioeconomically deprived quintile and among Asian rather than white or
black ethnic groups. Despite selecting practices from deprived, ethnically diverse areas, few participants
were from lower socioeconomic and ethnic minority groups, limiting both the subgroup analysis power and
the generalisability to more diverse populations. Failure to include socioeconomically deprived or ethnic
minority groups, in which PA levels were lower, could also increase health inequalities. In a RCT of an
intervention, it is not possible to separate out reluctance to participate in the intervention from reluctance to
participate in the trial itself, with requirements for informed consent, randomisation and rigorous follow-up
and evaluation. If the intervention were to be rolled out in routine primary care, uptake could be higher
and less prone to selection bias. Handing out the intervention materials (pedometer, handbook and diary)
in primary care consultations in which advice to increase low PA levels is already being offered may also
increase the intervention’s reach (e.g. in relevant chronic disease consultations, or as part of NHS Health
Checks, which cover a similar age group and aim to reduce cardiovascular risk59). The intervention could
also be a valuable addition to diabetes mellitus prevention strategies, such as the NHS Diabetes Prevention
Programme, whereby primary care is being used to identify patients at a high risk of developing diabetes
mellitus, many of whom are inactive193 and with higher proportions from ethnic minority groups. Using the
PACE-UP trial intervention in these ways would need further evaluation and monitoring, but this may have
the potential to improve generalisability and either decrease, or at least not increase, inequalities.
Comparison with other studies
We believe that this is the largest population-based trial of a pedometer-based walking intervention
with 12-month follow-up findings and the only pedometer trial with objective PA data on time in MVPA,
which is relevant to PA guidelines at 3 years. The results are consistent with, and extend, our findings
in 60- to 75-year-olds that were achieved in the smaller PACE-LIFT trial21 and also support the recent
change in NICE guidance to promoting pedometers as part of packages including support to set realistic
goals, monitoring and feedback.37 The intervention used in the PACE-LIFT trial also included pedometer
feedback, use of a step count diary and practice nurse PA consultations based around BCTs. However,
the PACE-LIFT trial intervention comprised four longer practice nurse consultations, which also included
individual accelerometer feedback on PA intensity. The PACE-LIFT trial was a two-arm trial with only a
single intervention arm, and was therefore unable to separate out PA monitor effects from those of the
nurse-support group. Despite including a much less intense intervention, the PACE-UP trial has delivered
similar levels of effect at both 3 and 12 months in PA outcomes and, furthermore, has shown what can
be achieved via a postal route. It is also reassuring that our interventions did not increase sedentary time,
given its potential harm,194,195 as compensation can sometimes occur. The absolute step count increase
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achieved in the PACE-UP trial was modest compared with that reported in systematic reviews.26,31,32
However, most trials with 12-month data have been based on small numbers and recruited either
volunteers196 or high-risk groups,35 or reported only self-reported PA data;97 all of these factors are likely to
lead to larger effect sizes. Although PA guidelines focus on time in MVPA in bouts, not on step counts, the
systematic reviews presented no data on this important outcome.26,31,32 The PACE-UP trial results confirm
the PACE-LIFT trial findings,21 with significant 12-month increases in MVPA in bouts. Based on the ‘3000 in
30’ formula, 33–35 extra minutes of MVPA per week in bouts corresponds to approximately 500 extra steps
per day. Thus, approximately three-quarters of the extra steps achieved in the PACE-UP trial (650–700 per day)
contributed to an increase in MVPA in bouts. We believe that our trial is the first to show that the ‘3000-in-30’
message43 can lead to an approximately one-third increase in weekly MVPA in bouts at 12 months, as was
achieved across both intervention groups. The ‘3000 steps in 30 minutes’ formula neatly captures intensity43
and could become an important new public health goal, particularly as many people now have the ability to
measure steps easily with their mobile phones. Based on a systematic review, which has quantified the
strength of association between walking and the risk of developing CHD,197 the increase of 33 minutes per
week in the postal delivery group in our study at 12 months, if sustained, would be expected to reduce the
risk of CHD by approximately 4.5% (95% CI 3% to 6%; see Appendix 8 for details). A cohort study that
has related pedometer-measured steps to mortality198 has similarly allowed us to estimate that a sustained
increase of 642 steps per day would be expected to lead to a decrease in all-cause mortality of approximately
4% (95% CI 1% to 7%; see Appendix 8 for details). Recalculating these estimates for the effect estimates
in the postal delivery group at 3 years makes little difference, with the resultant decreases being 4%
(95% CI 3% to 5%) for CHD and 4% (95% CI 1% to 5%) for total mortality.
Most pedometer-based interventions have not separated out the effects of the pedometer itself from the
effects of the additional support provided.21,24,31 The Healthy Steps trial97 showed that pedometers achieved
an additional effect compared with a primary care green prescription, but the PA outcomes presented were
based on self-report. The PACE-UP trial demonstrates that although the nurse intervention group had a
significantly greater effect on both step counts and time in MVPA at 3 months, by 12 months both the
nurse-supported and postal delivery interventions still had a significant effect, but with no evidence of a
difference between them. This stronger effect during the period of contact with the nurse, which was not
sustainable in the longer term, has also been shown in other interventions with health professionals.199
Both the nurse-support and postal delivery groups received a pedometer, diary and handbook as part of
the PACE-UP trial package; therefore, it is not possible to know how much the individual components
contributed. A systematic review suggested that step count diaries were common to successful pedometer
interventions,31 and approximately 80% of both of our intervention groups returned completed step count
diaries. In addition, our process evaluation showed that returning a completed diary was significantly
associated with an increase in step counts for both of the intervention groups. Qualitative findings also
confirmed that participants from both groups valued the handbook and diary, as well as the pedometer.162
Control group participants provided with the pedometer, diary and handbook by post at 12 months did not
significantly increase their PA levels; however, they were not asked to return completed step count diaries
after 3 months, which may have contributed to the lack of effect of the materials in this group.
We found no effect of the interventions on anthropometric measures, such as BMI or fat mass; this is
consistent with other similar studies.21,196 Our interventions also did not affect anxiety or depression scores,
which is consistent with other primary care pedometer-based interventions, suggesting either no effect
or insensitivity of these measures to change, particularly when levels are in the normal range for most
people.21,33 Although a few participants mentioned that they had negative effects from overdoing walking,
most intervention participants talked about feeling fitter, sleeping better, improved mood, having more
energy, less pain and keeping more active into older age.162 There is currently a lack of data comparing
individual, couple or household participation in walking studies.21,30 Household sampling allowed us to
investigate this in the PACE-UP trial, but, unfortunately, only 20% of the participants took part in the
study as a couple; therefore, we had reduced power for our subgroup analysis, which showed no effect
of taking part as a couple, similar to the findings in our PACE-LIFT trial.21
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The self-efficacy differences that we demonstrated between both intervention groups and the control
group at 3 months and between the nurse-support group and control group participants at 12 months
are consistent with the positive relationship between changing self-efficacy and PA behaviour that others
have reported.200 The BCTs most associated with self-efficacy and successful PA outcomes are goal- and
action-planning, prompting self-monitoring and feedback and planning of social support/change.200 All
of these BCTs were specifically recommended in recent guidance29 and were included in our study in
written materials for both intervention groups and as a focus of nurse PA consultations.70 Our qualitative
interviews found that more BCT comments were made by the nurse support group than by the postal
delivery group, apart from around self-monitoring.162 Increased self-efficacy has also been shown to be
important for long-term PA adherence;201 however, we found no difference in 3-year PA maintenance
between intervention groups, despite the nurse-support group having a higher level of self-efficacy than
the postal group at 12 months.
Walking is a safe intervention, which is indicated in many chronic diseases,1,8 although empirical data on
the safety of walking interventions are limited.24 A large trial based on 40- to 74-year-old women, which
encouraged a single 30-minute brisk walk 5 days weekly, reported increased falls and injuries.60 Our
findings in the PACE-UP trial, showing no increase in AEs, builds on similar evidence from the PACE-LIFT
trial,21 using both self-reported and objective primary care data, and highlights the potential importance
of building up MVPA gradually, particularly in older adults, those who are inactive or those who have
comorbidities.1,11 The suggestion of a protective effect of the interventions in the PACE-UP trial on both
falls and cardiovascular events at 12 months is plausible, but not definitive, as it is based on only a small
number of events.
We demonstrated a persistent intervention effect at 3 years, in terms of both step counts and time in MVPA
in bouts. This adds to the limited evidence from the systematic review by Hobbs et al.,26 who found only
two trials with objective PA measurement data beyond 12 months in this age group. One trial reported a
significant intervention effect on step counts at 18 months, but suffered high attrition bias,202 and another
trial found no effect at the 24-month follow-up on either step count or accelerometry-assessed vector
magnitude.203 Recent NICE guidance29 and a Cochrane systematic review23 also called for PA interventions
with a longer follow-up period and objective PA measures. Our qualitative evaluations at 3 years also add to
the limited evidence base on factors that lead to successful and unsuccessful PA maintenance190 and suggest
that many of the factors that were important barriers to, or facilitators of, increasing PA levels in the original
trial (e.g. health conditions, weather, ageing, social support, time) are still important when considering
maintenance. This provides support for the credibility of our work and suggests that barriers and facilitators
may be similar for both PA adoption and maintenance.204 Our findings support others in suggesting that
future interventions should focus on techniques to transform PA barriers into facilitators, for example by
demonstrating the value of PA for many chronic health conditions, as well as safe ways in which individuals
can increase their PA levels to change the presence of chronic health conditions from inhibiting to promoting
PA as people age.157,205,206
Our results on cost-effectiveness provide new evidence in a research area that reflects a dearth of primary
evidence.139,140 The evidence that the postal intervention has a 50% chance, and the nurse intervention a
5% chance, of being cost-effective within 12 months is new. Although lower than the 95% likelihood
of green prescriptions being cost-effective in New Zealand at 12 months,97 it is still a reasonably high
percentage for a behaviour change intervention to achieve at 12 months. The expectation that the postal
intervention is most cost-effective over a lifetime is very strong and is comparable to other findings
from models.141,142
Interpretation of the results
Primary care patients aged 45–75 years can achieve important increases in their PA levels using a
12-week pedometer-based walking intervention, including handbooks and PA diaries (available at
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www.journalslibrary.nihr.ac.uk/programmes/hta/103202/#/), delivered either by post with minimal support
or through practice nurse PA consultations, with both methods achieving similar 12-month effects. An
important part of the intervention was to try and gradually add in 3000 steps in 30 minutes most days
weekly. The persistent effect at 3 years suggests a long-term beneficial effect. This is a safe intervention
that is acceptable to patients and nurses. The postal delivery group was significantly more cost-effective
than the nurse-support and control groups in the long term, thus providing a cost-effective way of
delivering long-term quality-of-life benefits. The lack of an increase in PA levels at 3 years in the control
group, which received a simple postal intervention without further contact after the 12-month follow-up,
suggests that contacting participants after posting the intervention components to them and encouraging
the return of PA diaries may be important factors for success for the postal intervention route, but this
minimal support does not need to be face to face or provided by a health-care professional.
Conclusions
Implications for health care
l A primary care pedometer-based walking intervention, delivered by post with minimal support, could
provide an effective and cost-effective approach to addressing the public health physical inactivity challenge.
l The ‘3000 steps in 30 minutes’ formula neatly captures intensity and could become a useful new public
health goal, particularly as many people can measure steps easily with their mobile phones.
l The PACE-UP 12-week pedometer-based walking intervention could be considered for inclusion into
the NHS Health Check programme, aimed at a similar age group (40- to 74-year-olds), and/or the NHS
Diabetes Prevention Programme.
Recommendations for research
l The PACE-UP trial generalisability is limited by the 10% overall recruitment rate and a lower
recruitment rate in Asian and socioeconomically deprived patients. Further research into different
recruitment methods is needed, as is research assessing the recruitment rate achievable if this
programme were offered outside a trial setting over a more prolonged time period.
l Although the overall postal intervention outcomes were as effective and more cost-effective than the
nurse-supported intervention outcomes, further research is required to understand who would benefit
most from the individual tailoring offered by a nurse-supported intervention.
l There has been a recent dramatic increase in the use of wearables to monitor personal PA levels,
including through smartphones, wrist-worn devices, online monitoring and mobile apps. Further
research into how the PACE-UP 12-week PA programme could be integrated into the use of these
devices (with/without a pedometer) is needed.
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Data sharing statement
Anonymised individual patient data may be available for the trial effectiveness and cost-effectiveness
analyses. These will be stored in a secure data repository at St George’s, University of London. All queries
and requests should be submitted to the corresponding author for initial consideration.
Patient data
This work uses data provided by patients and collected by the NHS as part of their care and support. Using
patient data is vital to improve health and care for everyone. There is huge potential to make better use of
information from people’s patient records, to understand more about disease, develop new treatments,
monitor safety, and plan NHS services. Patient data should be kept safe and secure, to protect everyone’s
privacy, and it’s important that there are safeguards to make sure that it is stored and used responsibly.
Everyone should be able to find out about how patient data are used. #datasaveslives You can find out
more about the background to this citation here: https://understandingpatientdata.org.uk/data-citation.
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Appendix 1 Methods
study 
 
Health and lifestyle survey 
 __________________________________________________________ 
 
Study IDNO ____________ 
 
 
Thank you for filling in this questionnaire.  
 
It will take you about 15-20 minutes to complete. 
 
Please feel free to write comments by any question. 
 
All information will be kept strictly confidential. 
 
 
 
Please enter your date of birth  ____ / ____ / _____ 
 
Please enter today’s date             ____ / ____ / _____ 
  
Thank you 
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Section A - Some general questions about your health 
 
Please put a tick in the box next to the most appropriate answer for each 
question.  
 
 
 
How is your health in general?  
 
Very good                    
Good  
Fair  
Poor  
Very poor  
 
Are your day-to-day activities limited because of a health problem or disability   which 
has lasted, or is expected to last, at least 12 months? (Include problems related to old 
age.) 
 
Yes, limited a lot          
 
Yes, limited a little  
 
No  
 
3  How much physical or bodily pain have you had in the past 4 weeks? 
 
None 
Very mild or mild  
Moderate  
Severe or very severe  
 
4  In the past four weeks, how much did pain interfere with your normal activities? 
 
Not at all    
A little bit     
Moderately                   
Quite a bit or extremely   
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Section B - specific questions about your health 
 
Have you ever been told by a doctor or nurse that you have any of these conditions? 
(Please tick all that apply to you)   
                YES
Angina ………………………………..…….. 
A heart attack ………………….…..….….. 
Other heart problems………..…..…..…….. 
Stroke…………………………….…..……… 
High blood pressure…………….….……….   
Chronic bronchitis…………………..…..…… 
Asthma ……………………….…..……..…… 
Diabetes……………………………..…..…… 
Arthritis ………….…..…..……………………. 
 Cancer (apart from skin cancer)  ..……….. 
 Depression…….…..………………………..  
 Parkinson’s Disease….……………..………  
 
13 How many times have you fallen over in the last year ? 
None   
Once or twice  
Three times or more 
  Not sure  
 
14  How many different medications do you take every day? 
None      One         Two          Three          Four or more  
 
15 Have you ever smoked? 
Yes   No   (please go to question 17) 
 
16 Do you currently smoke? 
Yes   No   
17 One unit of alcohol is approximately half a pint of beer / cider, one glass of wine or 
sherry, or a single whisky, gin etc. 
Approximately how many units of alcohol do you have during the average 
week?.............. units. 
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Section C - Questions about your health today 
 
Under each heading, please tick the ONE box that best describes your health TODAY 
 
1   Mobility 
I have no problems in walking about                                                       
I have slight problems in walking about   
I have moderate problems in walking about   
I have severe problems in walking about   
I am unable to walk about  
2 Self-care 
I have no problems with self-care   
I have slight problems washing or dressing myself  
I have moderate problems washing or dressing myself  
I have severe problems washing or dressing myself  
I am unable to wash or dress myself  
3 Usual activities (e.g. work, study, housework, family or leisure) 
I have no problems doing my usual activities  
I have slight problems doing my usual activities  
I have moderate problems doing my usual activities  
I have severe problems doing my usual activities  
I am unable to do my usual activities  
4 Pain / discomfort 
I have no pain or discomfort   
I have slight pain or discomfort   
I have moderate pain or discomfort  
I have severe pain or discomfort   
I have extreme pain or discomfort   
5 Anxiety / depression 
 
I am not anxious or depressed   
I am slightly anxious or depressed   
I am moderately anxious or depressed  
I am severely anxious or depressed  
I am extremely anxious or depressed  
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Section C -  Your health today (continued)  
 
 We would like to know how good or bad your health is TODAY 
 The scale is numbered 0 to 100 
 100 means the best health you can imagine 
 0 means the worst health you can imagine 
 Mark an X on the scale to indicate how your health is TODAY 
 Now, please write the number you marked on the scale in the box 
below 
      YOUR HEALTH TODAY =   
 
 
 
 
 
 
 
 
Section D -  Your contact with your GP surgery 
1. During the last 3 months did you talk to a doctor or nurse at your general 
practice on your own behalf, either in person or by telephone? 
Yes   No   (If no, please go to section E) 
 
If yes, approximately how many times did this happen in the last 3 months? 
Once     
Twice     
Three times     
Four or more times   
 
DOI: 10.3310/hta22370 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 37
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Harris et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
133
Section E - Some questions on how you feel 
For each item below, please tick the box opposite the reply that comes closest to how you 
have been feeling over the past week. Don’t take too long over the answers: your immediate 
reaction will probably be most accurate.  
Tick only one box in each section 
 
1. I feel tense or ‘wound up’: 
Most of the time              
A lot of the time      
From time to time      
Not at all       
 
2. I feel as if I am slowed down: 
Nearly all of the time     
Very often       
Sometimes       
Not at all       
 
3. I still enjoy things I used to: 
Definitely as much      
Not quite as much      
Only a little       
Hardly at all       
 
4. I get a sort of frightened feeling like  
butterflies in the stomach: 
Not at all       
Occasionally       
Quite often       
Very often       
 
5. I get a sort of frightened feeling as if  
something bad is about to happen: 
Very definitely      
Yes, but not too badly     
A little, but it doesn’t worry me    
Not at all       
 
6. I have lost interest in my appearance: 
Definitely       
I don’t take so much care as I should do   
I might not take quite as much care   
I take just as much care     
 
7. I can laugh and see the funny side of things: 
As much as I always could     
Not quite so much now     
Definitely not so much now    
Not at all       
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8. I feel restless, as if I have to be on the move 
Very much indeed      
Quite a lot       
Not very much      
Not at all       
 
 
9. Worrying thoughts go through my mind: 
A great deal of the time     
A lot of the time      
From time to time but not too often   
Only occasionally      
 
 
10. I look forward with enjoyment to things: 
As much as I ever did     
Rather less than I used to     
Definitely less than I used to    
Hardly at all       
 
11. I feel cheerful: 
Not at all       
Not often       
Sometimes       
Most of the time      
 
12. I get sudden feelings of panic 
Very often indeed      
Quite often       
Not very often      
Not at all       
 
13. I can sit at ease and feel relaxed: 
Definitely       
Usually       
Not often       
Not at all       
 
14. I can enjoy a good book, radio or  
TV programme: 
Often        
           Sometimes       
           Not often       
Very seldom       
 
15. I feel lonely: 
All the time       
Often        
Sometimes       
Never        
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Section F - Some questions about difficulties you may 
have 
 
Here are a few things some people find difficult to do without help.  
Do you or would you have difficulty with these activities?  
 
    No Some Unable 
     Difficulty Difficulty to do alone 
 
 
1   Washing yourself all over          
2   Cutting your own toenails         
3   Getting on a bus           
4   Going up and down stairs         
5   Doing heavy housework         
6   Shopping & carrying heavy bags                  
7   Preparing and cooking a hot meal         
8   Reaching an overhead shelf         
9   Tying a good knot in a piece of string        
 
 
 
10 Do you have any problems with your balance? 
No   Yes  
 
 
11 Can you see well enough to recognise a friend across a road? 
Yes, without glasses             Yes, with glasses       No    
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Section G- Some questions about your attitudes to 
exercise and health 
 
Please tick one box to indicate how strongly you agree or disagree with each 
statement 
 
 
 Strongly 
agree 
Slightly 
agree 
Unsure Slightly 
disagree 
Strongly 
disagree 
 
 
1. Doing exercise is 
satisfying and 
rewarding to me 
 
 
 
 
 
 
 
 
 
 
 
2. Doing exercise 
regularly is good for 
me 
 
 
 
 
 
 
 
 
 
 
 
3. There is little I can do 
to make up for the 
physical losses that 
come with age 
 
 
 
 
 
 
 
 
 
 
 
4. Exercising regularly 
can be helpful for my 
health 
 
 
 
 
 
 
 
 
 
 
 
5. Exercising regularly 
can help me to get out 
of doors 
 
 
 
 
 
 
 
 
 
 
 
6. Exercising regularly 
can help me to control 
my weight or to lose 
weight 
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Section H - Some questions about physical activity 
          
1    How many times did you take a walk outside during the last week?  
 (include walking related to other activities e.g. for shopping, travel to work etc)       
  
 .............................................times last week 
2 How long did such a walk usually last? ………..minutes 
  
3 Did you take a walk that lasted longer than 1 hour during the last month? 
 
Yes  No  
 
3a If yes, how many times did you do that?  ……….times in the last month 
 
4 Do you walk a dog? 
  
Yes  No  
 
5 Do you have someone with whom you can go for a walk, or do other physical 
activities? 
Always    
 Often    
Sometimes    
 Never    
 
6 Do you ride a bicycle? 
  
Yes    No       (please go to question 7) 
    
6a If yes, how many times did you cycle last week? …….…times 
 
6b How long on average did you cycle for each time? ..…...minutes 
  
6c How would you describe your cycling pace? 
  
 Slow    
 Average   
 Fast    
 
7 Do you go swimming? 
    
Yes      No       (please go to question 8) 
    
7a If yes, how many times did you swim last week? …….….times 
 
7b How long on average did you swim for each time?.........minutes 
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7c How would you describe your swimming speed? 
 Slow    
 Average   
 Fast    
 
8 Do you have a garden or allotment? 
 
Yes       No       (please go to question 9) 
    
8a If yes, how many hours, on average, a week do you spend doing 
gardening? 
   
In summer…………………hours  In winter……………………hours 
 
9 Have you participated in any sporting activities in the last week? 
 
Yes    No    (if no, please go to question 10) 
 
9a    If yes, what kind of sporting activity?  ……………………………. 
 
9b   How many hours approximately did you spend participating in sporting 
activities in the last week?  
 
         Less than 1 hour in the last week      
          ……………… hours in the last week    
 
10 How often did you perspire during physical activity in the last week? 
 
 Never   
 1-2 times   
 3-4 times   
 5 or more times  
 
11 Do you have a staircase in your home? 
 
Yes     No     
 
11a Do you climb stairs regularly (at least once per day)? 
 
Yes     No     (go to section I) 
 
11b If yes, approximately how many times per day do you climb the stairs? 
 
 ........................... times per day 
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Section I – Some questions about your belief in your 
ability to exercise 
 
How sure are you that you will do each of the following: 
 
     Very  Pretty  A little Not at all 
     Sure  Sure  Sure  Sure 
 
1 Exercise regularly          
(3 times a week for  
20 minutes)  
 
2 Exercise when you          
 are feeling tired 
 
3 Exercise when you           
are feeling under pressure 
to get things done 
 
4 Exercise when you           
are feeling down or  
depressed 
 
5 Exercise when you           
 have too much work to do  
at home 
 
6 Exercise when there          
are other more interesting 
things to do 
 
7 Exercise when your          
family or friends do not 
provide any support 
 
8 Exercise when you           
don’t really feel like it 
 
9 Exercise when you           
are away from home  
(e.g. visiting, on holiday) 
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Section J – Finally, some questions about you & your 
living circumstances 
 
1     What is your current marital status? 
   Married (or living with someone as a couple)     
Widowed          
Divorced or separated        
Single           
Other           
If other, please describe……………………………………… 
 
2 How many people in your household, including yourself, are there 
Aged under 18 ………………… 
 
Aged 18-64…………………….. 
 
Aged 65 or over………………… 
 
 
3    Who lives in your household with you? (please tick all that apply) 
   I live on my own          (please go to question 4) 
My husband / wife / partner     
Other family members      
Other adults        
 
4 Do you have someone with whom you would be able to discuss a very personal 
and serious problem? 
 Yes           No          
  
5 At what age did you finish your continuous full-time education at school, 
college or university? 
 14 or under     15   
16      17   
18      19 or over  
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More questions about you & your living circumstances 
 
6 Do you have any qualifications? 
Yes               No         (Please go to question 7) 
If yes, which of these qualifications do you have? If you have any of the qualifications 
listed, please tick every box that applies. If your UK qualifications are not listed, tick the box 
that contains its nearest equivalent. If you have qualifications from outside the UK, tick the 
‘Foreign qualifications’ box and the nearest UK equivalents (if known). 
  1 - 4 O levels / CSEs / GCSEs (any grades), Entry Level, Foundation Diploma 
  NVQ Level 1, Foundation GNVQ, Basic Skills 
  5+ O levels (passes) / CSEs (grade 1) / GCSEs (grades A*- C), School Certificate, 1 A level / 
2 - 3 AS levels / VCEs, Higher Diploma 
  NVQ Level 2, Intermediate GNVQ, City and Guilds Craft, BTEC First / General Diploma, RSA 
Diploma 
  Apprenticeship 
  2+ A levels / VCEs, 4+ AS levels, Higher School Certificate, Advanced Diploma 
  NVQ Level 3, Advanced GNVQ, City and Guilds Advanced Craft, ONC, OND, BTEC  
National, RSA Advanced Diploma 
  Degree (for example BA, BSc), Higher degree (for example MA, PhD,PGCE) 
  NVQ Level 4 - 5, HNC, HND, RSA Higher Diploma, BTEC Higher Level 
  Professional qualifications (for example teaching, nursing, accountancy) 
  Other vocational / work-related qualifications 
  Foreign qualifications 
  No qualifications 
7 What is your employment status? 
 In full time employment        
In part time employment        
Seeking work         
Looking after home or family       
Retired          
Student          
Not working due to long-term sickness or disability    
Other  (please describe)      ……………………………    
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Answer question 8 for your main job, or if you are not working, your last main job. 
Your main job is the job in which you usually work (worked) the most hours. 
8 What is (was) your full and specific job title? 
For example, PRIMARY SCHOOL TEACHER, CAR MECHANIC, DISTRICT NURSE, 
STRUCTURAL ENGINEER 
 Do not state your grade or pay band. 
 
 …………………………………………………………………………………………………… 
 
8a Briefly describe what you do (did) in your main job. 
 
 …………………………………………………………………………………………………… 
 
8b At your workplace, what is (was) the main activity of your employer or 
business? 
For example, PRIMARY EDUCATION, REPAIRING CARS, CONTRACT CATERING, 
COMPUTER SERVICING. If you are (were) a civil servant, write GOVERNMENT 
………………………………………………………………………………………………… 
………………………………………………………………………………………………… 
9 Do you, or the people you live with, own or rent your own home? 
Own (with or without a mortgage)                                                       
Rent from council or housing association     
Rent privately         
Other , please describe…………………………………    
 
10 Do you have to cut back spending or borrow money to pay your electricity, gas, 
telephone or council tax bills? 
Always                      
Often    
Occasionally   
Never    
 
11 In total, how many cars or vans are owned, or available for use, by members of 
your household? 
None            One             Two              Three                    Four or more    
 
11 Do you yourself drive a car or van? 
Never                 Occasionally                  Most days                Every day   
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12 What is your ethnic group?  
Please choose one section from A to E, then tick  one box to best describe your ethnic 
group or background. 
A  White       B   Mixed /multiple ethnic groups 
  English / Welsh / Scottish/ Northern Irish / British   White and Black Caribbean 
  Irish         White and Black African             
  Gypsy or Irish Traveller      White and Asian 
  Any other White background,write in  …………                          Any other Mixed /multiple ethnic 
    ……………………………………………..                     background, write in  ………………………. 
  
C    Asian / Asian British          Black / African / Caribbean / 
    Indian                    Black British              
    Pakistani           African 
    Bangladeshi         Caribbean    
    Chinese          Any other Black / African / Caribbean  
    Any other Asian background,write in ………         background, write in ………………………. 
……………………………………………………….   ……………………………………………………..
  
Other ethnic group    
    Arab 
    Any other ethnic group, write in ………………… 
      ……………………………………………………… 
        
Please write below any other comments you have on 
your health or this questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thank you for filling in this questionnaire.  
E
D
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 study 
 
Health and lifestyle 3 month survey 
 __________________________________________________________ 
  
Study IDNO ____________ 
 
 
Thank you for filling in this questionnaire.  
 
It will take you about 15 minutes to complete. 
 
Please feel free to write comments by any question. 
 
All information will be kept strictly confidential. 
 
 
 
Please enter your date of birth  ____ / ____ / _____ 
 
Please enter today’s date              ____ / ____ / _____ 
 
 
Thank you 
 
 
 
Usual activity group 
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Section A - Some general questions about your health 
 
Please put a tick in the box next to the most appropriate answer 
for each question.  
 
 
 
1 How is your health in general?  
 
Very good  
Good  
Fair  
Poor  
Very poor  
 
 
2  How much physical or bodily pain have you had in the past 4 weeks? 
None 
Very mild or mild  
Moderate  
Severe or very severe  
3  In the past four weeks, how much did pain interfere with your normal activities? 
Not at all  
A little bit  
Moderately   
Quite a bit or extremely   
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Section B - Questions about your health today 
 
Under each heading, please tick the ONE box that best describes your health TODAY 
 
1   Mobility 
I have no problems in walking about       
I have slight problems in walking about      
I have moderate problems in walking about      
I have severe problems in walking about      
I am unable to walk about        
2 Self-care 
I have no problems with self-care       
I have slight problems washing or dressing myself     
I have moderate problems washing or dressing myself    
I have severe problems washing or dressing myself    
I am unable to wash or dress myself       
3 Usual activities (e.g. work, study, housework, family or leisure) 
I have no problems doing my usual activities     
I have slight problems doing my usual activities     
I have moderate problems doing my usual activities    
I have severe problems doing my usual activities     
I am unable to do my usual activities       
4 Pain / discomfort 
I have no pain or discomfort        
I have slight pain or discomfort       
I have moderate pain or discomfort       
I have severe pain or discomfort       
I have extreme pain or discomfort       
5 Anxiety / depression 
I am not anxious or depressed       
I am slightly anxious or depressed       
I am moderately anxious or depressed      
I am severely anxious or depressed       
I am extremely anxious or depressed      
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Section B - Continued:  about your health 
today 
 
We would like to know how good or bad your health is TODAY 
 
 The scale is numbered 0 to 100 
 100 means the best health you can imagine 
 0 means the worst health you can imagine 
 Mark an X on the scale to indicate how your health is TODAY 
 Now, please write the number you marked on the scale in the box 
below 
 
      YOUR HEALTH TODAY =   
 
 
 
 
 Section C - Some questions on injuries and health 
 
These questions ask about any injuries or changes in your health that you may have 
had in the 3 months that you have been involved in this study. 
 
In the last 3 months have you had any of the following: 
 
1 A fall?     Yes    No   
 
1a If yes, how many times?      ….……….....times in the last 3 months 
 
2 Any fractures (broken bones)?  Yes    No   
 
2a If yes, please give details of what bones were injured  
 
…………………………………………………………………………………… 
 
…………………………………………………………………………………… 
 
3 Any sprains or injuries?   Yes    No   
 
3a If yes, please give details of the sprain or injury  
…………………………………………………………………………………… 
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Some questions on injuries and health continued 
 
If you have not had a fall, fracture, sprain or injury, please go to question 6. 
 
If you have had a fall, fracture, sprain or injury, please go to question 4.  
 
 
4.  Did you or your family have to pay for anything as a result of your fall(s), 
fracture(s), sprain(s) or injury (ies)? (Please consider any costs linked to your 
continuing care or recovery) 
 
Yes    No   
 
4a. If yes, roughly how much did you spend?.................................................... 
 
4b What was this spent on………………………………………………………...... 
 
........................................................................................................................... 
 
 
5. In the past 3 months did you have to stop doing your usual activities due to a 
fall, fracture, sprain or injury?   
 
Yes    No   
 
5a. If yes, how many days did you stop your usual activities? …………………..days 
 
   
 
6 In the last 3 months have you noticed a deterioration in any health problems 
that you already had at the start of this research project? 
 
Yes    No   
 
6a If yes, please give details  
…………………………………………………………………………………………………… 
…………………………………………………………………………………………………… 
 
7 In the last 3 months have you noticed an improvement in any health problems 
that you already had at the start of this research project? 
 
Yes      No    
 
7a If yes, please give details  
………………………………………………………………………………………….…..…… 
……………………………………………………………………………………………..….… 
DOI: 10.3310/hta22370 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 37
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Harris et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
149
Section D - Some questions on how you feel 
For each item below, please tick the box opposite the reply that comes closest to how you 
have been feeling over the past week. Don’t take too long over the answers: your immediate 
reaction will probably be most accurate.  
Tick only one box in each section 
 
16. I feel tense or ‘wound up’: 
Most of the time              
A lot of the time      
Time to time       
Not at all       
 
17. I feel as if I am slowed down: 
Nearly all of the time     
Very often       
Sometimes       
Not at all       
 
18. I still enjoy things I used to: 
Definitely as much      
Not quite as much      
Only a little       
Hardly at all       
 
19. I get a sort of frightened feeling like  
butterflies in the stomach: 
Not at all       
Occasionally       
Quite often       
Very often       
 
20. I get a sort of frightened feeling as if  
something bad is about to happen: 
Very definitely      
Yes, but not too badly     
A little, but it doesn’t worry me    
Not at all       
 
21. I have lost interest in my appearance: 
Definitely       
I don’t take so much care as I should do   
I might not take quite as much care   
I take just as much care     
 
22. I can laugh and see the funny side of things: 
As much as I always could     
Not quite so much now     
Definitely not so much now    
Not at all       
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23. I feel restless, as if I have to be on the move 
Very much indeed      
Quite a lot       
Not very much      
Not at all       
 
24. Worrying thoughts go through my mind: 
A great deal of the time     
A lot of the time      
From time to time but not too often   
Only occasionally      
 
25. I look forward with enjoyment to things: 
As much as I ever did     
Rather less than I used to     
Definitely less than I used to    
Hardly at all       
 
26. I feel cheerful: 
Not at all       
Not often       
Sometimes       
Most of the time      
 
27. I get sudden feelings of panic 
Very often indeed      
Quite often       
Not very often      
Not at all       
 
28. I can sit at ease and feel relaxed: 
Definitely       
Usually       
Not often       
Not at all       
 
29. I can enjoy a good book, radio or  
TV programme: 
Often        
           Sometimes       
           Not often       
Very seldom       
 
30. I feel lonely: 
All the time       
Often        
Sometimes       
Never        
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Section E - Some questions about your attitudes to 
exercise and health 
Please indicate how strongly you agree or disagree with each statement 
    
Please tick one box to indicate how strongly you agree or disagree with each 
statement 
 
 
 Strongly 
agree 
Slightly 
agree 
Unsure Slightly 
disagree 
Strongly 
disagree 
 
 
7. Doing exercise is 
satisfying and 
rewarding to me 
 
 
 
 
 
 
 
 
 
 
 
8. Doing exercise 
regularly is good for 
me 
 
 
 
 
 
 
 
 
 
 
 
9. There is little I can do 
to make up for the 
physical losses that 
come with age 
 
 
 
 
 
 
 
 
 
 
 
10. Exercising regularly 
can be helpful for my 
health 
 
 
 
 
 
 
 
 
 
 
 
11. Exercising regularly 
can help me to get out 
of doors 
 
 
 
 
 
 
 
 
 
 
 
12. Exercising regularly 
can help me to control 
my weight or to lose 
weight 
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Section F – Some questions about your belief in your 
ability to exercise 
 
How sure are you that you will do each of the following: 
 
     Very  Pretty  A little Not at all 
     Sure  Sure  Sure  Sure 
 
1 Exercise regularly          
(3 times a week for  
20 minutes)  
 
2 Exercise when you          
 are feeling tired 
 
3 Exercise when you           
are feeling under pressure 
 to get things done 
 
4 Exercise when you           
are feeling down or  
depressed 
 
5 Exercise when you           
 have too much work to do  
at home 
 
6 Exercise when there          
are other more interesting 
things to do 
 
7 Exercise when your          
family or friends do not 
 provide any support 
 
8 Exercise when you           
don’t really feel like it 
 
9 Exercise when you           
are away from home  
(e.g. visiting, on holiday) 
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Section G - Some questions about physical activity 
 
6    How many times did you take a walk outside during the last week?  
 (include walking related to other activities)        .................................times last week 
2 How long did such a walk usually last? ………..minutes 
 
3 Did you take a walk that lasted longer than 1 hour during the last month? 
 
Yes   No  
 
3a If yes, how many times did you do that?  ……….times last month 
 
 
4 Do you have someone with whom you can go for a walk, or do other physical 
activities? 
Always      Often     Sometimes         Never     
 
 
5 Do you ride a bicycle? Yes       No     (please go to question 6) 
    
 
5a If yes, how many times did you cycle last week? …….…times 
 
5b How long on average did you cycle for each time? ..…...minutes 
  
5c How would you describe your cycling pace? 
  
 Slow   Average   Fast  
 
 
6 Do you go swimming? Yes     No     (please go to question 7) 
    
 
6a If yes, how many times did you swim last week? …….….times 
 
 
6b How long on average did you swim for each time?.........minutes 
 
 
6c How would you describe your swimming speed? 
 Slow   Average   Fast  
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7a    If yes, what kind of sporting activity?  ……………………………. 
 
 
7b   How many hours approximately, did you spend participating in sporting 
activities in the last week?  
         Less than 1 hour in the last week                 ……… hours in the last week  
 
8 How often did you perspire during physical activity in the last week? 
 Never          1-2 times    3-4 times    5 or more times  
 
9. In the last 3 months (since you have been taking part in the PACE-UP trial)  
 do you think that your walking and physical activity has: 
  
 Decreased a lot    
 Decreased a little    
 Stayed about the same  
 Increased a little    
 Increased a lot    
7 Have you participated in any sporting activities in the last week? 
Yes   No    (if no, please go to question 8) 
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Section H - Some questions about the money you have 
spent to do with walking and other physical activity 
 
7 In the past 3 months, did you pay for any membership fees to do with walking? 
                                                                                                
No        (please go to question 2)    Yes          (please go to question 1a) 
                                                                         
1a. If yes, how much did you spend? …………………………….. 
 
1b. How often do you tend to pay this amount? (circle the correct frequency below) 
        
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify……………….. 
 
 
2.  In the past 3 months, did you pay for any individual classes, entrance fees or 
groups to do with walking?  
(if not included in membership fees above)
No        (please go to question 3) Yes           (please go to question 2a) 
                                                                         
2a. If yes, how much did you spend? …………………………….. 
 
2b. How often do you tend to pay this amount? (please circle the correct frequency 
below) 
        
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify…………….. 
 
 
3.  In the past 3 months, did you pay for shoes or clothing to do with walk
No        (please go to question 4) Yes           (please go to question 3a) 
                                                                         
3a. If yes, how much did you spend? …………………………….. 
 
3b. How often do you tend to pay this amount? (please circle the correct frequency 
below) 
        
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify…………………….  
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4. In the past 3 months, did you have to pay for food or drink to do with walking?                         
No        (please go to question 5) Yes           (please go to question 4a) 
                                                                         
4a. If yes, how much did you spend? …………………………….. 
 
4b. How often do you tend to pay this amount? (please circle the correct frequency 
below) 
 Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
If other, please specify………….…………….  
 
            
5. In the past 3 months, did you have to pay for anything else to do with walking? 
                                                                                                
No        (please go to question 6) Yes           (please go to question 5a) 
                                                                         
5a. If yes, what else did you have to pay for? ………………………………………….. 
5b. How much did you spend? …………………………….. 
5b. How often do you tend to pay this amount? (please circle the correct frequency 
below) 
   
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
If other, please specify……. ……………………. 
 
6.  In the past 3 months, did you spend money on other kinds of physical activity? 
                                                                                                
No             Yes           (please go to question 5a) 
                                                                         
6a. If yes, what other kinds of physical activity did you spend money on?  
(please list all that apply) …………………………………………. …………………………….. 
 
6b.  If yes, roughly how much did you spend in total on other kinds of physical activity 
over the past 3 months? 
…………………………………………………………………………………………………………… 
 
.................................................................................................................................................. 
 
13. In the past 3 months do you think that your spending on walking and physical 
activity has: 
 
Increased a lot         
Increased a little         
Stayed about the same        
Decreased a little         
Decreased a lot      
DOI: 10.3310/hta22370 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 37
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Harris et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
157
Please write below any other comments you have on 
your health or this questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          Thank you for filling in this questionnaire. 
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study 
 
Health and lifestyle 3 month survey 
 __________________________________________________________ 
 
Study IDNO ____________ 
 
 
Thank you for filling in this questionnaire.  
 
It will take you about 15 minutes to complete. 
 
Please feel free to write comments by any question. 
 
All information will be kept strictly confidential. 
 
 
 
Please enter your date of birth  ____ / ____ / _____ 
 
Please enter today’s date            ____ / ____ / _____   
 
 
 
Thank you 
 
 
 
Pedometer by post group 
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Section A - Some general questions about your health 
 
Please put a tick in the box next to the most appropriate answer 
for each question.  
 
 
 
8 How is your health in general?  
 
Very good     
Good      
Fair      
Poor      
Very poor     
 
 
2  How much physical or bodily pain have you had in the past 4 weeks? 
 
None          
Very mild or mild         
Moderate          
Severe or very severe    
 
3  In the past four weeks, how much did pain interfere with your normal activities? 
 
Not at all         
A little bit            
Moderately            
Quite a bit or extremely     
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Section B - Questions about your health today 
 
Under each heading, please tick the ONE box that best describes your health TODAY 
 
1   Mobility 
I have no problems in walking about       
I have slight problems in walking about      
I have moderate problems in walking about      
I have severe problems in walking about      
I am unable to walk about        
9 Self-care 
I have no problems with self-care       
I have slight problems washing or dressing myself     
I have moderate problems washing or dressing myself    
I have severe problems washing or dressing myself    
I am unable to wash or dress myself       
10 Usual activities (e.g. work, study, housework, family or leisure) 
I have no problems doing my usual activities     
I have slight problems doing my usual activities     
I have moderate problems doing my usual activities    
I have severe problems doing my usual activities     
I am unable to do my usual activities       
11 Pain / discomfort 
I have no pain or discomfort        
I have slight pain or discomfort       
I have moderate pain or discomfort       
I have severe pain or discomfort       
I have extreme pain or discomfort       
12 Anxiety / depression 
I am not anxious or depressed       
I am slightly anxious or depressed       
I am moderately anxious or depressed      
I am severely anxious or depressed       
I am extremely anxious or depressed      
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Section B - Continued:  about your health 
today 
 
We would like to know how good or bad your health is TODAY 
 
 The scale is numbered 0 to 100 
 100 means the best health you can imagine 
 0 means the worst health you can imagine 
 Mark an X on the scale to indicate how your health is TODAY 
 Now, please write the number you marked on the scale in the box 
below 
 
      YOUR HEALTH TODAY =   
 
 
 
 Section C - Some questions on injuries and health 
 
These questions ask about any injuries or changes in your health that you may have 
had in the 3 months that you have been involved in this study. 
 
In the last 3 months have you had any of the following: 
 
1 A fall?     Yes    No   
 
1a If yes, how many times?      ….……….....times in the last 3 months 
 
2 Any fractures (broken bones)?  Yes    No   
 
2a If yes, please give details of what bones were injured  
 
…………………………………………………………………………………… 
 
…………………………………………………………………………………… 
 
3 Any sprains or injuries?   Yes    No   
 
3a If yes, please give details of the sprain or injury  
…………………………………………………………………………………… 
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Some questions on injuries and health continued 
 
If you have not had a fall, fracture, sprain or injury, please go to question 6. 
 
If you have had a fall, fracture, sprain or injury, please go to question 4.  
 
 
4.  Did you or your family have to pay for anything as a result of your fall(s), 
fracture(s) sprain(s) or injury(ies)? (Please consider any costs linked to your 
continuing care or recovery) 
 
Yes    No   
 
4a. If yes, roughly how much did you spend?...................................................... 
 
4b. What was this spent on?…………………………………………………………. 
 
 
 
 
5. In the past 3 months did you have to stop doing your usual activities due to a 
fall, fracture, sprain or injury?   
 
Yes    No   
 
5a. If yes, how many days did you stop your usual activities? …………………..days 
   
 
 
 
6 In the last 3 months have you noticed a deterioration in any health problems that 
you already had at the start of this research project? 
 
Yes    No   
 
6a If yes, please give details  
…………………………………………………………………………………………………… 
…………………………………………………………………………………………………… 
 
7 In the last 3 months have you noticed an improvement in any health problems 
that you already had at the start of this research project? 
 
Yes      No    
 
7a If yes, please give details  
………………………………………………………………………………………….…..…… 
……………………………………………………………………………………………..….… 
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Section D - Some questions on how you feel 
For each item below, please tick the box opposite the reply that comes closest to how you have 
been feeling over the past week. Don’t take too long over the answers: your immediate reaction 
will probably be most accurate.  
Tick only one box in each section 
 
31. I feel tense or ‘wound up’: 
Most of the time              
A lot of the time      
Time to time       
Not at all       
 
32. I feel as if I am slowed down: 
Nearly all of the time     
Very often       
Sometimes       
Not at all       
 
33. I still enjoy things I used to: 
Definitely as much      
Not quite as much      
Only a little       
Hardly at all       
 
34. I get a sort of frightened feeling like  
butterflies in the stomach: 
Not at all       
Occasionally       
Quite often       
Very often       
 
35. I get a sort of frightened feeling as if  
something bad is about to happen: 
Very definitely      
Yes, but not too badly     
A little, but it doesn’t worry me    
Not at all       
 
36. I have lost interest in my appearance: 
Definitely       
I don’t take so much care as I should do   
I might not take quite as much care   
I take just as much care     
 
37. I can laugh and see the funny side of things: 
As much as I always could     
Not quite so much now     
Definitely not so much now    
Not at all       
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38. I feel restless, as if I have to be on the move 
Very much indeed      
Quite a lot       
Not very much      
Not at all       
 
39. Worrying thoughts go through my mind: 
A great deal of the time     
A lot of the time      
From time to time but not too often   
Only occasionally      
 
40. I look forward with enjoyment to things: 
As much as I ever did     
Rather less than I used to     
Definitely less than I used to    
Hardly at all       
 
41. I feel cheerful: 
Not at all       
Not often       
Sometimes       
Most of the time      
 
42. I get sudden feelings of panic 
Very often indeed      
Quite often       
Not very often      
Not at all       
 
43. I can sit at ease and feel relaxed: 
Definitely       
Usually       
Not often       
Not at all       
 
44. I can enjoy a good book, radio or  
TV programme: 
Often        
           Sometimes       
           Not often       
Very seldom       
 
45. I feel lonely: 
All the time       
Often        
Sometimes       
Never        
DOI: 10.3310/hta22370 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 37
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Harris et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
165
Section E - Some questions about your attitudes to 
exercise and health 
Please indicate how strongly you agree or disagree with each statement 
    
Please tick one box to indicate how strongly you agree or disagree with each statement 
 
 
 Strongly 
agree 
Slightly 
agree 
Unsure Slightly 
disagree 
Strongly 
disagree 
 
 
14. Doing exercise is 
satisfying and 
rewarding to me 
 
 
 
 
 
 
 
 
 
 
 
15. Doing exercise 
regularly is good for 
me 
 
 
 
 
 
 
 
 
 
 
 
16. There is little I can do 
to make up for the 
physical losses that 
come with age 
 
 
 
 
 
 
 
 
 
 
 
17. Exercising regularly 
can be helpful for my 
health 
 
 
 
 
 
 
 
 
 
 
 
18. Exercising regularly 
can help me to get out 
of doors 
 
 
 
 
 
 
 
 
 
 
 
19. Exercising regularly 
can help me to control 
my weight or to lose 
weight 
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Section F – Some questions about your belief in your 
ability to exercise 
 
How sure are you that you will do each of the following: 
 
     Very  Pretty  A little Not at all 
     Sure  Sure  Sure  Sure 
 
1 Exercise regularly          
(3 times a week for  
20 minutes)  
 
2 Exercise when you          
 are feeling tired 
 
3 Exercise when you           
are feeling under pressure 
 to get things done 
 
4 Exercise when you           
are feeling down or  
depressed 
 
5 Exercise when you           
 have too much work to do  
at home 
 
6 Exercise when there          
are other more interesting 
things to do 
 
7 Exercise when your          
family or friends do not 
 provide any support 
 
8 Exercise when you           
don’t really feel like it 
 
9 Exercise when you           
are away from home  
(e.g. visiting, on holiday) 
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Section G - Some questions about physical activity 
 
13    How many times did you take a walk outside during the last week?  
 (include walking related to other activities e.g. for shopping, travel to work etc)       
 .............................................times last week 
2 How long did such a walk usually last? ………..minutes 
3 Did you take a walk that lasted longer than 1 hour during the last month? 
 
Yes   No  
 
3a If yes, how many times did you do that?  ……….times last month 
 
 
4 Do you have someone with whom you can go for a walk, or do other physical 
activities? 
 
Always     Often   Sometimes   Never     
 
5 Do you ride a bicycle?  
 
Yes   No     (please go to question 6) 
    
5a If yes, how many times did you cycle last week? …….…times 
 
5b How long on average did you cycle for each time? ..…...minutes 
  
5c How would you describe your cycling pace? 
 
 Slow   Average   Fast  
 
 
6 Do you go swimming?  
 
Yes     No     (please go to question 7) 
    
6a If yes, how many times did you swim last week? …….….times 
 
6b How long on average did you swim for each time?.........minutes 
 
6c How would you describe your swimming speed? 
  
Slow   Average   Fast  
 
7 Have you participated in any sporting activities in the last week? 
 
Yes   No    (if no, please go to question 8) 
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7a    If yes, what kind of sporting activity?  ……………………………. 
 
 
7b     How much time approximately did you spend participating in sporting 
activities in the last week?  
 
         .........................hours ...........................minutes 
 
 
8 How often did you perspire during physical activity in the last week? 
  
 Never     1-2 times     3-4 times    5 or more times   
 
9. In the last 3 months (since you have been taking part in the PACE-UP trial)  
 do you think that your walking and physical activity has: 
  
 Decreased a lot    
 Decreased a little    
 Stayed about the same  
 Increased a little    
 Increased a lot    
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Section H - Some questions about the money you have 
spent to do with walking and other physical activity 
 
14 In the past 3 months, did you pay for any membership fees to do with walking? 
                                                                                                
No        (please go to question 2)   Yes          (please go to question 1a) 
                                                                         
1a. If yes, how much did you spend? …………………………….. 
1b. How often do you tend to pay this amount? (please circle the correct frequency below) 
        
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify……………….. 
 
 
2.  In the past 3 months, did you pay for any individual classes, entrance fees or groups 
to do with walking? (if not included in membership fees above)   
                                                                                              
No        (please go to question 3) Yes           (please go to question 2a) 
                                                                         
2a. If yes, how much did you spend? …………………………….. 
2b. How often do you tend to pay this amount? (please circle the correct frequency below) 
        
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify…………….. 
 
 
3  In the past 3 months, did you pay for shoes or clothing to do with walking? 
                                                                                                
No        (please go to question 4) Yes           (please go to question 3a) 
                                                                         
3a. If yes, how much did you spend? …………………………….. 
3b. How often do you tend to pay this amount? (please circle the correct frequency below) 
        
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify…………………….  
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4  In the past 3 months, did you have to pay for food or drink to do with walking? 
                                                                                                
No        (please go to question 5) Yes           (please go to question 4a) 
                                                                         
4a. If yes, how much did you spend? …………………………….. 
4b. How often do you tend to pay this amount? (please circle the correct frequency below) 
 
 Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify………….…………….  
                                                                      
 
5  In the past 3 months, did you have to pay for anything else to do with walking? 
                                                                                                
No        (please go to question 6) Yes           (please go to question 5a) 
                                                                         
5a. If yes, what else did you have to pay for? ………………………………………….. 
5b. How much did you spend? …………………………….. 
5b. How often do you tend to pay this amount? (please circle the correct frequency below) 
   
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
If other, please specify……. ……………………. 
 
6.  In the past 3 months, did you spend money on other kinds of physical activity? 
                                                                                                
No             Yes           (please go to question 5a) 
                                                                         
6a. If yes, what other kinds of physical activity did you spend money on? (please list all 
that apply) ………………………………………………………………. …………………………….. 
 
6b.  If yes, roughly how much did you spend in total on other kinds of physical activity 
over the past 3 months?  
.................................................................................................................................................... 
 
……………………………………………………………………………………………………………. 
 
20. In the past 3 months do you think that your spending on walking and physical 
activity has: 
 
Increased a lot         
Increased a little         
Stayed about the same        
Decreased a little         
Decreased a lot         
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Section I - Some questions about taking part in the  
PACE-UP trial 
 
1. How did you find wearing the pedometer? (please tick as many as you feel apply) 
 
         
I found it helpful       
I found it difficult to remember to wear     
I found it difficult to use      
I found it a nuisance      
I enjoyed wearing the pedometer     
I found it uncomfortable to wear     
  
Any other comments about wearing the pedometer?............................................ 
 
.................................................................................................................................... 
 
2. In the past 3 months, how much time have you spent working out how to use the 
pedometer? 
 ………………………………. (hours)  ………………………(minutes) 
                                                                                                
 
3. In the past 3 months, how much time have you spent planning your increase in 
walking / step-count? 
 ………………………………. (hours)  ………………………(minutes) 
                                                                                                
 
4. How did you find writing your step-counts in the PACE-UP physical activity 
diary? (please tick as many as apply) 
        
I found it helpful  
I found it difficult to remember to fill in 
I found it a nuisance  
I enjoyed writing in the diary 
Any other comments about writing in the PACE-UP physical activity diary?    
 
............................................................................................................................................... 
 
............................................................................................................................................... 
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More questions about taking part in the PACE-UP trial 
 
5. In the past 3 months, how often did you fill out the PACE-UP physical activity 
diary? ……………………………….  
 
                                                                                                
6. In the past 3 months, how long did you spend on average filling out the PACE-UP 
physical activity diary each time you did it ………………………(minutes)  
                                                                                         
 
 
 
Please write below any other comments you have on the 
PACE-UP trial or this questionnaire 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
          Thank you for filling in this questionnaire. 
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study 
 
Health and lifestyle 3 month survey 
 __________________________________________________________
 
Study IDNO ____________ 
 
 
Thank you for filling in this questionnaire.  
 
It will take you about 15 minutes to complete. 
 
Please feel free to write comments by any question. 
 
All information will be kept strictly confidential. 
 
 
 
Please enter your date of birth  ____ / ____ / _____ 
 
Please enter today’s date        ____ / ____ / _____ 
 
 
 
Thank you 
 
 
 
Nurse intervention group 
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Section A - Some general questions about your health 
 
Please put a tick in the box next to the most appropriate answer 
for each question.  
 
 
 
15 How is your health in general?  
 
Very good     
Good      
Fair      
Poor      
Very poor     
 
 
2  How much physical or bodily pain have you had in the past 4 weeks? 
 
None          
Very mild or mild         
Moderate          
Severe or very severe    
 
3  In the past four weeks, how much did pain interfere with your normal activities? 
 
Not at all         
A little bit            
Moderately            
Quite a bit or extremely     
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Section B - Questions about your health today 
 
Under each heading, please tick the ONE box that best describes your health TODAY 
 
1   Mobility 
I have no problems in walking about       
I have slight problems in walking about      
I have moderate problems in walking about      
I have severe problems in walking about      
I am unable to walk about        
16 Self-care 
I have no problems with self-care       
I have slight problems washing or dressing myself     
I have moderate problems washing or dressing myself    
I have severe problems washing or dressing myself    
I am unable to wash or dress myself       
17 Usual activities (e.g. work, study, housework, family or leisure) 
I have no problems doing my usual activities     
I have slight problems doing my usual activities     
I have moderate problems doing my usual activities    
I have severe problems doing my usual activities     
I am unable to do my usual activities       
18 Pain / discomfort 
I have no pain or discomfort        
I have slight pain or discomfort       
I have moderate pain or discomfort       
I have severe pain or discomfort       
I have extreme pain or discomfort       
19 Anxiety / depression 
I am not anxious or depressed       
I am slightly anxious or depressed       
I am moderately anxious or depressed      
I am severely anxious or depressed       
I am extremely anxious or depressed      
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Section B - Continued:  about your health 
today 
 
We would like to know how good or bad your health is TODAY 
 
 The scale is numbered 0 to 100 
 100 means the best health you can imagine 
 0 means the worst health you can imagine 
 Mark an X on the scale to indicate how your health is TODAY 
 Now, please write the number you marked on the scale in the box 
below 
 
      YOUR HEALTH TODAY =   
 
 
 
 Section C - Some questions on injuries and health 
 
These questions ask about any injuries or changes in your health that you may have 
had in the 3 months that you have been involved in this study. 
 
In the last 3 months have you had any of the following: 
 
1 A fall?     Yes    No   
 
1a If yes, how many times?      ….……….....times in the last 3 months 
 
2 Any fractures (broken bones)?  Yes    No   
 
2a If yes, please give details of what bones were injured  
 
…………………………………………………………………………………… 
 
…………………………………………………………………………………… 
 
3 Any sprains or injuries?   Yes    No   
 
3a If yes, please give details of the sprain or injury 
  
…………………………………………………………………………………… 
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Some questions on injuries and health continued 
 
If you have not had a fall, fracture, sprain or injury, please go to question 6. 
 
If you have had a fall, fracture, sprain or injury, please go to question 4.  
 
 
4.  Did you or your family have to pay for anything as a result of your fall(s), 
fracture(s), sprain(s) or injury(ies)? (Please consider any costs linked to your 
continuing care or recovery) 
 
Yes    No   
 
If yes, roughly how much did you spend?.................................................... 
 
What was this spent on? ………………………………………………………. 
 
 
 
5. In the past 3 months did you have to stop doing your usual activities due to a 
fall, fracture, sprain or injury?   
 
Yes    No   
 
If yes, how many days did you stop your usual activities? …………………..days 
   
 
6 In the last 3 months have you noticed a deterioration in any health problems 
that you already had at the start of this research project? 
 
Yes    No   
 
6a If yes, please give details  
…………………………………………………………………………………………………… 
…………………………………………………………………………………………………… 
 
7 In the last 3 months have you noticed an improvement in any health problems 
that you already had at the start of this research project? 
 
Yes      No    
 
7a If yes, please give details  
………………………………………………………………………………………….…..…… 
……………………………………………………………………………………………..….… 
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Section D - Some questions on how you feel 
For each item below, please tick the box opposite the reply that comes closest to how you 
have been feeling over the past week. Don’t take too long over the answers: your immediate 
reaction will probably be most accurate.  
Tick only one box in each section 
 
46. I feel tense or ‘wound up’: 
Most of the time              
A lot of the time      
Time to time       
Not at all       
 
47. I feel as if I am slowed down: 
Nearly all of the time     
Very often       
Sometimes       
Not at all       
 
48. I still enjoy things I used to: 
Definitely as much      
Not quite as much      
Only a little       
Hardly at all       
 
49. I get a sort of frightened feeling like  
butterflies in the stomach: 
Not at all       
Occasionally       
Quite often       
Very often       
 
50. I get a sort of frightened feeling as if  
something bad is about to happen: 
Very definitely      
Yes, but not too badly     
A little, but it doesn’t worry me    
Not at all       
 
51. I have lost interest in my appearance: 
Definitely       
I don’t take so much care as I should do   
I might not take quite as much care   
I take just as much care     
 
52. I can laugh and see the funny side of things: 
As much as I always could     
Not quite so much now     
Definitely not so much now    
Not at all       
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53. I feel restless, as if I have to be on the move 
Very much indeed      
Quite a lot       
Not very much      
Not at all       
 
54. Worrying thoughts go through my mind: 
A great deal of the time     
A lot of the time      
From time to time but not too often   
Only occasionally      
 
55. I look forward with enjoyment to things: 
As much as I ever did     
Rather less than I used to     
Definitely less than I used to    
Hardly at all       
 
56. I feel cheerful: 
Not at all       
Not often       
Sometimes       
Most of the time      
 
57. I get sudden feelings of panic 
Very often indeed      
Quite often       
Not very often      
Not at all       
 
58. I can sit at ease and feel relaxed: 
Definitely       
Usually       
Not often       
Not at all       
 
59. I can enjoy a good book, radio or  
TV programme: 
Often        
           Sometimes       
           Not often       
Very seldom       
 
60. I feel lonely: 
All the time       
Often        
Sometimes       
Never        
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Section E - Some questions about your attitudes to 
exercise and health 
Please indicate how strongly you agree or disagree with each statement 
    
Please tick one box to indicate how strongly you agree or disagree with each 
statement 
 
 
 Strongly 
agree 
Slightly 
agree 
Unsure Slightly 
disagree 
Strongly 
disagree 
 
 
21. Doing exercise is 
satisfying and 
rewarding to me 
 
 
 
 
 
 
 
 
 
 
 
22. Doing exercise 
regularly is good for 
me 
 
 
 
 
 
 
 
 
 
 
 
23. There is little I can do 
to make up for the 
physical losses that 
come with age 
 
 
 
 
 
 
 
 
 
 
 
24. Exercising regularly 
can be helpful for my 
health 
 
 
 
 
 
 
 
 
 
 
 
25. Exercising regularly 
can help me to get out 
of doors 
 
 
 
 
 
 
 
 
 
 
 
26. Exercising regularly 
can help me to control 
my weight or to lose 
weight 
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Section F – Some questions about your belief in your 
ability to exercise 
 
How sure are you that you will do each of the following: 
 
     Very  Pretty  A little Not at all 
     Sure  Sure  Sure  Sure 
 
1 Exercise regularly          
(3 times a week for  
20 minutes)  
 
2 Exercise when you          
 are feeling tired 
 
3 Exercise when you           
are feeling under pressure 
 to get things done 
 
4 Exercise when you           
are feeling down or  
depressed 
 
5 Exercise when you           
 have too much work to do  
at home 
 
6 Exercise when there          
are other more interesting 
things to do 
 
7 Exercise when your          
family or friends do not 
 provide any support 
 
8 Exercise when you           
don’t really feel like it 
 
9 Exercise when you           
are away from home  
(e.g. visiting, on holiday) 
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Section G - Some questions about physical activity 
20 How many times did you take a walk outside during the last week?  
 (include walking related to other activities e.g. for shopping, travel to work etc)       
 .............................................times last week 
2 How long did such a walk usually last? ………..minutes 
3 Did you take a walk that lasted longer than 1 hour during the last month? 
 
Yes   No  
 
3a If yes, how many times did you do that?  ……….times last month 
 
 
4 Do you have someone with whom you can go for a walk, or do other physical 
activities? 
 
Always     Often   Sometimes   Never     
 
 
5 Do you ride a bicycle?  
 
Yes   No     (please go to question 6) 
    
5a If yes, how many times did you cycle last week? …….…times 
 
5b How long on average did you cycle for each time? ..…...minutes 
  
5c How would you describe your cycling pace? 
 
 Slow   Average   Fast  
 
 
6 Do you go swimming?  
 
Yes     No     (please go to question 7) 
    
6a If yes, how many times did you swim last week? …….….times 
 
6b How long on average did you swim for each time?.........minutes 
 
6c How would you describe your swimming speed? 
  
Slow   Average   Fast  
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7 Have you participated in any sporting activities in the last week? 
 
Yes   No    (if no, please go to question 8) 
 
7a    If yes, what kind of sporting activity?  ……………………………. 
 
 
7b   How many hours approximately, did you spend participating in sporting 
activities in the last week?  
          
          Less than 1 hour in the last week                 ……… hours in the last week     
 
8 How often did you perspire during physical activity in the last week? 
  
 Never     1-2 times     3-4 times    5 or more times   
 
9. In the last 3 months (since you have been taking part in the PACE-UP trial)  
 do you think that your walking and physical activity has: 
  
 Decreased a lot    
 Decreased a little    
 Stayed about the same  
 Increased a little    
 Increased a lot    
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Section H - Some questions about the money you have 
spent to do with walking and other physical activity 
 
21 In the past 3 months, did you pay for any membership fees to do with walking? 
                                                                                                
No        (please go to question 2)    Yes          (please go to question 1a) 
                                                                         
1a. If yes, how much did you spend? …………………………….. 
1b. How often do you tend to pay this amount? (please circle the correct frequency 
below) 
        
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify……………….. 
 
 
2.  In the past 3 months, did you pay for any individual classes, entrance fees or 
groups to do with walking? (if not included in membership fees above)   
                                                                                                
No        (please go to question 3) Yes           (please go to question 2a) 
                                                                         
2a. If yes, how much did you spend? …………………………….. 
2b. How often do you tend to pay this amount? (please circle the correct frequency 
below) 
        
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify…………….. 
 
 
3  In the past 3 months, did you pay for shoes or clothing to do with walking? 
                                                                                                
No        (please go to question 4) Yes           (please go to question 3a) 
                                                                         
3a. If yes, how much did you spend? …………………………….. 
3b. How often do you tend to pay this amount? (please circle the correct frequency 
below) 
        
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify…………………….  
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4  In the past 3 months, did you have to pay for food or drink to do with walking? 
                                                                                                
No        (please go to question 5) Yes           (please go to question 4a) 
                                                                         
4a. If yes, how much did you spend? …………………………….. 
4b. How often do you tend to pay this amount? (please circle the correct frequency 
below) 
 
 Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify………….…………….  
                                                                      
 
5  In the past 3 months, did you have to pay for anything else to do with walking? 
                                                                                                
No        (please go to question 6) Yes           (please go to question 5a) 
                                                                         
5a. If yes, what else did you have to pay for? ………………………………………….. 
5b. How much did you spend? …………………………….. 
5b. How often do you tend to pay this amount? (please circle the correct frequency 
below) 
   
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
If other, please specify……. ……………………. 
 
6.  In the past 3 months, did you spend money on other kinds of physical activity? 
                                                                                                
No             Yes           (please go to question 5a) 
                                                                         
6a. If yes, what other kinds of physical activity did you spend money on? (please list all 
that apply) ……………………………………………………………….……………………………..  
 
6b.  If yes, roughly how much did you spend in total on other kinds of physical activity 
over the past 3 months? 
……………………………………………………………………………………………………………
27. In the past 3 months do you think that your spending on walking and physical 
activity has: 
 
Increased a lot 
Increased a little 
Stayed about the same 
Decreased a little 
Decreased a lot 
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Section I - Some questions about taking part in the  
PACE-UP trial 
7. How did you find wearing the pedometer? (please tick as many as apply) 
   
I found it helpful       
I found it difficult to remember to wear     
I found it difficult to use      
I found it a nuisance      
I enjoyed wearing the pedometer     
I found it uncomfortable to wear     
 
Any other comments about wearing the pedometer?............................................ 
.................................................................................................................................... 
8. In the past 3 months, how much time have you spent working out how to use 
the pedometer? …………………. (hours)  ………………(minutes) 
  
9. In the past 3 months, how much time have you spent planning your increase in 
walking / step-count? ………………………. (hours)  ………………(minutes) 
  
10. How did you find writing your step-counts in the PACE-UP physical activity 
diary? (please tick as many as apply) 
   
I found it helpful       
I found it difficult to remember to fill in    
I found it a nuisance      
I enjoyed writing in the diary     
 
11. In the past 3 months, how often did you fill out the PACE-UP physical activity 
diary? ………………………………. 
 
12. In the past 3 months, how long did you spend on average filling out the  
PACE-UP physical activity diary each time you did it ……………………… 
(minutes) 
Any other comments about writing in the PACE-UP physical activity diary?    
 
     ....................................................................................................................................... 
   
 
13. Did you visit the nurse for the PACE-UP trial? 
 
Yes   No   (If no, please go to the end of the questionnaire).  
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14. How did you find seeing the nurse for the PACE-UP trial appointments? 
(please tick as many as apply)                      
 
I found it helpful         
I found it difficult to get to the appointments     
I found it a nuisance        
I felt that seeing the nurse helped me to walk more    
Any other comments about seeing the nurse?....................................................... 
.................................................................................................................................... 
 
15.  Did you travel by car to see the nurse last time you attended for the PACE-UP 
trial? 
Yes   No   (If no, please go to question 10). 
 
      9a. Did you have to pay for parking while you had the consultation? 
 
Yes   No   (If no, please go to question 10). 
 
      9b.  If yes, how much did it cost to park? ....................................................................... 
 
 
16.   Did you walk to see the nurse last time you attended for the PACE-UP trial? 
 
Yes   No   (If no, please go to question 11). 
 
      10a.  If yes, how long did you spend walking (there and back)? ...............(in minutes) 
 
17.   Did you use public transport (bus, train, tram, tube, taxi) to travel to see the   
  nurse last time you attended for the PACE-UP trial? 
 
Yes   No   (If no, please go to question 12). 
 
11a.  If yes, what type of ticket or fare did you buy or use to travel to visit the nurse  
         last time you attended for the PACE-UP trial? 
 
Single ticket        
  Return ticket     
Season ticket    
Other ticket type      
  Don’t know          
 
11b. What was the total cost of this journey (to and from visiting the nurse)?     
 
.................................................................................................................................................. 
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Some more questions about taking part in the  
PACE-UP trial 
 
18. How long did it take you, in total, to travel to and from the practice the last time   
you visited the nurse for the PACE-UP trial   ……………………… minutes 
 
19.  How long did you have wait at the practice before meeting the nurse last time 
for the PACE-UP trial ?  ……………………… minutes 
 
20. Still thinking about the last time you met the nurse for the PACE-UP trial, how 
long did the meeting last? ……………………… minutes 
 
21.  Did you have to pay someone to look after a child or other family member in 
order to be able to attend the consultation? 
                
Yes   No   (If no, please go to the end of the questionnaire).  
 
      15a If yes, how much did you pay for your child or family member to be looked  
              after the last time you visited the nurse for the PACE-UP trial? …..………….  
                                                                            
 
Please write below any other comments you have on the 
PACE-UP trial or this questionnaire 
 
 
 
          Thank you for filling in this questionnaire. 
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study 
 
Health and lifestyle 12 month survey 
 __________________________________________________________ 
 
Study IDNO ____________ 
 
 
Thank you for filling in this questionnaire.  
 
It will take you about 15 minutes to complete. 
 
Please feel free to write comments by any question. 
 
All information will be kept strictly confidential. 
 
 
 
Please enter your date of birth  ____ / ____ / _____ 
 
Please enter today’s date              ____ / ____ / _____ 
 
 
Thank you 
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Section A - Some general questions about your health 
 
Please put a tick in the box next to the most appropriate answer 
for each question.  
 
 
 
22 How is your health in general?  
 
Very good     
Good      
Fair      
Poor      
Very poor     
 
 
2  How much physical or bodily pain have you had in the past 4 weeks? 
 
None     
Very mild or mild    
Moderate     
Severe or very severe    
 
3  In the past four weeks, how much did pain interfere with your normal activities? 
 
Not at all     
A little bit      
Moderately      
Quite a bit or extremely    
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Section B - Questions about your health today 
 
Under each heading, please tick the ONE box that best describes your health TODAY 
 
1   Mobility 
I have no problems in walking about       
I have slight problems in walking about      
I have moderate problems in walking about      
I have severe problems in walking about      
I am unable to walk about        
23 Self-care 
I have no problems with self-care       
I have slight problems washing or dressing myself     
I have moderate problems washing or dressing myself    
I have severe problems washing or dressing myself    
I am unable to wash or dress myself       
24 Usual activities (e.g. work, study, housework, family or leisure) 
I have no problems doing my usual activities     
I have slight problems doing my usual activities     
I have moderate problems doing my usual activities    
I have severe problems doing my usual activities     
I am unable to do my usual activities       
25 Pain / discomfort 
I have no pain or discomfort        
I have slight pain or discomfort       
I have moderate pain or discomfort       
I have severe pain or discomfort       
I have extreme pain or discomfort       
26 Anxiety / depression 
I am not anxious or depressed       
I am slightly anxious or depressed       
I am moderately anxious or depressed      
I am severely anxious or depressed       
I am extremely anxious or depressed      
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Section B -  Your health today (continued)  
 
 We would like to know how good or bad your health is TODAY 
 The scale is numbered 0 to 100 
 100 means the best health you can imagine 
 0 means the worst health you can imagine 
 Mark an X on the scale to indicate how your health is TODAY 
 Now, please write the number you marked on the scale in the box 
below 
 
 
      YOUR HEALTH TODAY =   
 
 
 
 
 Section C - Some questions on injuries and health 
 
These questions ask about any injuries or changes in your health that you may have 
had in the 12 months that you have been involved in this study. 
 
In the last 12 months have you had any of the following: 
 
1 A fall?     Yes    No   
 
1a If yes, how many times?      ….……….....times in the last 12 months 
 
2 Any fractures (broken bones)?  Yes    No   
 
2a If yes, please give details of what bones were injured  
 
…………………………………………………………………………………… 
 
…………………………………………………………………………………… 
 
3 Any sprains or injuries?   Yes    No   
 
3a If yes, please give details of the sprain or injury  
…………………………………………………………………………………… 
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Some more questions on injuries and health 
 
If you have not had a fall, fracture, sprain or injury, please go to question 6. 
 
If you have had a fall, fracture, sprain or injury, please go to question 4.  
 
 
4.  Did you or your family have to pay for anything as a result of your fall(s), 
fracture(s), sprain(s) or injury(ies)? (Please consider any costs linked to your 
continuing care or recovery) 
 
Yes    No   
 
If yes, roughly how much did you spend?...................................................... 
 
What was this spent on?…………………………………………………………. 
 
 
5. In the past 12 months did you have to stop doing your usual activities due to a 
fall. Fracture, sprain or injury?   
 
Yes    No   
 
If yes, how many days did you stop your usual activities? …………………..days 
 
   
6 In the last 12 months have you noticed a deterioration in any health problems 
that you already had at the start of this research project? 
 
Yes    No   
 
6a If yes, please give details  
…………………………………………………………………………………………………… 
…………………………………………………………………………………………………… 
 
7 In the last 12 months have you noticed an improvement in any health problems 
that you already had at the start of this research project? 
 
Yes      No    
 
7a If yes, please give details  
………………………………………………………………………………………….…..…… 
……………………………………………………………………………………………..….… 
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Section D - Some questions on how you feel 
For each item below, please tick the box opposite the reply that comes closest to how you have 
been feeling over the past week. Don’t take too long over the answers: your immediate reaction 
will probably be most accurate.  
Tick only one box in each section 
 
61. I feel tense or ‘wound up’: 
Most of the time              
A lot of the time      
Time to time       
Not at all       
 
62. I feel as if I am slowed down: 
Nearly all of the time     
Very often       
Sometimes       
Not at all       
 
63. I still enjoy things I used to: 
Definitely as much      
Not quite as much      
Only a little       
Hardly at all       
 
64. I get a sort of frightened feeling like  
butterflies in the stomach: 
Not at all       
Occasionally       
Quite often       
Very often       
 
65. I get a sort of frightened feeling as if  
something bad is about to happen: 
Very definitely      
Yes, but not too badly     
A little, but it doesn’t worry me    
Not at all       
 
66. I have lost interest in my appearance: 
Definitely       
I don’t take so much care as I should do   
I might not take quite as much care   
I take just as much care     
 
67. I can laugh and see the funny side of things: 
As much as I always could     
Not quite so much now     
Definitely not so much now    
Not at all       
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68. I feel restless, as if I have to be on the move 
Very much indeed      
Quite a lot       
Not very much      
Not at all       
 
69. Worrying thoughts go through my mind: 
A great deal of the time     
A lot of the time      
From time to time but not too often   
Only occasionally      
 
70. I look forward with enjoyment to things: 
As much as I ever did     
Rather less than I used to     
Definitely less than I used to    
Hardly at all       
 
71. I feel cheerful: 
Not at all       
Not often       
Sometimes       
Most of the time      
 
72. I get sudden feelings of panic 
Very often indeed      
Quite often       
Not very often      
Not at all       
 
73. I can sit at ease and feel relaxed: 
Definitely       
Usually       
Not often       
Not at all       
 
74. I can enjoy a good book, radio or  
TV programme: 
Often        
           Sometimes       
           Not often       
Very seldom       
 
75. I feel lonely: 
All the time       
Often        
Sometimes       
Never        
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Section E - Some questions about your attitudes to 
exercise and health 
Please indicate how strongly you agree or disagree with each statement 
    
Please tick one box to indicate how strongly you agree or disagree with each statement 
 
 
 Strongly 
agree 
Slightly 
agree 
Unsure Slightly 
disagree 
Strongly 
disagree 
 
 
28. Doing exercise is 
satisfying and 
rewarding to me 
 
 
 
 
 
 
 
 
 
 
 
29. Doing exercise 
regularly is good for 
me 
 
 
 
 
 
 
 
 
 
 
 
30. There is little I can do 
to make up for the 
physical losses that 
come with age 
 
 
 
 
 
 
 
 
 
 
 
31. Exercising regularly 
can be helpful for my 
health 
 
 
 
 
 
 
 
 
 
 
 
32. Exercising regularly 
can help me to get out 
of doors 
 
 
 
 
 
 
 
 
 
 
 
33. Exercising regularly 
can help me to control 
my weight or to lose 
weight 
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Section F – Some questions about your belief in your 
ability to exercise 
 
How sure are you that you will do each of the following: 
 
     Very  Pretty  A little Not at all 
     Sure  Sure  Sure  Sure 
 
1 Exercise regularly          
(3 times a week for  
20 minutes)  
 
2 Exercise when you          
 are feeling tired 
 
3 Exercise when you           
are feeling under pressure 
 to get things done 
 
4 Exercise when you           
are feeling down or  
depressed 
 
5 Exercise when you           
 have too much work to do  
at home 
 
6 Exercise when there          
are other more interesting 
things to do 
 
7 Exercise when your          
family or friends do not 
 provide any support 
 
8 Exercise when you           
don’t really feel like it 
 
9 Exercise when you           
are away from home  
(e.g. visiting, on holiday) 
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Section G - Some questions about physical activity 
 
27    How many times did you take a walk outside during the last week?  
 (include walking related to other activities)     .....................................times last week 
2 How long did such a walk usually last? ………..minutes 
3 Did you take a walk that lasted longer than 1 hour during the last month? 
 
Yes   No  
 
3a If yes, how many times did you do that?  ……….times last month 
 
4 Do you have someone with whom you can go for a walk, or do other physical 
activities? 
Always    Often    Sometimes   Never    
 
5 Do you ride a bicycle? Yes   No     (please go to question 6) 
    
5a If yes, how many times did you cycle last week? …….…times 
 
5b How long on average did you cycle for each time? ..…...minutes 
  
5c How would you describe your cycling pace? 
  
 Slow   Average   Fast  
 
6 Do you go swimming? Yes     No     (please go to question 7) 
    
6a If yes, how many times did you swim last week? …….….times 
 
6b How long on average did you swim for each time?................minutes 
 
6c How would you describe your swimming speed? 
 
 Slow   Average   Fast  
 
7 Have you participated in any sporting activities in the last week? 
 
Yes   No    (if no, please go to question 8) 
 
7a    If yes, what kind of sporting activity?  ……………………………. 
 
7b   How many hours approximately, did you spend participating in sporting 
activities in the last week?  
          
            Less than 1 hour in the last month             ……… hours in the last month     
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8 How often did you perspire during physical activity in the last week? 
 
 Never        1-2 times      3-4 times       5 or more times  
 
9.  In the last 12 months (since you have been taking part in the PACE-UP trial)  
 do you think that your walking and physical activity has: 
 Decreased a lot    
 Decreased a little  
 Stayed about the same  
 Increased a little    
 Increased a lot    
 
Section H - Some questions about the money you have 
spent to do with walking and other physical activity 
 
28 In the past 3 months, did you pay for any membership fees to do with walking? 
                                    
No   (please go to question 2)    Yes          (please go to question 1a)  
1a. If yes, how much did you spend? …………………………….. 
1b. How often do you tend to pay this amount? (please circle the correct frequency below) 
        
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify……………….. 
 
 
2.  In the past 3 months, did you pay for any individual classes, entrance fees or groups 
to do with walking? (if not included in membership fees above)   
No       (please go to question 3) Yes          (please go to question 2a) 
2a. If yes, how much did you spend? …………………………….. 
2b. How often do you tend to pay this amount? (please circle the correct frequency below) 
        
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify…………….. 
 
3.  In the past 3 months, did you pay for shoes or clothing to do with walking?                               
No        (please go to question 4) Yes          (please go to question 3a) 
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Some more questions about the money you have spent to 
do with walking and other physical activity 
 
3a. If yes, how much did you spend? …………………………….. 
3b. How often do you tend to pay this amount? (please circle the correct frequency below) 
        
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify…………………….  
 
4  In the past 3 months, did you have to pay for food or drink to do with walking?                          
No        (please go to question 5) Yes           (please go to question 4a) 
                                                                         
4a. If yes, how much did you spend? …………………………….. 
4b. How often do you tend to pay this amount? (please circle the correct frequency below) 
 
 Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
 
If other, please specify………….…………….  
                                                                      
5  In the past 3 months, did you have to pay for anything else to do with walking?                         
No        (please go to question 6) Yes           (please go to question 5a) 
                                                                         
5a. If yes, what else did you have to pay for? ………………………………………….. 
5b. How much did you spend? …………………………….. 
5b. How often do you tend to pay this amount? (please circle the correct frequency below) 
   
Weekly / Monthly/ Annually / Each time / It is a one off / Don’t know / Other 
If other, please specify……. ……………………. 
6.  In the past 3 months, did you spend money on other kinds of physical activity?                        
No             Yes           (please go to question 5a) 
                                                                         
6a. If yes, what other kinds of physical activity did you spend money on? (please list all 
that apply) ……………………………………………………………….……………………………..  
 
6b.  If yes, roughly how much did you spend in total on other kinds of physical activity 
over the past 3 months? ……………………………………………………………………………. 
……………………………………………………………………………………………………………. 
 
Thank you for filling in this questionnaire. 
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study 
 
7 day physical activity questionnaire 
 __________________________________________________________ 
 
Study IDNO ____________ 
 
Please can you fill out this questionnaire just AFTER you have 
finished wearing the accelerometer for 7 days.  
 
There are 2 short sections, each asking about your physical activity 
over the 7 days when you were wearing the accelerometer.  
It will take you about 5 minutes. 
 
Please answer each question as best you can from memory, you do 
not need to look back at your diary or calculate anything. 
 
Please feel free to write comments by any question. 
 
All information will be kept confidential. 
 
 
Please enter your date of birth  ____ / ____ / _____ 
 
Please enter today’s date       ____ / ____ / _____ 
 
 
Thank you 
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Section 1: International Physical Activity Questionnaire 
 
The questions will ask you about the time you spent being physically active in the 
last 7 days. Please answer each question even if you do not consider yourself 
to be active. Please think about the activities you do at work, as part of your 
housework and gardening, to get from place to place, and in your spare time for 
recreation, exercise or sport. 
 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous 
physical activities refer to activities that take hard physical effort and make you 
breathe much harder than normal.  Think only about those physical activities that 
you did for at least 10 minutes at a time. 
 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling?  
 
_____ days per week  
 
   No vigorous physical activities  Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities 
on one of those days? 
_____ hours per day  
_____ minutes per day 
Don’t know / Not sure  
 
Think about all the moderate activities that you did in the last 7 days.  
Moderate activities refer to activities that take moderate physical effort and 
make you breathe somewhat harder than normal.  Think only about those 
physical activities that you did for at least 10 minutes at a time. 
 
 
3. During the last 7 days, on how many days did you do moderate physical 
activities like carrying light loads, bicycling at a regular pace, or doubles 
tennis?  Do not include walking. 
_____ days per week 
 
 No moderate physical activities  Skip to question 5 
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4. How much time did you usually spend doing moderate physical activities 
on one of those days? 
_____ hours per day 
_____ minutes per day 
Don’t know / Not sure  
 
 
Think about the time you spent walking in the last 7 days.  This includes at 
work and at home, walking to travel from place to place, and any other walking 
that you might do solely for recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least  
10 minutes at a time?   
_____ days per week 
  
   No walking     Skip to question 7 
 
 
6. How much time did you usually spend walking on one of those days? 
 
_____ hours per day 
_____ minutes per day 
  Don’t know / Not sure  
 
The last question is about the time you spent sitting on weekdays during the 
last 7 days.  Include time spent at work, at home, while doing course work and 
during leisure time.  This may include time spent sitting at a desk, visiting 
friends, reading, or sitting or lying down to watch television. 
 
7. During the last 7 days, how much time did you spend sitting on a week 
day? 
_____ hours per day  
_____ minutes per day 
  Don’t know / Not sure  
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Section 2: General Practice Physical Activity Questionnaire 
 
1. Please tell us about the type of physical activity involved in your work  
  Please mark 
one box only 
a I am not in employment (e.g. retired, retired for health 
reasons, unemployed, full-time carer etc) 
 
b I spend most of my time at work sitting (e.g. in an office)  
c I spend most of my time at work standing or walking. 
However, my work does not require much physical effort  
(eg. shop assistant, hair dresser, security guard, childminder) 
 
d My work involves definite physical effort including handling of 
heavy objects and use of tools (e.g plumber, electrician, 
carpenter, cleaner, hospital nurse, gardener, postal delivery 
workers etc) 
 
e My work involves vigorous physical activity including 
handling of very heavy objects e.g. scaffolder, construction 
worker, refuse collector etc.) 
 
 
2. During the last week, how many hours did you spend on each of the 
following activities? Please answer whether you are in employment or not. 
  None Some but 
less than 
1 hour 
More than 1 
but less than 
3 hours 
3 hours 
or more 
a Physical exercise such as 
swimming, jogging, aerobics, 
football, tennis, gym workout etc 
    
b Cycling, including cycling to 
work and during leisure time 
    
c Walking including walking to 
work, shopping, for pleasure etc 
    
d Housework / Childcare     
e Gardening / DIY     
 
3. How would you describe your usual walking pace? Please tick one box only. 
Slow pace  
(i.e. less than 3 mph) 
Steady average 
pace 
Brisk pace Fast pace 
(i.e.over 4 mph) 
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Explanation of patient and public involvement across the study
Patient and public involvement across the study is described in our publication of the main results,93 and is
reproduced here under the terms of the Creative Commons Attribution Licence (CC BY 4.0).
Pilot work with older primary care patients from three general practices was carried out ahead of seeking
trial funding, with focus groups at each practice discussing ideas for a pedometer-based PA intervention.
Patients were enthusiastic about the study and felt that the postal approach to recruitment and the
interventions offered would be acceptable. They had input into aspects of the study design; for example,
they encouraged us to offer participants in the usual-care arm a pedometer at the end of the follow-up
period, and they encouraged us to recruit couples as well as individuals, and to allow couples to attend
nurse appointments together.
One of the patient advisors was a TSC member, and was involved in discussions about recruitment and
study conduct, as well as advising about patient materials, the dissemination of results to participants and
safety reporting mechanisms.
The burden of the intervention was assessed by all participants in the nurse group with a questionnaire as
part of the process evaluation, and by samples of both intervention groups as part of the qualitative
evaluation of intervention participants.162
All participants were provided with timely feedback of their individual trial results after completion of the
12-month follow-up, including their PA and body size measurements over the trial duration. Summaries of
results for the whole trial were disseminated to all trial participants as A4 feedback sheets after completion
of the baseline assessments and after analysis of the main results. A trial website (www.paceup.sgul.ac.uk/)
has been created, and details have been circulated to participants. This also provides a summary of the trial
results and details about further trial follow-up. All publications relating to the trial are provided on the
website.
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Appendix 2 Results
Informed consent obtained, including access to 
primary care records for AEs and health service use data
Baseline assessment:18
•  Health and lifestyle questionnaire
•  Height, weight, waist circumference, fat mass measured
•  7-day (consecutive) hip-worn monitors from waking until sleeping
    • Accelerometer (GT3X+, Actigraph LLC) for baseline and outcome assessment
    • Pedometer (Yamax Digiwalker CW200) (to set individual step count targets)
•  After returning monitors, participants received a £10 gift voucher
Control group Postal pedometer group
Sent by post:
• a pedometer (SW-200
   Yamax-DigiWalker)
• PACE-UP handbook
   (supplementary file)
• PA diary, with 12-week walking 
   programme instructions, based 
   on their own baseline step count
   (supplementary file)
They were telephoned after 
1 week, to check arrival of 
resources
Nurse-supported group
Received at their first practice nurse
appointment:
•  a pedometer (SW-200 Yamax
    Digi-Walker)
•  PACE-UP handbook
    (supplementary file)
•  PA diary, with 12-week walking 
    programme instructions, based on 
    their own baseline step count 
    (supplementary file)
Two further nurse appointments were
offered at 1 and 2 months later
(total of three nurse appointments)
Participants were seen individually or
as couples; for couples, both individual 
goals and opportunities to increase 
PA together were discussed
Randomisation
Participants not providing ≥ 5 days of 
≥ 540 minutes daily of accelerometer data
either wore it for a further 7 days or were
excluded, prior to randomisation
Follow-up
• 3-month postal assessment (questionnaire, 7-day accelerometry)
•  12-month face-to-face assessment (questionnaire, anthropometry, 7-day accelerometry)
• 6-month and 9-month brief contacts (telephone, text or e-mail) to check safety outcomes and contact details
Recruitment from October 2012 to November 2013
Received usual care from
the practice with no
additional trial contact
FIGURE 17 Trial procedures and complex intervention components.
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FIGURE 18 Residuals from the 12-month models for steps and weekly MVPA in ≥ 10-minute bouts. (a) Steps model:
distribution of residual; (b) steps model: standardised normal probability plot; (c) weekly MVPA in ≥ 10-minute
bouts; and (d) weekly MVPA in ≥ 10-minute bouts. (continued )
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FIGURE 18 Residuals from the 12-month models for steps and weekly MVPA in ≥ 10-minute bouts. (a) Steps model:
distribution of residual; (b) steps model: standardised normal probability plot; (c) weekly MVPA in ≥ 10-minute
bouts; and (d) weekly MVPA in ≥ 10-minute bouts.
TABLE 23 The number of days with ≥ 540 minutes’ accelerometer wear time by treatment group at baseline,
3 months and 12 months
Number of
days with
≥ 540 minutes’
wear time
Time point, number of participants in each trial arm (%)
Baseline 3 months 12 months
Control
(n= 338)
Postal
delivery
(n= 339)
Nurse
support
(n= 346)
Control
(n= 318)
Postal
delivery
(n= 317)
Nurse
support
(n= 319)
Control
(n= 323)
Postal
delivery
(n= 312)
Nurse
support
(n= 321)
1 0 2 (0.6) 3 (1) 1 (0.3) 0 1 (0.3)
2 2 (0.6) 9 (3) 6 (2) 1 (0.3) 1 (0.3) 2 (0.6)
3 9 (3) 8 (3) 3 (1) 5 (2) 4 (1) 2 (0.6)
4 21 (7) 16 (5) 11 (3) 16 (5) 20 (6) 14 (4)
5 29 (9) 39 (12) 40 (12) 37 (12) 25 (8) 35 (11) 42 (13) 38 (12) 35 (11)
6 85 (25) 83 (24) 84 (24) 64 (20) 79 (25) 67 (21) 78 (24) 57 (18) 79 (25)
7 224 (66) 217 (64) 222 (64) 185 (58) 178 (56) 194 (61) 180 (56) 192 (62) 188 (59)
≥ 5 338 (100) 339 (100) 346 (100) 286 (90) 282 (89) 296 (93) 300 (93) 287 (92) 302 (94)
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TABLE 24 Summary data for main outcome and ancillary outcome variables
Outcome
Time point, mean number of participants in each trial arm (SD)
Control group Postal delivery group Nurse-support group
Baseline 3 months 12 months Baseline 3 months 12 months Baseline 3 months 12 months
Accelerometry data (n) 338 318 323 339 317 312 346 319 321
Daily step count 7379 (2696) 7327 (2688) 7246 (2671) 7402 (2476) 8086 (3014) 8010 (2922) 7653 (2826) 8707 (3206) 8131 (3228)
Total weekly minutes of MVPA in
≥ 10-minute bouts
84 (97) 87 (101) 89 (94) 92 (90) 136 (125) 129 (124) 105 (116) 164 (154) 138 (141)
Daily sedentary time (minutes) 613 (68) 614 (70) 616 (72) 614 (71) 614 (74) 617 (71) 619 (78) 613 (77) 620 (79)
Daily wear time (minutes) 789 (73) 795 (78) 791 (76) 787 (78) 798 (84) 800 (80) 797 (84) 805 (85) 807 (89)
Clinical measurements (n) 338 323 339 314 346 321
BMI (kg/m2) 27.7 (5.4) 27.5 (5.2) 28 (5.5) 27.7 (5.6) 27.6 (5.2) 27.5 (5.2)
Fat mass (kg) 26 (10.3) 25.8 (9.8) 26.8 (11.0) 26.5 (11.2) 26 (10.6) 25.6 (11.1)
Waist circumference (cm) 93.1 (14.3) 93.4 (14.7) 94.1 (13.9) 94.3 (14.1) 93.2 (13.2) 93.7 (13.4)
Questionnaire data (n) 335 316 318 335 312 311 342 310 319
HADS anxiety score 4.8 (3.3) 4.7 (3.4) 4.7 (3.4) 4.6 (3.3) 4.4 (3.3) 4.4 (3.4) 4.6 (3.6) 4.4 (3.5) 4.5 (3.9)
HADS depression score 3.9 (2.8) 2.7 (2.6) 2.6 (2.9) 3.8 (2.6) 2.4 (2.7) 2.4 (2.6) 3.9 (2.9) 2.4 (2.9) 2.6 (3.0)
EQ-5D score 0.8 (0.1) 0.8 (0.1) 0.8 (0.2) 0.9 (0.1) 0.9 (0.1) 0.8 (0.1) 0.9 (0.1) 0.8 (0.1) 0.8 (0.1)
Exercise self-efficacy score 22.3 (7.0) 20.4 (6.7) 21.0 (7.1) 22.1 (7.2) 21.4 (6.7) 21.7 (7.0) 22.0 (7.3) 22.9 (6.7) 22.4 (7.1)
Self-reported pain 0.9 (0.8) 0.9 (0.8) 1.0 (0.8) 1.0 (0.8) 1.0 (0.8) 1.0 (0.8) 0.9 (0.8) 1.0 (0.8) 1.0 (0.8)
Notes
Accelerometry data are adjusted for the day of the week and day order of wearing the accelerometer, with participant as a random effect in a multilevel model.
At baseline, data were available for all participants for accelerometry variables, BMI and waist circumference. Fat mass was available for 335, 337 and 346 participants in the control, postal
delivery and nurse-support groups, respectively. There were no clinical measurements at 3 months. At 12 months, fat mass was available in the control, postal delivery and nurse-support
groups for 319, 308 and 320 participants, respectively.
Questionnaire variables were missing for varying numbers of participants at each time point.
Full references for the HADS anxiety and depression scores, EQ-5D scores and exercise self-efficacy are given in the trial protocol.20
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TABLE 25 Physical activity measured by self-report IPAQ and GPPAQ measurements
Questionnaire
Trial arm
Control group Postal delivery group Nurse-support group
Baseline 3 months 12 months Baseline 3 months 12 months Baseline 3 months 12 months
IPAQ (N = 279) (N = 234) (N = 274) (N = 270) (N = 225) (N = 251) (N = 284) (N = 241) (N = 257)
Total weekly minutes of, mean (SD)
Vigorous and moderate activity in
≥ 10-minute bouts
194 (310) 242 (387) 237 (365) 159 (266) 191 (315) 204 (294) 167 (259) 227 (340) 214 (361)
Walking in ≥ 10-minute bouts 323 (327) 370 (336) 365 (336) 316 (326) 357 (292) 389 (320) 307 (275) 417 (308) 371 (307)
Achieved at least 150 minutes of, n (%)
Vigorous +moderate activity in
≥ 10-minute bouts
102 (37) 93 (40) 112 (41) 86 (32) 85 (38) 108 (43) 101 (36) 89 (37) 99 (39)
Achieved at least 150 minutes of
walking in ≥ 10-minute bouts
178 (64) 160 (68) 192 (70) 176 (65) 168 (75) 198 (79) 193 (68) 201 (83) 197 (77)
GPPAQ (N = 322) (N = 308) (N = 315) (N = 318) (N = 296) (N = 303) (N = 333) (N = 305) (N = 318)
Physical Activity Index, n (%)
Active 44 (14) 37 (12) 49 (16) 36 (11) 36 (12) 51 (17) 34 (10) 39 (13) 41 (13)
Including walking: active 93 (29) 94 (31) 103 (33) 79 (25) 92 (31) 101 (33) 90 (27) 102 (33) 96 (30)
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TABLE 26 Sensitivity and imputation analyses for the primary outcome (step count at 12 months)
Analysis
Participants
(N)
Comparison between trial arms
Postal delivery vs.
control
Nurse support vs.
control
Nurse support vs.
postal delivery
Effect
(95% CI) p-value
Effect
(95% CI) p-value
Effect
(95% CI) p-value
Analysis based on all participants with follow-up data
Minimum daily wear time 540 minutes
At least 5 days at
baseline and 1 day at
12 months
956 642
(329 to 955)
< 0.001 677
(365 to 989)
< 0.001 36
(–277 to 349)
0.82
At least 5 days at
baseline and 5 days at
12 months
889 607
(285 to 930)
< 0.001 732
(412 to 1051)
< 0.001 124
(–198 to 446)
0.45
Minimum daily wear time of 600 minutes
At least 5 days at
baseline and 1 day at
12 months
877 675
(352 to 997)
< 0.001 714
(392 to 1036)
< 0.001 39
(–283 to 362)
0.81
At least 5 days at
baseline and 5 days at
12 months
760 752
(411 to 1093)
< 0.001 796
(456 to 1136)
< 0.001 44
(–295 to 384)
0.80
Model adjusting for change
in wear time between
baseline and 12 months
956 579
(273 to 885)
< 0.001 637
(332 to 941)
< 0.001 58
(–248 to 363)
0.71
Analyses based on all randomised participants: missing step counts imputed for participants with no follow-up
data at 12 months
Missing at random
Imputed using treatment
group, baseline steps, sex,
age, practice, month
baseline accelerometry
1023 638
(324 to 953)
< 0.001 679
(367 to 992)
< 0.001 41
(–270 to 352)
0.80
Imputed using treatment
group, baseline steps, sex,
age, practice, month
baseline accelerometry,
NS-SEC, self-reported pain
and fat massa
1013 673
(356 to 989)
< 0.001 686
(372 to 1000)
< 0.001 13
(–303 to 330)
0.94
Missing not at random, using extreme assumptions for missing data
Control group: 12-month step count equal to baseline step count
Both intervention groups: 12-month step count changes by
–1500 steps 1023 651
(338 to 964)
< 0.001 783
(472 to 1095)
< 0.001 132
(–181 to 445)
0.41
Same as baseline step
count
1023 771
(458 to 1084)
< 0.001 892
(580 to 1204)
< 0.001 121
(–192 to 434)
0.45
+1500 steps 1023 890
(577 to 1203)
< 0.001 1000
(688 to 1312)
< 0.001 110
(–203 to 423)
0.49
a Of the 67 participants with inadequate accelerometry at 12 months, baseline data for the NS-SEC were also missing for
10 participants, and so imputed values were not available for these 10 participants when including the NS-SEC as
a predictor.
APPENDIX 2
NIHR Journals Library www.journalslibrary.nihr.ac.uk
212
Appendix 3 Economic evaluation
TABLE 27 Resource use and cost components of ‘set-up costs’
Activity (trial arm
applicable to)
Sources of data
Trial armResource use Unit cost (£)
Design
Designing of intervention Time spent by designers (diaries,
administrative records)
Salary cost (PSSRU,
administrative records)
Two intervention
arms
Designing of participants’
handbooks and diaries
Designing of nurse
trainers’ handbooks
l Time spent by designers
(diaries, administrative records)
l Number of handbooks
(administrative records)
l Salary cost (PSSRU,
administrative records)
l Price per handbook
(administrative records)
Pedometer plus
nurse group
Setting up GP practices
Planning for recruitment
of practices
Time spent by recruiters (diaries,
administrative records)
Salary cost (PSSRU,
administrative records)
All trial arms
Visits to recruit six
practices
l Time spent by recruiters
(diaries, administrative records)
l Number of round trips
to practices (administrative
records)
l Salary cost (PSSRU,
administrative records)
l Fare per round trip
(TfL tariff guide,
administrative records)
Searching practice
computers to identify
participants
Time spent by practice managers
and trial staff (diaries,
administrative records)
Salary cost (PSSRU,
administrative records)
Identify households from
anonymised address list
Time spent by trial staff (diaries,
administrative records)
Salary cost (administrative
records)
Practice staff members
review lists for exclusion
Time spent by practice staff
(administrative records)
Salary cost (PSSRU)
Printing letters at practice l Time spent by practice
administrative and trial staff
(diaries, administrative records)
l Number of printed letters
(administrative records)
l Salary cost (PSSRU,
administrative records)
l Cost per printed letter
(invoice)
Packing envelopes with
leaflets and letters
l Time spent by practice
administrative staff and trial
staff (diaries,
administrative records)
l Number of envelopes
(administrative records)
l Number of postal stamps
(administrative records)
l Number of information leaflets
(administrative records)
l Salary cost (PSSRU,
administrative records)
l Price per envelope
(administrative records)
l Price per postal stamp
(administrative records)
l Price per information
leaflets (administrative
records)
All trial arms
Preparing rooms at
practices for trial
l Time spent by trial staff
(diaries, administrative records)
l Number of office cabinets
(administrative records)
l Number of round trips to
practices (administrative
records)
l Salary cost
(administrative records)
l Price per cabinet
(administrative records)
l Fare per round trip
(TfL tariff guide)
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TABLE 27 Resource use and cost components of ‘set-up costs’ (continued )
Activity (trial arm
applicable to)
Sources of data
Trial armResource use Unit cost (£)
Training
Training of trial manager l Time spent by trainers of
internal training programme
(diaries, administrative records)
l Time spent by trial manager
(diaries, administrative records)
l Number of external courses
attended (administrative records)
l Salary cost
(administrative records)
l Course fee (administrative
records)
All trial arms
Preparation of nurse
training course
Time spent by course trainers
(diaries, administrative records)
Salary cost (administrative
records)
Pedometer plus
nurse group
Mini training day of
nurses
l Time spent by course
trainers (diaries)
l Time spent by nurses
(administrative records)
l Number of round trips
to training centres
(administrative records)
l Number of pedometers
(administrative records)
l Salary cost (PSSRU,
administrative records)
l Fare per round trip
(TfL tariff guide,
administrative records)
l Price per pedometer
(administrative records)
Full training day of nurses l Time spent by course trainers
(diaries, administrative records)
l Time spent by nurses
(administrative records)
l Number of round trips
to training centre
(administrative records)
l Number of refreshments
(administrative records)
l Salary cost (PSSRU,
administrative records)
l Fare per round trip
(TfL tariff guide,
administrative records)
l Cost of refreshment
(administrative records)
Training for an absentee
nurse
l Time spent by course trainers
(diaries, administrative records)
l Time spent by nurse
(administrative records)
l Number of round trips
to training centre
(administrative records)
l Salary cost (PSSRU,
administrative records)
l Fare per round trip
(TfL tariff guide,
administrative records)
Pedometer plus
nurse group
Discussion of nurses’
recorded sessions (nurse
group)
l Time spent by course trainers
(diaries, administrative records)
l Time spent by nurse
(administrative records)
l Duration of telephone calls
(administrative records)
l Salary cost (PSSRU,
administrative records)
l Telephone charge per
minute (BT tariff guide)
Follow-up half-day
training (nurse group)
l Time spent by course trainers
(diaries, administrative records)
l Time spent by nurse
(administrative records)
l Number of round trips
to training centre
(administrative records)
l Number of refreshments
(administrative records)
l Salary cost (PSSRU,
administrative records)
l Fare per round trip
(TfL tariff guide,
administrative records)
l Cost of refreshment
(administrative records)
Training of research
assistants (all trial arms)
l Time spent by course trainers
(diaries, administrative records)
l Time spent by research
assistants (administrative
records)
Salary cost (administrative
records)
BT, British Telecom; PSSRU, Personal Social Services Research Unit; TfL, Transport for London.
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TABLE 28 Components of the cost of delivering care and sources of data by trial arm
Components
Sources of data
Trial armResource use Unit cost (£)
Envelopes for posting
pedometers
Number used (administrative
records)
Price per envelope (invoice) Two intervention
arms
Stamps for posting
pedometers
Number used (administrative
records)
Price per stamp (invoice)
Pedometers posted to
participants (including
replacements)
Number used (administrative
records)
Price per pedometer (invoice)
Replacement batteries for
pedometer
Number used (administrative
records)
Price per battery (invoice)
Patient handbooks posted to
participants
Number given out
(administrative records)
Cost per handbook
(administrative records)
Walking plan/diary posted to
participants
Number posted (administrative
records)
Cost per walking plan
(administrative records)
Time of nurse consultation
with participants
Duration of each (n= 3)
consultation (nurse data base)
Salary cost for nurse (PSSRU
2014)103
Pedometer plus
nurse-support
arm
Time of research assistants
to arrange a consultation
appointment for participants
Time spent by three research
assistants (diary)
Salary cost (administrative
records)
Telephone calls by research
assistants to arrange a
consultation appointment
for participants
Duration of telephone calls
(administrative records)
Telephone charge per minute
[BT tariff guide (average of
landline/mobile phone)]
BT, British Telecom; PSSRU, Personal Social Services Research Unit.
TABLE 29 Health provider cost of health service use
Components
Source of data
Trial armResource use Unit cost (£)a
GP consultations Number of GP consultations
(GP data)
Cost per GP consultation
(PSSRU 2014)103
All three trial
arms
Nurse consultationsb Number of nurse consultations
(GP data)
Cost per nurse consultation
(PSSRU 2014)103
Hospital admissions Number of elective and
emergency hospital admissions
by diagnosis or procedure
(GP data)
Cost of hospital admission
[determined by type of diagnosis
and/or related procedure (NHS
Reference Costs 2014–15)]102
A&E visits Number of A&E visits (GP data) Cost per A&E admission (NHS
Reference Costs 2014–15)102
Outpatient referrals Number of outpatient visits by
department (GP data)c
Cost per outpatient visit (NHS
Reference Costs 2014–15)102
a The unit cost for hospital admissions, outpatient visits (for referrals) and A&E visits will be generated primarily from NHS
reference costs by identifying the procedures relevant to the diagnosis related (based on clinical opinion) to the use of health
care. The type of health-care use (elective or non-elective, consultant led or not) will be accounted for as appropriate.
b Nurse consultations excludes the PA consultations conducted as part of the trial.
c Based on discussion with the trial team [with input from a GPs – TH’s (principal investigator) experience], it was assumed
that each outpatient referral generates one outpatient visit.
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TABLE 30 Personal costs of participating in the interventions or control arms of the trial
Components
Source of data
Trial armResource use Unit cost
Time working out how to use
pedometer
Duration (3-month questionnaire) Wage rate of participants
(ONS 2015207)
Both intervention
arms
Time planning how to
increase walking/step count
Time filling in PACE-UP diary
Parking fees to visit nurse Number of nurse visits (nurse
database)
Parking charge per last visit
(3-month questionnaire)
Pedometer plus
nurse support
group
Time spent in consultation
with nursea
Duration of the three
consultations (nurse database)
Wage rate of participants
(ONS 2015)
Time travelling (irrespective of
mode of transport) to visit
nurseb
Duration travelling (3-month
questionnaire); number of nurse
visits (nurse database)
Transportation cost (for those
who took public transport) of
attending the nurse visit
Number of nurse visits (nurse
database)
Fare for last nurse visit
(3-month questionnaire)
Time waiting time prior to
consultation with nurse
Duration of waiting time at last
visit to nurse (3-month
questionnaire); number of nurse
visits (nurse database)
Wage rate of participants
(ONS 2015)
Child care during nurse visits Number of nurse visits (nurse
database)
Child care charge for last
nurse visit (3-month
questionnaire)
a The nurse consultations took place in weeks 0, 5 and 9.
b To avoid double-counting, data on the time spent walking to the nurse consultation are excluded.
TABLE 31 Resource use and cost components of ‘set-up cost’a
Activity
(trial arm applicable to) Resource
Total
quantity
Group, cost (£) per
participant
Nurse
support
Postal
delivery
Designb
Designing of intervention
(both intervention arms)
Professor × 1 0.5 days 4.43 4.43
Readers × 3 1 day
Senior lecturers × 3 3.5 days
Consultants × 2 1 day
Designing of participants’
handbooks and diaries
(both intervention groups)
Professor × 3 1.5 days 3.56 3.56
Readers × 2 1 day
Senior lecturers × 3 2 days
Consultants × 2 0.5 days
Designing of nurse trainers
handbooks (nurse-support
group)
Senior lecturers × 1 1 day 2.74 0.00
Consultants × 1 0.5 days
Handbooks 9 handbooks 0.19 0.00
APPENDIX 3
NIHR Journals Library www.journalslibrary.nihr.ac.uk
216
TABLE 31 Resource use and cost components of ‘set-up cost’a (continued )
Activity
(trial arm applicable to) Resource
Total
quantity
Group, cost (£) per
participant
Nurse
support
Postal
delivery
Setting up GP practices
Planning for recruitment of
practices (all trial arms)
Professor × 1 1 hour 0.99 0.99
Senior lecturer × 1 5 hours
Consultants × 2 5 hours
Visits to recruit six practices
(all trial arms)
Senior lecturers × 2 13 hours 1.47 1.47
Trial manager × 1 7 hours
Consultant × 1 5 hours
Round trips to practices (by all) 25 hours 0.10 0.10
Searching practice computers
to identify participants
(all trial arms)
Senior lecturer × 1 6 hours 0.71 0.71
Trial manager × 1 6 hours
Practice manager × 6 6 hours
Identify households from
anonymised address list
(all trial arms)
Senior lecturer × 1 32 hours 2.28 2.28
Trial manager × 1 32 hours
Practice staff reviews lists for
exclusion (all trial arms)
GP × 5 (for sorting out two practices) 20 hours 4.50 4.00
Nurse × 10 (for sorting out other five
practices)
50 hours 1.96 1.96
Printing letters at practice
(all trial arms)
Trial manager × 1 64 hours 1.57 1.57
Practice administrative staff × 2 4 hours
Number of printed letters 24,000 0.94 0.94
Packing envelopes with
leaflets and letters
(all trial arms)
Trial manager × 1 240 hours 7.04 7.04
Research assistants × 2 56 hours
Practice administration staff × 11 27.5 hours
Cost of envelopes £497.30 0.49 0.49
Cost of Postal stamps £5530.50 5.41 5.41
Cost of Information leaflets £5973.00 5.84 5.84
Preparing rooms at practices
for trial (all trial arms)
Round trip to practices by research assistant 14 trips 0.04 0.04
Research assistants × 2 –c 0.11 0.11
Training
Training of trial manager
(all trial arms)
Trial manager × 1 4 days 1.51 1.51
Senior lecturer × 1 2 days
Preparation of nurse training
course (nurse-support group)
Trial manager × 1 1 day 9.63 0.00
Senior lecturer × 1 2 days
Reader × 1 0.5 days
Consultants × 2 2 days
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TABLE 31 Resource use and cost components of ‘set-up cost’a (continued )
Activity
(trial arm applicable to) Resource
Total
quantity
Group, cost (£) per
participant
Nurse
support
Postal
delivery
Mini training day of nurses
(nurse-support group)
Nurses × 11 33 hours 7.46 0.00
Trial manager × 1 17.33 hours
Senior lecturer × 1 17.33 hours
Round trips to the training centre (by tutors) 16 hours 0.19 0.00
Pedometers given to nurses 12 hours 0.04 0.00
Full training day of nurses
(nurse-support group)
Nurses × 10 107.5 hours 22.99 0.00
Reader × 1 1 hour
Senior lecturer × 1 10 hours
Consultants × 2 22.5 hours
Round trips for training by nurses × 10 10 trips 0.12 0.00
Round trips for training by consultants × 2 2 trips 0.13 0.00
Refreshments 1 set 0.26 0.00
Training for an absentee
nurse (nurse-support group)
Nurse × 1 10 hours 2.47 0.00
Trial manager × 1 11.33 hours
Research assistant × 1 11.33 hours
Round trips to training centre 2 trips 0.02 0.00
Discussion of nurses’
recorded sessions
(nurse-support group)
Senior lecturer × 1 0.5 days 3.78 0.00
Consultants × 2 1 day
Nurses × 9 4.5 days 0.99 0.00
Senior lecturer × 1 0.5 days
Consultants × 2 1 day
Duration of telephone calls 270 minutes 0.09 0.00
Follow-up half-day training
(nurse-support group)
Nurses × 9 4.5 days 7.70 0.00
Trial manager × 1 0.5 days
Senior lecturer × 1 0.5 days
Consultants × 2 1 day
Nurse time travelling × 9 6.75 hours 0.78 0.00
Round trips to training centre (nurses) 9 trips 0.10 0.00
Refreshment 1 set 0.15 0.00
Training of research assistants
(all trial arms)
Research assistant × 3 6.6 days 1.91 1.91
Senior lecturer × 1 0.5 days
Reader × 1 0.5 days
Trial manager × 1 4 days
Total cost per participant 104.64 44.83
a Data source: interviews with the trial principal investigator and trial manager, review of trial records, diaries and routine
administrative records.
b Design was included as materials could not be used wholesale from a previous study and we judged that this may occur
in the future, following further learning from this trial.
c Value removed at present to maintain confidentiality.
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TABLE 32 Components of delivery cost of intervention (postal delivery group)
Components
Resource
(from
administrative
records)
Quantity
of resource
Unit cost (£)
(data source)
Analysis
3-month 12-month
Total
cost (£)
Cost (£) per
participant
Total
cost (£)
Cost (£) per
participant
Envelopes for
posting
pedometers
(including
replacements)
Number of
envelopes
426 0.03 (invoice) 12.78 0.04 12.78 0.04
Stamps for
posting
pedometer
Number of
stamps
426 2.50 (invoice) 1065.00 3.14 1065 3.14
Pedometers
(including
replacements)
given to
participants
Number of
pedometers
426 1/4a (invoice) 426.00 1.26 1704 5.03
Replacement
batteries for
pedometer
Number of
replacement
batteries
11 0.67 (invoice) 7.37 0.02 7.37 0.02
Patient
handbooks
Number of
handbooks
339 0.80
(administrative
records)
271 0.80 271 0.80
Step count
diary
Number of
diaries
339 1.30
(administrative
records)
440.70 1.30 440.70 1.30
Total cost (£) per participant 6.56 10.33
a £1 was the pro rata unit cost for 3 months and £4 was the pro rata unit cost for 12 months. As pedometers were
required only for the period of analysis, but could be used beyond, their costs were spread over their expected lifetime,
following Sharples et al. (2014).208 As pedometers had an expected lifetime of 2 years, the average cost of pedometer
was multiplied by 13 (intervention period in weeks)/104 [life expectancy of pedometer (in weeks) – based on experience
from the PACE-LIFT trial], in the case of the 3-month analysis and 52 out of 104 for the 12-month analysis.
TABLE 33 Components of delivery cost of intervention (nurse-support group)
Components
Resource
(data source)
Quantity
of resource
Unit cost (£)
(data source)
Analysis
3-month 12-month
Total
cost (£)
Cost (£) per
participant
Total
cost (£)
Cost (£) per
participant
Pedometers
given to
participants
Number of
pedometers
(administrative
records)
346 1/4a (invoice) 346.00 1.00 1384 4.00
Patient
handbooks
Number of
handbooks
(administrative
records)
346 0.80
(administrative
records)
277.00 1.00 277 1.00
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TABLE 34 Costs to participants of participating in interventions and PA
Intervention-related participant costs
Trial arm, mean cost (£) (SD)
Control
(N= 323)
Postal delivery
(N= 312)
Nurse support
(N= 321)
Time working out how to use pedometer 0 (0) 2 (6) 1 (3)
Time planning how to increase walking/step count 0 (0) 5 (15) 3 (4)
Time filling in the PACE-UP diary 0 (0) 51 (80) 58 (122)
Parking fees to visit nurse 0 (0) 0 (0) 0.11 (0.73)
Time spent in consultation with nurse 0 (0) 0 (0) 10 (5)
Time travelling (irrespective of mode of transport) to visit nurse 0 (0) 0 (0) 11 (10)
Transportation cost (for those who took public transport) of
attending the nurse visit
0 (0) 0 (0) 0.13 (1.33)
Time waiting time prior to consultation with nurse 0 (0) 0 (0) 3 (4)
Child care during nurse visits 0 (0) 0 (0) 0.3 (3.21)
Personal costs of participation in PA 411 (817) 492 (1293) 333 (684)
Personal costs from falls/fractures/sprains/injuries 17 (103) 22 (184) 6 (40)
TABLE 33 Components of delivery cost of intervention (nurse-support group) (continued )
Components
Resource
(data source)
Quantity
of resource
Unit cost (£)
(data source)
Analysis
3-month 12-month
Total
cost (£)
Cost (£) per
participant
Total
cost (£)
Cost (£) per
participant
Step count
diary
Number of
diaries
(administrative
records)
346 1.30
(administrative
records)
449.80 1.30 449.80 1.30
Research
assistants’ time
to arrange
consultation
Time spent by
research
assistants
(diary)
50.46 hours 16.51
(administrative
records)
833.07 2.41 833.07 2.41
Telephone calls
by research
assistants to
arrange
consultation
Duration of
telephone calls
(administrative
records)
3027.5
minutes
0.11 (BT tariff)a 333.03 0.96 333.03 0.96
Cost of nurse visit per participant (project database for nurse group) 43.00 42.00
Total cost per participant 49.67 51.67
BT, British Telecom.
a £1 was the pro rata unit cost for 3 months and £4 was the pro rata unit cost for 12 months.
APPENDIX 3
NIHR Journals Library www.journalslibrary.nihr.ac.uk
220
TABLE 35 Health service use by trial arm with unit costs
Health service use
Trial arm (quantity)
Unit cost (£),
weighted
average (Q1–Q3) Source for unit cost
Control
(N= 323)
Postal
delivery
(N= 312)
Nurse
support
(N= 321)
Outpatient referrals (total)a 164 158 186
Ophthalmology 10 18 15 86 (70–99) NHS Reference Costs
2014–15102
Urology 4 3 6 99 (76–116)
General medicine 4 0 2 157 (120–187)
ENT 9 6 12 92 (70–109)
Podiatry 9 7 7 44 (27–45)
Trauma and orthopaedics 14 13 10 113 (88–133)
Physiotherapy 26 33 37 46 (35–50)
Nephrology 0 1 0 145 (94–178)
Oral surgery 0 2 0 115 (85–142)
Gynaecology 6 7 14 134 (104–164)
Audiology 4 6 7 104 (55–174)
Colorectal surgery 1 5 1 117 (83–135)
Neurology 8 8 5 174 (136–204)
Cardiology 12 5 4 131 (92–154)
Gastroenterology 6 2 6 130 (99–153)
Rheumatology 4 6 7 135 (99–150)
Dermatology 1 8 7 98 (74–109)
General surgery 4 1 3 125 (98–165)
Endocrinology 2 1 2 144 (100–167)
Neurosurgery 2 0 0 181 (138–228)
Oncology 8 5 11 133 (97–165)
Psychotherapy 1 0 0 100 (47–217)
Respiratory medicine 4 6 3 150 (107–181)
Clinical neurophysiology 2 0 1 165 (107–197)
Programmed pulmonary
rehabilitation
0 0 1 20 (12–31)
Pain management 2 0 4 135 (82–164)
Allergy service 0 1 0 149 (126–175)
Dietetics 2 2 3 62 (38–76)
Vascular surgery 2 1 4 149 (100–176)
Mental illness 1 1 1 234 (181–256)
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TABLE 35 Health service use by trial arm with unit costs (continued )
Health service use
Trial arm (quantity)
Unit cost (£),
weighted
average (Q1–Q3) Source for unit cost
Control
(N= 323)
Postal
delivery
(N= 312)
Nurse
support
(N= 321)
Clinical genetics 1 0 1 429 (248–601)
Clinical haematology 2 1 0 160 (93–189)
Spinal surgery services 0 1 0 142 (112–164)
Maxillofacial surgery 0 0 1 111 (70–133)
Plastic surgery 1 1 1 93 (68–109)
Clinical immunology 0 1 0 215 (140–243)
Interventional radiology 1 0 0 192 (88–260)
Breast surgery 9 4 5 139 (103–166)
Tropical medicine 0 1 0 202 (203–203)
Clinical psychology 1 0 3 177 (116–245)
Old age psychiatry 0 1 2 108 (108–108)
Referral to A&E 1 0 0 135 (54–166)
Community-based referrals
(total)b
27 19 21
District nurse 1 3 2 39 (31–43) PSSRU’s Unit Costs of Health
and Social Care 2014103
Community podiatrist 4 3 8 42 (35–58) PSSRU’s Unit Costs of Health
and Social Care 2014103
Community dietitian 0 2 0 80 (53–96) NHS Reference Costs
2014–15102
Smoking cessation
(nurse-support group)
5 3 4 14 15.5 minutes’ nurse time;
PSSRU’s Unit Costs of Health
and Social Care 2014103
Healthy lifestyle
(nurse-support group)
0 2 0 14 15.5 minutes’ nurse time;
PSSRU’s Unit Costs of Health
and Social Care 2014103
Community
gynaecologist
5 1 0 134 (104–164) NHS Reference Costs
2014–15102
Community
physiotherapist
7 4 1 52 (44–58) PSSRU’s Unit Costs of Health
and Social Care 2014103
Community diabetic 1 0 0 69 (38–93) NHS Reference Costs
2014–15102
DESMOND diabetes
programme
4 0 6 230 Gillett et al. (2010)209
(inflated to 2014)
Expert patient
programme
0 1 0 302 Richardson et al. (2008)210
(inflated to 2014)
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TABLE 35 Health service use by trial arm with unit costs (continued )
Health service use
Trial arm (quantity)
Unit cost (£),
weighted
average (Q1–Q3) Source for unit cost
Control
(N= 323)
Postal
delivery
(N= 312)
Nurse
support
(N= 321)
Primary care – excludes
practice visits related to
delivery and participation in
the intervention (total)c
2074 1748 2094
GP (11.7 minutes) 1743 1436 1729 42 PSSRU’s Unit Costs of Health
and Social Care 2014103
GP nurse (15.5 minutes) 331 312 365 14 PSSRU’s Unit Costs of Health
and Social Care 2014103
A&E visitd 49 36 46 124 NHS Reference Costs
2014–15102
Non-elective hospital
admissions (total)e,f
12 4 20
Biliary acute pancreatitis 0 0 3 2037 (1247–2492) NHS Reference Costs
2014–15102
Cardiac catheterisation
for coronary artery
disease
1 0 1 2643 (1980–3028)
Chest pain 0 1 0 490 (370–563)
Abdominal pain 0 0 1 718 (922–1298)
Acute ST segment
elevation myocardial
infarction
2 0 0 1497 (1102–1740)
Transient ischaemic
attack
0 0 1 878 (643–994)
Guillain–Barré syndrome 0 0 1 1571 (1069–1792)
Pneumonia 1 0 0 1894 (1406–2238)
Epilepsy 1 0 0 1125 (788–1266)
Stroke and
cerebrovascular accident
1 0 0 2817 (2018–3396)
UTI 0 0 1 1530 (1187–1755)
Detached retina 0 0 1 908 (303–1935)
Anxiety states 0 0 1 1393 (984–1628)
Infective endocarditis 1 0 0 4480 (2351–5906)
Acute appendicitis 0 0 1 3017 (2459–3365)
IUD removed 0 0 1 1780 (1142–2135)
Ankle fracture 1 0 0 3762 (3109–4271)
No procedure (NES) 4 3 8 611 (408–726)
continued
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TABLE 35 Health service use by trial arm with unit costs (continued )
Health service use
Trial arm (quantity)
Unit cost (£),
weighted
average (Q1–Q3) Source for unit cost
Control
(N= 323)
Postal
delivery
(N= 312)
Nurse
support
(N= 321)
Elective hospital admissions
(total)e,g
10 2 3
Cardiac catheterisation 2 0 0 2086 (1185–2709) NHS Reference Costs
2014–15102
Percut translum balloon
angioplasty multicoronary
1 0 0 1813 (880–2233)
Inguinal hernia 0 1 0 2121 (1682–2392)
Coronary artery bypass
graft operations
0 1 0 9310 (7369–9929)
Laparoscopic
cholecystectomy
3 0 0 2567 (2082–2924)
Endarterectomy of
femoral artery (NEC)
0 0 2 6028 (4593–7209)
Malignant neoplasm of
female breast for
chemotherapy
1 0 0 1780 (856–2139)
Endarterectomy of
carotid artery (NEC)
1 0 0 3911 (2986–4497)
Neurophysiological
operation (NOS)
2 0 0 1497 (1111–2118)
Ovarian cancer 0 0 1 1469 (741–1966)
Total resource use (all health
service use)
2336 1967 2370
ENT, ear, nose and throat; IUD, intrauterine device; NES, not elsewhere classified; NOS, not otherwise specified; UTI, urinary
tract infection.
a Outpatient referrals: when appropriate, linked to outpatient service descriptions in the reference costs (and reviewed by
principal investigator) and weighted by average for consultant-/non-consultant-led attendances taken; referrals to private
sector excluded (n = 1).
b Community referral services: costed as referenced; if service use was unclear, a NHS hospital outpatient department was
assigned by the principal investigator.
c Primary care: GP visits – 11.7 minutes; nurse visits – 15.5 minutes.
d A&E visit: as the reason for A&E visits was not recorded, an average A&E visit cost for 2013–14 was assigned.
e Hospital admissions: the principal investigator (blind to the study group) reviewed all hospital admissions, and provided
either a ‘best guess diagnosis/procedure’ or listed ‘unknown’ (n= 2). As details on the type of procedure or severity of
the symptoms were not available, a weighted (by activity) average of all of the possible scores/procedures was used to
derive the average cost for elective.
f Emergency admissions: the unit cost is a weighted average of the non-elective short-stay and non-elective long-stay
admissions, as the length of stay was unclear.
g Hospital admissions without a procedure: treated as non-elective short-stay admissions (≤ 1 day). When the hospital admission
code was unclear, the diagnosis was reviewed by the principal investigator for advice on the nearest appropriate code.
Notes
Unit costs are rounded to the nearest whole number and presented in the 2013–14 price year. The health service use
presented in this table refers to the base-case sample. All of the data are based on participant-specific GP records for the
trial period with different assumptions and approaches for costing by type of service use.
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FIGURE 20 Cost-effectiveness acceptability curve showing the probability of within-trial cost-effectiveness for nurse
support vs. postal delivery at different willingness-to-pay threshold levels.
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FIGURE 19 Cost-effectiveness plane for nurse support vs. postal delivery at 12 months.
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TABLE 36 Within-trial sensitivity analyses (at 12 months)
Parameter
Comparison by trial arm, mean (95% CI)
Postal delivery vs. control Nurse support vs. control Nurse support vs. postal delivery
Incremental
cost (£) Incremental QALY ICER
Incremental
cost (£) Incremental QALY ICER
Incremental
cost (£) Incremental QALY ICER
Base case –91
(–215 to 33)
–0.0043
(–0.0172 to 0.0087)
Less costly, but
less effective
than control
126
(–37 to 290)
–0.0066 (–0.0201
to 0.0068)
Intervention
dominated
by control
217
(8 to 354)
–0.0024
(–0.0156 to 0.0109)
Nurse support
dominated by
postal delivery
Whole sample
(all randomised)
–40
(–169 to –89)
–0.0070
(–0.0195 to 0.0054)
Less costly, but
less effective
than control
150
(–6 to 306)
–0.0093
(–0.0222 to 0.0036)
Intervention
dominated
by control
190
(48 to 332)
–0.0023
(–0.0148 to 0.0102)
Nurse support
dominated by
postal delivery
Health service use,
including only GP data
on referrals and
admissions
–55
(–166 to –56)
–0.0043
(–0.0172 to 0.0087)
Less costly, but
less effective
than control
129
(–17 to 275)
–0.0066
(–0.020 to 0.0068)
Intervention
dominated
by control
184
(61 to 307)
–0.0024
(–0.0156 to 0.0109)
Nurse support
dominated by
postal delivery
Health service use,
including only self-
reported serious
adverse effects
21
(–65 to 107)
–0.0043
(–0.0172 to 0.0087)
Intervention
dominated by
control
144
(65 to 224)
–0.0066
(–0.020 to 0.0068)
Intervention
dominated
by control
123
(47 to 200)
–0.0024
(–0.0156 to 0.0109)
Nurse support
dominated by
postal delivery
Health service use,
including only GP data
on adverse effects
–11
(–107 to 85)
–0.0043
(–0.0172 to 0.0087)
Less costly, but
less effective
than control
64
(–15 to 142)
–0.0066
(–0.020 to 0.0068)
Intervention
dominated
by control
74
(13 to 135)
–0.0024
(–0.0156 to 0.0109)
Nurse support
dominated by
postal delivery
Excluding all health
service use costs
55.2
(55 to 55.4)
–0.0043
(–0.0172 to 0.0087)
Intervention
dominated by
control
156.2
(–154 to 158)
–0.0066
(–0.0201 to 0.0068)
Intervention
dominated
by control
101
(99 to 103)
–0.0024
(–0.0156 to 0.0109)
Nurse support
dominated by
postal delivery
Changing cost
perspective (both
participant – all
participant costs – and
NHS costs)
36
(–177 to 250)
–0.0043
(–0.0172 to 0.0087)
Intervention
dominated by
control
107
(–97 to 311)
–0.0066
(–0.020 to 0.0068)
Intervention
dominated
by control
71
(–150 to 291)
–0.0024
(–0.0156 to 0.0109)
Nurse support
dominated by
postal delivery
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Parameter
Comparison by trial arm, mean (95% CI)
Postal delivery vs. control Nurse support vs. control Nurse support vs. postal delivery
Incremental
cost (£) Incremental QALY ICER
Incremental
cost (£) Incremental QALY ICER
Incremental
cost (£) Incremental QALY ICER
Changing cost
perspective [both
participant (part; this
excludes time costs of
working out how to use
pedometer, diary and
planning to increase
work) and NHS costs]
–22
(–235 to 191)
–0.0043
(–0.0172 to 0.0087)
Less costly, but
less effective
than control
47
(–157 to 250)
–0.0066
(–0.020 to 0.0068)
Intervention
dominated
by control
69
(–152 to 289)
–0.0024
(–0.0156 to 0.0109)
Nurse support
dominated by
postal delivery
Combination of
excluding all health
service use cost and
including all participant
costs (minus health
service use cost borne
by participants)
179
(–1 to 361)
–0.0043
(–0.0172 to 0.0087)
Intervention
dominated by
control
153
(24 to 281)
–0.0066
(–0.020 to 0.0068)
Intervention
dominated
by control
–27
(–203 to 149)
–0.0024
(–0.0156 to 0.0109)
Less costly but
less effective
than control
Pedometer lasts for
1 year (equivalent to
pedometers not being
reusable and the full
cost of pedometer
borne in year 1)
–86
(–210 to 38)
–0.0043
(–0.0172 to 0.0087)
Less costly, but
less effective
than control
130
(–33 to 294)
–0.0066
(–0.0201 to 0.0068)
Intervention
dominated
by control
216
(80 to 353)
–0.0024
(–0.0156 to 0.0109)
Nurse support
dominated by
postal delivery
Pedometer lasts for
4 years (double length
of life considered in
the base case)
–93
(–218 to 31)
–0.0043
(–0.0172 to 0.0087)
Less costly, but
less effective
than control
124
(–39 to 287)
–0.0066
(–0.0201 to 0.0068)
Intervention
dominated
by control
218
(81 to 354)
–0.0024
(–0.0156 to 0.0109)
Nurse support
dominated by
postal delivery
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Summary of methods of the economic model by Anokye, Lord
and Fox-Rushby130
Anokye et al.130 developed a Markov model to follow a cohort of physically inactive but healthy adults over
their remaining lifetime. To see the impact of an intervention on costs and effects, the model is run twice –
once with the intervention and once without the intervention, as a control. The model adopted a NHS
perspective, based costs in 2010–11 prices (£) and used a 3.5% discount rate.
For the intervention, a cohort of 100,000 people aged 33 years (the average age of people in trials of brief
interventions designed to increase PA) are ‘run in’ for 1 year, with the proportion of people becoming
active in each arm reflecting evidence on effectiveness [i.e. achieving a minimum of 150 minutes of at least
moderately intensive PA or at least 75 minutes of vigorously intensive PA per week (current guidance of
sufficient PA)].
The model represented the most robustly evidenced risk reductions achievable from PA (i.e. in CHD, stroke
and type 2 diabetes mellitus). Those people who are physically active at the end of the ‘run in’ period went
on to have a longer life expectancy and better quality of life as a result of risk reductions. The model assumed
that no one developed disease during the run-in period, although deaths from other causes could occur.
From the beginning of year 1 (cycle 2), each person in each cycle could be in one of six states: (1) event
free (no CHD, stroke or type 2 diabetes mellitus), (2) non-fatal CHD, (3) non-fatal stroke, (4) type 2
diabetes mellitus, (5) death related to CVD and (6) death from non-CVD causes, each of which had
defined annual risks of moving to another state. Data on the RRs (Relative Risks) of developing each
disease condition were estimated from epidemiological studies measuring baseline PA (exposure) and
related to subsequent onset of CHD, stroke or type 2 diabetes mellitus (outcomes) over a 10-year period.
Although PA can change over time, this was not explicitly modelled, as the impact of changing habits is
captured in the cohort RR estimates. Three Finnish studies211–213 followed up people who were either
inactive or active for a number of years, and found that the relationship between activity and outcomes
somewhat diluted as people moved in and out of PA over time.
The model assumed that a proportion of CHD and stroke events were immediately fatal, whereas this
was not the case for a diagnosis of type 2 diabetes mellitus, although all of those surviving either a
CVD-related event or diagnosis with type 2 diabetes mellitus faced increased CVD-related and non-CVD-related
mortality risks. For simplicity, the model assumed that individuals experienced only one type of disease (although
they could face multiple events within this disease).
Estimates of lifetime costs and QALYs were derived from the model through weighting time spent in each
health state for different parts of the cohort by annual costs and utility values associated with each state.
To these, we added the costs of intervention delivery and a short-term (1-year) gain in QALYs, through
mental health improvement, arising from participation in PA (see Pavey et al.132 for estimation).
Data to populate the model were derived from a variety of sources:
1. effectiveness and cost of brief advice (to increase PA) delivered in primary care – from systematic
literature review and meta-analysis
2. cost and utility estimates of disease conditions – economic evaluations conducted for existing guidelines
for CVD and diabetes mellitus, and science-based guidelines on PA and health; rates of disease were
converted to probabilities214
3. relative risks of each disease for physically active people and inactive people were based on cohorts that
were followed up for 19 (CHD, stroke) and 12 (diabetes mellitus) years;211,212,215 RRs were assumed to
hold for 10 years, in the base case, after which no benefit was derived
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4. probabilities for developing disease conditions in inactive people were derived by adjusting the UK
general population age-specific incidence rates216–218 using the attributable risk fraction;219 probabilities
for active people used the RR data211,212,215
5. the probability that a primary stroke or CHD event was fatal216 was assumed to be independent of PA,
as a result of a lack of data
6. probability of CVD and non-CVD mortality – RRs of stroke and CHD220 and type 2 diabetes mellitus216
mortality among people with stroke, CHD or type 2 diabetes mellitus were used to adjust age-specific
probabilities for ‘healthy people’, as represented in UK interim life tables.
Deterministic sensitivity analyses explored the effectiveness of the intervention, the health impacts of PA, the
starting age of the cohort, the discount rate and costs. Uncertainties around all parameters in the model
(except for baseline mortality) were addressed simultaneously using PSA (with 10,000 Monte Carlo
simulations).
The main results concluded that additional QALYs through brief advice could be bought at an average
cost of £1730 for a cohort of 100,000 people from the age of 33 years over their remaining lifetime.
Conclusions that this was a ‘good buy’ only changed when the assumption of short-term QALYs gained
was dropped, when the cost-effectiveness ratio fell to £27,000 per QALY. Further details can be seen in
Anokye et al.130
TABLE 37 Parameter values for the long-term cost-effectiveness model
Parameter Value (95% CI) Source of data
RRs of
Becoming active (at year 1) This study (PACE-UP)
Postal delivery vs. control 1.8 (1.4 to 2.3)
Nurse support vs. control 1.7 (1.3 to 2.2)
Nurse support vs. postal delivery 0.9 (0.7 to 1.3)
Disease (active vs. inactive)
CHD 0.90 Hu et al. (2003)211
Stroke 0.86 Hu et al. (2005)212
Diabetes mellitus 0.67 Hu et al. (2007)213
Non-CVD-related mortality after:
Non-fatal CHD 1.71 Brønnum-Hansen et al. (2001)220
Non-fatal stroke 1.71
Diabetes mellitus 1.49 Pries et al. (2009)221
CVD-related mortality after:
Non-fatal CHD 3.89 Brønnum-Hansen et al. (2001)
Non-fatal stroke 3.89
Diabetes mellitus 2.61 Pries et al. (2009)221
continued
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TABLE 37 Parameter values for the long-term cost-effectiveness model (continued )
Parameter Value (95% CI) Source of data
Fatality cases (%)
CHD
59–64 11.55 Ward et al. (2005)222
65–74 21.07
≥ 75 14.76
Stroke
55–64 23.28 Ward et al. (2005)222
65–74 23.47
≥ 75 23.42
Incidence rates for (%)
CHD
59–64 0.63 Ward et al. (2005); National Clinical Guideline
Centre (2011)223
65–74 0.97
≥ 75 0.97
Stroke
59–64 0.29
65–74 0.69
≥ 75 1.43
Diabetes mellitus
59 0.06 Gonzalez et al. (2009)224
60–69 0.10
70–79 0.11
≥ 80 0.11
Quality of life
Age-specific quality of life
59–64 0.82 Health Survey for England (2011)225
65–74 0.78
≥ 75 0.72
Health state utility weight
Healthy 1.00 Ward et al. (2005); National Clinical Guideline
Centre (2011)222,223
CHD (first event) 0.80
Post CHD (first event) 0.92
Stroke (first event) 0.63
Post stroke (first event) 0.65
Diabetes mellitus 0.90
Short-term psychological benefit of achieving
150 minutes of MVPA per week
0.01 This study (PACE-UP)
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TABLE 37 Parameter values for the long-term cost-effectiveness model (continued )
Parameter Value (95% CI) Source of data
Annual cost (£)
Control 467 (365 to 569) This study (PACE-UP)
Post 376 (307 to 445)
Nurse 593 (473 to 714)
CHD (first event) 4248 National Clinical Guideline Centre (2011)223
Post CHD (first event) 485
Stroke (first event) 10,968
Post stroke (first event) 2409
Diabetes mellitus 979
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FIGURE 21 Cost-effectiveness acceptability curve showing the probability of lifetime cost-effectiveness for the
nurse support group compared with the postal delivery group at different willingness-to-pay threshold levels.
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Appendix 4 Generalisability
Adapted from Normansell et al.148 This article is distributed under the terms of the Creative CommonsAttribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits
unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes
were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Telephone interview schedule for non-participants
Introduction:
Clarify purpose of interview, gain verbal consent and confirm anonymity and confidentiality.
Opening questions:
1. What did you think of the information that we originally sent you about the PACE-UP study?
2. Can you tell me a bit more about what influenced your decision not to take part in the study?
3. Did you discuss participating in research with anyone else?
Reasons for not participating:
Using the completed questionnaire, explore the reasons already given, including:
1. I do not have time
2. I cannot/am not interested in increasing my physical activity
3. I am already very physically active
4. I am not interested in research
5. I do not want to be put in a group by chance.
Additional possible reasons for not-participating:
Offer a number of other predefined reasons for non-participation and explore further any positive responses:
1. Lack of time.
2. Unable or nor interested in increasing PA.
3. Already active.
4. Not interested in research.
5. Do not want to be put in a group by chance.
6. Length of programme.
7. Travel difficulties.
8. Wearing a physical activity monitor.
9. Unpleasant/unsafe walking environment.
10. Programme is not relevant to you.
11. Programme is not for your age group.
12. Programme would clash with work/being away from home.
13. Medical problems prevent participation.
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Trial design questions:
1. Venue.
2. Exercise type.
3. Group activity.
4. Anything else that would have facilitated participation?
End:
Summary and invite any final comments.
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Non-participant health and physical activity survey
 study 
 
Health and physical activity survey 
 __________________________________________________________ 
 
Study IDNO ____________ 
 
Although you have decided not to take part in our research project, it would be very 
helpful if you could answer the questions below. We will then be able to see what 
sort of people did NOT take part and why not. This could help us to improve our 
research in future to make it suitable to a wider range of people. You do not have 
to answer any questions if you prefer not to. 
 
Thank you for filling in this questionnaire.  
It will take you about 5 to 10 minutes. 
 
 
Please feel free to write comments by any question. 
 
All information will be kept confidential. 
 
 
Please enter your date of birth  ____ / ____ / _____ 
 
Please enter today’s date        ____ / ____ / _____ 
 
Thank you 
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Section A - Some general questions about your health 
 
Please put a tick in the box next to the most appropriate answer for each 
question.  
 
 
How is your health in general?  
 
Very good  
Good    
Fair    
Poor    
Very poor   
 
Are your day-to-day activities limited because of a health problem or disability       
     which has lasted, or is expected to last, at least 12 months?  
     Include problems related to old age.  
 
Yes, limited a lot  
 
Yes, limited a little  
 
No  
 
 
3   Approximately how tall are you?......................................................... 
 
 
4   Approximately how much do you weigh?........................................... 
 
 
5  Do you currently smoke? 
Yes  No  
 
6     During the last 3 months did you talk to a doctor or nurse at your general practice    
       on your own behalf, either in person or by telephone? 
 
Yes   No    (If no, please go to section B) 
 
6a   If yes, approximately how many times did this happen in the last 3 months? 
 
 Once    Twice    Three times Four or more times   
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Section B - specific questions about your health 
 
Have you ever been told by a doctor or nurse that you have any of these conditions? 
 (Please tick all that apply to you)          
YES  
  
Angina ………………………………..……..     
A heart attack ………………….…..….…..    
Other heart problems………..…..…..……..    
Stroke…………………………….…..………    
High blood pressure…………….….……….      
Chronic bronchitis…………………..…..……    
Asthma ……………………….…..……..……    
Diabetes……………………………..…..……    
Arthritis ………….…..…..…………………….    
 Cancer (apart from skin cancer)  ..………..    
 Depression…….…..………………………..     
 Parkinson’s Disease….……………..………  
  
 
13 Can you see well enough to recognise a friend across a road? 
Yes, without glasses                  Yes, with glasses                        No    
 
14 Do you have any problems with your balance? 
Yes    No   
 
15 How many times have you fallen over in the last year ? 
None    
Once or twice  
Three times or more                
  Not sure  
 
16 How many different medications do you take every day? 
None      One         Two          Three          Four or more  
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Section C - Questions about your health today 
 
Under each heading, please tick the ONE box that best describes your health TODAY 
 
1   Mobility 
I have no problems in walking about                                                        
I have slight problems in walking about      
I have moderate problems in walking about      
I have severe problems in walking about      
I am unable to walk about        
2 Self-care 
I have no problems with self-care                                                              
I have slight problems washing or dressing myself                                   
I have moderate problems washing or dressing myself                            
I have severe problems washing or dressing myself                                
I am unable to wash or dress myself                                                        
3 Usual activities (e.g. work, study, housework, family or leisure) 
I have no problems doing my usual activities  
I have slight problems doing my usual activities
I have moderate problems doing my usual activities
I have severe problems doing my usual activities
I am unable to do my usual activities
4 Pain / discomfort 
I have no pain or discomfort 
I have slight pain or discomfort 
I have moderate pain or discomfort 
I have severe pain or discomfort 
I have extreme pain or discomfort 
5 Anxiety / depression 
 
I am not anxious or depressed 
I am slightly anxious or depressed 
I am moderately anxious or depressed  
I am severely anxious or depressed  
I am extremely anxious or depressed  
APPENDIX 4
NIHR Journals Library www.journalslibrary.nihr.ac.uk
238
Section D - Some questions about physical activity 
1    Please tell us about the type of physical activity involved in your work (Please tick one 
box only) 
a) I am not in employment (e.g. retired, retired for health reasons,         
unemployed, full-time carer etc) 
 
b) I spend most of my time at work sitting (e.g. in an office)   
 
c) I spend most of my time at work standing or walking.     
However, my work does not require much physical effort  
(e.g. shop assistant, hair-dresser, security guard). 
 
d) My work involves definite physical effort including handling    
of heavy objects & tools (e.g. plumber, electrician, carpenter,  
cleaner, hospital nurse, gardener, postal delivery workers etc). 
 
e) My work involves vigorous physical activity including handling    
of very heavy objects e.g. scaffolder, construction worker,  
refuse collector etc.) 
 
2   During the last week, how many hours did you spend on each of the following activities?   
Please answer whether you are in employment or not 
  None Some but 
less than 
1 hour  
More than 1 
but less than
3 hours
3 hours 
or more 
a Physical exercise such as swimming, 
jogging, aerobics, football, tennis, 
gym workout etc 
 
    
b Cycling, including cycling to work and 
during leisure time 
    
c Walking including walking to work, 
shopping, for pleasure etc 
    
d Housework / Childcare     
e Gardening / DIY     
3    How would you describe your usual walking pace? Please tick one only. 
Slow pace (i.e less 
than 3 mph)  
Steady average 
pace 
Brisk pace   Fast pace (i.e. over 
4 mph)  
    
 
4 Do you have someone with whom you can go for a walk, or do other physical 
activities? 
Always Often Sometimes Never 
   
DOI: 10.3310/hta22370 HEALTH TECHNOLOGY ASSESSMENT 2018 VOL. 22 NO. 37
© Queen’s Printer and Controller of HMSO 2018. This work was produced by Harris et al. under the terms of a commissioning contract issued by the Secretary of State for Health
and Social Care. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional
journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising. Applications for commercial reproduction should
be addressed to: NIHR Journals Library, National Institute for Health Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science
Park, Southampton SO16 7NS, UK.
239
Section E – Some questions about why you do not want  
to take part in this physical activity trial 
I do not want to take part in this physical activity trial because: 
 (Please tick one box on each line)  
       Yes 
 
1  I do not have time                
2 I cannot increase my physical activity                    
3  I am not interested in increasing my                               
physical activity 
4 I am already very physically active                             
5 I am not interested in research                                  
6 I do not want to be put in a group by chance     
 
The following reasons are important to me for not wanting to take part in the trial: 
…………………………………………………………………………………………………….….. 
 
………………………………………………………………………………………………………... 
Could we contact you sometime in the next 3 months to arrange an interview to ask you 
in more detail about your reasons for not wanting to take part in the trial? 
Yes, you can contact me     No, you cannot contact me    
If yes please provide contact details below: 
Home Tel................................... Mobile…………………………  Email…………………………. 
No Not sure
Section F- Some questions about your attitudes to exercise 
and health 
Please tick one box to indicate how strongly you agree or disagree with each statement 
 Strongly 
agree 
Slightly 
agree 
Unsure Slightly 
disagree 
Strongly 
disagree 
1. Exercising regularly can be 
helpful for my health 
 
 
 
 
 
 
 
 
 
 
 
2. Doing exercise is satisfying 
and rewarding to me 
 
 
 
 
 
 
 
 
 
 
 
3. There is little I can do to make 
up for the physical losses that 
come with age 
 
 
 
 
 
 
 
 
 
 
4. Exercising regularly can help 
me to control my weight or to 
lose weight 
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Section G – Finally, some questions about you & your 
living circumstances  
 
1     What is your current marital status? 
   Married (or living with someone as a couple)   
Widowed   
Divorced or separated   
Single   
Other   
If other, please describe……………………………………… 
2 How many people in your household, including yourself, are there 
Aged under 18 …………………  Aged 18-64…………………….. 
 
Aged 65 or over………………… 
 
3 At what age did you finish your continuous full-time education at school, college 
or university? 
 14 or under     15   
16      17   
18      19 or over  
 
4 What is your employment status? 
 In full time employment        
In part time employment        
Seeking work         
Looking after home or family       
Retired          
Student          
Not working due to long-term sickness or disability    
Other  (please describe)      ……………………………    
  
5 Do you, or the people you live with, own or rent your own home? 
Own (with or without a mortgage)   
   
Rent from council or housing association     
Rent privately         
Other, please describe…………………………………     
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10 What is your ethnic group?  
Choose one section from A to E, then tick  one box to best describe your ethnic 
group or background. 
A   White groups B   Mixed /multiple ethnic 
  English / Welsh / Scottish/ Northern Irish / British  White and Black Caribbean 
  Irish  White and Black African             
  Gypsy or Irish Traveller  White and Asian 
  Any other White background, write in  …………      Any other Mixed /multiple ethnic 
    …………………………………………….. background, write in  
……………………….  
   
C   Asian / Asian British Caribbean /             D  Black / African / 
Black British   
    Indian                               Pakistani           African 
    Bangladeshi         Caribbean    
    Chinese Caribbean       Any other Black / African / 
background, write in   
 
    Any other Asian background, write in ………  
 ……………………….………………………………
……………………….………………………………
 
  
  
 
E    Other ethnic group   
    Arab 
    Any other ethnic group, write in ………………… 
       ……………………………………………………… 
Please write below any other comments you have on 
your health or this questionnaire 
 
 
 
 
 
 
 
 
 
 
Thank you for filling in this questionnaire, please 
return it in the freepost envelope 
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Appendix 5 Process evaluation
TABLE 38 Implementation process: training delivered to nurses
Training event
Time spent in minutes Total, time
spent in
minutesPA guidance Trial protocols Safety reporting BCT
Pre-trial visit 20 30 0 0 50
Pre-trial reading 20 10 10 20 60
Nurse reflection 15 0 0 15 30
Training day –
13 September 2012
10 40 30 250 330
Training half-day –
18 January 2013
0 60 10 95 165
Training half-day –
21 May 2013
10 40 10 60 120
Training half-day –
24 September 2013
10 60 10 95 175
BCT trainer individual
feedback
0 0 0 30 30
Total time
(minutes)
85 240 70 565 960
Total time
(hours and minutes)
1 hour
25 minutes
4 hours
0 minutes
1 hour
10 minutes
9 hours
25 minutes
16 hours
TABLE 39 Fidelity: content delivered in nurse intervention group sessions in accordance with nurse checklists
Fidelity item
Session
1 2 3
Attended session, n/N (%) 330/346 (95) 296/346 (86) 263/346 (76)
Mean number of items completed (range) 11 (10–11) 6 (5–6) 6 (5–6)
Participant reported that they had used pedometer
and diary ‘every day’ or ‘sometimes’, n/N (%)
285/296 (96) 258/263 (98)
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TABLE 41 Pedometer use from questionnaire data
Used pedometer during the 12-week
intervention
Trial arm, n (%)
Postal delivery group
(N= 294)
Nurse-support group
(N= 303)
Every day or most days 238 (81) 269 (89)
A few days or occasionally 44 (15) 30 (10)
Never 12 (4) 4 (1)
TABLE 42 Duration of sessions
Session
Nurse self-report Audio-recording
Number of
Participants
Mean
time in
minutes
(SD)
Range
(minutes)
Median
time in
minutes
(IQR)
Number of
Participants
Mean
time in
minutes
(SD)
Range
(minutes)
Median
time in
minutes
(IQR)
1 320 30 (4) 10–55 25 (20–30) 10 21 (6) 12–29 22 (15–26)
2 211 24 (3) 7.5–45 20 (15–25) 7 21 (7) 10–29 23 (17–24)
3 256 22 (4) 5–60 20 (15–25) 5 14 (5) 9–21 12 (10–16)
IQR, interquartile range.
Notes
Fifty-eight participants attended as 29 couples and their consultation times have been halved for comparison with individual
consultation times.
Six participants attended as three couples (all in session 1) and their consultation times have been halved for comparison
with individual consultation times. Their consultation durations were 27 minutes, 44 minutes and 57 minutes
(mean 43 minutes).
TABLE 40 Nurse-support and postal intervention group PA diary return and use
Diary return and use
Trial arm, n (%)
Postal delivery group
(N= 339)
Nurse-support group
(N= 346)
Number of diaries returned 268 (79) 281 (81)
Targets altered 4 (1) 89 (32)
Target increased 0 (0) 9 (3)
Target decreased 4 (1) 80 (29)
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Nurse and patient alliance questionnaires
Consultaon Experience – Paent Form      Paent no………………….. 
 Instructions:  Here are some statements about your Physical Acvity Consultations with the nurse.  
For each statement, please circle the number that matches your own experience. 
 
 
Strongly 
disagree Disagree 
Neither 
agree nor 
disagree Agree 
Strongly 
agree 
1. My physical acvity nurse and I 
worked together on seng goals that 
were important to me 
1  2 3 4 5 
2. The diﬃcules that prevented me 
from increasing my physical acvity 
were too great to overcome 
1  2 3 4 5 
3. I felt heard, understood and 
respected by my physical acvity 
nurse 
1  2 3 4 5 
4. In our meengs together, we 
discussed everything I wanted to 
discuss 
1  2 3 4 5 
5. I understand how to make lasng 
changes in my acvity levels 1  2 3 4 5 
6. The approach taken by my physical 
acvity nurse suited me 1  2 3 4 5 
7. I feel able to keep up the physical 
acvity changes I have already made 1  2 3 4 5 
8. I feel conﬁdent now that I can 
connue to make posive changes in 
physical acvity without the nurse  
1  2 3 4 5 
9. I feel conﬁdent about overcoming 
obstacles to increasing my acvity 
levels in future 
1  2 3 4 5 
10. The pedometer I used in the 
PACE-UP study was helpful to me 1  2 3 4 5 
11. The diary I used in the PACE-UP 
study was helpful to me 1 2 3 4 5 
 Far 
too many Too many Just right Too few 
Far 
too few 
12. The number of appointments 
with the physical acvity nurse was 1  2 3 4 5 
 
Any other comments? 
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Consultaon Experience – Nurse Quesonnaire            Paent no…………… 
 
Instructions:  For each of the following statements, please circle the number that matches your own   
                              experience of meengs with the paent 
 
 
Strongly 
disagree Disagree 
Neither 
agree nor 
disagree Agree 
Strongly 
agree 
1. The paent and I worked together 
on seng goals that were important 
to the paent 
1  2 3 4 5 
2. The diﬃcules that prevented the 
paent from increasing their physical 
acvity were too great to overcome 
1  2 3 4 5 
3. The paent felt heard, understood 
and respected  1  2 3 4 5 
4. In our meengs together, the 
paent discussed everything they 
wanted to discuss 
1  2 3 4 5 
5. The paent understands how to 
make lasng changes in acvity levels 1  2 3 4 5 
6. The approach to making change 
suited the paent 1  2 3 4 5 
7. The paent feels able to keep up 
the physical activity changes they 
have already made 
1  2 3 4 5 
8. The paent feels conﬁdent to 
connue to make posive changes in 
physical acvity on their own 
1  2 3 4 5 
9. The paent feels conﬁdent about 
overcoming obstacles to increasing 
acvity levels in future 
1  2 3 4 5 
10. The pedometer used in the PACE-
UP study was helpful to the paent 1  2 3 4 5 
11. The diary used in the PACE-UP 
trial was helpful to the paent 1 2 3 4 5 
 Far 
too many Too many Just right Too few 
Far 
too few 
12. The number of appointments 
with the physical acvity nurse was 1  2 3 4 5 
 
Any other comments? 
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Consultaon Experience – Nurse Quesonnaire Extra Quesons
 
Paent no……………   and   Paent no……………   
How many sessions did they aend together?     ………… sessions 
 
Instructions: For each of the following statements, please circle the number that matches your own 
experience of meengs with the couple 
 
 
Strongly 
disagree Disagree 
Neither 
agree nor 
disagree Agree 
Strongly 
agree 
Seeing them together was helpful 
for them both 1  2 3 4 5 
Seeing them together made the 
consultation more diﬃcult for me 1  2 3 4 5 
Seeing them together helped with 
their movaon 1  2 3 4 5 
Seeing them together made it more 
diﬃcult for them to set individual 
targets if they needed to 
1  2 3 4 5 
Seeing them together was an 
eﬃcient use of me 1  2 3 4 5 
 
 
Any other comments about seeing them together as a couple? 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 for Couples 
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Nurse session checklists
 – Checklist for nurses  
Session One: First Steps        
 Date………………..........            Nurse inials …………                Paent IDNO…………………. 
Seen as individual or couple  ............................................ 
Content of session (20-30 minutes) Page(s) in 
paent 
handbook or 
diary 
Completed? 
1. Health beneﬁts and personal beneﬁts of increasing walking. Handbook P 3  
2. Oponal paent handout on advantages and disadvantages. Handout  
3. How much physical acvity should adults and older adults do? Handbook P 4  
4. What is moderate intensity physical acvity, how does it relate to 
step-count? 
Handbook P 4  
5. Aims of the PACE-UP programme, seng goals relang to paent’s 
baseline steps, reviewing their baseline step-count. 
Handbook P 5  
6. Tailoring the programme, are the PACE-UP goals appropriate? Would 
they like to go slower or faster? 
Handbook P 5  
7. How to safely increase walking. Handbook P 6  
8. Teach use of pedometer. Diary P 2  
9. Recording walks and daily steps in the PACE-UP diary. Diary P 3  
10. Ideas to increase walking & daily step-count. Diary P 4 & 6  
11. Oponal discussion & paent handout on rewards for making change. Handout  
12. Final check: Summarise what has been agreed and check paent 
understanding. 
  
13. Plan date / me for next meeng 4 weeks and contact details. 
Remind paent to bring pedometer and diary. 
 
  
 
Date /me of next meeng............................................ 
 
Approximately how long did the session take? .................................. minutes 
 
Any other comments / reminders for next meeng. 
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 – Checklist for nurses  
Session Two: Connuing the Changes 
Date………………..........            Nurse inials …………                Paent IDNO…………………. 
Seen as individual or couple  ............................................    
Content of session (20 Minutes) Page(s) in 
paent 
handbook or 
diary 
Completed? 
1. Review step-count and walking goals in paent diary. Diary P 3,5,7,9  
2. Encourage progress in increasing walking and achieving step-count 
goals 
  
3. Troubleshoot any problems with pedometer or diary.   
4. Review target and agree goals for next month Handbook P5 
(or diary 
11,13,15,17) 
 
5. Oponal paent handout on barriers and facilitators to increasing 
physical acvity 
Handout  
6. Oponal paent handout on pacing and avoiding boom and bust Handout  
7. Oponal paent handout on building conﬁdence to change Handout  
8. Final check: Summarise what has been agreed and check paent 
understanding 
  
9. Arrange date / me for next meeng. 
Remind paent to bring pedometer and diary. 
  
Date /me of next meeng............................................ 
Approximately how long did the session take? .................................. minutes 
 
Did the paent use the pedometer and diary?   
Everyday   Somemes   Not at all  
Comment ....................................................................................................... 
Did the paent achieve their step-count goal?   
Yes   No    
Comment ....................................................................................................... 
 
Any other comments / reminders for next meeng. 
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 – Checklist for nurses  
Session Three: Building lasng habits   
Date………………..........            Nurse inials …………                Paent IDNO…………………. 
Seen as individual or couple  ............................................                                         
Content of session (20 Minutes) Page(s) in paent 
handbook or diary 
Completed? 
1. Review step-count and walking goals in paent diary Diary 11,13,15,17  
2. Review overall progress over the sessions Diary 3-17  
3. Encourage progress in increasing walking and achieving 
step-count goals  
  
4. Troubleshoot any problems with pedometer or diary   
5. Oponal paent handout on barriers and facilitators to increasing 
physical acvity 
Handout  
6. Oponal paent handout on pacing and avoiding boom and bust Handout  
7. Oponal paent handout on preparing for setbacks Handout  
8. Oponal handout on building lasng habits Handout  
9. Seng goals: maintaining current acvity or increasing further? Handbook P5 or 
Diary P19 
 
10. Remind the paent about PACE-UP trial follow-up (research 
assistant to contact in 3-4 weeks) 
  
 
Approximately how long did the session take? .................................. minutes 
 
Since the last session, did the paent use the pedometer and diary?   
Everyday   Somemes   Not at all  
Comment ....................................................................................................... 
 
Did the paent achieve their step-count goal?   
Yes   No    
Comment ....................................................................................................... 
 
 
Any other comments 
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 IDNO................................                        Date of birth .................................................. 
  Pedometer use in last 12 months – usual physical acvity group 
You have been in the usual physical acvity group in the PACE-UP trial.  We have not 
yet given you a pedometer for you to use to monitor your step-count. We know that 
some people may already have a pedometer. We are interested to ﬁnd out how many 
people in PACE-UP this applies to.  
1. Had you used a pedometer (step-counter) before the trial started?   
Yes    No  
2. Have you obtained a pedometer in the last 12 months? 
Yes    No  
3. Did you use a pedometer during the last 12 months? 
Yes    (please go to Queson 4)  No   (please turn over) 
 
4. If yes, how oen did you use a pedometer during the last 12 months? 
Every day or most days of the week       
At least once a week         
At least once a month         
Less than once per month        
If you have worn a pedometer, can you give us some details about when and 
why you wear it?..................................………………………………………………………….. 
……………………………………………………………………………………………………………………………
…………………………………………………………………………………………………………… P.T.O. 
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If there are any other comments that you would like to make about wearing or using a 
pedometer, please write them here.  
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
............................................................................................................................  
 
 
Thank you for taking part in the PACE-UP trial. When we receive your accelerometer 
back, we will be sending you a pedometer to keep, along with feedback on your 
physical acvity levels from the accelerometer that you have worn. 
APPENDIX 5
NIHR Journals Library www.journalslibrary.nihr.ac.uk
252
 IDNO................................                         Date of birth .................................................. 
   Pedometer use in last 12 months – pedometer by post group 
You were posted out a pedometer and a 12-week diary to use about 12 months ago by 
the researcher. We are interested in how oen you have used the pedometer over 
the past year and whether you have found it helpful. 
1. Had you used a pedometer before the trial started? 
Yes    No   
 
2. For the 12 week period of the diary: 
How oen did you wear the pedometer?   
Every day or most days for the 12 weeks      
At least a few days each week for the 12 weeks     
Occasionally           
Never            
 
3. For the last 9 months, since the diary ﬁnished: 
How oen did you wear the pedometer?   
Every day or most days of the week       
At least once a week         
At least once a month         
Less than once per month        
Never            
If you have worn the pedometer since you stopped using the diary, can you give us 
some details about when and why you wear it? 
………………………………………………………………………………………………………………………………… 
...............................................................................................................................    P.T.O 
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4. Please indicate how strongly you agree or disagree with each statement by 
cking one of the boxes  
    Strongly    Slightly   Unsure Slightly        Strongly 
          Agree    Agree   Disagree      Disagree 
The pedometer is helpful                                                                                   
for monitoring physical                                                                                                                   
acvity     
 
The pedometer is easy                                                                                        
to use         
 
Using the pedometer can                                                                                    
help you to increase your                                                                                                             
walking 
 
The pedometer is diﬃcult                                                                                  
to wear with some clothes 
 
I would recommend a                                                                                         
pedometer to others who                                                                                                        
are trying to walk more                                                                                
If there are any other posive or negave comments that you would like to make 
about wearing or using the pedometer, please write them here.  
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................
...........................................................................................................................................  
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 IDNO................................                         Date of birth .................................................. 
   Pedometer use in last 12 months – physical acvity nurse group 
You were given a pedometer and a 12-week diary to use about 12 months ago by your 
physical acvity nurse. We are interested in how oen you have used the pedometer 
over the past year and whether or not you have found it helpful. 
5. Had you used a pedometer before the trial started? 
Yes    No   
 
6. For the 12 week period of the diary and while you were in contact with the nurse: 
How oen did you wear the pedometer?   
Every day or most days for the 12 weeks      
At least a few days each week for the 12 weeks     
Occasionally           
Never            
 
7. For the last 9 months, since you have stopped seeing the physical acvity nurse: 
How oen did you wear the pedometer?   
Every day or most days of the week       
At least once per week         
At least once a month         
Less than once per month        
Never            
If you have worn the pedometer since you stopped seeing the nurse, can you give us 
some details about when and why you wear it? 
………………………………………………………………………………………………………………………………… 
........................................................................................ .......................................    P.T.O 
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8. Please indicate how strongly you agree or disagree with each statement by cking 
one of the boxes  
    Strongly    Slightly   Unsure Slightly        Strongly 
          Agree    Agree   Disagree      Disagree 
The pedometer is helpful                                                                                                              
for monitoring physical                                                                                                                   
acvity     
 
The pedometer is easy                                                                                                                   
to use         
 
Using the pedometer can                                                                                                              
help you to increase your                                                                                                             
walking 
 
The pedometer is diﬃcult                                                                                                             
to wear with some clothes 
 
I would recommend a                                                                                                                    
pedometer to others who                                                                                                               
are trying to walk more                                                                             
If there are any other posive or negave comments that you would like to make about 
wearing or using the pedometer, please write them here.  
................................................................................................................................................
................................................................................................................................................
................................................................................................................................................
...........................................................................................................................  
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Appendix 6 Qualitative evaluation
Initial thoughts for nurse focus group: interview schedule
Introductions
Introduce ourselves. Explain one will lead while the other takes notes, just in case the recording fails, etc.
The main point of this session is to find out what it was like to be involved in this study and to help patients to
increase their physical activity using this particular method and this schedule of visits. It’s important that you
tell us what it was like, warts and all – so that we can let the team know what went well and what could have
been better both for you and for your study patients. It’s also important that we have all of your views – so if
you disagree with what someone has said, then make sure we hear your perspective too. Hopefully, it will be
a discussion between all of you, with us just throwing in a few questions to keep things going. OK?
Anonymity and confidentiality. Now say we won’t use their names if we extract something they said for a
paper – also, nobody but us will know who said what, and it won’t be passed on to other members of the team.
Tell them we’re turning on the recorders.
Ask the nurses to introduce themselves for the recording.
PTO (please turn over) for the schedule itself.
The schedule
First of all, the training:
1. What stood out most for you from the actual training sessions?
i. What specific parts of the training do you recall as being particularly useful? (Challenge if they say
‘all of it!’ – must be precise).
ii. Was anything less useful or could be improved?
iii. Would you have liked anything more in the way of training or materials?
iv. What do you feel about the number of training sessions? (too many/not enough/about right?)
v. What did you feel about the balance of the training sessions between communication/behaviour
change techniques and practical trial aspects (physical activity guidelines/using pedometers/
handbooks/reporting adverse events etc.).
2. Did your physical activity consulting change as a result of the training or from being involved in the trial?
i. If so, how? If not, why not?
ii. Have any other aspects of your work changed?
Moving on to the nurse handbook and patient handbook and diary.
3. What was it like using the handbook/diary? (remind the nurses about the handbook/diary by showing it
to them – have one copy to look at together, or else it will turn into individual silent reading sessions).
i. How did you find using it?
ii. How did the patients find it? What were the best bits? Which bits caused most difficulty? How did
you get round this?
iii. How could the handbook be improved?
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And now the pedometer and setting targets.
4. What about using the pedometer?
i. How easy was it to explain to people how to use it?
ii. How common were difficulties with the pedometer? What kind of difficulties did people have?
iii. Were most people happy to wear the pedometer while coming to see you & keep a step-count record?
iv. Were targets that we had suggested realistic for most people? Did a lot of people change their
targets? If people changed them did they tend to set higher or lower targets?
Patient engagement.
5. How acceptable did patients find the intervention?
i. Were any patients more responsive to the PA intervention than others?
– What were the characteristics of someone who really ‘went for it’?
– What about the characteristics of someone who really didn’t get on with it?
– Did anyone say anything to you that hinted at why they didn’t like it?
– Did you have experience of working with couples in the trial? How did you find this? What were
the positive aspects? And the negative?
The trial protocol.
6. How about the trial protocol – the schedule for seeing patients (3 visits a month apart, first visit
approximately 30 minutes, others approximately 20 minutes).
i. Was it possible to do what was required of you in the time prescribed?
ii. Were there enough sessions/too many?
iii. Did most patients actually get the 3 visits at the right time? How did it vary between patients?
iv. Did you have problems with non-attenders? How did you manage this?
v. If things went wrong, how easy was it for you to get help/support from the study team?
vi. How did you feel about having some of your sessions recorded? Was recording them or receiving
feedback on the sessions helpful?
7. Some of you are also involved in NHS health checks at your practices, do you see this intervention as
something that could be useful for those identified in health checks as needing to increase their
physical activity levels?
i. If yes, how could this work? If no, why not?
8. From the nurse perspective, if we were to do the trial again with different practices, or try to put the
intervention into your routine practice . . .
i. What would be the main things to keep?
ii. The main things to change?
9. And from the patients’ perspective, as far as you can tell . . .
i. What would be the main things to keep?
ii. The main things to change?
10. Anything else that you think we have missed / that you want to tell us?
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TABLE 43 Interview participant details
ID Sex Self-reported ethnicity Group Age (years)
Change in average steps
per day from baseline to
12 months
1 Female Any other white background Nurse 48 +1697
2 Male White British Nurse 45 +113
3 Male White British Pedometer 53 +3708
4 Male Bangladeshi Pedometer 52 –234
5 Female White British Pedometer 57 +1718
6 Female White British Pedometer 51 –2141
7 Female White British Pedometer 60 –1808
8 Female White British Pedometer 65 –1781
9 Female Black Caribbean Pedometer 69 +243
10 Male Black African Nurse 64 –1920
11 Male White British Pedometer 70 +1543
12 Female White and black Caribbean Nurse 66 +1211
13 Female White British Pedometer 66 –446
14 Female Any other white background Nurse 49 +4756
15 Female Any other white background Nurse 49 –1097
16 Female White British Nurse 47 +1573
17 Female Any other white background Pedometer 66 –1027
18 Female White British Nurse 62 –2836
19 Female White British Pedometer 66 –1797
20 Male White British Nurse 52 +3924
21 Female Black African Nurse 47 +2962
22 Male White British Nurse 63 –2652
23 Female White British Pedometer 64 +226
24 Female Any other white background Pedometer 50 +1031
25 Male White British Pedometer 67 –955
26 Female White British Nurse 65 –2013
27 Male White and Asian Pedometer 61 –611
28 Female Chinese Nurse 72 +4062
29 Male White British Nurse 59 –493
30 Female White British Nurse 51 +3269
31 Male White British Pedometer 59 –756
32 Female White British Nurse 63 +1966
33 Female White British Nurse 49 –746
34 Female Black Caribbean Pedometer 73 +403
35 Female White British Nurse 64 +2100
continued
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TABLE 43 Interview participant details (continued )
ID Sex Self-reported ethnicity Group Age (years)
Change in average steps
per day from baseline to
12 months
36 Female White British Pedometer 64 +1639
37 Female Indian Pedometer 51 –1720
38 Female White British Pedometer 59 +539
39 Female White British Nurse 61 –1425
40 Male White British Nurse 48 –3826
41 Male White British Nurse 65 –43
42 Male White British Pedometer 72 –2133
43 Female White British Pedometer 48 +2253
ID, identifier.
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Appendix 7 Three-year follow-up
Qualitative interview schedule: intervention group 3-year follow-up
Introduction:
1. Introduce self, explain you are calling from PACE-UP trial, confirm the name of the person.
2. Remind of initial consent to be approached for an interview in the 3-year follow-up consent letter.
3. Explain this is a telephone interview to discuss in a bit more detail their physical activity experiences
since being involved in the trial. It should take no more than 20–25 minutes but explain that if they
have lots of things they would like to feedback, then you have more time.
4. If participant happy to continue, thank them for their participation.
5. Explain that you would like to record the interview with their permission.
(Start recorder)
1. Explain you are now going to say their participant number for the benefit of the tape and ask them just
to verbally confirm again that they happy to be interviewed and for a recording to be made.
2. Explain that everything they say will be kept confidential and any comments they make will be linked to
an anonymous number rather than a name.
3. Explain that if the participant wants to stop the interview at any time it’s not a problem at all and to
just let the interviewer know.
Main questions:
1. Can you tell me about what physical activity you did last week? Was that a typical week for you?
2. Do you think taking part in the PACE-UP trial has changed the physical activity you are doing now?
3. Is there anything about the PACE-UP trial that you particularly remember? i.e. take home message.
4. Do still you use the pedometer, diary or handbook given to you after the PACE-UP trial? If so, how
often do you use them? If no, do you use anything else? i.e. phone, Fitbit.
5. What normally motivates you to be physically active? Is that different to how it was before you
participated in PACE-UP?
6. Would you recommend the PACE-UP trial to family and friends?
7. Are there any additional resources or support that you could suggest that might help to keep you
physically active? i.e. family, friends, text messages, online resources, annual visit to nurse, walking
groups . . .
Closing:
That was all the questions I had for you, is there anything else you would like to add or think I’ve missed?
Thank you for taking the time out to answer our questions, as a token of our thanks we will be sending a
£10 high-street voucher to you within the next week.
Prompts
Pedometer use
l In what way do you think the pedometer influences your physical activity?
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Barriers to being physically active
l Are there any barriers or difficulties you’ve had to overcome when it comes to physical activity?
Motivation
l Do you set yourself any physical activity targets/goals? If yes, prompt more.
l Do you adopt any strategies to help you stay motivated to be physically active? If yes, prompt more.
Peer/social support and physical activity
l Under question 5 if not discussed.
Qualitative interview schedule: control group 3-year follow-up
Introduction:
1. Introduce self, explain you are calling from PACE-UP trial, confirm the name of the person.
2. Remind of initial consent to be approached for an interview in the 3 year follow-up consent letter.
3. Explain this is a telephone interview to discuss in a bit more detail their physical activity experiences
since being involved in the trial. It should take no more than 20–25 minutes but explain that if they
have lots of things they would like to feedback, then you have more time.
4. If participant happy to continue, thank them for their participation.
5. Explain that you would like to record the interview with their permission.
(Start recorder)
1. Explain you are now going to say their participant number for the benefit of the tape and ask them just
to verbally confirm again that they happy to be interviewed and for a recording to be made.
2. Explain that everything they say will be kept confidential and any comments they make will be linked to
an anonymous number rather than a name.
3. Explain that if the participant wants to stop the interview at any time it’s not a problem at all and to
just let the interviewer know.
Main questions:
1. Can you tell me about what physical activity you did last week? Was that a typical week for you?
2. Do you think taking part in the PACE-UP trial has changed the physical activity you are doing now?
3. Is there anything about the PACE-UP trial that you particularly remember? i.e. take home message.
4. What normally motivates you to be physically active? Is that different from how it was before you
participated in PACE-UP?
5. As a participant in the study you will have received a pedometer, diary and handbook after the main
trial was over. Did you find these resources helpful? Have you continued to use any of these resources?
Do you use anything else? i.e. phone, Fitbit . . .
6. Would you recommend the PACE-UP trial to family and friends?
7. Are there any additional resources or support that you could suggest that might help to keep you
physically active?’ i.e. family, friends, text messages, online resources, annual visit to nurse, walking
groups . . .
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Closing:
That was all the questions I had for you, is there anything else you would like to add or think I’ve missed?
Thank you for taking the time out to answer our questions, as a token of our thanks we will be sending a
£10 high-street voucher to you within the next week.
Prompt sheet
Pedometer use
l In what way do you think using a pedometer influences your physical activity?
Barriers to being physically active
l Are there any barriers or difficulties you’ve had to overcome when it comes to physical activity?
Motivation
l Do you set yourself any physical activity targets/goals? If yes, prompt more.
l Do you adopt any strategies to help you stay motivated to be physically active? If yes, prompt more.
Peer/social support and physical activity
l Under question 5 if not discussed.
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Three-year health and lifestyle questionnaire
+3 
Health and lifestyle survey 
 __________________________________________________________ 
 
Study IDNO ____________ 
 
 
Thank you for filling in this questionnaire.  
 
It will take you about 10-15 minutes to complete. 
 
Please feel free to write comments by any question. 
 
All information will be kept strictly confidential. 
 
 
 
Please enter your date of birth  ____ / ____ / _____ 
 
Please enter today’s date              ____ / ____ / _____ 
 
Thank you 
   
 
 
 
    
 
   
This project was funded by the Naonal Instute for Health Research Health Technology Assessment Programme (HTA) - 
Project number 10/32/02 
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Section A - Some general questions about your health 
 
Please put a tick in the box next to the most appropriate answer 
for each question.  
 
 
 
1 How is your health in general?  
 
Very good     
Good      
Fair      
Poor      
Very poor     
 
 
2  How much physical or bodily pain have you had in the past 4 weeks? 
 
None          
Very mild or mild         
Moderate          
Severe or very severe    
 
 
 
3  What is your current weight? 
 
  ________________________kg   
 
 
or  ___________stones and __________pounds 
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Section B - Questions about your health today 
Under each heading, please tick the ONE box that best describes your health TODAY 
 
1   Mobility 
I have no problems in walking about       
I have slight problems in walking about      
I have moderate problems in walking about      
I have severe problems in walking about      
I am unable to walk about        
2 Self-care 
I have no problems with self-care       
I have slight problems washing or dressing myself     
I have moderate problems washing or dressing myself    
I have severe problems washing or dressing myself    
I am unable to wash or dress myself       
3 Usual activities (e.g. work, study, housework, family or leisure) 
I have no problems doing my usual activities     
I have slight problems doing my usual activities     
I have moderate problems doing my usual activities    
I have severe problems doing my usual activities     
I am unable to do my usual activities       
4 Pain / discomfort 
I have no pain or discomfort        
I have slight pain or discomfort       
I have moderate pain or discomfort       
I have severe pain or discomfort       
I have extreme pain or discomfort       
5 Anxiety / depression 
I am not anxious or depressed       
I am slightly anxious or depressed       
I am moderately anxious or depressed      
I am severely anxious or depressed       
I am extremely anxious or depressed      
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Section C - Some questions on how you feel 
Please tick the reply that comes closest to how you have been feeling over the past 
week. Don’t take too long: your immediate reaction will probably be most accurate. 
Tick only one box for each question 
 
1. I feel tense or ‘wound up’: 
Most of the time      A lot of the time   
From time to time      Not at all    
 
2. I feel as if I am slowed down: 
Nearly all of the time      Very often    
Sometimes       Not at all    
 
3. I still enjoy things I used to: 
Definitely as much      Not quite as much   
Only a little       Hardly at all    
 
4. I get a sort of frightened feeling like butterflies in the stomach: 
Not at all       Occasionally    
Quite often       Very often    
 
5. I get a sort of frightened feeling as if something bad is about to happen: 
Very definitely       Yes, but not too badly   
A little, but it doesn’t worry me    Not at all    
 
6. I have lost interest in my appearance: 
Definitely     I don’t take so much care as I should   
I might not take as much care  I take just as much care    
 
7. I can laugh and see the funny side of things: 
As much as I always could     Not quite so much now  
Definitely not so much now     Not at all    
 
8. I feel restless, as if I have to be on the move 
Very much indeed      Quite a lot    
Not very much       Not at all    
 
9. Worrying thoughts go through my mind: 
A great deal of the time     A lot of the time   
From time to time, not too often    Only occasionally   
 
10. I look forward with enjoyment to things: 
As much as I ever did     Rather less than I used to  
Definitely less than I used to    Hardly at all  
 
11. I feel cheerful: 
Not at all       Not often    
Sometimes       Most of the time   
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12. I get sudden feelings of panic 
Very often indeed      Quite often   
Not very often       Not at all   
 
13. I can sit at ease and feel relaxed: 
Definitely       Usually   
Not often       Not at all   
 
14. I can enjoy a good book, radio or TV programme: 
Often                   Sometimes   
           Not often       Very seldom   
 
15. I feel lonely: 
All the time       Often    
Sometimes       Never    
 
 Section D – Some questions about your belief in your 
ability to exercise  
 
 
How sure are you that you will do each of the following: 
 
      Very  Pretty  A little  Not 
      Sure  Sure  Sure  Sure 
 
1. Exercise regularly (3 times weekly for 20 mins)        
 
2.   Exercise when you are feeling tired         
  
3.   Exercise when you are under pressure        
 
4.  Exercise when you are feeling down          
 
5.  Exercise when you have too much work         
  
6.  Exercise when there are more interesting        
     things to do 
 
7.  Exercise when family or friends do not        
     provide any support 
 
8.  Exercise when you don’t really feel like it        
 
9.  Exercise when you are away from home        
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Section E - Some questions on falls, injuries & illnesses 
 
These questions ask about any falls, injuries or illnesses that you may have had in the 
last 12 months. 
 
In the last 12 months have you had any of the following: 
 
1 A fall?     Yes    No   
1a If yes, how many times?      ….……….... times in the last 12 months 
 
2 Any fractures (broken bones)?  Yes    No   
2a If yes, please give details of what bones were injured  
…………………………………………………………………………………… 
…………………………………………………………………………………… 
 
3 Any sprains or injuries?   Yes    No   
3a If yes, please give details of the sprain or injury  
…………………………………………………………………………………… 
 
6     Have you attended an Accident and Emergency department?  Yes       No         
 
If yes, please give details of what this was for and when……………………………... 
  
.......................................................................................................................................... 
    
.......................................................................................................................................... 
 
5 Have you been admitted to hospital?       Yes      No          
 
If yes, please give details of what this was for and when.…………………………… 
......................................................................................................................................... 
 
.......................................................................................................................................... 
 
.......................................................................................................................................... 
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Section F - Some questions about physical activity 
1   How many times did you take a walk outside during the last week?  
 (include walking related to other activities)   ............................times last week 
2 How long did such a walk usually last? ………..minutes 
3 Did you take a walk lasting longer than 1 hour during the last month?
Yes   No  
3a If yes, how many times did you do that?  ……….times last month 
 
4        Do you have someone to go for a walk, or do other physical activities 
with? 
Always    Often    Sometimes   Never  
  
5 Do you ride a bicycle? Yes   No   (please go to Qu. 6) 
    
5a If yes, how many times did you cycle last week? …….…times 
 
5b How long on average did you cycle for each time? ..…...minutes 
  
6 Do you go swimming? Yes     No     (please go to Qu.7)  
    
6a If yes, how many times did you swim last week? …….….times 
 
6b How long on average did you swim for each time?................minutes 
7 Do you have a garden or allotment?    Yes   No  
7a If yes, how many hours, on average, a week do you spend gardening? 
 In summer .............................hours In winter ...........................hours 
8 Have you participated in any sporting activities in the last week? 
Yes    No    (if no, please go to Qu. 9) 
8a    If yes, what kind of sporting activity?  …………………………….................. 
 
8b   How many hours approximately, did you spend participating in 
            Less than 1 hour in the last week             ……… hours in the last week  
sporting activities in the last week?  
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9 Do you have a hobby? (other than gardening or sports)? 
Yes    No    (if no, please go to Qu.10) 
9a If yes, what kind of hobby?  
.................................................................................................................... 
9b How many hours a week approximately do you spend on it? 
       Less than 1 hour in the last week          ……… hours in the last week     
10 Do you do odd jobs around the house yourself (e.g. painting and 
 
 Yes    No    (if no, please go to question 11) 
 If yes, for how many hours a week? ..............................hours weekly 
11  Do you do light housework, such as dusting and washing dishes? 
 Yes    No    (if no, please go to question 12) 
 If yes, for how many hours a week? ..............................hours weekly 
12  Do you do heavy housework, such as vacuuming, scrubbing floors?  
 Yes    No    (if no, please go to question 13) 
 If yes, for how many hours a week? ..............................hours weekly 
13    Did you use a pedometer during the last 12 months? 
Yes    (please go to Qu. 14)  No   (please go to Qu. 15) 
14    If yes, how often did you use a pedometer during the last 12 months? 
All the time        
About once a week       
About once a month      
Less frequently than once per month    
15     Have you used any other device to measure or monitor your physical  
 activity in the last 12 months?  
Smart Phone        
Wrist worn device (e.g. fitbit, jawbone, axivity)   
Waist worn device       
Clip on device       
Other-Please specify below     
None         
…………………………………………………………………………………… 
  
carpentry)?
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16. Have you had any significant life events in the last 12 months that you 
think may have affected your physical activity levels? (Some examples are 
family bereavement, retirement, moved house, new long-term illness or disability, new 
grandchild).  
If yes, please give details of what has happened and how it has affected 
your physical activity. 
…………………………………………………………………………………............ 
…………………………………………………………………………………............ 
………………………………………………………………………………................ 
 
Thank you for filling in this questionnaire 
APPENDIX 7
NIHR Journals Library www.journalslibrary.nihr.ac.uk
272
Appendix 8 Discussion
What is the potential benefit of our intervention on coronary heart
disease and all-cause mortality?
Several systematic reviews have assessed the health benefits of walking based on pooling data from cohort
studies. Typically, the RRs are 0.8 in people who are physically more active compared with those who are
much less active. The difficulty of interpreting such analyses is their focus on comparing two extreme groups:
the physically active versus those who are inactive. Zheng et al.197 recognised the importance of studying the
functional form of the dose–response effect of walking on the risk of developing CHD. They concluded that
the risk of developing CHD decreases as the amount of brisk walking increases.197 Specifically, Zheng et al.197
concluded that 150 minutes of brisk walking per week reduces the incidence of CHD by 19% (a RR of 0.81,
95% CI 0.77 to 0.86); RR estimates were similar in both sexes and in older and younger subjects. From this,
we can estimate (see below*) that the increase of 33 minutes per week in the postal delivery group in our
study at 12 months would be expected to reduce the participants’ risk of developing CHD by 4.5% (95% CI
3.3% to 5.6%) if sustained. In a prospective study assessing the benefits of walking in a free-living population
sample,198 it was found that a higher daily step count measured by pedometer was linearly associated with
reductions in all-cause mortality. Using the same method (see below**) we estimate that the 643 step increase
in our postal delivery group would result in a 4% (95% CI 1% to 7%) decrease in mortality.
*From the paper by Zheng et al.,197 we can take the fact that log (risk) increases linearly with minutes of
MVPA and that increasing MVPA per week by 150 minutes reduces the risk by 19% (a RR of 0.81), to
estimate that increasing MVPA by 33 minutes per week would result in a RR of 0.81(33/150) = 0.810.22
(95% CI 0.770.22 to 0.860.22) = 0.955 (95% CI 0.944 to 0.967). That is a 4.5% (95% CI 3% to 6%) reduction
in the risk of developing CHD.
**From the paper by Dwyer et al.,198 the adjusted hazard ratio for all-cause mortality associated with
an additional 1000 steps was 0.94 (95% CI 0.90 to 0.98). Using the same approach as above,
an increase of 642 steps is estimated to reduce the risk by 0.94(642/1000) = 0.94(.642) (95% CI 0.90(.642) to
0.98(.642)) = 0.96 (95% CI 0.93 to 0.99). That is a 4% (95% CI 1% to 7%) reduction in all-cause mortality.
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